Sidney Kimmel Comprehensive Cancer Center Comprehensive Bibliography (2023-01-01

Sidney Kimmel Comprehensive Cancer Center Comprehensive Bibliography (2023-01-01 - Present) [Just Cancer Related]

PUBLICATION
+ 1.	Agarwal A, Pinto J, Renslo B, Bar-Ad V[MORA], Taleei R, Luginbuhl A[TaCO]. Feasibility of collagen matrix tiles with cesium-131 brachytherapy for use in the treatment of head and neck cancer. Brachytherapy. 2023; 22(1):120-124. ( Abstract )	01/01/2023
¶ 2.	Bakouny Z, Labaki C, Grover P, . . . Bashir B[IRT], . . . Rivera AV, . . . Shyr Y, Choueiri TK, Wise-Draper TM, COVID-19 and Cancer Consortium. Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19. JAMA Oncol. 2023 Jan 01; 9(1):128-134. ( Abstract )	01/01/2023
+ 3.	Bashir B[IRT], Mueller AC[MORA]. Pancreatic Adenocarcinoma: An Evolving Yet Unimpressive Treatment Landscape. JCO Oncol Pract. 2023 Jan; 19(1):33-34. ( Abstract )	01/01/2023
¶ 4.	Brandwein-Weber M, Urken ML, Topf MC, Lewis JS, Kang SY, Curry JM[MORA], Chai R, Khan M, Modica I, Chung D, Rosenthal EL. Radical shift in the communication paradigm in head and neck frozen section analysis: Intraoperative three-dimensional specimen scanning. Head Neck. 2023 Jan; 45(1):7-9. ( Abstract )	01/01/2023
¶ 5.	Chandramouly G, Jamsen J, Borisonnik N, Tyagi M, Calbert ML, Tredinnick T, Ozdemir AY, Kent T, Demidova EV, Arora S, Wilson SH, Pomerantz RT[MORA]. Polλ promotes microhomology-mediated end-joining. Nat Struct Mol Biol. 2023 Jan; 30(1):107-114. ( Abstract )	01/01/2023
¶ * 6.	Chervoneva I[CRiC], Peck AR, Sun Y, Yi M, Udhane SS, Langenheim JF, Girondo MA, Jorns JM, Chaudhary LN, Kamaraju S, Bergom C, Flister MJ, Hooke JA, Kovatich AJ, Shriver CD, Hu H, Palazzo JP, Bibbo M, Hyslop T[CRiC], Nevalainen MT, Pestell RG, Fuchs SY, Mitchell EP[CRiC], Rui H. High PD-L2 Predicts Early Recurrence of ER-Positive Breast Cancer. JCO Precis Oncol. 2023 Jan; 7:e2100498. ( Abstract )	01/01/2023
7.	Cowan JM, Juric M, Petrie RJ[TaCO]. Culturing and Imaging Glioma Stem Cells in 3D Collagen Matrices. Curr Protoc. 2023 Jan; 3(1):e643. ( Abstract )	01/01/2023
+ 8.	Elliott Z, Parsel S, Swendseid B, Xiao KB, Sagheer SH, Curry JM[MORA], Rabinowitz M, Nyquist G, Rosen MR, Evans J, Farrell CJ, Luginbuhl AJ[TaCO]. Nasopharyngectomy Without Maxillary Swing via a Combined Open Lateral and Endoscopic Approach. Laryngoscope. 2023 Jan; 133(1):105-108. ( Abstract )	01/01/2023
* 9.	Foecke Munden E, Kemp M, Guth A, Chang AM, Worster B[CRiC], Olarewaju I, Denton M, Rising KL[CRiC]. Patient-Important Needs and Goals Related to Nutrition Interventions during Cancer Treatment. Nutr Cancer. 2023; 75(4):1143-1150. ( Abstract )	01/01/2023
* 10.	Forman EM[CRiC], Berry MP, Butryn ML[CRiC], Hagerman CJ, Huang Z, Juarascio AS, LaFata EM, Ontañón S, Tilford JM, Zhang F. Using artificial intelligence to optimize delivery of weight loss treatment: Protocol for an efficacy and cost-effectiveness trial. Contemp Clin Trials. 2023 Jan; 124:107029. ( Abstract )	01/01/2023
11.	Gleason L, Nikbakht N[IRT]. Prognostic Relevance of Dominant Blood T-Cell Clones in Early Mycosis Fungoides. JAMA Dermatol. 2023 Jan 01; 159(1):116. ( Abstract )	01/01/2023
¶ 12.	Herzog TJ, Vergote I, Gomella LG[MORA], Milenkova T, French T, Tonikian R, Poehlein C, Hussain M. Testing for homologous recombination repair or homologous recombination deficiency for poly (ADP-ribose) polymerase inhibitors: A current perspective. Eur J Cancer. 2023 Jan; 179:136-146. ( Abstract )	01/01/2023
¶ 13.	Hobday S, Armache M, Paquin R, Nurimba M, Baddour K, Linder D, Kouame G, Tharrington S, Albergotti WG, Mady LJ[CRiC]. The Body Mass Index Paradox in Head and Neck Cancer: A Systematic Review and Meta-Analysis. Nutr Cancer. 2023; 75(1):48-60. ( Abstract )	01/01/2023
¶ * 14.	Lombardo J, Schmucker AM, Keith SW, Ronghe A, Smith A, Ali AS, Niazi M, Denton M, Swartz K, Chapman A[CRiC], Simone NL[CRiC]. Markers and associations of nutrition identified in a senior adult oncology clinic. J Geriatr Oncol. 2023 Jan; 14(1):101388. ( Abstract )	01/01/2023
¶ 15.	Mei M, Pillai R, Kim S, Estrada-Merly N, Afkhami M, Yang L, Meng Z, Abid MB, Aljurf M, Bacher U, Beitinjaneh A, Bredeson C, Cahn JY, Cerny J, Copelan E, Cutler C, DeFilipp Z, Diaz Perez MA, Farhadfar N, Freytes CO, Gadalla SM, Ganguly S, Gale RP, Gergis U[IRT], Grunwald MR, Hamilton BK, Hashmi S, Hildebrandt GC, Lazarus HM, Litzow M, Munker R, Murthy HS, Nathan S, Nishihori T, Patel SS, Rizzieri D, Seo S, Shah MV, Solh M, Verdonck LF, Vij R, Sobecks RM, Oran B, Scott BL, Saber W, Nakamura R. The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis. Haematologica. 2023 Jan 01; 108(1):150-160. ( Abstract )	01/01/2023
¶ 16.	Park JS, Saeidian AH, Youssefian L, Hsu S, Vahidnezhad H, Uitto J[CRiC]. Acquired ichthyosis, asteatotic dermatitis or xerosis? An update on pathoetiology and drug-induced associations. J Eur Acad Dermatol Venereol. 2023 Jan; 37(1):47-56. ( Abstract )	01/01/2023
+ 17.	Sarfaraz N, Somarowthu S[MORA], Bouchard MJ[TaCO]. The interplay of long noncoding RNAs and hepatitis B virus. J Med Virol. 2023 Jan; 95(1):e28058. ( Abstract )	01/01/2023
¶ 18.	Shah SD, Nayak AP, Sharma P, Villalba DR, Addya S, Huang W, Shapiro P, Kane MA, Deshpande DA[TaCO]. Targeted Inhibition of Select Extracellular Signal-regulated Kinases 1 and 2 Functions Mitigates Pathological Features of Asthma in Mice. Am J Respir Cell Mol Biol. 2023 Jan; 68(1):23-38. ( Abstract )	01/01/2023
19.	Villars J, Gardner CA, Zhan T, Binder AF[IRT]. Delay in Time to Antibiotics for De Novo Inpatient Neutropenic Fever May Not Impact Overall Survival for Patients With a Cancer Diagnosis. Am J Med Qual. 2023 Jan-Feb 01; 38(1):9-16. ( Abstract )	01/02/2023
¶ 20.	Huffman BM, Basu Mallick A[MORA], Horick NK, Wang-Gillam A, Hosein PJ, Morse MA, Beg MS, Murphy JE, Mavroukakis S, Zaki A, Schlechter BL, Sanoff H, Manz C, Wolpin BM, Arlen P, Lacy J, Cleary JM. Effect of a MUC5AC Antibody (NPC-1C) Administered With Second-Line Gemcitabine and Nab-Paclitaxel on the Survival of Patients With Advanced Pancreatic Ductal Adenocarcinoma: A Randomized Clinical Trial. JAMA Netw Open. 2023 Jan 03; 6(1):e2249720. ( Abstract )	01/03/2023
¶ +* 21.	Lapadula D, Lam B, Terai M, Sugase T, Tanaka R, Farias E, Kadamb R, Lopez-Anton M, Heine CC, Modasia B, Aguirre-Ghiso JA, Aplin AE[TaCO], Sato T[IRT], Benovic JL[TaCO]. IGF1R Inhibition Enhances the Therapeutic Effects of Gq/11 Inhibition in Metastatic Uveal Melanoma Progression. Mol Cancer Ther. 2023 Jan 03; 22(1):63-74. ( Abstract )	01/03/2023
¶ 22.	Zierath R, Claggett B, Hall ME, Correa A, Barber S, Gao Y, Talegawkar S, Ezekwe EI, Tucker K, Diez Roux AV[CRiC], Sims M, Shah AM. Measures of Food Inadequacy and Cardiovascular Disease Risk in Black Individuals in the US From the Jackson Heart Study. JAMA Netw Open. 2023 Jan 03; 6(1):e2252055. ( Abstract )	01/03/2023
¶ 23.	Quinn Z, Leiby B, Sonpavde G, Choudhury AD, Sweeney C, Einstein D, Szmulewitz R, Sartor O, Knudsen K, Yang ES, Kelly WK[MORA]. Phase I Study of Niraparib in Combination with Radium-223 for the Treatment of Metastatic Castrate-Resistant Prostate Cancer. Clin Cancer Res. 2023 Jan 04; 29(1):50-59. ( Abstract )	01/04/2023
24.	Hajjar ER, Herens A, Kelly EL, Madden K, Lungen JM, Worster BK[CRiC]. A Longitudinal Observational Study of Medical Cannabis Use and Polypharmacy among Patients Presenting to Dispensaries in Pennsylvania. Biomedicines. 2023 Jan 08; 11(1). ( Abstract )	01/08/2023
¶ 25.	Epperla N, Zhao Q, Chowdhury SM, Shea L, Moyo TK, Reddy N, Sheets J, Weiner DM, Geethakumari PR, Kandarpa M, Bruno XJ, Thomas C, Churnetski MC, Hsu A, Zurbriggen L, Tan XC, Lindsey K, Maakaron J, Caimi PF, Torka P, Bello C, Ayyappan S, Oh TS, Karmali R, Kim SH, Kress A, Kothari S, Sawalha Y, Christian B, David KA, Greenwell IB, Janakiram M, Kenkre VP, Olszewski AJ, Cohen JB, Palmisiano N[IRT], Umyarova E, Wilcox RA, Awan FT, Alderuccio JP, Barta SK, Grover NS, Ghosh N, Bartlett NL, Herrera AF, Shouse G. Postibrutinib relapse outcomes for patients with marginal zone lymphoma. Blood Adv. 2023 Jan 10; 7(1):88-91. ( Abstract )	01/10/2023
¶ 26.	Sedrak MS, Sun CL, Ji J, Cohen HJ, Gross CP, Tew WP, Klepin HD, Wildes TM, Dotan E, Freedman RA, O'Connor T, Chow S, Fenton MA, Moy B, Chapman AE[CRiC], Dale W, Katheria V, Kuderer NM, Lyman GH, Magnuson A, Muss HB. Low-Intensity Adjuvant Chemotherapy for Breast Cancer in Older Women: Results From the Prospective Multicenter HOPE Trial. J Clin Oncol. 2023 Jan 10; 41(2):316-326. ( Abstract )	01/10/2023
¶ 27.	Goyal L, Meric-Bernstam F, Hollebecque A, Valle JW, Morizane C, Karasic TB, Abrams TA, Furuse J, Kelley RK, Cassier PA, Klümpen HJ, Chang HM, Chen LT, Tabernero J, Oh DY, Mahipal A, Moehler M, Mitchell EP[CRiC], Komatsu Y, Masuda K, Ahn D, Epstein RS, Halim AB, Fu Y, Salimi T, Wacheck V, He Y, Liu M, Benhadji KA, Bridgewater JA, FOENIX-CCA2 Study Investigators. Futibatinib for FGFR2-Rearranged Intrahepatic Cholangiocarcinoma. N Engl J Med. 2023 Jan 19; 388(3):228-239. ( Abstract )	01/19/2023
28.	Huynh A, Arnold DM, Michael JV, Clare R, Smith JW, Daka M, Ianosi-Irimie M, McKenzie SE[IRT], Kelton JG, Nazy I. Characteristics of VITT antibodies in patients vaccinated with Ad26.COV2.S. Blood Adv. 2023 Jan 24; 7(2):246-250. ( Abstract )	01/24/2023
29.	Zhang Y, Qiu JG, Jia XY, Ke Y, Zhang MK, Stieg D, Liu WJ, Liu LZ[CRiC], Wang L, Jiang BH. METTL3-mediated N6-methyladenosine modification and HDAC5/YY1 promote IFFO1 downregulation in tumor development and chemo-resistance. Cancer Lett. 2023 Jan 28; 553:215971. ( Abstract )	01/28/2023
¶ 30.	Shalowitz DI, Hung P, Zahnd WE, Eberth J[CRiC]. Pre-pandemic geographic access to hospital-based telehealth for cancer care in the United States. PLoS One. 2023 Jan 31; 18(1):e0281071. ( Abstract )	01/31/2023
31.	Adekeye A[CRiC], Lung KC, Brill KL. Pediatric and Adolescent Breast Conditions: A Review. J Pediatr Adolesc Gynecol. 2023 Feb; 36(1):5-13. ( Abstract )	02/01/2023
32.	Aumiller JL, Wedegaertner PB[TaCO]. Disruption of the interaction between mutationally activated Gα and Gβγ attenuates aberrant signaling. J Biol Chem. 2023 Feb; 299(2):102880. ( Abstract )	02/01/2023
¶ 33.	Inamdar S, Tylek T, Thumsi A, Suresh AP, Jaggarapu MMCS, Halim M, Mantri S, Esrafili A, Ng ND, Schmitzer E, Lintecum K, de Ávila C, Fryer JD, Xu Y, Spiller KL[IRT], Acharya AP. Biomaterial mediated simultaneous delivery of spermine and alpha ketoglutarate modulate metabolism and innate immune cell phenotype in sepsis mouse models. Biomaterials. 2023 Feb; 293:121973. ( Abstract )	02/01/2023
¶ 34.	Le TK, Cha L, Gee G, Dean LT, Juon HS[CRiC], Tseng W. Asian American Self-Reported Discrimination in Healthcare and Having a Usual Source of Care. J Racial Ethn Health Disparities. 2023 Feb; 10(1):259-270. ( Abstract )	02/01/2023
¶ +* 35.	Machado P, Liu JB[TaCO], Needleman L, Lazar M[MORA], Willis AI, Brill K, Nazarian S, Berger A, Forsberg F[TaCO]. Sentinel Lymph Node Identification in Patients With Breast Cancer Using Lymphosonography. Ultrasound Med Biol. 2023 Feb; 49(2):616-625. ( Abstract )	02/01/2023
+ 36.	McIntire RK, Keith SW, Nowlan T, Butt S, Cambareri K, Callaghan J, Halstead T, Chandrasekar T, Kelly WK[MORA], Leader AE[CRiC]. Predictors of consenting to participate in a clinical trial among urban cancer patients. Contemp Clin Trials. 2023 Feb; 125:107061. ( Abstract )	02/01/2023
37.	Mitchell EP[CRiC]. Increased Cancer Incidence and Mortality Rates in Sexual and Gender Minorities. J Natl Med Assoc. 2023 Feb; 115(1):1-2. ( Abstract )	02/01/2023
¶ 38.	Rodriguez RM, Nichol G, Eucker SA, Chang AM, O'Laughlin KN, Pauley A, Rising KL[CRiC], Eswaran V, Morse D, Li C, Patel A, Duber HC, Arreguin M, Shughart L, Glidden D, PROCOVAXED Study Network. Effect of COVID-19 Vaccine Messaging Platforms in Emergency Departments on Vaccine Acceptance and Uptake: A Cluster Randomized Clinical Trial. JAMA Intern Med. 2023 Feb 01; 183(2):115-123. ( Abstract )	02/01/2023
39.	Romisher A, Albornoz C, Nikbakht N[IRT]. Asymptomatic Soft Tumor on the Forearm. Cutis. 2023 Feb; 111(2):E4-E6. ( Abstract )	02/01/2023
¶ 40.	Taylor MH, Leboulleux S, Panaseykin Y, Konda B, de La Fouchardiere C, Hughes BGM, Gianoukakis AG, Park YJ, Romanov I, Krzyzanowska MK, Garbinsky D, Sherif B, Pan JJ, Binder TA, Sauter N, Xie R, Brose MS[TaCO]. Health-related quality-of-life analyses from a multicenter, randomized, double-blind phase 2 study of patients with differentiated thyroid cancer treated with lenvatinib 18 or 24 mg/day. Cancer Med. 2023 Feb; 12(4):4332-4342. ( Abstract )	02/01/2023
+* 41.	Till BM[CRiC], Grenda TR[MORA], Okusanya OT[MORA], Evans Iii NR. Robotic Minimally Invasive Esophagectomy. Thorac Surg Clin. 2023 Feb; 33(1):81-88. ( Abstract )	02/01/2023
+* 42.	Till BM, Mack S, Whitehorn G, Rahman U, Thosani D, Grenda T[MORA], Evans NR[CRiC], Okusanya O[MORA]. Impact of stereotactic body radiation therapy volume on surgical patient selection, short-term survival, and long-term survival in early-stage non-small cell lung cancer. J Thorac Cardiovasc Surg. 2023 Feb; 165(2):471-479. ( Abstract )	02/01/2023
+* 43.	Till BM, Whitehorn G, Mack SJ, Thosani D, Rahman U, Grenda T[MORA], Evans NR[CRiC], Okusanya OT[MORA]. Hospital Utilization of Stereotactic Body Radiation Therapy and Rates of Surgical Refusal. Ann Thorac Surg. 2023 Feb; 115(2):347-354. ( Abstract )	02/01/2023
* 44.	Worster B[CRiC], Waldman L, Garber G, Zhan T, Lopez A[CRiC], Trachtenberg O, Handley N[CRiC], Rising KL[CRiC], Csik V, Leader A[CRiC]. Increasing equitable access to telehealth oncology care in the COVID-19 National Emergency: Creation of a telehealth task force. Cancer Med. 2023 Feb; 12(3):2842-2849. ( Abstract )	02/01/2023
¶ * 45.	Yeo TP, Cannaday S, Thompson RE, Fogg R, Nevler A, Lavu H[MORA], Yeo CJ[MORA]. Distress, Depression, and the Effect of ZIP Code in Pancreaticobiliary Cancer Patients and Their Significant Others. J Am Coll Surg. 2023 Feb 01; 236(2):339-349. ( Abstract )	02/01/2023
46.	Le Minh G, Reginato MJ[TaCO]. Role of O-GlcNAcylation on cancer stem cells: Connecting nutrient sensing to cell plasticity. Adv Cancer Res. 2023; 157:195-228. ( Abstract )	02/03/2023
47.	Radler MR, Liu X, Peng M, Doyle B, Toyo-Oka K, Spiliotis ET[TaCO]. Pyramidal neuron morphogenesis requires a septin network that stabilizes filopodia and suppresses lamellipodia during neurite initiation. Curr Biol. 2023 Feb 06; 33(3):434-448.e8. ( Abstract )	02/06/2023
48.	Redding A, Grabocka E[MORA]. A Splendid New Beginning at the End of a 40-Year Quest: The First KRASG12D Inhibitor in Pancreatic Cancer. Cancer Discov. 2023 Feb 06; 13(2):260-262. ( Abstract )	02/06/2023
49.	Rosenberg M, Thapa S, Jeurkar C, Kasner M[IRT]. Copper Deficiency Mimicking Myelodysplastic Syndrome: Zinc Supplementation in the Setting of COVID-19. Case Rep Oncol. 2023 Feb 7; 16(1):55-61. ( Abstract )	02/07/2023
¶ 50.	Makker V, Aghajanian C, Cohn AL, Romeo M, Bratos R, Brose MS[TaCO], Messing M, Dutta L, Dutcus CE, Huang J, Schmidt EV, Orlowski R, Taylor MH. A Phase Ib/II Study of Lenvatinib and Pembrolizumab in Advanced Endometrial Carcinoma (Study 111/KEYNOTE-146): Long-Term Efficacy and Safety Update. J Clin Oncol. 2023 Feb 10; 41(5):974-979. ( Abstract )	02/10/2023
+* 51.	Barton JR, Londregan AK, Alexander TD, Entezari AA, Bar-Ad S, Cheng L, Lepore AC[TaCO], Snook AE[IRT], Covarrubias M, Waldman SA[IRT]. Intestinal neuropod cell GUCY2C regulates visceral pain. J Clin Invest. 2023 Feb 15; 133(4). ( Abstract )	02/15/2023
52.	Gleason L, Hunter E, Cohen A, Suriano J, Nikbakht N[IRT]. Atezolizumab-induced psoriasiform drug eruption successfully treated with ixekizumab: a case report and literature review. Dermatol Online J. 2023 Feb 15; 29(1). ( Abstract )	02/15/2023
¶ 53.	Abu-Khalaf MM[CRiC], Alex Hodge K, Hatzis C, Baldelli E, El Gazzah E, Valdes F, Sikov WM, Mita MM, Denduluri N, Murphy R, Zelterman D, Liotta L, Dunetz B, Dunetz R, Petricoin EF, Pierobon M. AKT/mTOR signaling modulates resistance to endocrine therapy and CDK4/6 inhibition in metastatic breast cancers. NPJ Precis Oncol. 2023 Feb 16; 7(1):18. ( Abstract )	02/16/2023
¶ 54.	Connors J, Joyner D, Mege NJ, Cusimano GM, Bell MR, Marcy J, Taramangalam B, Kim KM, Lin PJC, Tam YK, Weissman D, Kutzler MA, Alameh MG, Haddad EK[IRT]. Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individuals. Commun Biol. 2023 Feb 17; 6(1):188. ( Abstract )	02/17/2023
¶ 55.	Tsien CI, Pugh SL, Dicker AP[CRiC], Raizer JJ, Matuszak MM, Lallana EC, Huang J, Algan O, Deb N, Portelance L, Villano JL, Hamm JT, Oh KS, Ali AN, Kim MM, Lindhorst SM, Mehta MP. NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma. J Clin Oncol. 2023 Feb 20; 41(6):1285-1295. ( Abstract )	02/20/2023
¶ * 56.	Dhital B, Santasusagna S, Kirthika P, Xu M, Li P, Carceles-Cordon M, Soni RK, Li Z, Hendrickson RC, Schiewer MJ[MORA], Kelly WK[MORA], Sternberg CN, Luo J, Lujambio A, Cordon-Cardo C, Alvarez-Fernandez M, Malumbres M, Huang H, Ertel A, Domingo-Domenech J, Rodriguez-Bravo V. Harnessing transcriptionally driven chromosomal instability adaptation to target therapy-refractory lethal prostate cancer. Cell Rep Med. 2023 Feb 21; 4(2):100937. ( Abstract )	02/21/2023
¶ 57.	Major A, Porcu P[IRT], Haverkos BM. Rational Targets of Therapy in Extranodal NK/T-Cell Lymphoma. Cancers (Basel). 2023 Feb 21; 15(5). ( Abstract )	02/21/2023
¶ 58.	Simão DC, Zarrabi KK, Mendes JL, Luz R, Garcia JA, Kelly WK[MORA], Barata PC. Bispecific T-Cell Engagers Therapies in Solid Tumors: Focusing on Prostate Cancer. Cancers (Basel). 2023 Feb 23; 15(5). ( Abstract )	02/23/2023
59.	Montoya B, Knudson CJ, Melo-Silva CR, Tang L, Kafle S, Sigal LJ[IRT]. Resistance To Poxvirus Lethality Does Not Require the Necroptosis Proteins RIPK3 or MLKL. J Virol. 2023 Feb 28; 97(2):e0194522. ( Abstract )	02/28/2023
+* 60.	Chandrasekar T, Clark CB, Gomella A, Wessner CE, Wang S, Nam K[TaCO], Liu JB[TaCO], Forsberg F[TaCO], Lyshchik A[TaCO], Halpern E[TaCO], Mark JR, Lallas CD[MORA], Gomella LG[MORA], Kania L, Trabulsi EJ[MORA], Eisenbrey JR[TaCO]. Volumetric Quantitative Contrast-enhanced Ultrasonography Evaluation of Complex Renal Cysts: An Adjunctive Metric to the Bosniak Classification System to Predict Malignancy. Eur Urol Focus. 2023 Mar; 9(2):336-344. ( Abstract )	03/01/2023
61.	Demarest K, Lavu H[MORA], Collins E, Batra V. Comprehensive Diagnosis and Management of Malignant Bowel Obstruction: A Review. J Pain Palliat Care Pharmacother. 2023 Mar; 37(1):91-105. ( Abstract )	03/01/2023
¶ 62.	Forghani F, Castillo R, Castillo E, PhD BJ, Rusthoven C, Kwak J, Moiseenko V, Grills I, Miften M, Vinogradskiy Y[CRiC], Guerrero T. Is individual perfusion dose-response different than ventilation dose-response for lung cancer patients treated with radiotherapy? Br J Radiol. 2023 Mar; 96(1143):20220119. ( Abstract )	03/01/2023
¶ 63.	Graff SL, Wildes T, Duma N, Dizon DS, LoConte NK, Mitchell E[CRiC], Murphy MC, Perez EA, Temkin SM, Kunz PL, Winkfield KM. Understanding Modern Medical Centers: Beyond Simone-Intersectional Maxims for a New Era. J Clin Oncol. 2023 Mar 01; 41(7):1350-1358. ( Abstract )	03/01/2023
+* 64.	Salib A, Halpern E[TaCO], Eisenbrey J[TaCO], Chandrasekar T, Chung PH, Forsberg F[TaCO], Trabulsi EJ[MORA]. The evolving role of contrast-enhanced ultrasound in urology: a review. World J Urol. 2023 Mar; 41(3):673-678. ( Abstract )	03/01/2023
¶ 65.	Wehkamp U, Ardigò M, Papadavid E, Querfeld C, Nikbakht N[IRT]. Publisher Correction to: Chlormethine Gel for Patients with Mycosis Fungoides Cutaneous T Cell Lymphoma: A Review of Efficacy and Safety in Clinical Trial and Real-World Settings. Adv Ther. 2023 Mar; 40(3):1299-1300. ( Abstract )	03/01/2023
¶ 66.	Wu B, Liu DA, Guan L, Myint PK, Chin L, Dang H[MORA], Xu Y, Ren J, Li T, Yu Z, Jabban S, Mills GB, Nukpezah J, Chen YH, Furth EE, Gimotty PA, Wells RG, Weaver VM, Radhakrishnan R, Wang XW, Guo W. Stiff matrix induces exosome secretion to promote tumour growth. Nat Cell Biol. 2023 Mar; 25(3):415-424. ( Abstract )	03/01/2023
¶ 67.	Zahnd WE, Hung P, Shi SK, Zgodic A, Merrell MA, Crouch EL, Probst JC, Eberth JM[CRiC]. Availability of hospital-based cancer services before and after rural hospital closure, 2008-2017. J Rural Health. 2023 Mar; 39(2):416-425. ( Abstract )	03/01/2023
68.	Haslund-Gourley BS, Wigdahl B[IRT], Comunale MA. IgG N-glycan Signatures as Potential Diagnostic and Prognostic Biomarkers. Diagnostics (Basel). 2023 Mar 07; 13(6). ( Abstract )	03/07/2023
¶ 69.	Ventura E, Ducci G, Benot Dominguez R, Ruggiero V, Belfiore A, Sacco E, Vanoni M, Iozzo RV[TaCO], Giordano A, Morrione A. Progranulin Oncogenic Network in Solid Tumors. Cancers (Basel). 2023 Mar 10; 15(6). ( Abstract )	03/10/2023
¶ * 70.	Gary EN, Tursi NJ, Warner BM, Cuismano G, Connors J, Parzych EM, Griffin BD, Bell MR, Ali AR, Frase D, Hojecki CE, Canziani GA, Chaiken I[IRT], Kannan T, Moffat E, Embury-Hyatt C, Wooton SK, Kossenkov A, Patel A, Kobasa D, Kutzler MA, Haddad EK[IRT], Weiner DB. Adenosine deaminase augments SARS-CoV-2 specific cellular and humoral responses in aged mouse models of immunization and challenge. Front Immunol. 2023 Mar 14; 14:1138609. ( Abstract )	03/14/2023
71.	Lopez AM[CRiC]. Integrative oncology in cancer care: Reaching a tipping point. Cancer. 2023 Mar 15; 129(6):834-835. ( Abstract )	03/15/2023
¶ 72.	Stankov I, Henson RM, Headen I, Purtle J, Langellier BA[CRiC]. Use of qualitative systems mapping and causal loop diagrams to understand food environments, diet and obesity: a scoping review protocol. BMJ Open. 2023 Mar 17; 13(3):e066875. ( Abstract )	03/17/2023
73.	Poiset SJ, Reddy A, Tucker CM, Kenyon LC, Judy KD, Shi W[MORA]. Hemangioblastoma with late leptomeningeal metastasis: a case report. J Med Case Rep. 2023 Mar 20; 17(1):102. ( Abstract )	03/20/2023
74.	Cartes-Saavedra B, Lagos D, Macuada J, Arancibia D, Burté F, Sjöberg-Herrera MK, Andrés ME, Horvath R, Yu-Wai-Man P, Hajnoczky G[TaCO], Eisner V. OPA1 disease-causing mutants have domain-specific effects on mitochondrial ultrastructure and fusion. Proc Natl Acad Sci U S A. 2023 Mar 21; 120(12):e2207471120. ( Abstract )	03/21/2023
+ 75.	Banner L, Cohen A, McGrath L, Nikbakht N[IRT], South AP[MORA]. A novel KRT14 null mutation leads to autosomal recessive epidermolysis bullosa simplex. Clin Exp Dermatol. 2023 Mar 22; 48(4):431-433. ( Abstract )	03/22/2023
76.	Meyer SE[MORA]. Context is key for FLT3-ITD. Blood. 2023 Mar 23; 141(12):1373-1374. ( Abstract )	03/23/2023
77.	Sales D, Lin E, Stoffel V, Dickson S, Khan ZK, Beld J, Jain P[IRT]. Apigenin improves cytotoxicity of antiretroviral drugs against HTLV-1 infected cells through the modulation of AhR signaling. NeuroImmune Pharm Ther. 2023 Mar 25; 2(1):49-62. ( Abstract )	03/25/2023
78.	Lee P, Makkena A, Tantawi M, Velasquez-Botero F, Eisenbrey JR[TaCO], Shaw CM. Microwave ablation as a primary versus secondary treatment for hepatocellular carcinoma. Diagn Interv Radiol. 2023 Mar 29; 29(2):359-366. ( Abstract )	03/29/2023
¶ 79.	Pratt-Chapman ML, Wang Y, Quinn GP, Shirima S, Adler S, Brazinskaite R, Kamen C, Radix A, Warren B, Eckstrand K, Lopez AM[CRiC]. Cancer patient and provider responses to companion scales assessing experiences with LGBTQI-affirming healthcare. Front Oncol. 2023; 13:869561. ( Abstract )	03/31/2023
¶ 80.	Ai H, Chao NJ, Rizzieri DA, . . . Gergis U[IRT], . . . Xia B, Chen B, Ma L. Expert consensus on microtransplant for acute myeloid leukemia in elderly patients -report from the international microtransplant interest group. Heliyon. 2023 Apr; 9(4):e14924. ( Abstract )	04/01/2023
¶ +* 81.	Banoub RG, Crippen MM, Fiorella MA, Ross HM, Sagalow ES, Bar-Ad V[MORA], Cohen D, Gargano SM, Tuluc M, Selman Y, Goldman R, Cottrill E, Luginbuhl A[TaCO], Fundakowski C, Mady LJ, Cognetti D[TaCO], Topf MC, Curry JM[MORA]. Variance in 3D anatomic localization of surgical margins based on conventional margin labeling in head and neck squamous cell carcinoma. Oral Oncol. 2023 Apr; 139:106360. ( Abstract )	04/01/2023
¶ 82.	Blank SV, Huh WK, Bell M, Dilley S, Hardesty M, Hoskins ER, Lachance J, Musa F, Prendergast E, Rimel BJ, Shahin M[MORA], Valea F. Doubling down on the future of gynecologic oncology: The SGO future of the profession summit report. Gynecol Oncol. 2023 Apr; 171:76-82. ( Abstract )	04/01/2023
83.	Brandimarti R, Irollo E, Meucci O[IRT]. The US9-Derived Protein gPTB9TM Modulates APP Processing Without Targeting Secretase Activities. Mol Neurobiol. 2023 Apr; 60(4):1811-1825. ( Abstract )	04/01/2023
¶ 84.	Byng D, Thomas SM, Rushing CN, Lynch T, McCarthy A, Francescatti AB, Frank ES, Partridge AH, Thompson AM, Retèl VP, van Harten WH, Grimm LJ, Hyslop T[CRiC], Hwang ES, Ryser MD. Surveillance Imaging after Primary Diagnosis of Ductal Carcinoma in Situ. Radiology. 2023 Apr; 307(1):e221210. ( Abstract )	04/01/2023
85.	Chen CG, Kapoor A, Xie C, Moss A, Vadigepalli R, Ricard-Blum S, Iozzo RV[TaCO]. Conditional expression of endorepellin in the tumor vasculature attenuates breast cancer growth, angiogenesis and hyaluronan deposition. Matrix Biol. 2023 Apr; 118:92-109. ( Abstract )	04/01/2023
86.	Cummings M, Edmonds P, Shahin MS[MORA], Sorosky JI. Juvenile granulosa cell tumor in an adult woman during pregnancy: A case report and review of the literature. Gynecol Oncol Rep. 2023 Apr; 46:101164. ( Abstract )	04/01/2023
¶ 87.	Eberth JM[CRiC], Zgodic A, Pelland SC, Wang SY, Miller DP. Outcomes of Shared Decision-Making for Low-Dose Screening for Lung Cancer in an Academic Medical Center. J Cancer Educ. 2023 Apr; 38(2):522-537. ( Abstract )	04/01/2023
¶ 88.	Fayanju OM, Greenup RA, Zafar SY, Hyslop T[CRiC], Hwang ES, Fish LJ. Modifiable Barriers and Facilitators for Breast Cancer Care: A Thematic Analysis of Patient and Provider Perspectives. J Surg Res. 2023 Apr; 284:269-279. ( Abstract )	04/01/2023
¶ 89.	Fayanju OM, Oyekunle T, Thomas SM, Ingraham KL, Fish LJ, Greenup RA, Oeffinger KC, Zafar SY, Hyslop T[CRiC], Hwang ES, Patierno SR, Barrett NJ. Modifiable patient-reported factors associated with cancer-screening knowledge and participation in a community-based health assessment. Am J Surg. 2023 Apr; 225(4):617-629. ( Abstract )	04/01/2023
¶ 90.	Gates JC, Clark AP, Cherkas E, Shreenivas AV, Kraus D, Danzinger N, Huang RSP, Johnson J[MORA], Ross JS. Genomic profiling and precision medicine in complex ameloblastoma. Head Neck. 2023 Apr; 45(4):816-826. ( Abstract )	04/01/2023
91.	Gomella LG[MORA]. Cardio-Oncology, Nephro-Oncology and the Urologic Oncology Collaboration. Can J Urol. 2023 Apr; 30(2):11457-11458. ( Abstract )	04/01/2023
92.	Kramer D, George G, Summer R[TaCO]. Moving senolytics closer to the clinic in IPF. EBioMedicine. 2023 Apr; 90:104513. ( Abstract )	04/01/2023
+ 93.	Leader AE[CRiC], Melillo RJ, Greene Q, Blanding-Godbolt J, Shimada A, Eischen CM[IRT], Aplin AE[TaCO]. Engaging community members in cancer research: an assessment of an NCI-designated cancer center. Cancer Causes Control. 2023 Apr; 34(4):307-319. ( Abstract )	04/01/2023
94.	Ly NS, Li J, Faggioni R, Roskos LK, Brose MS[TaCO]. Population Pharmacokinetics and Exposure-Response Analysis for the Phase 3 COSMIC-311 Trial of Cabozantinib for Radioiodine-Refractory Differentiated Thyroid Cancer. Clin Pharmacokinet. 2023 Apr; 62(4):587-598. ( Abstract )	04/01/2023
¶ 95.	Muhsen IN, Galeano S, Niederwieser D, Koh MBC, Ljungman P, Machado CM, Kharfan-Dabaja MA, de la Camara R, Kodera Y, Szer J, Rasheed W, Cesaro S, Hashmi SK, Seber A, Atsuta Y, Saleh MFM, Srivastava A, Styczynski J, Alrajhi A, Almaghrabi R, Abid MB, Chemaly RF, Gergis U[IRT], Brissot E, El Fakih R, Riches M, Mikulska M, Worel N, Weisdorf D, Greinix H, Cordonnier C, Aljurf M. Endemic or regionally limited bacterial and viral infections in haematopoietic stem-cell transplantation recipients: a Worldwide Network for Blood and Marrow Transplantation (WBMT) Review. Lancet Haematol. 2023 Apr; 10(4):e284-e294. ( Abstract )	04/01/2023
¶ 96.	Muhsen IN, Galeano S, Niederwieser D, Koh MBC, Ljungman P, Machado CM, Kharfan-Dabaja MA, de la Camara R, Kodera Y, Szer J, Rasheed W, Cesaro S, Hashmi SK, Seber A, Atsuta Y, Saleh MFM, Srivastava A, Styczynski J, Alrajhi A, Almaghrabi R, Abid MB, Chemaly RF, Gergis U[IRT], Brissot E, El Fakih R, Riches M, Mikulska M, Worel N, Weisdorf D, Greinix H, Cordonnier C, Aljurf M. Endemic or regionally limited parasitic and fungal infections in haematopoietic stem-cell transplantation recipients: a Worldwide Network for Blood and Marrow Transplantation (WBMT) Review. Lancet Haematol. 2023 Apr; 10(4):e295-e305. ( Abstract )	04/01/2023
* 97.	Nevler A, Khalilieh S, Lavu H[MORA], Bowne W, Yeo CJ[MORA]. Hypercapnic Tissue Gene Expression and Survival in Early-Stage Pancreatic Ductal Adenocarcinoma. J Am Coll Surg. 2023 Apr 01; 236(4):913-922. ( Abstract )	04/01/2023
¶ + 98.	Ohri N, Bar-Ad V[MORA], Fernandez C, Rakowski C, Leiby BE, Hoeltzel G, Sung A, Zubair N, Henao C, Dicker AP[CRiC]. Remote Activity Monitoring and Electronic Patient-Reported Outcomes Collection During Radiotherapy for Head and Neck Cancer: A Pilot Study. JCO Clin Cancer Inform. 2023 Apr; 7:e2200132. ( Abstract )	04/01/2023
¶ 99.	Okyere AD, Song J, Patwa V, Carter RL, Enjamuri N, Lucchese AM, Ibetti J, de Lucia C, Schumacher SM, Koch WJ, Cheung JY, Benovic JL[TaCO], Tilley DG. Pepducin ICL1-9-Mediated β2-Adrenergic Receptor-Dependent Cardiomyocyte Contractility Occurs in a G Protein/ROCK/PKD-Sensitive Manner. Cardiovasc Drugs Ther. 2023 Apr; 37(2):245-256. ( Abstract )	04/01/2023
¶ 100.	Pratt-Chapman ML, Wang Y, Eckstrand K, Radix A, Quinn GP, Schabath MB, Lopez AM[CRiC]. Together-Equitable-Accessible-Meaningful (TEAM) Training to Improve Cancer Care for Sexual and Gender Minorities (SGM): Outcomes from a Pilot Study. J Cancer Educ. 2023 Apr; 38(2):419-425. ( Abstract )	04/01/2023
* 101.	Scott ER, Singh A, Quinn AM, Morano S, Karp A, Boyd K, Ho M, Schneider A, McPartland C, Denisenko A, Shumaker A, Clark CB, Chandrasekar T, Mann M, Trabulsi EJ[MORA], Desai V, Pugliese R, Lallas CD[MORA]. The use of individualized 3D-printed models on trainee and patient education, and surgical planning for robotic partial nephrectomies. J Robot Surg. 2023 Apr; 17(2):465-472. ( Abstract )	04/01/2023
* 102.	Sholevar C, Torjani A, Kavanagh TR, Yudkoff C, Xiao K, Swaminathan V, Rshaidat H, Bowne WB, Krampitz GW, Nevler A, Yeo CJ[MORA], Lavu H[MORA]. Euglycemic diabetic ketoacidosis (EDKA) after pancreaticoduodenectomy: An under-recognized metabolic abnormality with outcome implications. Surgery. 2023 Apr; 173(4):888-893. ( Abstract )	04/01/2023
+* 103.	Sussman S, Philips R, Renslo B, Givens A, Swendseid B, Tassone P, Goldman RA, Curry JM[MORA], Cognetti DM[TaCO], Luginbuhl AJ[TaCO]. Effects of Prior Tracheostomy on Total Laryngectomy Outcomes. Otolaryngol Head Neck Surg. 2023 Apr; 168(4):782-789. ( Abstract )	04/01/2023
¶ 104.	Wisinski KB, Flamand Y, Wilson MA, Luke JJ, Tawbi HA, Hong F, Mitchell EP[CRiC], Zwiebel JA, Chen H, Gray RJ, Li S, McShane LM, Rubinstein LV, Patton D, Williams PM, Hamilton SR, Behrens RJ, Pennington KP, Conley BA, Arteaga CL, Harris LN, O'Dwyer PJ, Chen AP, Flaherty KT. Trametinib in Patients With NF1-, GNAQ-, or GNA11-Mutant Tumors: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols S1 and S2. JCO Precis Oncol. 2023 Apr; 7:e2200421. ( Abstract )	04/01/2023
105.	Yan B, Hooper DC[IRT], Yuan Z, Wang C, Chen Y, Lu B. Autoantibodies Drive Heart Damage Caused by Concomitant Radiation and PD-1 Blockade. Cancer Immunol Res. 2023 Apr 03; 11(4):546-555. ( Abstract )	04/03/2023
¶ 106.	Dhingra A, Tobias JW, Philp NJ[TaCO], Boesze-Battaglia K. Transcriptomic Changes Predict Metabolic Alterations in LC3 Associated Phagocytosis in Aged Mice. Int J Mol Sci. 2023 Apr 04; 24(7). ( Abstract )	04/04/2023
+ 107.	Kunwor R, Silver DP[MORA], Abu-Khalaf M[CRiC]. PARP Inhibitors for the Treatment of BRCA1/2-Mutated Metastatic Breast Cancer: A Systematic Review and Meta-analysis. Hematol Oncol Stem Cell Ther. 2023 Apr 04; 16(3):186-196. ( Abstract )	04/04/2023
* 108.	Banner L, Joffe D, Lee E, Porcu P[IRT], Nikbakht N[IRT]. Incidence of cutaneous melanoma and Merkel cell carcinoma in patients with primary cutaneous B-cell lymphomas: A population study of the SEER registry. Front Med (Lausanne). 2023; 10:1110511. ( Abstract )	04/06/2023
109.	Meredith L, Chao T, Nevler A, Basu Mallick A[MORA], Singla RK, McCue PA, Bowne WB, Jiang W. A rare metastatic mesenteric malignant PEComa with TSC2 mutation treated with palliative surgical resection and nab-sirolimus: a case report. Diagn Pathol. 2023 Apr 11; 18(1):45. ( Abstract )	04/11/2023
¶ 110.	Clark AS, Hong F, Finn RS, DeMichele AM, Mitchell EP[CRiC], Zwiebel J, Arnaldez FI, Gray RJ, Wang V, McShane LM, Rubinstein LV, Patton D, Williams PM, Hamilton SR, Copur MS, Kasbari SS, Thind R, Conley BA, Arteaga CL, O'Dwyer PJ, Harris LN, Chen AP, Flaherty KT. Phase II Study of Palbociclib (PD-0332991) in CCND1, 2, or 3 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1B. Clin Cancer Res. 2023 Apr 14; 29(8):1477-1483. ( Abstract )	04/14/2023
+* 111.	Fradin J, Kim FJ[MORA], Lu-Yao GL[CRiC], Storozynsky E, Kelly WK[MORA]. Review of Cardiovascular Risk of Androgen Deprivation Therapy and the Influence of Race in Men with Prostate Cancer. Cancers (Basel). 2023 Apr 15; 15(8). ( Abstract )	04/15/2023
¶ 112.	Bhardwaj M, Lee JJ, Versace AM, Harper SL, Goldman AR, Crissey MAS, Jain V, Singh MP, Vernon M, Aplin AE[TaCO], Lee S, Morita M, Winkler JD, Liu Q, Speicher DW, Amaravadi RK. Lysosomal lipid peroxidation regulates tumor immunity. J Clin Invest. 2023 Apr 17; 133(8). ( Abstract )	04/17/2023
¶ 113.	McCarty C, Yi M, Sous S, Leslie M, Tariq E, Dondapati P, Kameyama H, Nuguri S, Hills N, Wilkerson M, Davis R, Mesiya S, Rui H, Chervoneva I[CRiC], Zhang R, Tanaka T. Sustained Inflammation of Breast Tumors after Needle Biopsy. Pathobiology. 2023; 90(2):114-122. ( Abstract )	04/17/2023
¶ 114.	Le Minh G, Esquea EM, Dhameliya TT, Merzy J, Lee MH, Ball LE, Reginato MJ[TaCO]. Kruppel-like factor 8 regulates triple negative breast cancer stem cell-like activity. Front Oncol. 2023; 13:1141834. ( Abstract )	04/19/2023
¶ 115.	Glinskii OV, Glinsky VV, Xie L, Bunyak F, Glinskii VV, Sinha S, Gupta S, Iozzo RV[TaCO], Mohan RR. Corneal injury is associated with stromal and vascular alterations within cranial dura mater. PLoS One. 2023; 18(4):e0284082. ( Abstract )	04/20/2023
¶ * 116.	Sindaco P, Pandey H, Isabelle C, Chakravarti N, Brammer JE, Porcu P[IRT], Mishra A[IRT]. The role of interleukin-15 in the development and treatment of hematological malignancies. Front Immunol. 2023; 14:1141208. ( Abstract )	04/20/2023
+* 117.	Lacerda Q, Falatah H, Liu JB[TaCO], Wessner CE, Oeffinger B, Rochani A, Leeper DB, Forsberg F[TaCO], Curry JM[MORA], Kaushal G, Keith SW, O'Kane P, Wheatley MA[MORA], Eisenbrey JR[TaCO]. Improved Tumor Control Following Radiosensitization with Ultrasound-Sensitive Oxygen Microbubbles and Tumor Mitochondrial Respiration Inhibitors in a Preclinical Model of Head and Neck Cancer. Pharmaceutics. 2023 Apr 21; 15(4). ( Abstract )	04/21/2023
¶ 118.	Demidova EV, Serebriiskii IG, Vlasenkova R, Kelow S, Andrake MD, Hartman TR, Kent T, Virtucio J, Rosen GL, Pomerantz RT[MORA], Dunbrack RL, Golemis EA, Hall MJ, Chen DYT, Daly MB, Arora S. Candidate variants in DNA replication and repair genes in early-onset renal cell carcinoma patients referred for germline testing. BMC Genomics. 2023 Apr 24; 24(1):212. ( Abstract )	04/24/2023
119.	Tartaglia G, Park PH, Alexander MH, Nyström A, Rosenbloom J, South AP[MORA]. Trametinib-Induced Epidermal Thinning Accelerates a Mouse Model of Junctional Epidermolysis Bullosa. Biomolecules. 2023 Apr 25; 13(5). ( Abstract )	04/25/2023
¶ 120.	Tomar D, Thomas M, Garbincius JF, Kolmetzky DW, Salik O, Jadiya P, Joseph SK, Carpenter AC, Hajnoczky G[TaCO], Elrod JW. MICU1 regulates mitochondrial cristae structure and function independently of the mitochondrial Ca uniporter channel. Sci Signal. 2023 Apr 25; 16(782):eabi8948. ( Abstract )	04/25/2023
¶ 121.	Liou KT, McConnell KM, Currier MB, Baser RE, MacLeod J, Walker D, Casaw C, Wong G, Piulson L, Popkin K, Lopez AM[CRiC], Panageas K, Bradt J, Mao JJ. Telehealth-Based Music Therapy Versus Cognitive Behavioral Therapy for Anxiety in Cancer Survivors: Rationale and Protocol for a Comparative Effectiveness Trial. JMIR Res Protoc. 2023 Apr 27; 12:e46281. ( Abstract )	04/27/2023
¶ 122.	Bao T, Greenlee H, Lopez AM[CRiC], Kadro ZO, Lopez G, Carlson LE. How to Make Evidence-Based Integrative Medicine a Part of Everyday Oncology Practice. Am Soc Clin Oncol Educ Book. 2023 May; 43:e389830. ( Abstract )	05/01/2023
¶ 123.	Boyiadzis M, Zhang MJ, Chen K, . . . Wagner JL[IRT], . . . de Lima M, Page K, Weisdorf DJ. Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients. Leukemia. 2023 May; 37(5):1006-1017. ( Abstract )	05/01/2023
124.	Brown KG, Li J, Margolis R, Trinh B, Eisenbrey JR[TaCO], Hoyt K. Assessment of Transarterial Chemoembolization Using Super-resolution Ultrasound Imaging and a Rat Model of Hepatocellular Carcinoma. Ultrasound Med Biol. 2023 May; 49(5):1318-1326. ( Abstract )	05/01/2023
¶ 125.	Burnett AL, Nyame YA, Mitchell E[CRiC]. Disparities in prostate cancer. J Natl Med Assoc. 2023 May; 115(2S):S38-S45. ( Abstract )	05/01/2023
126.	Collins ML, Okusanya O[MORA]. Current Management of Carcinoid Tumor: When Is a Wedge Enough? Thorac Surg Clin. 2023 May; 33(2):159-164. ( Abstract )	05/01/2023
* 127.	Daskalakis C, Shimada A, Myers RE[CRiC], Eastburn K, DiCarlo MA, Shusted CS, Barta JA[CRiC]. Decision Preferences in Shared Decision-Making for Lung Cancer Screening among White and African American Individuals. Ann Am Thorac Soc. 2023 May; 20(5):756-758. ( Abstract )	05/01/2023
¶ * 128.	Duma N, Evans N[CRiC], Mitchell E[CRiC]. Disparities in lung cancer. J Natl Med Assoc. 2023 May; 115(2S):S46-S53. ( Abstract )	05/01/2023
¶ 129.	Expert Panel on Urological Imaging, Ganeshan D, Khatri G, Ali N, Avery R, Caserta MP, Chang SD, De Leon AD, Gupta RT, Lyshchik A[TaCO], Michalski J, Nicola R, Pierorazio PM, Purysko AS, Smith AD, Taffel MT, Nikolaidis P. ACR Appropriateness Criteria® Staging of Renal Cell Carcinoma: 2022 Update. J Am Coll Radiol. 2023 May; 20(5S):S246-S264. ( Abstract )	05/01/2023
130.	Hagerman CJ, Miller NA, Butryn ML[CRiC]. Latent Profile Analysis of Physical Activity Motivation during Behavioral Weight Loss Treatment. Psychol Sport Exerc. 2023 May; 66. ( Abstract )	05/01/2023
131.	Hsu T, Elias R, Swartz K, Chapman A[CRiC]. Developing Sustainable Cancer and Aging Programs. Am Soc Clin Oncol Educ Book. 2023 May; 43:e390980. ( Abstract )	05/01/2023
* 132.	Le D, Kim HJ, Wen KY[CRiC], Juon HS[CRiC]. Disparities in awareness of the HPV vaccine and HPV-associated cancers among racial/ethnic minority populations: 2018 HINTS. Ethn Health. 2023 May; 28(4):586-600. ( Abstract )	05/01/2023
¶ 133.	Lilly GL, Sweeny L, Santucci N, Cannady S, Frost A, Anagnos V, Curry J[MORA], Sagalow E, Freeman C, Puram SV, Pipkorn P, Slijepcevic A, Fuson A, Bonaventure C, Wax MK. Perioperative Hypercoagulability in Free Flap Reconstructions Performed for Intracranial Tumors. Laryngoscope. 2023 May; 133(5):1103-1109. ( Abstract )	05/01/2023
¶ 134.	Lin D[MORA], Nguyen H, Shah R, Qiao Y, Hartman J, Sugarman R. Quality-adjusted time without symptoms or toxicity analysis of nivolumab plus chemotherapy versus chemotherapy alone for the management of previously untreated patients with advanced gastric cancer, gastroesophageal junction cancer, or esophageal adenocarcinoma. Gastric Cancer. 2023 May; 26(3):415-424. ( Abstract )	05/01/2023
135.	Mitra R, Adams CM, Eischen CM[IRT]. Decoding the lncRNAome Across Diverse Cellular Stresses Reveals Core p53-effector Pan-cancer Suppressive lncRNAs. Cancer Res Commun. 2023 May; 3(5):842-859. ( Abstract )	05/01/2023
136.	Nerli R, Kalloli M, Rangrez S, Ghagane SC, Vinchurkar K, Chandra S, Thakur ML[TaCO]. Diagnosis of Oral Cancers by Targeting VPAC Receptors: Preliminary Report. Asian Pac J Cancer Prev. 2023 May 01; 24(5):1711-1715. ( Abstract )	05/01/2023
137.	Newman L, Mitchell E[CRiC]. Disparities in triple negative breast cancer. J Natl Med Assoc. 2023 May; 115(2S):S8-S12. ( Abstract )	05/01/2023
138.	Perkins R, Mitchell E[CRiC]. Cervical cancer disparities. J Natl Med Assoc. 2023 May; 115(2S):S19-S25. ( Abstract )	05/01/2023
139.	Risser GE, Machour M, Hernaez-Estrada B, Li D, Levenberg S, Spiller KL[IRT]. Effects of Interleukin-4 (IL-4)-releasing microparticles and adoptive transfer of macrophages on immunomodulation and angiogenesis. Biomaterials. 2023 May; 296:122095. ( Abstract )	05/01/2023
¶ + 140.	Vitale I, Pietrocola F, Guilbaud E, Aaronson SA, . . . Alnemri ES[IRT], . . . Hajnoczky G[TaCO], . . . Piacentini M, Kroemer G, Galluzzi L. Apoptotic cell death in disease-Current understanding of the NCCD 2023. Cell Death Differ. 2023 May; 30(5):1097-1154. ( Abstract )	05/01/2023
¶ 141.	Winn R, Winkfield K, Mitchell E[CRiC]. Addressing disparities in cancer care and incorporating precision medicine for minority populations. J Natl Med Assoc. 2023 May; 115(2S):S2-S7. ( Abstract )	05/01/2023
+ 142.	Micaily I, Lee S, Basu Mallick A[MORA], Zhan T, O'Neill R, Gargano S, Hozack B, Thapa S, Martinez-Outschoorn U[TaCO], Abraham J, Jiang W. TOMM20 as a Potential Prognostic Biomarker in Chordoma: Results From a High-Volume, Single-Center Study. Am J Clin Pathol. 2023 May 02; 159(5):492-501. ( Abstract )	05/02/2023
¶ 143.	Adams CM, Mitra R, Xiao Y, Michener P, Palazzo J, Chao A, Gour J, Cassel J, Salvino JM, Eischen CM[IRT]. Targeted MDM2 Degradation Reveals a New Vulnerability for p53-Inactivated Triple-Negative Breast Cancer. Cancer Discov. 2023 May 04; 13(5):1210-1229. ( Abstract )	05/04/2023
¶ 144.	Krieger N, Chen JT, Testa C, Diez Roux A[CRiC], Tilling K, Watkins S, Simpkin AJ, Suderman M, Davey Smith G, De Vivo I, Waterman PD, Relton C. Use of Correct and Incorrect Methods of Accounting for Age in Studies of Epigenetic Accelerated Aging: Implications and Recommendations for Best Practices. Am J Epidemiol. 2023 May 05; 192(5):800-811. ( Abstract )	05/05/2023
* 145.	Melo-Silva CR, Knudson CJ, Tang L, Kafle S, Springer LE, Choi J, Snyder CM[IRT], Wang Y, Kim SV[IRT], Sigal LJ[IRT]. Multiple and Consecutive Genome Editing Using i-GONAD and Breeding Enrichment Facilitates the Production of Genetically Modified Mice. Cells. 2023 May 08; 12(9). ( Abstract )	05/08/2023
¶ 146.	D'Angelica MI, Ellis RJ, Liu JB, Brajcich BC, Gönen M, Thompson VM, Cohen ME, Seo SK, Zabor EC, Babicky ML, Bentrem DJ, Behrman SW, Bertens KA, Celinski SA, Chan CHF, Dillhoff M, Dixon MEB, Fernandez-Del Castillo C, Gholami S, House MG, Karanicolas PJ, Lavu H[MORA], Maithel SK, McAuliffe JC, Ott MJ, Reames BN, Sanford DE, Sarpel U, Scaife CL, Serrano PE, Smith T, Snyder RA, Talamonti MS, Weber SM, Yopp AC, Pitt HA, Ko CY. Piperacillin-Tazobactam Compared With Cefoxitin as Antimicrobial Prophylaxis for Pancreatoduodenectomy: A Randomized Clinical Trial. JAMA. 2023 May 09; 329(18):1579-1588. ( Abstract )	05/09/2023
147.	Rodríguez-Prados M, Berezhnaya E, Castromonte MT, Menezes-Filho SL, Paillard M, Hajnoczky G[TaCO]. MICU1 occludes the mitochondrial calcium uniporter in divalent-free conditions. Proc Natl Acad Sci U S A. 2023 May 09; 120(19):e2218999120. ( Abstract )	05/09/2023
148.	De Gregorio C, Catalán E, Garrido G, Morandé P, Bennett JC, Muñoz C, Cofré G, Huang YL, Cuadra B, Murgas P, Calvo M, Altermatt F, Yubero MJ, Palisson F, South AP[MORA], Ezquer M, Fuentes I. Maintenance of chronicity signatures in fibroblasts isolated from recessive dystrophic epidermolysis bullosa chronic wound dressings under culture conditions. Biol Res. 2023 May 10; 56(1):23. ( Abstract )	05/10/2023
¶ 149.	Vekariya U, Toma M, Nieborowska-Skorska M, Le BV, Caron MC, Kukuyan AM, Sullivan-Reed K, Podszywalow-Bartnicka P, Chitrala KN, Atkins J, Drzewiecka M, Feng W, Chan J, Chatla S, Golovine K, Jelinek J, Sliwinski T, Ghosh J, Matlawska-Wasowska K, Chandramouly G, Nejati R, Wasik M, Sykes SM, Piwocka K, Hadzijusufovic E, Valent P, Pomerantz RT[MORA], Morton G, Childers W, Zhao H, Paietta EM, Levine RL, Tallman MS, Fernandez HF, Litzow MR, Gupta GP, Masson JY, Skorski T. DNA polymerase θ protects leukemia cells from metabolically induced DNA damage. Blood. 2023 May 11; 141(19):2372-2389. ( Abstract )	05/11/2023
¶ 150.	Moskalenko M, Jones BL, Mueller A[MORA], Lewis S, Shiao JC, Zakem SJ, Robin TP, Goodman KA. Fiducial Markers Allow Accurate and Reproducible Delivery of Liver Stereotactic Body Radiation Therapy. Curr Oncol. 2023 May 16; 30(5):5054-5061. ( Abstract )	05/16/2023
¶ 151.	Ranjan T, Sengupta S, Glantz MJ, Green RM, Yu A, Aregawi D, Chaudhary R, Chen R, Zuccarello M, Lu-Emerson C, Moulding HD, Belman N, Glass J[MORA], Mammoser A, Anderson M, Valluri J, Marko N, Schroeder J, Jubelirer S, Chow F, Claudio PP, Alberico AM, Lirette ST, Denning KL, Howard CM. Cancer stem cell assay-guided chemotherapy improves survival of patients with recurrent glioblastoma in a randomized trial. Cell Rep Med. 2023 May 16; 4(5):101025. ( Abstract )	05/16/2023
¶ 152.	Doherty M, Heintz J, Leader A[CRiC], Wittenberg D, Ben-Shalom Y, Jacoby J, Castro A, West S. Guaranteed Income and Financial Treatment Trial (GIFT Trial or GIFTT): a 12-month, randomized controlled trial to compare the effectiveness of monthly unconditional cash transfers to treatment as usual in reducing financial toxicity in people with cancer who have low incomes. Front Psychol. 2023 May 18; 14:1179320. ( Abstract )	05/18/2023
+ 153.	Basta MD, Petruk S, Summer R[TaCO], Rosenbloom J, Wermuth PJ, Macarak E, Levin AV, Mazo A[MORA], Walker JL. Changes in nascent chromatin structure regulate activation of the pro-fibrotic transcriptome and myofibroblast emergence in organ fibrosis. iScience. 2023 May 19; 26(5):106570. ( Abstract )	05/19/2023
¶ 154.	Halabi S, Yang Q, Roy A, Luo B, Araujo JC, Logothetis C, Sternberg CN, Armstrong AJ, Carducci MA, Chi KN, de Bono JS, Petrylak DP, Fizazi K, Higano CS, Morris MJ, Rathkopf DE, Saad F, Ryan CJ, Small EJ, Kelly WK[MORA]. External Validation of a Prognostic Model of Overall Survival in Men With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer. J Clin Oncol. 2023 May 20; 41(15):2736-2746. ( Abstract )	05/20/2023
¶ * 155.	Hohl SD, Matulewicz RS, Salloum RG, Ostroff JS, Baker TB, Schnoll R, Warren G, Bernstein SL, Minion M, Lenhoff K, Dahl N, Juon HS[CRiC], Tsosie U, Fleisher L, D'Angelo H, Ramsey AT, Ashing KT, Rolland B, Nolan MB, Bird JE, Nguyen CVT, Pauk D, Adsit RT, Tindle HA, Shoenbill K, Yeung S, Presant CA, Wiseman KP, Wen KY[CRiC], Chichester LA, Chen LS. Integrating Tobacco Treatment Into Oncology Care: Reach and Effectiveness of Evidence-Based Tobacco Treatment Across National Cancer Institute-Designated Cancer Centers. J Clin Oncol. 2023 May 20; 41(15):2756-2766. ( Abstract )	05/20/2023
¶ 156.	Ogunmowo TH, Jing H, Raychaudhuri S, Kusick GF, Imoto Y, Li S, Itoh K, Ma Y, Jafri H, Dalva MB[TaCO], Chapman ER, Ha T, Watanabe S, Liu J. Membrane compression by synaptic vesicle exocytosis triggers ultrafast endocytosis. Nat Commun. 2023 May 20; 14(1):2888. ( Abstract )	05/20/2023
¶ 157.	Spence RA, Hinyard LJ, Jagsi R, Jimenez RB, Lopez AM[CRiC], Chavez-MacGregor M, Spector-Bagdady K, Rosenberg AR. ASCO Ethical Guidance for the US Oncology Community Where Reproductive Health Care Is Limited by Law. J Clin Oncol. 2023 May 20; 41(15):2852-2858. ( Abstract )	05/20/2023
¶ 158.	Nichtová Z, Fernandez-Sanz C, De La Fuente S, Yuan Y, Hurst S, Lanvermann S, Tsai HY, Weaver D, Baggett A, Thompson C, Bouchet-Marquis C, Várnai P, Seifert EL, Dorn GW, Sheu SS[TaCO], Csordás G. Enhanced Mitochondria-SR Tethering Triggers Adaptive Cardiac Muscle Remodeling. Circ Res. 2023 May 26; 132(11):e171-e187. ( Abstract )	05/26/2023
* 159.	Ream C, Sabitsky M, Huang R, Hammelef E, Yeo TP, Lavu H[MORA], Yeo CJ[MORA], Bowne W, Nevler A. Association of Smoking and Respiratory Disease History with Pancreatic Pathologies Requiring Surgical Resection. Cancers (Basel). 2023 May 26; 15(11). ( Abstract )	05/26/2023
160.	Cappelli L, Khan MM, Kayne A, Poiset S, Miller R, Ali A, Niazi M, Shi W[MORA], Alnahhas I. Differences in clinical outcomes based on molecular markers in glioblastoma patients treated with concurrent tumor-treating fields and chemoradiation: exploratory analysis of the SPARE trial. Chin Clin Oncol. 2023 Jun; 12(3):23. ( Abstract )	06/01/2023
¶ +* 161.	De Ravin E, Armache M, Campbell F, Rising KL[CRiC], Worster B[CRiC], Handley NR[CRiC], Fundakowski CE, Cognetti DM[TaCO], Mady LJ. Feasibility and Cost of Telehealth Head and Neck Cancer Survivorship Care: A Systematic Review. Otolaryngol Head Neck Surg. 2023 Jun; 168(6):1312-1323. ( Abstract )	06/01/2023
* 162.	Gleason L, Tekmen V, Cohen A, Bhatti S, Beksac B, Cha J, Porcu P[IRT], Nikbakht N[IRT]. Recalcitrant Cutaneous Mastocytosis Treated With Genetically Informed Targeted Therapy: A Case Report. Int J Dermatol Venereol. 2023 Jun; 6(2):107-109. ( Abstract )	06/01/2023
¶ 163.	Gudenkauf LM, Chavez MN, Maconi ML, Geiss C, Seyedroudbari A, Thin P, Hoogland AI, Nguyen K, Murthy V, Armstrong WR, Komrokji K, Oswald LB, Jim HSL, El-Haddad G, Fendler WP, Herrmann K, Cella D, Czernin J, Hofman MS, Dicker AP[CRiC], Calais J, Tagawa ST, Gonzalez BD. Developing a Patient-Reported Outcome Measure for Radionuclide Therapy for Prostate Cancer. J Nucl Med. 2023 Jun; 64(6):869-872. ( Abstract )	06/01/2023
¶ 164.	Hamid O, Hassel JC, Shoushtari AN, Meier F, Bauer TM, Salama AKS, Kirkwood JM, Ascierto PA, Lorigan PC, Mauch C, Orloff M[IRT], Evans TRJ, Holland C, Edukulla R, Abedin SE, Middleton MR. Tebentafusp in combination with durvalumab and/or tremelimumab in patients with metastatic cutaneous melanoma: a phase 1 study. J Immunother Cancer. 2023 Jun; 11(6). ( Abstract )	06/01/2023
¶ 165.	Kennedy GT, Azari FS, Chang A, Nadeem B, Bernstein E, Segil A, Din A, Desphande C, Okusanya O[MORA], Keating J, Predina J, Newton A, Kucharczuk JC, Singhal S. Single-institution experience of 500 pulmonary resections guided by intraoperative molecular imaging. J Thorac Cardiovasc Surg. 2023 Jun; 165(6):1928-1938.e1. ( Abstract )	06/01/2023
¶ + 166.	Khanna O, Fathi Kazerooni A, Arif S, Mahtabfar A, Momin AA, Andrews CE, Hafazalla K, Baldassari MP, Velagapudi L, Garcia JA, Sako C, Farrell CJ, Evans JJ, Judy KD, Andrews DW[IRT], Flanders AE, Shi W[MORA], Davatzikos C. Radiomic signatures of meningiomas using the Ki-67 proliferation index as a prognostic marker of clinical outcomes. Neurosurg Focus. 2023 Jun; 54(6):E17. ( Abstract )	06/01/2023
¶ 167.	Lee NY, Harris J, Kim J, Garden A, Mechalakos J, Pfister DG, Chan ATC, Hu K, Colevas AD, Frank S, Shenouda G, Bar-Ad V[MORA], Waldron JN, Harari PM, Raben A, Torres-Saavedra P, Le QT. Long-term Outcomes of Bevacizumab and Chemoradiation for Locoregionally Advanced Nasopharyngeal Carcinoma: A Nonrandomized Controlled Trial. JAMA Netw Open. 2023 Jun 01; 6(6):e2316094. ( Abstract )	06/01/2023
168.	Lin R, Flerova E, Wamsley CE, McCue PA, Lallas CD[MORA], Jiang W, Huang J, Wang ZX, Li L. Sarcomatoid renal cell tumor harboring a novel BYSL::TFEB fusion with concurrent TFEB amplification. Genes Chromosomes Cancer. 2023 Jun; 62(6):353-360. ( Abstract )	06/01/2023
¶ 169.	Li Z, Jiao X, Robertson AG, Di Sante G, Ashton AW, DiRocco A, Wang M, Zhao J, Addya S, Wang C, McCue PA, South AP[MORA], Cordon-Cardo C, Liu R, Patel K, Hamid R, Parmar J, DuHadaway JB, Jones SJM, Casimiro MC, Schultz N, Kossenkov A, Phoon LY, Chen H, Lan L, Sun Y, Iczkowski KA, Rui H, Pestell RG. The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responses. Oncogene. 2023 Jun; 42(22):1857-1873. ( Abstract )	06/01/2023
¶ * 170.	Machado P, Liu JB[TaCO], Needleman L, Lee C, Forsberg F[TaCO]. Anatomy Versus Physiology: Is Breast Lymphatic Drainage to the Internal Thoracic (Internal Mammary) Lymphatic System Clinically Relevant? J Breast Cancer. 2023 Jun; 26(3):286-291. ( Abstract )	06/01/2023
¶ +* 171.	Mark JR, Gomella LG[MORA], Lallas CD[MORA], Smentkowski KE, Calvaresi A, Handley N[CRiC], Den RB, Mille P, Tester WJ[MORA], Hoffman-Censits J, Dicker AP[CRiC], Klonicke E, Halpern E[TaCO], McCue P, Kelly WK[MORA], Trabulsi EJ[MORA]. Enhancing bladder cancer care through the multidisciplinary clinic approach. Can J Urol. 2023 Jun; 30(3):11526-11531. ( Abstract )	06/01/2023
¶ 172.	Mathias W, Nichols KA, Golden-Wright J, Fairman CM, Felder TM, Workman L, Wickersham KE, Flicker KJ, Sheng J, Noblet SB, Adams SA, Eberth JM[CRiC], Heiney SP, Wilcox S, Hébert JR, Friedman DB. Implementation During a Pandemic: Findings, Successes, and Lessons Learned from Community Grantees. J Cancer Educ. 2023 Jun; 38(3):957-962. ( Abstract )	06/01/2023
¶ 173.	McCarthy GA, Di Niro R, Finan JM, Jain A[MORA], Guo Y, Wyatt CR, Guimaraes AR, Waugh TA, Keith D, Morgan TK, Sears RC, Brody JR. Deletion of the mRNA stability factor ELAVL1 (HuR) in pancreatic cancer cells disrupts the tumor microenvironment integrity. NAR Cancer. 2023 Jun; 5(2):zcad016. ( Abstract )	06/01/2023
¶ * 174.	McCarthy GA, Jain A[MORA], Di Niro R, Schultz CW, Jiang W, Yeo CJ[MORA], Bowers J, Finan J, Rhodes K, Casta L, Hou V, Stefanoni A, Brown SZ, Nevler A, Agostini LC, Getts L, Getts R, Brody JR. A Novel 3DNA® Nanocarrier effectively delivers payloads to pancreatic tumors. Transl Oncol. 2023 Jun; 32:101662. ( Abstract )	06/01/2023
¶ * 175.	McIntire RK, Juon HS[CRiC], Keith SW, Simone NL[CRiC], Waters D, Lewis E, Zeigler-Johnson C. A novel method for measuring the burden of breast cancer in neighborhoods. Prev Med Rep. 2023 Jun; 33:102218. ( Abstract )	06/01/2023
176.	Mitchell EP[CRiC]. Participation of All in The National Cancer Plan. J Natl Med Assoc. 2023 Jun; 115(3):271-272. ( Abstract )	06/01/2023
* 177.	Nelson NG, Lombardo JF, Shimada A, Ruggiero ML, Smith AP, Ko K, Leader AE[CRiC], Mitchell EP[CRiC], Simone NL[CRiC]. Physician Perceptions on Cancer Screening for LGBTQ+ Patients. Cancers (Basel). 2023 Jun 01; 15(11). ( Abstract )	06/01/2023
¶ 178.	O'Dwyer PJ, Gray RJ, Flaherty KT, Chen AP, Li S, Wang V, McShane LM, Patton DR, Tricoli JV, Williams PM, Iafrate AJ, Sklar J, Mitchell EP[CRiC], Takebe N, Sims DJ, Coffey B, Fu T, Routbort M, Rubinstein LV, Little RF, Arteaga CL, Marinucci D, Hamilton SR, Conley BA, Harris LN, Doroshow JH. The NCI-MATCH trial: lessons for precision oncology. Nat Med. 2023 Jun; 29(6):1349-1357. ( Abstract )	06/01/2023
179.	Perillo M, Punzo A, Caliceti C, Sell C[CRiC], Lorenzini A. The spontaneous immortalization probability of mammalian cell culture strains, as their proliferative capacity, correlates with species body mass, not longevity. Biomed J. 2023 Jun; 46(3):100596. ( Abstract )	06/01/2023
¶ 180.	Ryu S, Deshmukh S, Timmerman RD, Movsas B, Gerszten P, Yin FF, Dicker A[CRiC], Abraham CD, Zhong J, Shiao SL, Tuli R, Desai A, Mell LK, Iyengar P, Hitchcock YJ, Allen AM, Burton S, Brown D, Sharp HJ, Dunlap NE, Siddiqui MS, Chen TH, Pugh SL, Kachnic LA. Stereotactic Radiosurgery vs Conventional Radiotherapy for Localized Vertebral Metastases of the Spine: Phase 3 Results of NRG Oncology/RTOG 0631 Randomized Clinical Trial. JAMA Oncol. 2023 Jun 01; 9(6):800-807. ( Abstract )	06/01/2023
+* 181.	Savitch SL, Zheng R, Abdelsattar ZM, Barta JA[CRiC], Okusanya OT[MORA], Evans NR[CRiC], Grenda TR[MORA]. Surgical Outcomes in the National Lung Screening Trial Compared With Contemporary Practice. Ann Thorac Surg. 2023 Jun; 115(6):1369-1377. ( Abstract )	06/01/2023
182.	Seifert EL, Hajnoczky G[TaCO]. Fuel oxidation under the control of mitochondrial shape and dynamics. EMBO J. 2023 Jun 01; 42(11):e114129. ( Abstract )	06/01/2023
183.	Tekumalla S, Xu D, Awh K, Philp N[TaCO], Milman T, Garg S. DIAGNOSTIC YIELD OF IN VITRO VITREOUS BIOPSY FOR INTRAOCULAR LYMPHOMA AT VARIABLE VITREOUS CUTTER SPEEDS USING 25-GAUGE VITRECTOMY. Retina. 2023 Jun 01; 43(6):1005-1009. ( Abstract )	06/01/2023
¶ * 184.	Wilde L[IRT], Porazzi P, Trotta R, De Dominici M, Palmisiano N, Keiffer G[IRT], Rancani K, Yingling K, Calabretta B[IRT], Kasner M[IRT]. A phase I study of the combination of palbociclib and dexamethasone for the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia. Leuk Res. 2023 Jun; 129:107075. ( Abstract )	06/01/2023
¶ 185.	Yeon M, Bertolini I, Agarwal E, Ghosh JC, Tang HY, Speicher DW, Keeney F, Sossey-Alaoui K, Pluskota E, Bialkowska K, Plow EF, Languino LR[TaCO], Skordalakes E, Caino MC, Altieri DC. Parkin ubiquitination of Kindlin-2 enables mitochondria-associated metastasis suppression. J Biol Chem. 2023 Jun; 299(6):104774. ( Abstract )	06/01/2023
¶ +* 186.	Yu TZ, Agnihotri A, Zheng R, Bashir B[IRT], Nasher N, Yeo CJ[MORA], Nevler A, Lavu H[MORA], Bowne WB, Kumar A. Salvage endoscopic ultrasound-guided gastrojejunostomy as a bridge to definitive surgical therapy for duodenal adenocarcinoma presenting with duodenal stent obstruction. Clin J Gastroenterol. 2023 Jun; 16(3):387-391. ( Abstract )	06/01/2023
¶ 187.	Eskander RN, Sill MW, Beffa L, Moore RG, Hope JM, Musa FB, Mannel R, Shahin MS[MORA], Cantuaria GH, Girda E, Mathews C, Kavecansky J, Leath CA, Gien LT, Hinchcliff EM, Lele SB, Landrum LM, Backes F, O'Cearbhaill RE, Al Baghdadi T, Hill EK, Thaker PH, John VS, Welch S, Fader AN, Powell MA, Aghajanian C. Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer. N Engl J Med. 2023 Jun 08; 388(23):2159-2170. ( Abstract )	06/08/2023
¶ 188.	Mirza MR, Chase DM, Slomovitz BM, dePont Christensen R, Novák Z, Black D, Gilbert L, Sharma S, Valabrega G, Landrum LM, Hanker LC, Stuckey A, Boere I, Gold MA, Auranen A, Pothuri B, Cibula D, McCourt C, Raspagliesi F, Shahin MS[MORA], Gill SE, Monk BJ, Buscema J, Herzog TJ, Copeland LJ, Tian M, He Z, Stevens S, Zografos E, Coleman RL, Powell MA, RUBY Investigators. Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer. N Engl J Med. 2023 Jun 08; 388(23):2145-2158. ( Abstract )	06/08/2023
* 189.	Hernandez-Lara MA, Yadav SK, Conaway S, Shah SD, Penn RB[TaCO], Deshpande DA[TaCO]. Crosstalk between diacylglycerol kinase and protein kinase A in the regulation of airway smooth muscle cell proliferation. Respir Res. 2023 Jun 10; 24(1):155. ( Abstract )	06/10/2023
* 190.	Huang R, Hammelef E, Sabitsky M, Ream C, Khalilieh S, Zohar N, Lavu H[MORA], Bowne WB, Yeo CJ[MORA], Nevler A. Chronic Obstructive Pulmonary Disease Is Associated with Worse Oncologic Outcomes in Early-Stage Resected Pancreatic and Periampullary Cancers. Biomedicines. 2023 Jun 10; 11(6). ( Abstract )	06/10/2023
¶ 191.	Basova LV, Lindsey A, McGovern A, Rosander A, Delorme-Walker V, ElShamy WM, Pendyala VV, Gaskill PJ[IRT], Ellis RJ, Cherner M, Iudicello JE, Marcondes MCG. MRP8/14 Is a Molecular Signature Triggered by Dopamine in HIV Latent Myeloid Targets That Increases HIV Transcription and Distinguishes HIV+ Methamphetamine Users with Detectable CSF Viral Load and Brain Pathology. Viruses. 2023 Jun 13; 15(6). ( Abstract )	06/13/2023
¶ + 192.	Zarrabi KK, Narayan V, Mille PJ, Zibelman MR, Miron B, Bashir B[IRT], Kelly WK[MORA]. Bispecific PSMA antibodies and CAR-T in metastatic castration-resistant prostate cancer. Ther Adv Urol. 2023; 15:17562872231182219. ( Abstract )	06/15/2023
¶ 193.	Budhu A, Pehrsson EC, He A, Goyal L, Kelley RK, Dang H[MORA], Xie C, Monge C, Tandon M, Ma L, Revsine M, Kuhlman L, Zhang K, Baiev I, Lamm R, Patel K, Kleiner DE, Hewitt SM, Tran B, Shetty J, Wu X, Zhao Y, Shen TW, Choudhari S, Kriga Y, Ylaya K, Warner AC, Edmondson EF, Forgues M, Greten TF, Wang XW. Tumor biology and immune infiltration define primary liver cancer subsets linked to overall survival after immunotherapy. Cell Rep Med. 2023 Jun 20; 4(6):101052. ( Abstract )	06/20/2023
¶ 194.	Diray-Arce J, Fourati S, Doni Jayavelu N, Patel R, Maguire C, Chang AC, Dandekar R, Qi J, Lee BH, van Zalm P, Schroeder A, Chen E, Konstorum A, Brito A, Gygi JP, Kho A, Chen J, Pawar S, Gonzalez-Reiche AS, Hoch A, Milliren CE, Overton JA, Westendorf K, IMPACC Network, Cairns CB, Rouphael N, Bosinger SE, Kim-Schulze S, Krammer F, Rosen L, Grubaugh ND, van Bakel H, Wilson M, Rajan J, Steen H, Eckalbar W, Cotsapas C, Langelier CR, Levy O, Altman MC, Maecker H, Montgomery RR, Haddad EK[IRT], Sekaly RP, Esserman D, Ozonoff A, Becker PM, Augustine AD, Guan L, Peters B, Kleinstein SH. Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patients. Cell Rep Med. 2023 Jun 20; 4(6):101079. ( Abstract )	06/20/2023
¶ 195.	Ragon BK, Shah MV, D'Souza A, Estrada-Merly N, Gowda L, George G, de Lima M, Hashmi S, Kharfan-Dabaja MA, Majhail NS, Banerjee R, Saad A, Hildebrandt GC, Mian H, Abid MB, Battiwalla M, Lekakis LJ, Patel SS, Murthy HS, Nieto Y, Strouse C, Badawy SM, Al Hadidi S, Dholaria B, Aljurf M, Vesole DH, Lee CH, Pawarode A, Gergis U[IRT], Miller KC, Holmberg LA, Afrough A, Solh M, Munshi PN, Nishihori T, Anderson LD, Wirk B, Kaur G, Qazilbash MH, Shah N, Kumar SK, Usmani SZ. Impact of second primary malignancy post-autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis. Blood Adv. 2023 Jun 27; 7(12):2746-2757. ( Abstract )	06/27/2023
¶ + 196.	Seyedsadr M, Wang Y, Elzoheiry M, Shree Gopal S, Jang S, Duran G, Chervoneva I[CRiC], Kasimoglou E, Wrobel JA, Hwang D, Garifallou J, Zhang X, Khan TH, Lorenz U, Su M, Ting JP, Broux B, Rostami A[IRT], Miskin D, Markovic-Plese S. IL-11 induces NLRP3 inflammasome activation in monocytes and inflammatory cell migration to the central nervous system. Proc Natl Acad Sci U S A. 2023 Jun 27; 120(26):e2221007120. ( Abstract )	06/27/2023
197.	Netting DJ, Mantegazza AR[IRT]. Examining the Kinetics of Phagocytosis-Coupled Inflammasome Activation in Murine Bone Marrow-Derived Dendritic Cells. Methods Mol Biol. 2023; 2692:289-309. ( Abstract )	06/28/2023
198.	Scharrig E, Mantegazza AR[IRT]. Dissecting Phagosomal Pattern Recognition Receptor-Dependent Signaling and Antigen MHC-II Presentation from Phagosomes in Murine Dendritic Cells. Methods Mol Biol. 2023; 2692:275-287. ( Abstract )	06/28/2023
199.	Le PM, Pal-Ghosh S, Menko AS[TaCO], Stepp MA. Immune Cells Localize to Sites of Corneal Erosions in C57BL/6 Mice. Biomolecules. 2023 Jun 29; 13(7). ( Abstract )	06/29/2023
¶ +* 200.	Han A, Mukha D, Chua V, Purwin TJ, Tiago M, Modasia B, Baqai U, Aumiller JL, Bechtel N, Hunter E, Danielson M, Terai M, Wedegaertner PB[TaCO], Sato T[IRT], Landreville S, Davies MA, Kurtenbach S, Harbour JW, Schug ZT, Aplin AE[TaCO]. Co-Targeting FASN and mTOR Suppresses Uveal Melanoma Growth. Cancers (Basel). 2023 Jun 30; 15(13). ( Abstract )	06/30/2023
201.	Nguyen J, Maio V, Walsh K, Handley N[CRiC], Patel S, Keith SW, Csik VP. Hematologic Malignancy Episodes Exceed Target Price in Oncology Care Model. Am J Med Qual. 2023 Jul-Aug 01; 38(4):174-180. ( Abstract )	06/30/2023
¶ 202.	Bonomi M, Blakaj DM, Kabarriti R, Colvett K, Takiar V, Biagioli M, Bar-Ad V[MORA], Goyal S, Muzyka B, Niermann K, Abrouk N, Oronsky B, Reid T, Caroen S, Sonis S, Sher DJ. PREVLAR: Phase 2a Randomized Trial to Assess the Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Head and Neck Chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2023 Jul 01; 116(3):551-559. ( Abstract )	07/01/2023
¶ 203.	Caudell JJ, Torres-Saavedra PA, Rosenthal DI, Axelrod RS[MORA], Nguyen-Tan PF, Sherman EJ, Weber RS, Galvin JM, El-Naggar AK, Konski AA, Echevarria MI, Dunlap NE, Shenouda G, Singh AK, Beitler JJ, Garsa A, Bonner JA, Garden AS, Algan O, Harris J, Le QT. Long-Term Update of NRG/RTOG 0522: A Randomized Phase 3 Trial of Concurrent Radiation and Cisplatin With or Without Cetuximab in Locoregionally Advanced Head and Neck Cancer. Int J Radiat Oncol Biol Phys. 2023 Jul 01; 116(3):533-543. ( Abstract )	07/01/2023
¶ 204.	Eberth JM[CRiC], Gieske MR, Silvestri GA. Changing recommendations for lung cancer screening: National Lung Cancer Roundtable member perspectives. Cancer. 2023 Jul 01; 129(13):1953-1958. ( Abstract )	07/01/2023
¶ 205.	Joseph J, Premeaux TA, Pinto DO, Rao A, Guha S, Panfil AR, Carey AJ, Ndhlovu LC, Bergmann-Leitner ES, Jain P[IRT]. Retroviral b-Zip protein (HBZ) contributes to the release of soluble and exosomal immune checkpoint molecules in the context of neuroinflammation. J Extracell Biol. 2023 Jul; 2(7). ( Abstract )	07/01/2023
206.	Kriegsmann M, Kriegsmann K, Steinbuss G, Zgorzelski C, Albrecht T, Heinrich S, Farkas S, Roth W, Dang H[MORA], Hausen A, Gaida MM. Implementation of deep learning in liver pathology optimizes diagnosis of benign lesions and adenocarcinoma metastasis. Clin Transl Med. 2023 Jul; 13(7):e1299. ( Abstract )	07/01/2023
¶ 207.	LaFleur B, Curiel-Lewandrowski C, Tapia E, Parker J, White L, Chow HS, South AP[MORA]. Characterizing Dermal Transcriptional Change in the Progression from Sun-Protected Skin to Actinic Keratosis. J Invest Dermatol. 2023 Jul; 143(7):1299-1302.e3. ( Abstract )	07/01/2023
* 208.	Liu JB[TaCO], Machado P, Eisenbrey JR[TaCO], Gummadi S, Forsberg F[TaCO], Wessner CE, Kumar AR, Chiang A, Infantolino A, Schlachterman A, Kowalski T, Coben R, Loren D. Identification of sentinel lymph nodes in esophageal cancer patients using contrast-enhanced EUS with peritumoral injections. Endosc Ultrasound. 2023; 12(4):362-368. ( Abstract )	07/01/2023
+* 209.	Machado P, Liu JB[TaCO], Needleman L, Lazar M[MORA], Willis AI, Brill K, Nazarian S, Berger A, Forsberg F[TaCO]. Sentinel Lymph Node Identification in Post Neoadjuvant Chemotherapy Breast Cancer Patients Undergoing Surgical Excision Using Lymphosonography. J Ultrasound Med. 2023 Jul; 42(7):1509-1517. ( Abstract )	07/01/2023
¶ 210.	Nguyen PL, Huang HR, Spratt DE, Davicioni E, Sandler HM, Shipley WU, Efstathiou JA, Simko JP, Pollack A, Dicker AP[CRiC], Roach M, Rosenthal SA, Zeitzer KL, Mendez LC, Hartford AC, Hall WA, Desai AB, Rabinovitch RA, Peters CA, Rodgers JP, Tran P, Feng FY. Analysis of a Biopsy-Based Genomic Classifier in High-Risk Prostate Cancer: Meta-Analysis of the NRG Oncology/Radiation Therapy Oncology Group 9202, 9413, and 9902 Phase 3 Randomized Trials. Int J Radiat Oncol Biol Phys. 2023 Jul 01; 116(3):521-529. ( Abstract )	07/01/2023
¶ 211.	Pathak R, Leslie M, Dondapati P, Davis R, Tanaka K, Jett E, Chervoneva I[CRiC], Tanaka T. Increased breast cancer mortality due to treatment delay and needle biopsy type: a retrospective analysis of SEER-medicare. Breast Cancer. 2023 Jul; 30(4):627-636. ( Abstract )	07/01/2023
212.	Seyedin R, Snider JT, Rajagopalan K, Wade SW, Gergis U[IRT]. Chimeric antigen receptor T-cell treatment patterns in relapsed or refractory large B-cell lymphoma. Future Oncol. 2023 Jul; 19(22):1535-1547. ( Abstract )	07/01/2023
213.	Simhal RK, Shah YB, Wang KR, Martin J, Shah S, Wright A, D'Amico M, Leong JY, Lallas CD[MORA], Shenot PJ, Shah MS, Murphy AM. Gender Diversity in Urology Residency Program Leadership Is Associated With Gender Diversity in Residency Cohort. Urology. 2023 Jul; 177:222-226. ( Abstract )	07/01/2023
¶ 214.	Kc M, Fan J, Hyslop T[CRiC], Hassan S, Cecchini M, Wang SY, Silber A, Leapman MS, Leeds I, Wheeler SB, Spees LP, Gross CP, Lustberg M, Greenup RA, Justice AC, Oeffinger KC, Dinan MA. Relative Burden of Cancer and Noncancer Mortality Among Long-Term Survivors of Breast, Prostate, and Colorectal Cancer in the US. JAMA Netw Open. 2023 Jul 03; 6(7):e2323115. ( Abstract )	07/03/2023
¶ 215.	Liou KT, Ashare R, Worster B[CRiC], Jones KF, Yeager KA, Acevedo AM, Ferrer R, Meghani SH. SIO-ASCO guideline on integrative medicine for cancer pain management: implications for racial and ethnic pain disparities. JNCI Cancer Spectr. 2023 Jul 03; 7(4). ( Abstract )	07/03/2023
¶ 216.	Ashare RL, Turay E, Worster B[CRiC], Wetherill RR, Bidwell LC, Doucette A, Meghani SH. Social Determinants of Health Associated with How Cannabis is Obtained and Used in Patients with Cancer Receiving Care at a Cancer Treatment Center in Pennsylvania. Cannabis. 2023 Jul 5; 6(2):1-12. ( Abstract )	07/05/2023
+ 217.	Cohen AJ, Nikbakht N[IRT], Uitto J[CRiC]. Keloid Disorder: Genetic Basis, Gene Expression Profiles, and Immunological Modulation of the Fibrotic Processes in the Skin. Cold Spring Harb Perspect Biol. 2023 Jul 05; 15(7). ( Abstract )	07/05/2023
218.	Li F, Hou CD, Lokareddy RK, Yang R, Forti F, Briani F, Cingolani G[MORA]. High-resolution cryo-EM structure of the Pseudomonas bacteriophage E217. Nat Commun. 2023 Jul 08; 14(1):4052. ( Abstract )	07/08/2023
219.	Braverman-Bronstein A, Vidaña-Pérez D, Diez Roux AV[CRiC], Pérez Ferrer C, Sánchez BN, Barrientos-Gutiérrez T. Association of service facilities and amenities with adolescent birth rates in Mexican cities. BMC Public Health. 2023 Jul 10; 23(1):1321. ( Abstract )	07/10/2023
220.	Basta MD, Petruk S, Mazo A[MORA], Walker JL. Fibrosis-the tale of H3K27 histone methyltransferases and demethylases. Front Cell Dev Biol. 2023; 11:1193344. ( Abstract )	07/15/2023
¶ 221.	Nangarlia A, Hassen FF, Canziani G, Bandi P, Talukder C, Zhang F, Krauth D, Gary EN, Weiner DB, Bieniasz P, Navas-Martin S, O'Keefe BR, Ang CG, Chaiken I[IRT]. Irreversible Inactivation of SARS-CoV-2 by Lectin Engagement with Two Glycan Clusters on the Spike Protein. Biochemistry. 2023 Jul 18; 62(14):2115-2127. ( Abstract )	07/18/2023
¶ 222.	Giantonio BJ, Catalano PJ, Meropol NJ, O'Dwyer PJ, Mitchell EP[CRiC], Alberts SR, Schwartz MA, Benson AB. Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200. J Clin Oncol. 2023 Jul 20; 41(21):3670-3675. ( Abstract )	07/20/2023
223.	Yi M, Zhan T, Peck AR, Hooke JA, Kovatich AJ, Shriver CD, Hu H, Sun Y, Rui H, Chervoneva I[CRiC]. Selection of optimal quantile protein biomarkers based on cell-level immunohistochemistry data. BMC Bioinformatics. 2023 Jul 22; 24(1):298. ( Abstract )	07/22/2023
¶ * 224.	Isabelle C, Johnson WT, McConnell K, Vogel A, Brammer JE, Boles A, Keller R, Sindaco P, Nisenfeld L, Uppal G, Nikbakht N[IRT], Calabretta B[IRT], Porazzi P, Gong J, Chakravarti N, Porcu P[IRT], Mishra A[IRT]. Preclinical evaluation of anti-CD38 therapy in mature T-cell neoplasms. Blood Adv. 2023 Jul 25; 7(14):3637-3641. ( Abstract )	07/25/2023
+* 225.	Agarwal A, Philips R, Chitguppi C, Gargano S, Sahin Z, Curry J[MORA], Luginbuhl A[TaCO], Cognetti D[TaCO], Toskala E, Rabinowitz MR, Rosen MR, Nyquist GG. Effect of p16 Status on Survival Outcomes in Sinonasal Squamous Cell Carcinoma. Ann Otol Rhinol Laryngol. 2023 Aug; 132(8):917-925. ( Abstract )	08/01/2023
¶ 226.	Bakely L, Correa-Salazar C, Rangel Gómez MG, González-Fagoaga JE, González AAA, Parrado EA, Riosmena F, Martinez-Donate AP[CRiC]. Exploring the Association Between Detention Conditions, Detention-Related Abuse, and Mental Health Among Deported Mexican Migrants. J Health Care Poor Underserved. 2023 Aug; 34(3):1021-1036. ( Abstract )	08/01/2023
¶ 227.	Bernardi P, Gerle C, Halestrap AP, Jonas EA, Karch J, Mnatsakanyan N, Pavlov E, Sheu SS[TaCO], Soukas AA. Identity, structure, and function of the mitochondrial permeability transition pore: controversies, consensus, recent advances, and future directions. Cell Death Differ. 2023 Aug; 30(8):1869-1885. ( Abstract )	08/01/2023
¶ * 228.	Chandrasekar T, Denisenko A, Mico V, McPartland C, Shah Y, Mark JR, Lallas CD[MORA], Fonshell C, Danella J, Jacobs B, Lanchoney T, Raman JD, Tomaszewski J, Reese A, Singer EA, Ginzburg S, Smaldone M, Uzzo R, Guzzo TJ, Trabulsi EJ[MORA]. Multiparametric MRI is not sufficient for prostate cancer staging: A single institutional experience validated by a multi-institutional regional collaborative. Urol Oncol. 2023 Aug; 41(8):355.e1-355.e8. ( Abstract )	08/01/2023
229.	Chen VE, Kim M, Nelson N, Kim IK, Shi W[MORA]. Cost-effectiveness analysis of 3 radiation treatment strategies for patients with multiple brain metastases. Neurooncol Pract. 2023 Aug; 10(4):344-351. ( Abstract )	08/01/2023
230.	Cultrara C, Uhl C, Kirby K, Abed Elrazaq E, Zellander A, Andrews DW[IRT], Scott CB, Galluzzi L, Exley MA, Zilberberg J. A biologic-device combination product delivering tumor-derived antigens elicits immunogenic cell death-associated immune responses against glioblastoma. J Immunother Cancer. 2023 Aug; 11(8). ( Abstract )	08/01/2023
+* 231.	Curry J[MORA], Alnemri A, Philips R, Fiorella M, Sussman S, Stapp R, Solomides C, Harshyne L, South A[MORA], Luginbuhl A[TaCO], Tuluc M, Martinez-Outschoorn U[TaCO], Argiris A, Linnenbach A, Johnson J[MORA]. CD8+ and FoxP3+ T-Cell Cellular Density and Spatial Distribution After Programmed Death-Ligand 1 Check Point Inhibition. Laryngoscope. 2023 Aug; 133(8):1875-1884. ( Abstract )	08/01/2023
232.	Fenstermaker TK, Petruk S, Kovermann SK, Brock HW, Mazo A[MORA]. RNA polymerase II associates with active genes during DNA replication. Nature. 2023 Aug; 620(7973):426-433. ( Abstract )	08/01/2023
¶ * 233.	Fong ZV, Teinor J, Yeo TP, Rinaldi D, Greer JB, Lavu H[MORA], Qadan M, Johnston FM, Ferrone CR, Chang DC, Yeo CJ[MORA], Wolfgang CL, Warshaw AL, Lillemoe KD, Fernandez-Del Castillo C, Wolff JL, Wu AW, Weiss MJ. Profile of the Postoperative Care Provided for Patients With Pancreatic and Periampullary Cancers by Family and Unpaid Caregivers. JCO Oncol Pract. 2023 Aug; 19(8):551-559. ( Abstract )	08/01/2023
+* 234.	Gleason L, Cohen A, South AP[MORA], Porcu P[IRT], Nikbakht N[IRT]. Emergence of Malignant T-Cell Intraclonal CDR3 Variants in Mycosis Fungoides. JAMA Dermatol. 2023 Aug 01; 159(8):888-890. ( Abstract )	08/01/2023
¶ * 235.	Ippolito M, De Pascali F, Hopfinger N, Komolov KE, Laurinavichyute D, Reddy PAN, Sakkal LA, Rajkowski KZ, Nayak AP, Lee J, Lee J, Cao G, Donover PS, Reichman M, An SS, Salvino JM, Penn RB[TaCO], Armen RS, Scott CP, Benovic JL[TaCO]. Identification of a β-arrestin-biased negative allosteric modulator for the β-adrenergic receptor. Proc Natl Acad Sci U S A. 2023 Aug; 120(31):e2302668120. ( Abstract )	08/01/2023
+* 236.	Johnson JM[MORA], Vathiotis IA, Harshyne LA, Ali A, Bar-Ad V[MORA], Axelrod R[MORA], Lorber E, Curry J[MORA], Cognetti DM[TaCO], Luginbuhl AJ[TaCO], Tuluc M, Keith S, Mahoney MG[IRT], Argiris A. Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck. J Immunother Cancer. 2023 Aug; 11(8). ( Abstract )	08/01/2023
¶ +* 237.	Lin D[MORA], Luo R, Ye Z, Wei Q, Bae H, Juon HS[CRiC], Hann HW, Posey J[MORA], Wang C. Genomic characterization of early-stage hepatocellular carcinoma patients with Hepatitis B using circulating tumor DNA. Clin Res Hepatol Gastroenterol. 2023 Aug; 47(7):102161. ( Abstract )	08/01/2023
¶ 238.	Lopez AM[CRiC], Leibel L, Stein-Seroussi D, Salvador C, Leary Safon R, Riggs TTJ, Mann MD, MacLeod J, Walker EM. Advancing Health Equity, Inclusion, and Belonging in Integrative Oncology. J Integr Complement Med. 2023 Aug; 29(8):462-467. ( Abstract )	08/01/2023
¶ 239.	Lopez Mercado D, Rivera-González AC, Stimpson JP, Langellier BA[CRiC], Bustamante AV, Young MT, Ponce NA, Barajas CB, Roby DH, Ortega AN. Undocumented Latino Immigrants and the Latino Health Paradox. Am J Prev Med. 2023 Aug; 65(2):296-306. ( Abstract )	08/01/2023
¶ 240.	Mastrolonardo EV, Lu JS, Elliott Z, Knops A, Philips R, Urdang Z, Mady LJ, Curry JM[MORA]. Evaluating the impact of hemodynamic support measures on head and neck free tissue transfer outcomes: A population-based analysis. Oral Oncol. 2023 Aug; 143:106461. ( Abstract )	08/01/2023
241.	Mitchell EP[CRiC]. Saving lives with the new breast cancer screening guidelines. J Natl Med Assoc. 2023 Aug; 115(4):337. ( Abstract )	08/01/2023
¶ 242.	Moey MYY, Hennessy C, French B, . . . Mahmood S, Bashir B[IRT], . . . Gupta S, Morgans A, Nohria A, COVID-19 and Cancer Consortium. COVID-19 severity and cardiovascular outcomes in SARS-CoV-2-infected patients with cancer and cardiovascular disease. Transl Oncol. 2023 Aug; 34:101709. ( Abstract )	08/01/2023
¶ * 243.	Müller PC, Breuer E, Nickel F, Zani S, Kauffmann E, De Franco L, Tschuor C, Krohn PS, Burgdorf SK, Jonas JP, Oberkofler CE, Petrowsky H, Saint-Marc O, Seelen L, Molenaar IQ, Wellner U, Keck T, Coratti A, van Dam JL, de Wilde R, Koerkamp BG, Valle V, Giulianotti P, Ghabi E, Moskal D, Lavu H[MORA], Vrochides D, Martinie J, Yeo C[MORA], Sánchez-Velázquez P, Ielpo B, Ajay PS, Shah MM, Kooby DA, Gao S, Hao J, He J, Boggi U, Hackert T, Allen P, Borel-Rinkes IHM, Clavien PA. Robotic Distal Pancreatectomy: A Novel Standard of Care? Benchmark Values for Surgical Outcomes From 16 International Expert Centers. Ann Surg. 2023 Aug 01; 278(2):253-259. ( Abstract )	08/01/2023
244.	Myers R[CRiC], Hallman MH, Davis K, DiCarlo M, Daskalakis C, Shimada A, Chambers C. Primary care provider perspectives on a planned multi-cancer early detection test clinical trial. Contemp Clin Trials Commun. 2023 Aug; 34:101183. ( Abstract )	08/01/2023
* 245.	Nerwal T, Qoshe L, Iyer S, Medina G, Felix A, Lavu H[MORA], Yeo CJ[MORA], Winter JM. Early Postoperative Vital Signs Predict Subsequent 90-Day Mortality After Pancreaticoduodenectomy. J Gastrointest Surg. 2023 Aug; 27(8):1660-1667. ( Abstract )	08/01/2023
246.	Niazi M, Russial O, Cappelli L, Miller R, Chen Y, Vakhnenko Y, Liu H, Shi W[MORA]. Efficacy of scalp-sparing volumetric-modulated arc therapy approach in reducing scalp radiation dose for patients with glioblastoma: a cross-sectional study. Chin Clin Oncol. 2023 Aug; 12(4):36. ( Abstract )	08/01/2023
¶ 247.	Reck M, Ciuleanu TE, Lee JS, Schenker M, Zurawski B, Kim SW, Mahave M, Alexandru A, Peters S, Pluzanski A, Caro RB, Linardou H, Burgers JA, Nishio M, Martinez-Marti A, Azuma K, Axelrod R[MORA], Paz-Ares LG, Ramalingam SS, Borghaei H, O'Byrne KJ, Li L, Bushong J, Gupta RG, Grootendorst DJ, Eccles LJ, Brahmer JR. Systemic and Intracranial Outcomes With First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC and Baseline Brain Metastases From CheckMate 227 Part 1. J Thorac Oncol. 2023 Aug; 18(8):1055-1069. ( Abstract )	08/01/2023
¶ 248.	Sartor O, Karrison TG, Sandler HM, Gomella LG[MORA], Amin MB, Purdy J, Michalski JM, Garzotto MG, Pervez N, Balogh AG, Rodrigues GB, Souhami L, Reaume MN, Williams SG, Hannan R, Jones CU, Horwitz EM, Rodgers JP, Feng FY, Rosenthal SA. Androgen Deprivation and Radiotherapy with or Without Docetaxel for Localized High-risk Prostate Cancer: Long-term Follow-up from the Randomized NRG Oncology RTOG 0521 Trial. Eur Urol. 2023 Aug; 84(2):156-163. ( Abstract )	08/01/2023
249.	Sung S, Steele LA, Risser GE, Spiller KL[IRT]. Biomaterial-assisted macrophage cell therapy for regenerative medicine. Adv Drug Deliv Rev. 2023 Aug; 199:114979. ( Abstract )	08/01/2023
¶ 250.	Ventura E, Belfiore A, Iozzo RV[TaCO], Giordano A, Morrione A. Progranulin and EGFR modulate receptor-like tyrosine kinase sorting and stability in mesothelioma cells. Am J Physiol Cell Physiol. 2023 Aug 01; 325(2):C391-C405. ( Abstract )	08/01/2023
251.	Wilson HP, Aplin AE[TaCO]. Site matters in metastatic melanoma. Trends Cancer. 2023 Aug; 9(8):603-605. ( Abstract )	08/01/2023
252.	Yi M, Zhan T, Peck AR, Hooke JA, Kovatich AJ, Shriver CD, Hu H, Sun Y, Rui H, Chervoneva I[CRiC]. Quantile Index Biomarkers Based on Single-Cell Expression Data. Lab Invest. 2023 Aug; 103(8):100158. ( Abstract )	08/01/2023
253.	Gal A, Balicza P, Weaver D, Naghdi S, Joseph SK, Várnai P, Gyuris T, Horváth A, Nagy L, Seifert EL, Molnar MJ, Hajnoczky G[TaCO]. MSTO1 is a cytoplasmic pro-mitochondrial fusion protein, whose mutation induces myopathy and ataxia in humans. EMBO Mol Med. 2023 Aug 07; 15(8):e17911. ( Abstract )	08/07/2023
254.	Gál A, Santos JH, Molnár MJ, Hajnoczky G[TaCO]. Answer to Gerber et al. "Autosomal recessive pathogenic MSTO1 variants in hereditary optic atrophy". EMBO Mol Med. 2023 Aug 07; 15(8):e16251. ( Abstract )	08/07/2023
¶ 255.	Tamari R, McLornan DP, Ahn KW, . . . Gergis U[IRT], . . . Scott BL, . . . Czerw T, Yakoub-Agha I, Saber W. A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis. Blood Adv. 2023 Aug 08; 7(15):3993-4002. ( Abstract )	08/08/2023
256.	Coelho DM, de Souza Andrade AC, Silva UM, Lazo M, Slesinski SC, Quistberg A, Diez Roux AV[CRiC], de Lima Friche AA, Caiaffa WT. Gender differences in the association of individual and contextual socioeconomic status with hypertension in 230 Latin American cities from the SALURBAL study: a multilevel analysis. BMC Public Health. 2023 Aug 11; 23(1):1532. ( Abstract )	08/11/2023
¶ 257.	Garcia Castro DR, Mazuk JR, Heine EM, Simpson D, Pinches RS, Lozzi C, Hoffman K, Morrin P, Mathis D, Lebedev MV, Nissley E, Han KH, Farmer T, Merry DE[MORA], Tong Q, Pennuto M, Montie HL. Increased SIRT3 combined with PARP inhibition rescues motor function of SBMA mice. iScience. 2023 Aug 18; 26(8):107375. ( Abstract )	08/18/2023
¶ 258.	Smith S, Seth J, Midkiff A, Stahl R, Syu YC, Shkriabai N, Kvaratskhelia M, Musier-Forsyth K, Jain P[IRT], Green PL, Panfil AR. The Pleiotropic Effects of YBX1 on HTLV-1 Transcription. Int J Mol Sci. 2023 Aug 23; 24(17). ( Abstract )	08/23/2023
¶ * 259.	Barta JA[CRiC], Erkmen CP, Shusted CS, Myers RE[CRiC], Saia C, Cohen S, Wainwright J, Zeigler-Johnson C, Dako F, Wender R, Kane GC, Vachani A, Rendle KA. The Philadelphia Lung Cancer Learning Community: a multi-health-system, citywide approach to lung cancer screening. JNCI Cancer Spectr. 2023 Aug 31; 7(5). ( Abstract )	08/31/2023
+* 260.	Ali AS, Manukian G, Johnson JM[MORA], Vathiotis I, Axelrod R[MORA], Keith SW, Curry J[MORA], Cognetti D[TaCO], Luginbuhl A[TaCO], Argiris A, Bar-Ad V[MORA]. In-Field Toxicity Analysis of a Phase 1 Clinical Trial of Nivolumab and Ipilimumab With Definitive Radiation Therapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck. Int J Radiat Oncol Biol Phys. 2023 Sep 01; 117(1):181-185. ( Abstract )	09/01/2023
¶ 261.	Brose MS[TaCO], Hong DS, Drilon A. Important Considerations for Real-World Analysis of Neurotrophic Tyrosine Receptor Kinase Fusion Cancer and Tropomyosin Receptor Kinase Inhibitors. JCO Precis Oncol. 2023 Sep; 7:e2300217. ( Abstract )	09/01/2023
262.	Cohen AJ, Gleason LK, Bhatti SA, Nikbakht N[IRT]. Neutrophilic panniculitis associated with myelodysplastic syndrome/myeloproliferative neoplasm: a case report and literature review. Int J Dermatol Venereol. 2023 Sep; 6(3):168-171. ( Abstract )	09/01/2023
+* 263.	Collins ML, Whitehorn GL, Mack SJ, Till BM, Rshaidat H, Grenda TR[MORA], Evans NR[CRiC], Okusanya OT[MORA]. Is wedge a dirty word? Demographic and facility-level variables associated with high-quality wedge resection. JTCVS Open. 2023 Sep; 15:481-488. ( Abstract )	09/01/2023
264.	Duchemin NJ, Loonawat R, Yeakle K, Rosenkranz A, Bouchard MJ[TaCO]. Hypoxia-inducible factor affects hepatitis B virus transcripts and genome levels as well as the expression and subcellular location of the hepatitis B virus core protein. Virology. 2023 Sep; 586:76-90. ( Abstract )	09/01/2023
265.	Fejza A, Camicia L, Carobolante G, Poletto E, Paulitti A, Schinello G, Di Siena E, Cannizzaro R, Iozzo RV[TaCO], Baldassarre G, Andreuzzi E, Spessotto P, Mongiat M. Emilin2 fosters vascular stability by promoting pericyte recruitment. Matrix Biol. 2023 Sep; 122:18-32. ( Abstract )	09/01/2023
¶ * 266.	Filipescu D, Carcamo S, Agarwal A, Tung N, Humblin É, Goldberg MS, Vyas NS, Beaumont KG, Demircioglu D, Sridhar S, Ghiraldini FG, Capparelli C[TaCO], Aplin AE[TaCO], Salmon H, Sebra R, Kamphorst AO, Merad M, Hasson D, Bernstein E. MacroH2A restricts inflammatory gene expression in melanoma cancer-associated fibroblasts by coordinating chromatin looping. Nat Cell Biol. 2023 Sep; 25(9):1332-1345. ( Abstract )	09/01/2023
+* 267.	Fiorella M, Alnemri A, Sussman S, Koka A, Johnson J[MORA], Cognetti D[TaCO], Curry J[MORA], Mady L[CRiC], Worster B[CRiC], Leader AE[CRiC], Luginbuhl A[TaCO]. Impact of Head and Neck Cancer Diagnosis and Treatment on Patient-Partner Intimacy. Otolaryngol Head Neck Surg. 2023 Sep; 169(3):520-527. ( Abstract )	09/01/2023
* 268.	Flerova E, Alpdogan O[IRT], Bhatti S, Nikbakht N[IRT], Wang ZX, Gong JZ. Anaplastic Large Cell Transformation of Mycosis Fungoides: Case Report and Review of the Literature. Am J Dermatopathol. 2023 Sep 01; 45(9):e74-e82. ( Abstract )	09/01/2023
* 269.	Gomaa S, Cappelli L, Swartz K, Zhan T, Chapman A[CRiC], Lopez AM[CRiC], Lombardo J, Wen KY[CRiC]. The association of the G8 questionnaire with treatment side effects and unscheduled care among older adults with breast cancer: A retrospective cohort study. J Geriatr Oncol. 2023 Sep; 14(7):101566. ( Abstract )	09/01/2023
¶ +* 270.	Gomaa S, Kelly WK[MORA], Mitchell E[CRiC], Storozynsky E, Zeigler-Johnson C, Juon HS[CRiC], Wen KY[CRiC]. Racial disparities in new-onset diabetes mellitus in prostate cancer patients on androgen deprivation therapy: a retrospective analysis of TriNetX data. World J Urol. 2023 Sep; 41(9):2351-2357. ( Abstract )	09/01/2023
¶ +* 271.	Hill BL, Calder AN, Flemming JP, Guo Y, Gilmore SL, Trofa MA, Daniels SK, Nielsen TN, Gleason LK, Antysheva Z, Demina K, Kotlov N, Davitt CJH, Cognetti DM[TaCO], Prendergast GC, Snook AE[IRT], Johnson JM[MORA], Kumar G, Linnenbach AJ, Martinez-Outschoorn U[TaCO], South AP[MORA], Curry JM[MORA], Harshyne LA, Luginbuhl AJ[TaCO], Mahoney MG[IRT]. IL-8 correlates with nonresponse to neoadjuvant nivolumab in HPV positive HNSCC via a potential extracellular vesicle miR-146a mediated mechanism. Mol Carcinog. 2023 Sep; 62(9):1428-1443. ( Abstract )	09/01/2023
272.	Ibikunle S, Grosso D, Gergis U[IRT]. The two-step approach to allogeneic hematopoietic stem cell transplantation. Front Immunol. 2023; 14:1237782. ( Abstract )	09/01/2023
273.	Irollo E, Nash B, Luchetta J, Brandimarti R, Meucci O[IRT]. The Endolysosomal Transporter DMT1 is Required for Morphine Regulation of Neuronal Ferritin Heavy Chain. J Neuroimmune Pharmacol. 2023 Sep; 18(3):495-508. ( Abstract )	09/01/2023
¶ 274.	Kohler RE, Hemler J, Wagner RB, Sullivan B, Macenat M, Tagai EK, Miller SM, Wen KY[CRiC], Ayers C, Einstein MH, Hudson SV. Confusion and anxiety in between abnormal cervical cancer screening results and colposcopy: "The land of the unknown". Patient Educ Couns. 2023 Sep; 114:107810. ( Abstract )	09/01/2023
¶ + 275.	Lee MD, Patel SH, Mohan S, Akbari H, Bakas S, Nasrallah MP, Calabrese E, Rudie J, Villanueva-Meyer J, LaMontagne P, Marcus DS, Colen RR, Balana C, Choi YS, Badve C, Barnholtz-Sloan JS, Sloan AE, Booth TC, Palmer JD, Dicker AP[CRiC], Flanders AE, Shi W[MORA], Griffith B, Poisson LM, Chakravarti A, Mahajan A, Chang S, Orringer D, Davatzikos C, Jain R, ReSPOND Consortium. Association of partial T2-FLAIR mismatch sign and isocitrate dehydrogenase mutation in WHO grade 4 gliomas: results from the ReSPOND consortium. Neuroradiology. 2023 Sep; 65(9):1343-1352. ( Abstract )	09/01/2023
¶ 276.	Mastrolonardo EV, Mann DS, Sethi HK, Yun BH, Sina EM, Armache M, Worster B[CRiC], Fundakowski CE, Mady LJ. Perioperative opioids and survival outcomes in resectable head and neck cancer: A systematic review. Cancer Med. 2023 Sep; 12(18):18882-18888. ( Abstract )	09/01/2023
¶ * 277.	Micaily I, Blais EM, Carhart R, Lam S, Cohen SJ, Cannaday SJ, Halverson D, Matrisian LM, DeArbeloa P, Thach D, Petricoin E, Pishvaian MJ, Lavu H[MORA], Yeo CJ[MORA], Basu-Mallick A[MORA]. Association of Pancreatic Adenocarcinoma Location With DNA Damage Response Status and Response to Platinum-Based Therapy. JCO Precis Oncol. 2023 Sep; 7:e2200648. ( Abstract )	09/01/2023
¶ 278.	O'Cearbhaill RE, Miller A, Soslow RA, Lankes HA, DeLair D, Segura S, Chavan S, Zamarin D, DeBernardo R, Moore K, Moroney J, Shahin M[MORA], Thaker PH, Wahner-Hendrickson AE, Aghajanian C. A phase 2 study of dasatinib in recurrent clear cell carcinoma of the ovary, fallopian tube, peritoneum or endometrium: NRG oncology/gynecologic oncology group study 0283. Gynecol Oncol. 2023 Sep; 176:16-24. ( Abstract )	09/01/2023
¶ 279.	Papadopoulou V, Stride EP, Borden MA, Eisenbrey JR[TaCO], Dayton PA. Radiotherapy Sensitization With Ultrasound-Stimulated Intravenously Injected Oxygen Microbubbles Can Have Contrary Effects Depending on the Study Model. Ultrasound Med Biol. 2023 Sep; 49(9):2203-2204. ( Abstract )	09/01/2023
¶ 280.	Reyngold M, Karam SD, Hajj C, Wu AJ, Cuaron J, Lobaugh S, Yorke ED, Dickinson S, Jones B, Vinogradskiy Y[CRiC], Shukla-Dave A, Do RKG, Sigel C, Zhang Z, Crane CH, Goodman KA. Phase 1 Dose Escalation Study of SBRT Using 3 Fractions for Locally Advanced Pancreatic Cancer. Int J Radiat Oncol Biol Phys. 2023 Sep 01; 117(1):53-63. ( Abstract )	09/01/2023
281.	Sykulev Y[IRT]. Factors contributing to the potency of CD8 T cells. Trends Immunol. 2023 Sep; 44(9):693-700. ( Abstract )	09/01/2023
282.	Tassone P, Wieser M, Givens A, Elliott Z, Philips R, Curry J[MORA], Barrette LX, Cannady S, Mahomva C, Lamarre E, Prendes B, Robillard K, Sweeny L. Factors Leading to Gastrostomy Tube and Tracheostomy Requirements in Patients Treated Initially With Radiotherapy and Salvaged With Surgery and Free Flap Reconstruction. Laryngoscope. 2023 Sep; 133(9):2141-2147. ( Abstract )	09/01/2023
¶ 283.	Zahnd WE, Silverman AF, Self S, Hung P, Natafgi N, Adams SA, Merrell MA, Owens OL, Crouch EL, Eberth JM[CRiC]. The COVID-19 pandemic impact on independent and provider-based rural health clinics' operations and cancer prevention and screening provision in the United States. J Rural Health. 2023 Sep; 39(4):765-771. ( Abstract )	09/01/2023
¶ 284.	Zakem SJ, Jones B, Castillo R, Castillo E, Miften M, Goodman KA, Schefter T, Olsen J, Vinogradskiy Y[CRiC]. Cardiac metabolic changes on F-positron emission tomography after thoracic radiotherapy predict for overall survival in esophageal cancer patients. J Appl Clin Med Phys. 2023 Sep; 24(9):e13552. ( Abstract )	09/01/2023
¶ +* 285.	Glasheen MQ, Caksa S, Young AG, Wilski NA, Ott CA, Chervoneva I[CRiC], Flaherty KT, Herlyn M, Xu X, Aplin AE[TaCO], Capparelli C[TaCO]. Targeting Upregulated cIAP2 in SOX10-Deficient Drug Tolerant Melanoma. Mol Cancer Ther. 2023 Sep 05; 22(9):1087-1099. ( Abstract )	09/05/2023
¶ 286.	Stockton S, Catalano P, Cohen SJ, Burtness BA, Mitchell EP[CRiC], Dotan E, Lubner SJ, Kumar P, Mulcahy MF, Fisher GA, Crandall TL, Benson A. Paclitaxel With or Without Cixutumumab as Second-Line Treatment of Metastatic Esophageal or Gastroesophageal Junction Cancer: A Randomized Phase II ECOG-ACRIN Trial. Oncologist. 2023 Sep 07; 28(9):827-e822. ( Abstract )	09/07/2023
¶ 287.	Robilotti E, Zeitouni NC, Orloff M[IRT]. Biosafety and biohazard considerations of HSV-1-based oncolytic viral immunotherapy. Front Mol Biosci. 2023 Sep 12; 10:1178382. ( Abstract )	09/12/2023
¶ 288.	Takata H, Mitchell JL, Pacheco J, Pagliuzza A, Pinyakorn S, Buranapraditkun S, Sacdalan C, Leyre L, Nathanson S, Kakazu JC, Intasan J, Prueksakaew P, Chomchey N, Phanuphak N, de Souza M, Haddad EK[IRT], Rolland M, Tovanabutra S, Vasan S, Hsu DC, Chomont N, Trautmann L, RV254/SEARCH010, RV304/SEARCH013. An active HIV reservoir during ART is associated with maintenance of HIV-specific CD8 T cell magnitude and short-lived differentiation status. Cell Host Microbe. 2023 Sep 13; 31(9):1494-1506.e4. ( Abstract )	09/13/2023
¶ 289.	Cicardi ME, Hallgren JH, Mawrie D, Krishnamurthy K, Markandaiah SS, Nelson AT, Kankate V, Anderson EN, Pasinelli P, Pandey UB, Eischen CM[IRT], Trotti D. C9orf72 poly(PR) mediated neurodegeneration is associated with nucleolar stress. iScience. 2023 Sep 15; 26(9):107505. ( Abstract )	09/15/2023
* 290.	Purwin TJ, Caksa S, Sacan A, Capparelli C[TaCO], Aplin AE[TaCO]. Gene signature reveals decreased SOX10-dependent transcripts in malignant cells from immune checkpoint inhibitor-resistant cutaneous melanomas. iScience. 2023 Sep 15; 26(9):107472. ( Abstract )	09/15/2023
¶ 291.	Riley-Gillis B, Tsaih SW, King E, Wollenhaupt S, Reeb J, Peck AR, Wackman K, Lemke A, Rui H[MORA], Dezso Z, Flister MJ. Machine learning reveals genetic modifiers of the immune microenvironment of cancer. iScience. 2023 Sep 15; 26(9):107576. ( Abstract )	09/15/2023
¶ 292.	Marziliano A, Miller SM, Fleisher LG, Ropka ME, Stanton AL, Wen KY[CRiC], Cornelius T, Lapitan E, Diefenbach MA. Examining the impact of a multimedia intervention on decisional conflict and psychological distress among early-stage breast cancer patients: results from a nationwide RCT. Transl Behav Med. 2023 Sep 28; 13(10):727-735. ( Abstract )	09/28/2023
¶ 293.	Alexander SPH, Fabbro D, Kelly E, Mathie AA, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Davies JA, Beuve A, Brouckaert P, Bryant C, Burnett JC, Farndale RW, Friebe A, Garthwaite J, Hobbs AJ, Jarvis GE, Koesling D, Kuhn M, MacEwan D, Monie TP, Potter LR, Russwurm M, Schmidt HHHW, Stasch JP, Waldman SA[IRT]. The Concise Guide to PHARMACOLOGY 2023/24: Catalytic receptors. Br J Pharmacol. 2023 Oct; 180 Suppl 2:S241-S288. ( Abstract )	10/01/2023
294.	Bevilacqua LA, Okusanya OT[MORA]. Cost, Cryo, and Complications. Ann Thorac Surg. 2023 Oct; 116(4):809-810. ( Abstract )	10/01/2023
¶ 295.	Cairns A, Chagpar AB, Dupont E, Levine EA, Gass JS, Chiba A, Ollila DW, Howard-McNatt M, SHAVE2 Group (including Willis A[MORA] ). Does Preoperative MRI Reduce Positive Margins after Breast-Conserving Surgery? Ann Surg Oncol. 2023 Oct; 30(10):6053-6058. ( Abstract )	10/01/2023
296.	Chaudhary LN, Jorns JM, Sun Y, Cheng YC, Kamaraju S, Burfeind J, Gonyo MB, Kong AL, Patten C, Yen T, Cortina CS, Carson E, Johnson N, Bergom C, Tsaih SW, Banerjee A, Wang Y, Chervoneva I[CRiC], Weil E, Chitambar CR, Rui H. Frequent upregulation of HER2 protein in hormone-receptor-positive HER2-negative breast cancer after short-term neoadjuvant endocrine therapy. Breast Cancer Res Treat. 2023 Oct; 201(3):387-396. ( Abstract )	10/01/2023
297.	Conroy M, Kamaraju S, Powell M, Harris A, Beckius A, Nagavally S, Dawson A, Min H, Wright T, Wainaina N, Binder AF[IRT]. Racial and Ethnic Differences in the Use of Electronic Medical Record Messaging Among Patients With Breast Cancer: A Quality Improvement Study. Clin Breast Cancer. 2023 Oct; 23(7):e434-e440. ( Abstract )	10/01/2023
¶ * 298.	Ghassemi N, Castillo R, Castillo E, Jones BL, Miften M, Kavanagh B, Werner-Wasik M, Miller R, Barta JA[CRiC], Grills I, Leiby BE, Guerrero T, Rusthoven CG, Vinogradskiy Y[CRiC]. Evaluation of variables predicting PFT changes for lung cancer patients treated on a prospective 4DCT-ventilation functional avoidance clinical trial. Radiother Oncol. 2023 Oct; 187:109821. ( Abstract )	10/01/2023
¶ 299.	Gulati S, Hsu CY, Shah S, . . . Bashir B[IRT], . . . Connors JM, Shah DP, Rosovsky RP, COVID-19 and Cancer Consortium. Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19. JAMA Oncol. 2023 Oct 01; 9(10):1390-1400. ( Abstract )	10/01/2023
300.	Harhay MN, Klassen AC[CRiC], Gunen B, Hingorany S, Sweeting J, Lee J, HaileSelasse JR, Milliron BJ. Patient and Health Care Professional Perspectives on Addressing Obesity in ESKD. Am J Kidney Dis. 2023 Oct; 82(4):419-428. ( Abstract )	10/01/2023
301.	Koech CK, Rivera VI, Anton K[TaCO], Dixon RG. Advancing IR in Underserved Regions: Interventional Radiology Simulation Near and Far. Semin Intervent Radiol. 2023 Oct; 40(5):419-426. ( Abstract )	10/01/2023
¶ 302.	Lee W, Zamudio-Ochoa A, Buchel G, Podlesniy P, Marti Gutierrez N, Puigròs M, Calderon A, Tang HY, Li L, Mikhalchenko A, Koski A, Trullas R, Mitalipov S, Temiakov D[TaCO]. Molecular basis for maternal inheritance of human mitochondrial DNA. Nat Genet. 2023 Oct; 55(10):1632-1639. ( Abstract )	10/01/2023
303.	Lin R, Kenyon A, Wang ZX, Cai J, Iacovitti L[TaCO], Kenyon LC. Pilocytic astrocytoma harboring a novel GNAI3-BRAF fusion. Neuropathology. 2023 Oct; 43(5):391-395. ( Abstract )	10/01/2023
304.	Ott CA, Aplin AE[TaCO]. Targeting TEAD-ious resistance. Trends Cancer. 2023 Oct; 9(10):780-781. ( Abstract )	10/01/2023
¶ * 305.	Savsani E, Shaw CM, Forsberg F[TaCO], Wessner CE, Lyshchik A[TaCO], O'Kane P, Liu JB[TaCO], Balasubramanya R, Roth CG, Naringrekar H, Keith SW, Tan A, Anton K[TaCO], Bradigan K, Civan J, Schultz S, Shamimi-Noori S, Hunt S, Soulen MC, Mattrey RF, Kono Y, Eisenbrey JR[TaCO]. Contrast-enhanced US Evaluation of Hepatocellular Carcinoma Response to Chemoembolization: A Prospective Multicenter Trial. Radiology. 2023 Oct; 309(1):e230727. ( Abstract )	10/01/2023
¶ 306.	Yeager KA, Zahnd WE, Eberth JM[CRiC], Vanderpool RC, Rohweder C, Teal R, Vu M, Stradtman L, Frost EL, Trapl E, Gonzalez SK, Vu T, Ko LK, Cole A, Farris PE, Shannon J, Askelson N, Seegmiller L, White A, Edward J, Davis M, Petermann V, Wheeler SB. Financial navigation: Staff perspectives on patients' financial burden of cancer care. J Cancer Surviv. 2023 Oct; 17(5):1461-1470. ( Abstract )	10/01/2023
¶ 307.	Batchelor TT, Won M, Chakravarti A, Hadjipanayis CG, Shi W[MORA], Ashby LS, Stieber VW, Robins HI, Gray HJ, Voloschin A, Fiveash JB, Robinson CG, Chamarthy U, Kwok Y, Cescon TP, Sharma AK, Chaudhary R, Polley MY, Mehta MP. NRG/RTOG 0837: Randomized, phase II, double-blind, placebo-controlled trial of chemoradiation with or without cediranib in newly diagnosed glioblastoma. Neurooncol Adv. 2023 Oct 11; 5(1):vdad116. ( Abstract )	10/11/2023
¶ 308.	Weidhaas JB, Hu C, Komaki R, Masters GA, Blumenschein GR, Chang JY, Lu B, Dicker AP[CRiC], Bogart JA, Garces YI, Narayan S, Robinson CG, Kavadi VS, Greenberger JS, Koprowski CD, Welsh J, Gore EM, MacRae RM, Paulus R, Bradley JD. The Inherited KRAS-variant as a Biomarker of Cetuximab Response in NSCLC. Cancer Res Commun. 2023 Oct 11; 3(10):2074-2081. ( Abstract )	10/11/2023
¶ 309.	Brammer JE, Ballen K, Sokol L, Querfeld C, Nakamura R, Mishra A[IRT], McLaughlin EM, Feith D, Azimi N, Waldmann TA, Tagaya Y, Loughran T. Effective treatment with the selective cytokine inhibitor BNZ-1 reveals the cytokine dependency of T-LGL leukemia. Blood. 2023 Oct 12; 142(15):1271-1280. ( Abstract )	10/12/2023
¶ 310.	Nagaraj G, Vinayak S, Khaki AR, . . . Bashir B[IRT], . . . Mico V, . . . Lustberg MB, Accordino MK, Shah DP, COVID-19 and Cancer Consortium. Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study. Elife. 2023 Oct 17; 12. ( Abstract )	10/17/2023
¶ * 311.	Ponzini FM, Schultz CW, Leiby BE, Cannaday S, Yeo T, Posey J[MORA], Bowne WB, Yeo C[MORA], Brody JR, Lavu H[MORA], Nevler A. Repurposing the FDA-approved anthelmintic pyrvinium pamoate for pancreatic cancer treatment: study protocol for a phase I clinical trial in early-stage pancreatic ductal adenocarcinoma. BMJ Open. 2023 Oct 17; 13(10):e073839. ( Abstract )	10/17/2023
312.	Rosenberg M, Poluch M, Thomas C, Sindaco P, Khoo A, Porcu P[IRT]. Hepatitis B Virus and B-cell lymphoma: evidence, unmet need, clinical impact, and opportunities. Front Oncol. 2023 Oct 20; 13:1275800. ( Abstract )	10/20/2023
¶ * 313.	Haverkos B, Alpdogan O[IRT], Baiocchi R, Brammer JE, Feldman TA, Capra M, Brem EA, Nair S, Scheinberg P, Pereira J, Shune L, Joffe E, Young P, Spruill S, Katkov A, McRae R, Royston I, Faller DV, Rojkjaer L, Porcu P[IRT]. Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 study. Blood Adv. 2023 Oct 24; 7(20):6339-6350. ( Abstract )	10/24/2023
* 314.	Joffe D, Bhatti S, Banner L, Zaya R, Gleason L, Mishra A[IRT], Kirsch I, Porcu P[IRT], Nikbakht N[IRT]. The overlap of skin and blood T-cell clones in early-stage mycosis fungoides. Blood Adv. 2023 Oct 24; 7(20):6206-6210. ( Abstract )	10/24/2023
315.	Martinez-Donate AP[CRiC], Zumaeta-Castillo C, Yamasaki Y, Perez C, Martinez O, Hassrick EM, Ventimiglia J, Lazo-Elizondo M. Feasibility and acceptability of CRiSOL: A pilot peer-based intervention to address syndemic health issues afflicting Latino immigrants in the U.S. PLoS One. 2023 Oct 24; 18(10):e0287248. ( Abstract )	10/24/2023
¶ * 316.	Palmisiano N, Jeschke G, Wilde L[IRT], Alpdogan O[IRT], Carabasi M, Filicko-O'Hara J[IRT], Grosso D, Klumpp T, Martinez U, Wagner J, Carroll MP, Perl A, Kasner M[IRT]. A Phase I Trial of Sirolimus with "7&3" Induction Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukemia. Cancers (Basel). 2023 Oct 25; 15(21). ( Abstract )	10/25/2023
¶ 317.	Binder AF[IRT], Walker CJ, Mark TM, Baljevic M. Impacting T-cell fitness in multiple myeloma: potential roles for selinexor and XPO1 inhibitors. Front Immunol. 2023 Oct 26; 14:1275329. ( Abstract )	10/26/2023
¶ * 318.	Oyer HM, Steck AR, Longen CG, Venkat S, Bayrak K, Munger EB, Fu D, Castagnino PA, Sanders CM, Tancler NA, Mai MT, Myers JP, Schiewer MJ[MORA], Chen N, Mostaghel EA, Kim FJ[MORA]. Sigma1 Regulates Lipid Droplet-mediated Redox Homeostasis Required for Prostate Cancer Proliferation. Cancer Res Commun. 2023 Oct 30; 3(10):2195-2210. ( Abstract )	10/30/2023
¶ 319.	Schmitz RSJM, van den Belt-Dusebout AW, Clements K, Ren Y, Cresta C, Timbres J, Liu YH, Byng D, Lynch T, Menegaz BA, Collyar D, Hyslop T[CRiC], Thomas S, Love JK, Schaapveld M, Bhattacharjee P, Ryser MD, Sawyer E, Hwang ES, Thompson A, Wesseling J, Lips EH, Schmidt MK, Grand Challenge PRECISION consortium. Association of DCIS size and margin status with risk of developing breast cancer post-treatment: multinational, pooled cohort study. BMJ. 2023 Oct 30; 383:e076022. ( Abstract )	10/30/2023
+* 320.	Shusted CS, Juon HS[CRiC], Ruane B, Till B, Zeigler-Johnson C, McIntire RK, Grenda T[MORA], Okusanya O[MORA], Evans NR[CRiC], Kane GC, Barta JA[CRiC]. Individual- and neighborhood-level characteristics of lung cancer screening participants undergoing telemedicine shared decision making. BMC Health Serv Res. 2023 Oct 30; 23(1):1179. ( Abstract )	10/30/2023
+* 321.	Amin DR, Philips R, Bertoni DG, Mastrolonardo EV, Campbell DJ, Agarwal AM, Tekumalla S, Urdang ZD, Luginbuhl AJ[TaCO], Cognetti DM[TaCO], Curry JM[MORA]. Differences in Functional and Survival Outcomes Between Patients Receiving Primary Surgery vs Chemoradiation Therapy for Treatment of T1-T2 Oropharyngeal Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg. 2023 Nov 01; 149(11):980-986. ( Abstract )	11/01/2023
¶ 322.	Deutsch A, Lacouture M, Andriessen A, Choi JN, Ho AY, McLellan BN, Mitchell E[CRiC], Leventhal JS. INDIVIDUAL ARTICLE: USCOM Algorithm for the Prevention and Management of Cutaneous Immunotherapy-Related Adverse Events. J Drugs Dermatol. 2023 Nov 01; 22(11):SF389716s3-SF389716s10. ( Abstract )	11/01/2023
323.	Gleason L, Talasila S, Tekmen V, Nikbakht N[IRT]. Reduced Skin T-Cell Receptor Diversity in Large Cell Transformed Mycosis Fungoides. J Invest Dermatol. 2023 Nov; 143(11):2318-2322.e4. ( Abstract )	11/01/2023
324.	Gripp EW, Hess BD, Binder AF[IRT]. Utility of Respiratory Pathogen Panels in the Outpatient Oncology Setting. Am J Med Qual. 2023 Nov 01; 38(6):294-299. ( Abstract )	11/01/2023
¶ 325.	Jamy OH, Kasner M[IRT], Wall S, Ingram S, Dent D', Dudley WN, Dudley L, Scott JM, Wujcik D. Integrating electronic geriatric assessment and frailty screening for adults with acute myeloid leukemia to drive personalized treatment decisions. Leuk Res. 2023 Nov; 134:107393. ( Abstract )	11/01/2023
326.	Le Minh G, Esquea EM, Young RG, Huang J, Reginato MJ[TaCO]. On a sugar high: Role of O-GlcNAcylation in cancer. J Biol Chem. 2023 Nov; 299(11):105344. ( Abstract )	11/01/2023
327.	Lyons W, Lamm R, Duffner ER, Shames J, Willis AI, Lazar M[MORA]. Bracketed Localization in Breast-Conserving Surgery: Indications and Success Rates From a Single, High Volume, Academic Breast Cancer Center. Am Surg. 2023 Nov; 89(11):4373-4378. ( Abstract )	11/01/2023
¶ 328.	Nayak AP, Javed E, Villalba DR, Wang Y, Morelli HP, Shah SD, Kim N, Ostrom RS, Panettieri RA, An SS, Tang DD, Penn RB[TaCO]. Prorelaxant E-type Prostanoid Receptors Functionally Partition to Different Procontractile Receptors in Airway Smooth Muscle. Am J Respir Cell Mol Biol. 2023 Nov; 69(5):584-591. ( Abstract )	11/01/2023
¶ 329.	Nersisyan S, Montenont E, Loher P, Middleton EA, Campbell R, Bray P, Rigoutsos I[MORA]. Characterization of all small RNAs in and comparisons across cultured megakaryocytes and platelets of healthy individuals and COVID-19 patients. J Thromb Haemost. 2023 Nov; 21(11):3252-3267. ( Abstract )	11/01/2023
330.	Prasad K, Topf MC, Clookey S, Philips R, Curry J[MORA], Tassone P. Trends in Positive Surgical Margins in cT3-T4 Oral Cavity Squamous Cell Carcinoma. Otolaryngol Head Neck Surg. 2023 Nov; 169(5):1200-1207. ( Abstract )	11/01/2023
¶ * 331.	Roche ME, Ko YH, Domingo-Vidal M, Lin Z, Whitaker-Menezes D, Birbe RC, Tuluc M, Győrffy B, Caro J, Philp NJ[TaCO], Bartrons R, Martinez-Outschoorn U[TaCO]. TP53 Induced Glycolysis and Apoptosis Regulator and Monocarboxylate Transporter 4 drive metabolic reprogramming with c-MYC and NFkB activation in breast cancer. Int J Cancer. 2023 Nov 01; 153(9):1671-1683. ( Abstract )	11/01/2023
¶ 332.	South AP[MORA], Laimer M, Gueye M, Sui JY, Eichenfield LF, Mellerio JE, Nyström A. Type VII Collagen Deficiency in the Oncogenesis of Cutaneous Squamous Cell Carcinoma in Dystrophic Epidermolysis Bullosa. J Invest Dermatol. 2023 Nov; 143(11):2108-2119. ( Abstract )	11/01/2023
¶ 333.	Wei AZ, Chen LN, Orloff M[IRT], Ariyan CE, Asgari M, Barker CA, Buchbinder E, Chandra S, Couts K, Frumovitz MM, Futreal A, Gershenwald JE, Hanna EY, Izar B, LeBlanc AK, Leitao MM, Lipson EJ, Liu D, McCarter M, McQuade JL, Najjar Y, Rapisuwon S, Selig S, Shoushtari AN, Yeh I, Schwartz GK, Guo J, Patel SP, Carvajal RD. Proceedings from the Melanoma Research Foundation Mucosal Melanoma Meeting (December 16, 2022, New York, USA). Pigment Cell Melanoma Res. 2023 Nov; 36(6):542-556. ( Abstract )	11/01/2023
* 334.	Shenton LM, Perera U, Leader A[CRiC], Klassen AC[CRiC]. Perceptions of Facilitators and Barriers to Smoking Cessation Among Patients and Providers in a Cancer Center: A Single Institution Qualitative Exploratory Study. Integr Cancer Ther. 2023 Jan-Dec; 22:15347354231198072. ( Abstract )	11/02/2023
¶ 335.	Yu JB, Dicker AP[CRiC], Lester-Coll NH, Tsai CJ, Zawalich M. Practical Steps to Mitigate Cybersecurity Attacks on Radiation Oncology Practices. Pract Radiat Oncol. 2023 Sep-Oct; 13(5):429-433. ( Abstract )	11/02/2023
336.	Gautam D, Naik UP[TaCO], Naik MU, Yadav SK, Chaurasia RN, Dash D. Glutamate Receptor Dysregulation and Platelet Glutamate Dynamics in Alzheimer's and Parkinson's Diseases: Insights into Current Medications. Biomolecules. 2023 Nov 03; 13(11). ( Abstract )	11/03/2023
337.	Milliron BJ, Klobodu C, Deutsch J, Martyn K, Dychtwald D, Riahi E, Carro S, Hisek T, Darcy N, Klassen AC[CRiC]. "Keep Your Chin Up, and Keep Eating": Perceptions of Barriers and Facilitators to Healthful Dietary Behaviors Among Individuals With Gastrointestinal Cancer and Caregivers. Cancer Control. 2023 Jan-Dec; 30:10732748231208316. ( Abstract )	11/03/2023
338.	DeDreu J, Basta MD, Walker JL, Menko AS[TaCO]. Immune Responses Induced at One Hour Post Cataract Surgery Wounding of the Chick Lens. Biomolecules. 2023 Nov 04; 13(11). ( Abstract )	11/04/2023
339.	Akins RB, Ostberg K, Cherlin T, Tsiouplis NJ, Loher P, Rigoutsos I[MORA]. The Typical tRNA Co-Expresses Multiple 5' tRNA Halves Whose Sequences and Abundances Depend on Isodecoder and Isoacceptor and Change with Tissue Type, Cell Type, and Disease. Noncoding RNA. 2023 Nov 06; 9(6). ( Abstract )	11/06/2023
340.	Pan M, Xiao Y, Zhu L, Dong S, Liang L, Sun L, Shi W[MORA], Wang Y. Evaluation of Interfraction Setup Uncertainty of Patients With Glioblastoma Wearing TTFields (Tumor Treating Fields) During Radiation Therapy. Pract Radiat Oncol. 2023 Nov-Dec;; 13(6):522-530. ( Abstract )	11/06/2023
341.	Barton JR, Londregan AK, Alexander TD, Entezari AA, Covarrubias M, Waldman SA[IRT]. Enteroendocrine cell regulation of the gut-brain axis. Front Neurosci. 2023 Nov 7; 17:1272955. ( Abstract )	11/07/2023
+* 342.	Gomaa S, Posey J[MORA], Bashir B[IRT], Basu Mallick A[MORA], Vanderklok E, Schnoll M, Zhan T, Wen KY[CRiC]. Feasibility of a Text Messaging-Integrated and Chatbot-Interfaced Self-Management Program for Symptom Control in Patients With Gastrointestinal Cancer Undergoing Chemotherapy: Pilot Mixed Methods Study. JMIR Form Res. 2023 Nov 10; 7:e46128. ( Abstract )	11/10/2023
¶ 343.	Slovin SF, Knudsen K, Halabi S, de Leeuw R, Shafi A, Kang P, Wolf S, Luo B, Gopalan A, Curley T, Fleming M, Molina A, Fernandez C, Kelly WK[MORA]. Randomized Phase II Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in the Treatment of Metastatic Castration-Resistant Prostate Cancer. J Clin Oncol. 2023 Nov 10; 41(32):5015-5024. ( Abstract )	11/10/2023
¶ * 344.	Van NT, Zhang K, Wigmore RM, Kennedy AI, DaSilva CR, Huang J, Ambelil M, Villagomez JH, O'Connor GJ, Longman RS, Cao M, Snook AE[IRT], Platten M, Kasenty G, Sigal LJ[IRT], Prendergast GC, Kim SV[IRT]. Dietary L-Tryptophan consumption determines the number of colonic regulatory T cells and susceptibility to colitis via GPR15. Nat Commun. 2023 Nov 14; 14(1):7363. ( Abstract )	11/14/2023
¶ 345.	Parikh PJ, Lee P, Low DA, Kim J, Mittauer KE, Bassetti MF, Glide-Hurst CK, Raldow AC, Yang Y, Portelance L, Padgett KR, Zaki B, Zhang R, Kim H, Henke LE, Price AT, Mancias JD, Williams CL, Ng J, Pennell R, Pfeffer MR, Levin D, Mueller AC[MORA], Mooney KE, Kelly P, Shah AP, Boldrini L, Placidi L, Fuss M, Chuong MD. A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer. Int J Radiat Oncol Biol Phys. 2023 Nov 15; 117(4):799-808. ( Abstract )	11/15/2023
¶ 346.	Hadoux J, Elisei R, Brose MS[TaCO], Hoff AO, Robinson BG, Gao M, Jarzab B, Isaev P, Kopeckova K, Wadsley J, Führer D, Keam B, Bardet S, Sherman EJ, Tahara M, Hu MI, Singh R, Lin Y, Soldatenkova V, Wright J, Lin B, Maeda P, Capdevila J, Wirth LJ, LIBRETTO-531 Trial Investigators. Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer. N Engl J Med. 2023 Nov 16; 389(20):1851-1861. ( Abstract )	11/16/2023
347.	Myers RE[CRiC], Hallman MH, Shimada A, DiCarlo M, Davis K, Leach WT, Jackson H, Indictor A, Chambers CV. Primary Care Patient Interest in Multi-Cancer Early Detection for Cancer Screening. J Pers Med. 2023 Nov 16; 13(11). ( Abstract )	11/16/2023
348.	Xie C, Schaefer L, Iozzo RV[TaCO]. Global impact of proteoglycan science on human diseases. iScience. 2023 Nov 17; 26(11):108095. ( Abstract )	11/17/2023
* 349.	Rovner B[CRiC], Casten R, Nightingale G, Leiby BE, Kelley M, Rising K[CRiC]. Emergency Department Use in Black Individuals With Diabetes. Diabetes Spectr. 2023 Fall ; 36(4):391-397. ( Abstract )	11/20/2023
¶ 350.	Arang N, Lubrano S, Ceribelli M, Rigiracciolo DC, Saddawi-Konefka R, Faraji F, Ramirez SI, Kim D, Tosto FA, Stevenson E, Zhou Y, Wang Z, Bogomolovas J, Molinolo AA, Swaney DL, Krogan NJ, Yang J, Coma S, Pachter JA, Aplin AE[TaCO], Alessi DR, Thomas CJ, Gutkind JS. High-throughput chemogenetic drug screening reveals PKC-RhoA/PKN as a targetable signaling vulnerability in GNAQ-driven uveal melanoma. Cell Rep Med. 2023 Nov 21; 4(11):101244. ( Abstract )	11/21/2023
* 351.	Butryn ML[CRiC], Hagerman CJ, Crane NT, Ehmann MM, Forman EM[CRiC], Milliron BJ, Simone NL[CRiC]. A Proof-of-Concept Pilot Test of a Behavioral Intervention to Improve Adherence to Dietary Recommendations for Cancer Prevention. Cancer Control. 2023 Jan-Dec; 30:10732748231214122. ( Abstract )	11/21/2023
¶ +* 352.	Robbins J, Halegoua-DeMarzio D, Basu Mallick A[MORA], Vijayvergia N, Ganetzky R, Lavu H[MORA], Giri VN, Miller J, Maley W, Shah AP[IRT], DiMeglio M, Ambelil M, Yu R, Sato T[IRT], Lefler DS. Liver Transplantation in a Woman with Mahvash Disease. N Engl J Med. 2023 Nov 23; 389(21):1972-1978. ( Abstract )	11/23/2023
¶ 353.	Krais JJ, Glass DJ, Chudoba I, Wang Y, Feng W, Simpson D, Patel P, Liu Z, Neumann-Domer R, Betsch RG, Bernhardy AJ, Bradbury AM, Conger J, Yueh WT, Nacson J, Pomerantz RT[MORA], Gupta GP, Testa JR, Johnson N. Genetic separation of Brca1 functions reveal mutation-dependent Polθ vulnerabilities. Nat Commun. 2023 Nov 24; 14(1):7714. ( Abstract )	11/24/2023
¶ * 354.	Gomaa S, Lopez A[CRiC], Slamon R, Smith R, Lapitan E, Nightingale G, Miller SM, Wen KY[CRiC]. The lived experience of patients with breast cancer on adjuvant endocrine therapy: side effects and coping strategies during the first year of medication initiation. Support Care Cancer. 2023 Nov 27; 31(12):719. ( Abstract )	11/27/2023
355.	Chambers CV, Leach WT, Davis K, Myers RE[CRiC]. Primary Care Provider Receptivity to Multi-Cancer Early Detection Test Use in Cancer Screening. J Pers Med. 2023 Nov 29; 13(12). ( Abstract )	11/29/2023
¶ 356.	Lefkowitz RJ, Rockman HA, Shim PJ, Liu S, Ahn S, Pani B, Rajagopal S, Shenoy SK, Bouvier M, Benovic JL[TaCO], Liggett SB, Ruffolo RR, Bristow MR, Packer M. How carvedilol does not activate β-adrenoceptors. Nat Commun. 2023 Nov 30; 14(1):7866. ( Abstract )	11/30/2023
357.	Tan X, Zhang K, Shi W[MORA], Tang Z. Research progress on the regulation and mechanism of borneol on the blood-brain barrier in pathological states: a narrative review focused on ischemic stroke and cerebral glioma. Transl Cancer Res. 2023 Nov 30; 12(11):3198-3209. ( Abstract )	11/30/2023
358.	Andrews CE, Zilberberg J, Perez-Olle R, Exley MA, Andrews DW[IRT]. Targeted immunotherapy for glioblastoma involving whole tumor-derived autologous cells in the upfront setting after craniotomy. J Neurooncol. 2023 Dec; 165(3):389-398. ( Abstract )	12/01/2023
¶ * 359.	Baqai U, Kurimchak AM, Trachtenberg IV, Purwin TJ, Haj JI, Han A, Luo K, Pachon NF, Jeon A, Chua V, Davies MA, Gutkind JS, Benovic JL[TaCO], Duncan JS, Aplin AE[TaCO]. Kinome profiling identifies MARK3 and STK10 as potential therapeutic targets in uveal melanoma. J Biol Chem. 2023 Dec; 299(12):105418. ( Abstract )	12/01/2023
360.	Berry MP, Chwyl C, Metzler AL, Sun JH, Dart H, Forman EM[CRiC]. Associations between behaviour change technique clusters and weight loss outcomes of automated digital interventions: a systematic review and meta-regression. Health Psychol Rev. 2023 Dec; 17(4):521-549. ( Abstract )	12/01/2023
¶ 361.	Bilenduke E, Anderson S, Brenner A, Currier J, Eberth JM[CRiC], King J, Land SR, Risendal BC, Shannon J, Siegel LN, Wangen M, Waters AR, Zahnd WE, Studts JL. Equitable implementation of lung cancer screening: avoiding its potential to mirror existing inequities among people who use tobacco. Cancer Causes Control. 2023 Dec; 34(Suppl 1):209-216. ( Abstract )	12/01/2023
362.	Collyer E, Boyle BR, Gomez-Galvez Y, Iacovitti L[TaCO], Blanco-Suarez E. Absence of chordin-like 1 aids motor recovery in a mouse model of stroke. Exp Neurol. 2023 Dec; 370:114548. ( Abstract )	12/01/2023
* 363.	Deshpande DA[TaCO], Penn RB[TaCO]. Reactive Oxygen Species Behaving Badly: Oxidized Phosphatidylcholines Corrupt Ca Signaling in Airway Smooth Muscle. Am J Respir Cell Mol Biol. 2023 Dec; 69(6):605-607. ( Abstract )	12/01/2023
* 364.	DesJarlais AM, Miller R, Ali AS, Niazi MZ, Cappelli L, Glass J[MORA], Farrell CJ, Shi W[MORA]. Case report: durable response of gliomatosis cerebri with concurrent tumor-treating fields (TTFields) and chemoradiotherapy treatment. Chin Clin Oncol. 2023 Dec; 12(6):69. ( Abstract )	12/01/2023
365.	Gomella LG[MORA]. The Left Shift in Drugs for Advanced Prostate Cancer. Can J Urol. 2023 Dec; 30(6):11708-11709. ( Abstract )	12/01/2023
¶ 366.	Hirschey R, Rohweder C, Zahnd WE, Eberth JM[CRiC], Adsul P, Guan Y, Yeager KA, Haines H, Farris PE, Bea JW, Dwyer A, Madhivanan P, Ranganathan R, Seaman AT, Vu T, Wickersham K, Vu M, Teal R, Giannone K, Hilton A, Cole A, Islam JY, Askelson N. Prioritizing rural populations in state comprehensive cancer control plans: a qualitative assessment. Cancer Causes Control. 2023 Dec; 34(Suppl 1):159-169. ( Abstract )	12/01/2023
367.	Khanna O, Barsouk A, Momin AA, Mahtabfar A, Andrews CE, Hafazalla K, Lan M, Patel PD, Baldassari MP, Andrews DW[IRT], Evans JJ, Farrell CJ, Judy KD. Predictors of recurrence after surgical resection of parafalcine and parasagittal meningiomas. Acta Neurochir (Wien). 2023 Dec; 165(12):4175-4182. ( Abstract )	12/01/2023
¶ 368.	Leader AE[CRiC], Brandt HM, Briant KJ, Curry G, Ellis K, Gonzalez ET, Guerra CE, Harding G, Hull PC, Israel A, Mellilo R, Mesia RJ, Schiffelbein JE, Song Y, Surani Z, Tiro JA, Vadaparampil ST, Vanderpool RC, Paskett ED. Community Outreach and Engagement at U.S. Cancer Centers: Notes from the Third Cancer Center Community Impact Forum. Cancer Epidemiol Biomarkers Prev. 2023 Dec 01; 32(12):1777-1782. ( Abstract )	12/01/2023
369.	Londregan A, Alexander TD, Covarrubias M, Waldman SA[IRT]. Fundamental Neurochemistry Review: The role of enteroendocrine cells in visceral pain. J Neurochem. 2023 Dec; 167(6):719-732. ( Abstract )	12/01/2023
+* 370.	Mack SJ, Collins ML, Whitehorn GL, Till BM, Grenda TR[MORA], Evans NR[CRiC], Okusanya OT[MORA]. Intraoperative Versus Preoperative Diagnosis of Lung Cancer: Differences in Treatments and Patient Outcomes. Clin Lung Cancer. 2023 Dec; 24(8):726-732. ( Abstract )	12/01/2023
371.	Masel R, Roche ME, Martinez-Outschoorn U[TaCO]. Hodgkin Lymphoma: A disease shaped by the tumor micro- and macroenvironment. Best Pract Res Clin Haematol. 2023 Dec; 36(4):101514. ( Abstract )	12/01/2023
372.	Redding A, Grabocka E[MORA]. Stress granules and hormetic adaptation of cancer. Trends Cancer. 2023 Dec; 9(12):995-1005. ( Abstract )	12/01/2023
373.	Sathe AV, Siu A, Kang KC, Kayne A, Vinjamuri S, Kelly P, Shi W[MORA], Evans JJ, Farrell CJ. Early Versus Delayed Fractionated Stereotactic Radiotherapy for Nonfunctioning Pituitary Adenoma. World Neurosurg. 2023 Dec; 180:e317-e323. ( Abstract )	12/01/2023
¶ 374.	Semprini JT, Biddell CB, Eberth JM[CRiC], Charlton ME, Nash SH, Yeager KA, Evans D, Madhivanan P, Brandt HM, Askelson NM, Seaman AT, Zahnd WE. Measuring and addressing health equity: an assessment of cancer center designation requirements. Cancer Causes Control. 2023 Dec; 34(Suppl 1):23-33. ( Abstract )	12/01/2023
¶ + 375.	Testa A, Quaglia F, Naranjo NM, Verrillo CE, Shields CD, Lin S, Pickles MW, Hamza DF, Von Schalscha T, Cheresh DA, Leiby B, Liu Q, Ding J, Kelly WK[MORA], Hooper DC[IRT], Corey E, Plow EF, Altieri DC, Languino LR[TaCO]. Targeting the αVβ3/NgR2 pathway in neuroendocrine prostate cancer. Matrix Biol. 2023 Dec; 124:49-62. ( Abstract )	12/01/2023
¶ 376.	Wahlen MM, Lizarraga IM, Kahl AR, Zahnd WE, Eberth JM[CRiC], Overholser L, Askelson N, Hirschey R, Yeager K, Nash S, Engelbart JM, Charlton ME. Effect of rurality and travel distance on contralateral prophylactic mastectomy for unilateral breast cancer. Cancer Causes Control. 2023 Dec; 34(Suppl 1):171-186. ( Abstract )	12/01/2023
¶ 377.	Wan S, Rodrigues DB, Kwiatkowski J, Khanna O, Judy KD, Goldstein RC, Overbeek Bloem M, Yu Y, Rooks SE, Shi W[MORA], Hurwitz MD, Stauffer PR. Evaluation of a Balloon Implant for Simultaneous Magnetic Nanoparticle Hyperthermia and High-Dose-Rate Brachytherapy of Brain Tumor Resection Cavities. Cancers (Basel). 2023 Dec 01; 15(23). ( Abstract )	12/01/2023
¶ 378.	Dsouza N, Carroll-Scott A, Bilal U, Headen IE, Reis R, Martinez-Donate AP[CRiC]. Investigating the measurement properties of livability: a scoping review. Cities Health. 2023; 7(5):839-853. ( Abstract )	12/04/2023
¶ 379.	Singh BK, Yokoyama Y, Tanaka Y, Laczkó D, Deshpande DA[TaCO], Kambayashi T. Diacylglycerol kinase zeta deficiency attenuates papain-induced type 2 airway inflammation. Cell Immunol. 2023; 393-394:104780. ( Abstract )	12/06/2023
380.	Akkenepally SV, Yombo DJK, Yerubandi S, Reddy GB, Deshpande DA[TaCO], McCormack FX, Madala SK. Interleukin 31 receptor α promotes smooth muscle cell contraction and airway hyperresponsiveness in asthma. Nat Commun. 2023 Dec 11; 14(1):8207. ( Abstract )	12/11/2023
¶ * 381.	Santasusagna S, Zhu S, Jawalagatti V, Carceles-Cordon M, Ertel A, Garcia-Longarte S, Song WM, Fujiwara N, Li P, Mendizabal I, Petrylak DP, Kelly WK[MORA], Reddy EP, Wang L, Schiewer MJ[MORA], Lujambio A, Karnes J, Knudsen KE, Cordon-Cardo C, Dong H, Huang H, Carracedo A, Hoshida Y, Rodriguez-Bravo V, Domingo-Domenech J. Master Transcription Factor Reprogramming Unleashes Selective Translation Promoting Castration Resistance and Immune Evasion in Lethal Prostate Cancer. Cancer Discov. 2023 Dec 12; 13(12):2584-2609. ( Abstract )	12/12/2023
¶ 382.	Hassel JC, Piperno-Neumann S, Rutkowski P, Baurain JF, Schlaak M, Butler MO, Sullivan RJ, Dummer R, Kirkwood JM, Orloff M[IRT], Sacco JJ, Ochsenreither S, Joshua AM, Gastaud L, Curti B, Piulats JM, Salama AKS, Shoushtari AN, Demidov L, Milhem M, Chmielowski B, Kim KB, Carvajal RD, Hamid O, Collins L, Ranade K, Holland C, Pfeiffer C, Nathan P. Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma. N Engl J Med. 2023 Dec 14; 389(24):2256-2266. ( Abstract )	12/14/2023
* 383.	Bhatti S, Joffe D, Banner L, Talasila S, Mandel J, Lee J, Porcu P[IRT], Nikbakht N[IRT]. Utility of T-cell immunosequencing in distinguishing mycosis fungoides progression from treatment related cutaneous adverse events. Front Med (Lausanne). 2023 Dec 15; 10:1243459. ( Abstract )	12/15/2023
384.	Hariton WVJ, Schulze K, Rahimi S, Shojaeian T, Feldmeyer L, Schwob R, Overmiller AM, Sayar BS, Borradori L, Mahoney MG[IRT], Galichet A, Müller EJ. A desmosomal cadherin controls multipotent hair follicle stem cell quiescence and orchestrates regeneration through adhesion signaling. iScience. 2023 Dec 15; 26(12):108568. ( Abstract )	12/15/2023
¶ 385.	Trehan N, Debbas A, Sternick M, Johnson J[MORA], Gates JC. Treatment Response of Gingival Squamous-Cell Carcinoma to Palliative Intent Immunotherapy. Curr Oncol. 2023 Dec 18; 30(12):10519-10529. ( Abstract )	12/18/2023
¶ + 386.	Kameyama H, Dondapati P, Simmons R, Leslie M, Langenheim JF, Sun Y, Yi M, Rottschaefer A, Pathak R, Nuguri S, Fung KM, Tsaih SW, Chervoneva I[CRiC], Rui H[MORA], Tanaka T. Needle biopsy accelerates pro-metastatic changes and systemic dissemination in breast cancer: Implications for mortality by surgery delay. Cell Rep Med. 2023 Dec 19; 4(12):101330. ( Abstract )	12/19/2023
387.	Mandel J, Gleason L, Joffe D, Bhatti S, Nikbakht N[IRT]. Immunosequencing applications in cutaneous T-cell lymphoma. Front Immunol. 2023 Dec 21; 14:1300061. ( Abstract )	12/21/2023
388.	Benavides N, White JC, Sanmillan ML, Thomas M, Le T, Caywood E, Giraudo CG[IRT]. Novel Compound Heterozygous ZAP70 R37G A507T Mutations in Infant with Severe Immunodeficiency. J Clin Immunol. 2023 Dec 22; 44(1):27. ( Abstract )	12/22/2023
¶ 389.	Joseph J, Sandel G, Kulkarni R, Alatrash R, Herrera BB, Jain P[IRT]. Antibody and Cell-Based Therapies against Virus-Induced Cancers in the Context of HIV/AIDS. Pathogens. 2023 Dec 22; 13(1). ( Abstract )	12/22/2023
390.	Kostyak JC, McKenzie SE, Naik UP[TaCO]. The Function of ASK1 in Sepsis and Stress-Induced Disorders. Int J Mol Sci. 2023 Dec 22; 25(1). ( Abstract )	12/22/2023
391.	Myo Min KK, Ffrench CB, McClure BJ, Ortiz M, Dorward EL, Samuel MS, Ebert LM, Mahoney MG[IRT], Bonder CS. Desmoglein-2 as a cancer modulator: friend or foe? Front Oncol. 2023 Dec 22; 13:1327478. ( Abstract )	12/22/2023
392.	Buchel G, Nayak AR, Herbine K, Sarfallah A, Sokolova VO, Zamudio-Ochoa A, Temiakov D[TaCO]. Structural basis for DNA proofreading. Nat Commun. 2023 Dec 27; 14(1):8501. ( Abstract )	12/27/2023
¶ 393.	Poli ANR, Blyn RC, Buenconsejo GY, Hodanu M, Tang E, Danh C, Cassel J, Debler EW[MORA], Schulz D, Salvino JM. Synthesis and characterization of I-BET151 derivatives for use in identifying protein targets in the African trypanosome. Curr Res Chem Biol. 2023; 3. ( Abstract )	12/28/2023
394.	Jirka GW, Lefler DS, Russo J, Bashir B[IRT]. Colon adenocarcinoma and Birt-Hogg-Dubé syndrome in a young patient: case report and exploration of pathologic implications. Cancer Biol Ther. 2023 Dec 31; 24(1):2184153. ( Abstract )	12/31/2023
395.	Benavides N, Giraudo CG[IRT]. Extended-Synaptotagmin-1 and -2 control T cell signaling and function. EMBO Rep. 2024 Jan; 25(1):286-303. ( Abstract )	01/01/2024
¶ 396.	Chen Y, Pahlavian SH, Jacobs P, Neupane T, Forghani-Arani F, Castillo E, Castillo R, Vinogradskiy Y[CRiC]. Systematic Evaluation of the Impact of Lung Segmentation Methods on 4-Dimensional Computed Tomography Ventilation Imaging Using a Large Patient Database. Int J Radiat Oncol Biol Phys. 2024 Jan 01; 118(1):242-252. ( Abstract )	01/01/2024
* 397.	Dampier W, Berman R, Nonnemacher MR[IRT], Wigdahl B[IRT]. Computational analysis of cas proteins unlocks new potential in HIV-1 targeted gene therapy. Front Genome Ed. 2024 Jan; 5:1248982. ( Abstract )	01/01/2024
¶ 398.	Garman KS, Brown H, Alagesan P, McCall SJ, Patierno S, Wang Q, Wang F, Hyslop T[CRiC], Epplein M. Helicobacter pylori testing prior to or at gastric cancer diagnosis and survival in a diverse US patient population. Gastric Cancer. 2024 Jan; 27(1):28-35. ( Abstract )	01/01/2024
¶ 399.	Geskin LJ, Angello JT, Bagot M, Guenova E, Nikbakht N[IRT], Querfeld C, Scarisbrick JJ. Evaluating Response Trends of Chlormethine/Mechlorethamine Gel in Patients With Stage I-IIA Mycosis Fungoides: Analysis of Individual Patient Data From a Randomized Controlled Phase II Study to Facilitate Optimal Treatment Experiences. Clin Lymphoma Myeloma Leuk. 2024 Jan; 24(1):40-47. ( Abstract )	01/01/2024
¶ 400.	Hoang T, Sutera P, Nguyen T, Chang J, Jagtap S, Song Y, Shetty AC, Chowdhury DD, Chan A, Carrieri FA, Hathout L, Ennis R, Jabbour SK, Parikh R, Molitoris J, Song DY, DeWeese T, Marchionni L, Ren L, Sawant A, Simone N[CRiC], Lafargue A, Van Der Eecken K, Bunz F, Ost P, Tran PT, Deek MP. TP53 structure-function relationships in metastatic castrate-sensitive prostate cancer and the impact of APR-246 treatment. Prostate. 2024 Jan; 84(1):87-99. ( Abstract )	01/01/2024
¶ 401.	Li D, Loriot Y, Burgoyne AM, Cleary JM, Santoro A, Lin D[MORA], Aix SP, Garrido-Laguna I, Sudhagoni R, Guo X, Andrianova S, Paulson S. Cabozantinib plus atezolizumab in previously untreated advanced hepatocellular carcinoma and previously treated gastric cancer and gastroesophageal junction adenocarcinoma: results from two expansion cohorts of a multicentre, open-label, phase 1b trial (COSMIC-021). EClinicalMedicine. 2024 Jan; 67:102376. ( Abstract )	01/01/2024
¶ 402.	Oshima K, Siddiqui N, Orfila JE, Carter D, Laing J, Han X, Zakharevich I, Iozzo RV[TaCO], Ghasabyan A, Moore H, Zhang F, Linhardt RJ, Moore EE, Quillinan N, Schmidt EP, Herson PS, Hippensteel JA. A role for decorin in improving motor deficits after traumatic brain injury. Matrix Biol. 2024 Jan; 125:88-99. ( Abstract )	01/01/2024
¶ 403.	Pearson TA, Vitalis D, Pratt C, Campo R, Armoundas AA, Au D, Beech B, Brazhnik O, Chute CG, Davidson KW, Diez Roux AV[CRiC], Fine LJ, Gabriel D, Groenveld P, Hall J, Hamilton AB, Hu H, Ji H, Kind A, Kraus WE, Krumholz H, Mensah GA, Merchant RM, Mozaffarian D, Murray DM, Neumark-Sztainer D, Petersen M, Goff D. The Science of Precision Prevention: Research Opportunities and Clinical Applications to Reduce Cardiovascular Health Disparities. JACC Adv. 2024 Jan; 3(1). ( Abstract )	01/01/2024
¶ 404.	Richardson K, Sengupta M, Sujkowski A, Libohova K, Harris AC, Wessells R, Merry DE[MORA], Todi SV. A phenotypically robust model of spinal and bulbar muscular atrophy in Drosophila. J Neurosci Res. 2024 Jan; 102(1):e25278. ( Abstract )	01/01/2024
¶ 405.	Subbiah V, Hu MI, Mansfield AS, Taylor MH, Schuler M, Zhu VW, Hadoux J, Curigliano G, Wirth L, Gainor JF, Alonso G, Adkins D, Godbert Y, Ahn MJ, Cassier PA, Cho BC, Lin CC, Zalutskaya A, Barata T, Trask P, Scalori A, Bordogna W, Heinzmann S, Brose MS[TaCO]. Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study. Thyroid. 2024 Jan; 34(1):26-40. ( Abstract )	01/01/2024
* 406.	Swartz K, Chapman A[CRiC], Zhan T, Wen KY[CRiC]. Process evaluation of a G8 screening tool implementation in an outpatient oncology center. J Geriatr Oncol. 2024 Jan; 15(1):101605. ( Abstract )	01/01/2024
* 407.	Torkzaban M, Wessner CE, Halegoua-DeMarzio D, Lyshchik A[TaCO], Nam K[TaCO]. Diagnostic Performance of Quantitative Ultrasound Parameters in Non-alcoholic Fatty Liver Disease. Acad Radiol. 2024 Jan; 31(1):199-211. ( Abstract )	01/01/2024
¶ 408.	Turkheimer LM, Petroni GR, Berger AC, Schroen AT, Brenin DR, Lazar M[MORA], Libby B, Janowski EM, Showalter TN, Showalter SL. Novel Form of Breast Intraoperative Radiation Therapy with CT-Guided High-Dose-Rate Brachytherapy: Interim Results of a Prospective Phase-II Clinical Trial. J Am Coll Surg. 2024 Jan 01; 238(1):10-20. ( Abstract )	01/01/2024
¶ 409.	Fridley BL, Vandekar S, Chervoneva I[CRiC], Wrobel J, Ma S. Statistical analysis of single-cell protein data. Pac Symp Biocomput. 2024; 29:654-660. ( Abstract )	01/03/2024
¶ 410.	McGettigan SE, Aira LE, Kumar G, Ballet R, Butcher EC, Baumgarth N, Debes GF[IRT]. Secreted IgM modulates IL-10 expression in B cells. Nat Commun. 2024 Jan 05; 15(1):324. ( Abstract )	01/05/2024
¶ 411.	Patel SP, Othus M, Chae YK, Dennis MJ, Gordon S[IRT], Mutch D, Samlowski W, Robinson WRR, Sharon E, Ryan C, Lopez G, Plets M, Blanke C, Kurzrock R. A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609 Cohort 47) in Patients with Gestational Trophoblastic Neoplasia. Clin Cancer Res. 2024 Jan 05; 30(1):33-38. ( Abstract )	01/05/2024
412.	Pliatsika V, Cherlin T, Loher P, Vlantis P, Nagarkar P, Nersisyan S, Rigoutsos I[MORA]. MINRbase: a comprehensive database of nuclear- and mitochondrial-ribosomal-RNA-derived fragments (rRFs). Nucleic Acids Res. 2024 Jan 05; 52(D1):D229-D238. ( Abstract )	01/05/2024
¶ * 413.	Haslund-Gourley BS, Woloszczuk K, Hou J, Connors J, Cusimano G, Bell M, Taramangalam B, Fourati S, Mege N, Bernui M, Altman MC, Krammer F, van Bakel H, IMPACC Network, Maecker HT, Rouphael N, Diray-Arce J, Wigdahl B[IRT], Kutzler MA, Cairns CB, Haddad EK[IRT], Comunale MA. IgM N-glycosylation correlates with COVID-19 severity and rate of complement deposition. Nat Commun. 2024 Jan 09; 15(1):404. ( Abstract )	01/09/2024
¶ 414.	Ardigò M, Nikbakht N[IRT], Teoli M, Gleason L, Crisan L, Querfeld C. Chlormethine gel in combination with other therapies for treatment of mycosis fungoides: a review with patient cases. Front Med (Lausanne). 2024 Jan 11; 10:1308491. ( Abstract )	01/11/2024
¶ 415.	Wen KY[CRiC], Dayaratna S, Slamon R, Granda-Cameron C, Tagai EK, Kohler RE, Hudson SV, Miller SM. Chatbot-interfaced and cognitive-affective barrier-driven messages to improve colposcopy adherence after abnormal Pap test results in underserved urban women: A feasibility pilot study. Transl Behav Med. 2024 Jan 11; 14(1):1-12. ( Abstract )	01/11/2024
¶ 416.	Kelly WK[MORA], Danila DC, Lin CC, Lee JL, Matsubara N, Ward PJ, Armstrong AJ, Pook D, Kim M, Dorff TB, Fischer S, Lin YC, Horvath LG, Sumey C, Yang Z, Jurida G, Smith KM, Connarn JN, Penny HL, Stieglmaier J, Appleman LJ. Xaluritamig, a STEAP1 × CD3 XmAb 2+1 Immune Therapy for Metastatic Castration-Resistant Prostate Cancer: Results from Dose Exploration in a First-in-Human Study. Cancer Discov. 2024 Jan 12; 14(1):76-89. ( Abstract )	01/12/2024
417.	Aksamitiene E, Heffelfinger RN, Hoek JB[TaCO], Pribitkin ED. Standardized Pre-clinical Surgical Animal Model Protocol to Investigate the Cellular and Molecular Mechanisms of Ischemic Flap Healing. Biol Proced Online. 2024 Jan 17; 26(1):2. ( Abstract )	01/17/2024
¶ 418.	Geskin L, Querfeld C, Hodak E, Nikbakht N[IRT], Papadavid E, Ardigò M, Wehkamp U, Bagot M. Expert opinions and clinical experiences with chlormethine gel as maintenance treatment for patients with mycosis fungoides. Front Med (Lausanne). 2024 Jan 18:; 10:1298988. ( Abstract )	01/18/2024
¶ 419.	Voeltz GK, Sawyer EM, Hajnoczky G[TaCO], Prinz WA. Making the connection: How membrane contact sites have changed our view of organelle biology. Cell. 2024 Jan 18; 187(2):257-270. ( Abstract )	01/18/2024
¶ 420.	Makker V, Taylor MH, Aghajanian C, Cohn AL, Brose MS[TaCO], Simone CD, Cao ZA, Suttner L, Loboda A, Cristescu R, Jelinic P, Orlowski R, Dutta L, Matsui J, Dutcus CE, Minoshima Y, Messing MJ. Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: results from Study 111/KEYNOTE-146. J Immunother Cancer. 2024 Jan 19; 12(1). ( Abstract )	01/19/2024
421.	Lopez AM[CRiC]. Telehealth in Cancer Care: Inequities, Barriers, and Opportunities. Cancer J. 2024 Jan-Feb 01; 30(1):2-7. ( Abstract )	01/26/2024
¶ 422.	Chan JK, Tian C, Kesterson JP, Lin KY, Darcy K, Richardson MT, Kapp DS, Monk BJ, McNally L, Landrum L, Copeland L, Walker JL, Wenham RM, Phippen N, Spirtos NM, Tewari K, Shahin M[MORA], Berry L, Bell JG. Preoperative and pre-chemotherapy CA-125 levels in high-risk early-stage ovarian cancer - An NRG/GOG study. Gynecol Oncol. 2024 Feb; 181:54-59. ( Abstract )	02/01/2024
¶ 423.	Chuong MD, Lee P, Low DA, Kim J, Mittauer KE, Bassetti MF, Glide-Hurst CK, Raldow AC, Yang Y, Portelance L, Padgett KR, Zaki B, Zhang R, Kim H, Henke LE, Price AT, Mancias JD, Williams CL, Ng J, Pennell R, Raphael Pfeffer M, Levin D, Mueller AC[MORA], Mooney KE, Kelly P, Shah AP, Boldrini L, Placidi L, Fuss M, Jitendra Parikh P. Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancreatic cancer: A multi-center, open-label phase 2 study. Radiother Oncol. 2024 Feb; 191:110064. ( Abstract )	02/01/2024
¶ 424.	Dotan E, Lynch SM, Ryan JC, Mitchell EP[CRiC]. Disparities in care of older adults of color with cancer: A narrative review. Cancer Med. 2024 Feb; 13(3):e6790. ( Abstract )	02/01/2024
¶ 425.	Emiloju OE, Yin J, Koubek E, Reid JM, Borad MJ, Lou Y, Seetharam M, Edelman MJ, Sausville EA, Jiang Y, Kaseb AO, Posey JA[MORA], Davis SL, Gores GJ, Roberts LR, Takebe N, Schwartz GK, Hendrickson AEW, Kaufmann SH, Adjei AA, Hubbard JM, Costello BA. Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohort. Invest New Drugs. 2024 Feb; 42(1):127-135. ( Abstract )	02/01/2024
426.	Esquea EM, Young RG, Reginato MJ[TaCO]. Fructose promotes liver cancer via microbial acetate-induced O-GlcNAcylation. Trends Endocrinol Metab. 2024 Feb; 35(2):88-90. ( Abstract )	02/01/2024
427.	Flemming JP, Wermuth PJ, Mahoney MG[IRT]. Extracellular Vesicles in the Skin Microenvironment: Emerging Roles as Biomarkers and Therapeutic Tools in Dermatologic Health and Disease. J Invest Dermatol. 2024 Feb; 144(2):225-233. ( Abstract )	02/01/2024
428.	Forsberg F[TaCO]. Subharmonic-aided pressure estimation (SHAPE): on the cusp of clinical utility? Eur Radiol. 2024 Feb; 34(2):755-757. ( Abstract )	02/01/2024
¶ 429.	Gianoukakis AG, Choe JH, Bowles DW, Brose MS[TaCO], Wirth LJ, Owonikoko T, Babajanyan S, Worden FP. Real-world practice patterns and outcomes for RAI-refractory differentiated thyroid cancer. Eur Thyroid J. 2024 Feb 01; 13(1). ( Abstract )	02/01/2024
* 430.	Haslund-Gourley BS, Hou J, Woloszczuk K, Horn EJ, Dempsey G, Haddad EK[IRT], Wigdahl B[IRT], Comunale MA. Host glycosylation of immunoglobulins impairs the immune response to acute Lyme disease. EBioMedicine. 2024 Feb; 100:104979. ( Abstract )	02/01/2024
¶ * 431.	Lyshchik A[TaCO], Wessner CE, Bradigan K, Eisenbrey JR[TaCO], Forsberg F[TaCO], Yi M, Keith SW, Kono Y, Wilson SR, Medellin A, Rodgers SK, Planz V, Kamaya A, Finch L, Fetzer DT, Berzigotti A, Sidhu PS, Piscaglia F, CEUS LI-RADS Trial Group. Contrast-enhanced ultrasound liver imaging reporting and data system: clinical validation in a prospective multinational study in North America and Europe. Hepatology. 2024 Feb 01; 79(2):380-391. ( Abstract )	02/01/2024
+* 432.	Rosenbaum SR, Caksa S, Stefanski CD, Trachtenberg IV, Wilson HP, Wilski NA, Ott CA, Purwin TJ, Haj JI, Pomante D, Kotas D, Chervoneva I[CRiC], Capparelli C[TaCO], Aplin AE[TaCO]. SOX10 Loss Sensitizes Melanoma Cells to Cytokine-Mediated Inflammatory Cell Death. Mol Cancer Res. 2024 Feb 01; 22(2):209-220. ( Abstract )	02/01/2024
¶ 433.	Sajisevi M, Nguyen K, Callas P, . . . Cognetti DM[TaCO], . . . Garvey EA, . . . Wooten C, Woody NM, Young GD. Oncologic Safety of Close Margins in Patients With Low- to Intermediate-Grade Major Salivary Gland Carcinoma. JAMA Otolaryngol Head Neck Surg. 2024 Feb 01; 150(2):107-116. ( Abstract )	02/01/2024
¶ 434.	Shiao JC, Gao D, Mueller A[MORA], Holt DE, Moskalenko M, Zaccone J, Waxweiler TV, Robin TP, Nath SK. Pilot Curriculum for Continued Professional Development of Radiation Oncology Nurses. Adv Radiat Oncol. 2024 Feb; 9(2):101372. ( Abstract )	02/01/2024
¶ 435.	Shi W[MORA], Palmer JD, Alnahhas I. Emerging insights on management of high-grade glioma. Chin Clin Oncol. 2024 Feb; 13(1):1. ( Abstract )	02/01/2024
¶ 436.	Sung PJ, Selvam M, Riedel SS, Xie HM, Bryant K, Manning B, Wertheim GB, Kulej K, Pham L, Bowman RL, Peresie J, Nemeth MJ, Levine RL, Garcia BA, Meyer SE[MORA], Sidoli S, Bernt KM, Carroll M. FLT3 tyrosine kinase inhibition modulates PRC2 and promotes differentiation in acute myeloid leukemia. Leukemia. 2024 Feb; 38(2):291-301. ( Abstract )	02/01/2024
¶ 437.	Welsh JA, Goberdhan DCI, O'Driscoll L, . . . Mahoney MG[IRT], . . . Jovanovic-Talisman T, . . . Zimmerman AJ, Misev Consortium, Théry C, Witwer KW. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. J Extracell Vesicles. 2024 Feb; 13(2):e12404. ( Abstract )	02/01/2024
¶ 438.	Haverkos B, Zain J, Kamdar M, Neuwelt A, Davila E, Bradeen X, Major A, Bair S, Jasem J, Smith C, Abbott D, Porcu P[IRT]. Frontline chemoimmunotherapy with nivolumab and dose-adjusted EPOCH in peripheral T-cell lymphoma: a phase 1 trial. Blood Adv. 2024 Feb 13; 8(3):708-711. ( Abstract )	02/13/2024
439.	Varney MJ, Benovic JL[TaCO]. The Role of G Protein-Coupled Receptors and Receptor Kinases in Pancreatic β-Cell Function and Diabetes. Pharmacol Rev. 2024 Feb 13; 76(2):267-299. ( Abstract )	02/13/2024
¶ * 440.	Worster B[CRiC], Meghani SH, Leader AE[CRiC], Nugent SM, Jones KF, Yeager KA, Liou K, Ashare RL. Toward reducing racialized pain care disparities: Approaching cannabis research and access through the lens of equity and inclusion. Cancer. 2024 Feb 15; 130(4):497-504. ( Abstract )	02/15/2024
¶ 441.	Blaes AH, Abu-Khalaf MM[CRiC], Bender CM, Dent SF, Fung C, Smith SK, Watson S, Katta S, Merrill JK, Hudson SV. Coverage for evidence-based cancer survivorship care services. Support Care Cancer. 2024 Feb 17; 32(3):165. ( Abstract )	02/17/2024
442.	Terai M, Sato T[IRT]. Individualised neoantigen cancer vaccine therapy. Lancet. 2024 Feb 17; 403(10427):590-591. ( Abstract )	02/17/2024
* 443.	Zhao L, Wang Y, Sun X, Zhang X, Simone N[CRiC], He J[CRiC]. ELK1/MTOR/S6K1 Pathway Contributes to Acquired Resistance to Gefitinib in Non-Small Cell Lung Cancer. Int J Mol Sci. 2024 Feb 17; 25(4). ( Abstract )	02/17/2024
¶ * 444.	Shah MS[MORA], Wang KR, Shah YB, Ragam R, Simhal RK, Ghodoussipour S, Djaladat H, Mark JR, Lallas CD[MORA], Chandrasekar T. A Narrative Review on Robotic Surgery as Treatment for Renal Cell Carcinoma with Inferior Vena Cava Thrombus. J Clin Med. 2024 Feb 26; 13(5). ( Abstract )	02/26/2024
445.	Xu Q, Vinogradskiy Y[CRiC], Grimm J, Nie W, Dupre P, Chawla AK, Bajaj G, Yang H, LaCouture T, Fan J. Evaluation of a novel patient-specific quality assurance phantom for robotic single-isocentre, multiple-target stereotactic radiosurgery, and stereotactic radiotherapy. Br J Radiol. 2024 Feb 28; 97(1155):660-667. ( Abstract )	02/28/2024
446.	Bar J, Leibowitz R, Reinmuth N, Ammendola A, Jacob E, Moskovitz M, Levy-Barda A, Lotem M, Katsenelson R, Agbarya A, Abu-Amna M, Gottfried M, Harkovsky T, Wolf I, Tepper E, Loewenthal G, Yellin B, Brody Y, Dahan N, Yanko M, Lahav C, Harel M, Raveh Shoval S, Elon Y, Sela I, Dicker AP[CRiC], Shaked Y. Biological insights from plasma proteomics of non-small cell lung cancer patients treated with immunotherapy. Front Immunol. 2024 Feb 29; 15:1364473. ( Abstract )	02/29/2024
¶ 447.	Thompson CL, Buchanan AH, Myers R[CRiC], Weinberg DS. Integrating primary care, shared decision making, and community engagement to facilitate equitable access to multi-cancer early detection clinical trials. Front Oncol. 2024 Feb 29; 13:1307459. ( Abstract )	02/29/2024
¶ 448.	Argiris A, Flamand Y, Savvides P, Johnson JM[MORA], Vathiotis I, Levine M, Li S, Forastiere AA, Burtness B. A new prognostic model in chemotherapy-treated patients with recurrent or metastatic head and neck cancer: An analysis of ECOG-ACRIN E1305. Eur J Cancer. 2024 Mar; 199:113509. ( Abstract )	03/01/2024
+* 449.	Binder AF[IRT], Hossain A, Doshi R, Vivero A, Gonzalez KM, Gentsch A, Wilde L[IRT], Rising KL[CRiC]. Patient and caregiver perceptions of the possibility of home blood transfusions. Transfusion. 2024 Mar; 64(3):483-492. ( Abstract )	03/01/2024
¶ 450.	Braunstein Z, Waller A, Dotson E, McLaughlin E, Hanel W, Reneau J, Addison D, Porcu P[IRT], Brammer JE. Gemcitabine and liposomal doxorubicin (GemDox) for the treatment of relapsed and refractory T-cell lymphomas. Leuk Lymphoma. 2024 Mar; 65(3):301-311. ( Abstract )	03/01/2024
¶ 451.	Capdevila J, Krajewska J, Hernando J, Robinson B, Sherman SI, Jarzab B, Lin CC, Vaisman F, Hoff AO, Hitre E, Bowles DW, Williamson D, Levytskyy R, Oliver J, Keam B, Brose MS[TaCO]. Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Irrespective of Prior Vascular Endothelial Growth Factor Receptor-Targeted Therapy and Tumor Histology: A Subgroup Analysis of the COSMIC-311 Study. Thyroid. 2024 Mar; 34(3):347-359. ( Abstract )	03/01/2024
¶ 452.	Chen N, McGrath CB, Ericsson CI, Vaselkiv JB, Rencsok EM, Stopsack KH, Guard HE, Autio KA, Rathkopf DE, Enting D, Bitting RL, Mateo J, Githiaka CW, Chi KN, Cheng HH, Davis ID, Anderson SG, Badal SAM, Bjartell A, Russnes KM, Heath EI, Pomerantz MM, Henegan JC, Hyslop T[CRiC], Esteban E, Omlin A, McDermott R, Fay AP, Popoola AA, Ragin C, Nowak J, Gerke T, Kantoff PW, George DJ, Penney KL, Mucci LA, IRONMAN Registry. Marital Status, Living Arrangement, and Survival among Individuals with Advanced Prostate Cancer in the International Registry for Men with Advanced Prostate Cancer. Cancer Epidemiol Biomarkers Prev. 2024 Mar 01; 33(3):419-425. ( Abstract )	03/01/2024
¶ * 453.	Choi W, Jia Y, Kwak J, Werner-Wasik M, Dicker AP[CRiC], Simone NL[CRiC], Storozynsky E, Jain V, Vinogradskiy Y[CRiC]. Novel Functional Radiomics for Prediction of Cardiac Positron Emission Tomography Avidity in Lung Cancer Radiotherapy. JCO Clin Cancer Inform. 2024 Mar; 8:e2300241. ( Abstract )	03/01/2024
¶ 454.	Christopoulos P, Harel M, McGregor K, Brody Y, Puzanov I, Bar J, Elon Y, Sela I, Yellin B, Lahav C, Raveh S, Reiner-Benaim A, Reinmuth N, Nechushtan H, Farrugia D, Bustinza-Linares E, Lou Y, Leibowitz R, Kamer I, Zer Kuch A, Moskovitz M, Levy-Barda A, Koch I, Lotem M, Katzenelson R, Agbarya A, Price G, Cheley H, Abu-Amna M, Geldart T, Gottfried M, Tepper E, Polychronis A, Wolf I, Dicker AP[CRiC], Carbone DP, Gandara DR. Plasma Proteome-Based Test for First-Line Treatment Selection in Metastatic Non-Small Cell Lung Cancer. JCO Precis Oncol. 2024 Mar; 8:e2300555. ( Abstract )	03/01/2024
+* 455.	Collins ML, Mack SJ, Whitehorn GL, Till BM, Grenda TR[MORA], Evans NR[CRiC], Gordon SW[IRT], Okusanya OT[MORA]. Access to Guideline Concordant Care for Node-Positive Non-Small Cell Lung Cancer in the United States. Ann Thorac Surg. 2024 Mar; 117(3):568-575. ( Abstract )	03/01/2024
¶ 456.	Díaz LA, Fuentes-López E, Idalsoaga F, Ayares G, Corsi O, Arnold J, Cannistra M, Vio D, Márquez-Lomas A, Ramirez-Cadiz C, Medel MP, Hernandez-Tejero M, Ferreccio C, Lazo M[CRiC], Roblero JP, Cotter TG, Kulkarni AV, Kim W, Brahmania M, Louvet A, Tapper EB, Dunn W, Simonetto D, Shah VH, Kamath PS, Lazarus JV, Singal AK, Bataller R, Arrese M, Arab JP. Association between public health policies on alcohol and worldwide cancer, liver disease and cardiovascular disease outcomes. J Hepatol. 2024 Mar; 80(3):409-418. ( Abstract )	03/01/2024
¶ 457.	Lacey J, Huston A, Lopez G, Vozmediano JR, Lam CS, Narayanan S, Lu W, Wolf U, Subbiah IM, Richard P, Lopez AM[CRiC], Rao S, Frenkel M. Establishing an Integrative Oncology Service: Essential Aspects of Program Development. Curr Oncol Rep. 2024 Mar; 26(3):200-211. ( Abstract )	03/01/2024
¶ 458.	Lee IY, Hanft S, Schulder M, Judy KD, Wong ET, Elder JB, Evans LT, Zuccarello M, Wu J, Aulakh S, Agarwal V, Ramakrishna R, Gill BJ, Quiñones-Hinojosa A, Brennan C, Zacharia BE, Silva Correia CE, Diwanji M, Pennock GK, Scott C, Perez-Olle R, Andrews DW[IRT], Boockvar JA. Autologous cell immunotherapy (IGV-001) with IGF-1R antisense oligonucleotide in newly diagnosed glioblastoma patients. Future Oncol. 2024 Mar; 20(10):579-591. ( Abstract )	03/01/2024
459.	Liao G, Wang R, Wu Y, Maheshwari NK, Penn RB[TaCO], Tang DD. Nestin drives allergen-induced airway smooth muscle hyperplasia and airway remodeling. Allergy. 2024 Mar; 79(3):744-746. ( Abstract )	03/01/2024
¶ +* 460.	Loeb S, Keith SW, Cheng HH, Leader AE[CRiC], Gross L, Sanchez Nolasco T, Byrne N, Hartman R, Brown LH, Pieczonka CM, Gomella LG[MORA], Kelly WK[MORA], Lallas CD[MORA], Handley N[CRiC], Mille PJ, Mark JR, Brown GA, Chopra S, McClellan A, Wise DR, Hollifield L, Giri VN. TARGET: A Randomized, Noninferiority Trial of a Pretest, Patient-Driven Genetic Education Webtool Versus Genetic Counseling for Prostate Cancer Germline Testing. JCO Precis Oncol. 2024 Mar; 8:e2300552. ( Abstract )	03/01/2024
¶ 461.	Maranto C, Sabharwal L, Udhane V, Pitzen SP, McCluskey B, Qi S, O'Connor C, Devi S, Johnson S, Jacobsohn K, Banerjee A, Iczkowski KA, Wang L, Dehm SM, Nevalainen MT[TaCO]. Stat5 induces androgen receptor (AR) gene transcription in prostate cancer and offers a druggable pathway to target AR signaling. Sci Adv. 2024 Mar; 10(9):eadi2742. ( Abstract )	03/01/2024
¶ 462.	Piulats JM, Watkins C, Costa-García M, Del Carpio L, Piperno-Neumann S, Rutkowski P, Hassel JC, Espinosa E, de la Cruz-Merino L, Ochsenreither S, Shoushtari AN, Orloff M[IRT], Salama AKS, Goodall HM, Baurain JF, Nathan P. Overall survival from tebentafusp versus nivolumab plus ipilimumab in first-line metastatic uveal melanoma: a propensity score-weighted analysis. Ann Oncol. 2024 Mar; 35(3):317-326. ( Abstract )	03/01/2024
¶ 463.	Samuels M, Falkenius J, Bar-Ad V[MORA], Dunst J, van Triest B, Yachnin J, Rodriguez-Gutierrez A, Kuipers M, You X, Sarholz B, Locatelli G, Becker A, Troost EGC. A Phase 1 Study of the DNA-PK Inhibitor Peposertib in Combination With Radiation Therapy With or Without Cisplatin in Patients With Advanced Head and Neck Tumors. Int J Radiat Oncol Biol Phys. 2024 Mar 01; 118(3):743-756. ( Abstract )	03/01/2024
¶ 464.	Santoso AP, Vinogradskiy Y[CRiC], Robin TP, Goodman KA, Schefter TE, Miften M, Jones BL. Clinical and Dosimetric Impact of 2D kV Motion Monitoring and Intervention in Liver Stereotactic Body Radiation Therapy. Adv Radiat Oncol. 2024 Mar; 9(3):101409. ( Abstract )	03/01/2024
¶ 465.	Vandekerkhove G, Giri VN, Halabi S, McNair C[CRiC], Hamade K, Bitting RL, Wyatt AW. Toward Informed Selection and Interpretation of Clinical Genomic Tests in Prostate Cancer. JCO Precis Oncol. 2024 Mar; 8:e2300654. ( Abstract )	03/01/2024
¶ 466.	Williams LS, Williams KM, Gillis N, Bolton K, Damm F, Deuitch NT, Farhadfar N, Gergis U[IRT], Keel SB, Michelis FV, Panch SR, Porter CC, Sucheston-Campbell L, Tamari R, Stefanski HE, Godley LA, Lai C. Donor-Derived Malignancy and Transplantation Morbidity: Risks of Patient and Donor Genetics in Allogeneic Hematopoietic Stem Cell Transplantation. Transplant Cell Ther. 2024 Mar; 30(3):255-267. ( Abstract )	03/01/2024
* 467.	Zohar N, Nevler A, Maher SP, Rosenthal MC, Williams F, Bowne WB, Yeo CJ[MORA], Lavu H[MORA]. The Financial Implications of Pancreatic Surgery: The Hospital Is the Big Winner, Not the Surgeon! Ann Surg Open. 2024 Mar; 5(1):e362. ( Abstract )	03/01/2024
¶ 468.	Patel JN, Jiang C, Owzar K, Hertz DL, Wang J, Mulkey FA, Kelly WK[MORA], Halabi S, Furukawa Y, Lassiter C, Dorsey SG, Friedman PN, Small EJ, Carducci MA, Kelley MJ, Nakamura Y, Kubo M, Ratain MJ, Morris MJ, McLeod HL. Pharmacogenetic and clinical risk factors for bevacizumab-related gastrointestinal hemorrhage in prostate cancer patients treated on CALGB 90401 (Alliance). Pharmacogenomics J. 2024 Mar 04; 24(2):6. ( Abstract )	03/04/2024
¶ * 469.	Klassen AC[CRiC], Lee G, Chiang S, Murray R, Guan M, Lo WJ, Hill L, Leader AE[CRiC], Manganello J, Massey PM. Did the COVID-19 experience change U.S. parents' attitudes towards HPV vaccination? Results from a national survey. Vaccine. 2024 Mar 07; 42(7):1704-1713. ( Abstract )	03/07/2024
470.	D'Elia AM, Jones OL, Canziani G, Sarkar B, Chaiken I[IRT], Rodell CB. Injectable Granular Hydrogels Enable Avidity-Controlled Biotherapeutic Delivery. ACS Biomater Sci Eng. 2024 Mar 11; 10(3):1577-1588. ( Abstract )	03/11/2024
¶ + 471.	Lin Z, Roche ME, Diaz-Barros V, Domingo-Vidal M, Whitaker-Menezes D, Tuluc M, Uppal G, Caro J, Curry JM[MORA], Martinez-Outschoorn U[TaCO]. MiR-200c reprograms fibroblasts to recapitulate the phenotype of CAFs in breast cancer progression. Cell Stress. 2024 Mar 11; 8:1-20. ( Abstract )	03/11/2024
¶ 472.	Maziarz RT, Gergis U[IRT], Edwards ML, Song Y, Liu Q, Anderson A, Signorovitch J, Manghani R, Simantov R, Shin H, Sivaraman S. Health care costs among patients with hematologic malignancies receiving allogeneic transplants: a US payer perspective. Blood Adv. 2024 Mar 12; 8(5):1200-1208. ( Abstract )	03/12/2024
473.	Herbst CH, Bouteau A, Menykő EJ, Qin Z, Gyenge E, Su Q, Cooper V, Mabbott NA, Igyarto BZ[IRT]. Dendritic cells overcome Cre/Lox induced gene deficiency by siphoning cytosolic material from surrounding cells. iScience. 2024 Mar 15; 27(3):109119. ( Abstract )	03/15/2024
¶ 474.	Ji J, Bae M, Sun CL, Wildes TM, Freedman RA, Magnuson A, O'Connor T, Moy B, Klepin HD, Chapman AE[CRiC], Tew WP, Dotan E, Fenton MA, Kim H, Katheria V, Gross CP, Cohen HJ, Muss HB, Sedrak MS. Falls prechemotherapy and toxicity-related hospitalization during adjuvant chemotherapy for breast cancer in older women: Results from the prospective multicenter HOPE trial. Cancer. 2024 Mar 15; 130(6):936-946. ( Abstract )	03/15/2024
¶ +* 475.	Philips R, Alnemri A, Amin D, Patel J, Topf MC, Johnson JM[MORA], Bar-Ad V[MORA], Axelrod R[MORA], Argiris A, Fundakowski C, Luginbuhl AJ[TaCO], Cognetti DM[TaCO], Curry JM[MORA]. Effect of preoperative programmed death-1 or programmed death ligand-1 immune check point inhibition on complications after surgery for primary head and neck cancer. Cancer. 2024 Mar 15; 130(6):863-875. ( Abstract )	03/15/2024
476.	Magno E, Bussard KM[TaCO]. A Representative Clinical Course of Progression, with Molecular Insights, of Hormone Receptor-Positive, HER2-Negative Bone Metastatic Breast Cancer. Int J Mol Sci. 2024 Mar 17; 25(6). ( Abstract )	03/17/2024
¶ 477.	Frisbie VS, Hashimoto H, Xie Y, De Luna Vitorino FN, Baeza J, Nguyen T, Yuan Z, Kiselar J, Garcia BA, Debler EW[MORA]. Two DOT1 enzymes cooperatively mediate efficient ubiquitin-independent histone H3 lysine 76 tri-methylation in kinetoplastids. Nat Commun. 2024 Mar 19; 15(1):2467. ( Abstract )	03/19/2024
¶ 478.	Mays D, Macisco JM, Hawkins KB, Sleiman MM, Yockel MR, Xie S, Phan L[CRiC], Luta G, Lobo T, Abraham A, Prokhorov AV, Tercyak KP. A multilevel intervention in pediatric primary care for youth tobacco control: Outcomes of implementing an Ask, Advise, and Connect model. Transl Behav Med. 2024 Mar 21; 14(4):241-248. ( Abstract )	03/21/2024
* 479.	Nelson NG, Burke SE, Cappelli L, Matlack LE, Smith AP, Francois N, Lombardo JF, Shah YB, Wen KY[CRiC], Shafi AA, Simone NL[CRiC]. Temporal Considerations in Brain Metastases Radiation Therapy: The Intersection of Chronobiology and Patient Profiles. Clocks Sleep. 2024 Mar 21; 6(1):200-210. ( Abstract )	03/21/2024
480.	Cappelli L, Khan M, Vemula S, Hum C, Liu H, Yu Y, Chen Y, Zhang Y, Sharif M, Shi W[MORA]. Novel frameless LINAC radiosurgery solution for uveal melanoma. Front Oncol. 2024 Mar 25; 14:1365197. ( Abstract )	03/25/2024
481.	Cicardi ME, Kankate V, Sriramoji S, Krishnamurthy K, Markandaiah SS, Verdone BM, Girdhar A, Nelson A, Rivas LB, Boehringer A, Haeusler AR, Pasinelli P, Guo L[MORA], Trotti D. The nuclear import receptor Kapβ2 modifies neurotoxicity mediated by poly(GR) in C9orf72-linked ALS/FTD. Commun Biol. 2024 Mar 28; 7(1):376. ( Abstract )	03/28/2024
¶ 482.	Sutter J, Brettschneider J, Wigdahl B[IRT], Bruggeman PJ, Krebs FC, Miller V. Non-Thermal Plasma Reduces HSV-1 Infection of and Replication in HaCaT Keratinocytes In Vitro. Int J Mol Sci. 2024 Mar 29; 25(7). ( Abstract )	03/29/2024
¶ 483.	Buck LA, Xie Q, Willis M, Side CM, Giacometti LL, Gaskill PJ[IRT], Park K, Shaheen F, Guo L, Gorantla S, Barker JM. Impaired extinction of cocaine seeking in HIV-infected mice is accompanied by peripheral and central immune dysregulation. Commun Biol. 2024 Mar 30; 7(1):387. ( Abstract )	03/30/2024
¶ 484.	Beckermann KE, Patnaik A, Winer I, Tan W, Bashir B[IRT], Kyriakopoulos CE, Sweis RF, Chamberlain M, Rini BI. A phase 1b open-label study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of py314 in combination with pembrolizumab in patients with advanced renal cell carcinoma. Invest New Drugs. 2024 Apr; 42(2):179-184. ( Abstract )	04/01/2024
485.	Cao M, Carlson RD, Staudt RE, Snook AE[IRT]. In vitro assays to evaluate CAR-T cell cytotoxicity. Methods Cell Biol. 2024; 183:303-315. ( Abstract )	04/01/2024
¶ 486.	Comerford K, Lawson Y, Young M, Knight M, McKinney K, Mpasi P, Mitchell E[CRiC]. The role of dairy food intake for improving health among black Americans across the life continuum: A summary of the evidence. J Natl Med Assoc. 2024 Apr; 116(2 Pt 2):292-315. ( Abstract )	04/01/2024
¶ 487.	Elgohary G, Yang Y, Gergis M, Yi D, Gergis U[IRT]. Chimeric Antigen Receptor T - Cell Therapy for Large B-Cell Lymphoma Patients with Central Nervous System Involvement, a Systematic Review and Meta-analysis. Clin Lymphoma Myeloma Leuk. 2024 Apr; 24(4):e142-e151. ( Abstract )	04/01/2024
488.	Gomella LG[MORA]. Is PSMA PET disrupting traditional prostate cancer staging and treatment? Can J Urol. 2024 Apr; 31(2):11814-11815. ( Abstract )	04/01/2024
489.	Hou YM[MORA], Nakano Y. Breaking the deadlock in genetic code expansion. Nat Chem Biol. 2024 Apr; 20(4):406-407. ( Abstract )	04/01/2024
¶ 490.	Khera N, Edwards ML, Song Y, Sun R, Manghani R, Shin H, Simantov R, Signorovitch J, Sivaraman S, Gergis U[IRT]. Projected Impact of Omidubicel-onlv on Racial/Ethnic Disparities in Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) Outcomes in Hematologic Malignancies. Adv Ther. 2024 Apr; 41(4):1637-1651. ( Abstract )	04/01/2024
¶ 491.	Klobodu C, Vitolins MZ, Deutsch JM, Fisher K, Nasser JA[CRiC], Stott D, Murray MJ, Curtis L, Milliron BJ. Examining the Role of Nutrition in Cancer Survivorship and Female Fertility: A Narrative Review. Curr Dev Nutr. 2024 Apr; 8(4):102134. ( Abstract )	04/01/2024
¶ +* 492.	Lee JD, Zheng R, Okusanya OT[MORA], Evans NR[CRiC], Grenda TR[MORA]. Association between surgical quality and long-term survival in lung cancer. Lung Cancer. 2024 Apr; 190:107511. ( Abstract )	04/01/2024
493.	Lu L, Jang S, Zhu J, Qin Q, Sun L, Sun J[MORA]. Nur77 mitigates endothelial dysfunction through activation of both nitric oxide production and anti-oxidant pathways. Redox Biol. 2024 Apr; 70:103056. ( Abstract )	04/01/2024
¶ * 494.	Mandel AL, Simhal RK, Shah YB, Wang KR, Lallas CD[MORA], Shah MS[MORA]. Racial Disparities in Diagnosis and Treatment of Depression Associated with Androgen Deprivation Therapy for Prostate Cancer. Urology. 2024 Apr; 186:75-80. ( Abstract )	04/01/2024
¶ 495.	Mitchell E[CRiC], Comerford K, Knight M, McKinney K, Lawson Y. A review of dairy food intake for improving health among black adults in the US. J Natl Med Assoc. 2024 Apr; 116(2 Pt 2):253-273. ( Abstract )	04/01/2024
496.	Perillo M, Silla A, Punzo A, Caliceti C, Kriete A, Sell C[CRiC], Lorenzini A. Peto's paradox: Nature has used multiple strategies to keep cancer at bay while evolving long lifespans and large body masses. A systematic review. Biomed J. 2024 Apr; 47(2):100654. ( Abstract )	04/01/2024
* 497.	Shah MS[MORA], Lallas CD[MORA]. Reply to Editorial Comment on "Racial Disparities in Diagnosis and Treatment of Depression Associated with Androgen Deprivation Therapy for Prostate Cancer". Urology. 2024 Apr; 186:82. ( Abstract )	04/01/2024
* 498.	Simhal RK, Simon DP, Wang KR, Shah YB, Havranek B, Mark JR, Chandrasekar T, Shah MS[MORA], Lallas CD[MORA]. Perioperative and Complication Related Outcomes for Robotic-Assisted vs Open Radical Cystectomy: A Comparative National Surgical Quality Improvement Project Analysis. J Endourol. 2024 Apr; 38(4):331-339. ( Abstract )	04/01/2024
499.	Tartaglia G, Fuentes I, Patel N, Varughese A, Israel LE, Park PH, Alexander MH, Poojan S, Cao Q, Solomon B, Padron ZM, Dyer JA, Mellerio JE, McGrath JA, Palisson F, Salas-Alanis J, Han L, South AP[MORA]. Antiviral drugs prolong survival in murine recessive dystrophic epidermolysis bullosa. EMBO Mol Med. 2024 Apr; 16(4):870-884. ( Abstract )	04/01/2024
500.	Zohar N, Nevler A, Esquivel J, Yeo CJ[MORA], Benvenisti H, Elbaz N, Assaf D, Mor E, Bowne WB, International TOO HIPEC Consensus Group. International Expert Consensus on Defining Textbook Oncologic Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastasis. J Am Coll Surg. 2024 Apr 01; 238(4):387-401. ( Abstract )	04/01/2024
+* 501.	Leader AE[CRiC], McNair CM[CRiC], Johnson JM[MORA]. From Base Pairs to City Squares: Comprehensive Precision Oncology for the Future. Cancer Discov. 2024 Apr 04; 14(4):569-572. ( Abstract )	04/04/2024
* 502.	Nusrat F, Khanna A, Jain A, Jiang W, Lavu H[MORA], Yeo CJ[MORA], Bowne W, Nevler A. The Clinical Implications of KRAS Mutations and Variant Allele Frequencies in Pancreatic Ductal Adenocarcinoma. J Clin Med. 2024 Apr 04; 13(7). ( Abstract )	04/04/2024
¶ 503.	Fried W, Tyagi M, Minakhin L, Chandramouly G, Tredinnick T, Ramanjulu M, Auerbacher W, Calbert M, Rusanov T, Hoang T, Borisonnik N, Betsch R, Krais JJ, Wang Y, Vekariya UM, Gordon J, Morton G, Kent T, Skorski T, Johnson N, Childers W, Chen XS, Pomerantz RT[MORA]. Discovery of a small-molecule inhibitor that traps Polθ on DNA and synergizes with PARP inhibitors. Nat Commun. 2024 Apr 05; 15(1):2862. ( Abstract )	04/05/2024
+* 504.	Till BM, Mandel J, Unal E, Juckett L, Grenda T[MORA], Okusanya O[MORA], Palazzo F, Chojnacki K, Evans NR[CRiC]. Cessation of Routine Jejunostomy Tube Placement at Time of Minimally Invasive Ivor Lewis Esophagectomy and Impact on Body Mass Index. Semin Thorac Cardiovasc Surg. 2024 Spring; 36(1):112-119. ( Abstract )	04/08/2024
* 505.	Cavallo MR, Yo JC, Gallant KC, Cunanan CJ, Amirfallah A, Daniali M, Sanders AB, Aplin AE[TaCO], Pribitkin EA, Hartsough EJ[TaCO]. Mcl-1 mediates intrinsic resistance to RAF inhibitors in mutant BRAF papillary thyroid carcinoma. Cell Death Discov. 2024 Apr 15; 10(1):175. ( Abstract )	04/15/2024
¶ 506.	Phan HV, Tsitsiklis A, Maguire CP, Haddad EK[IRT], Becker PM, Kim-Schulze S, Lee B, Chen J, Hoch A, Pickering H, van Zalm P, Altman MC, Augustine AD, Calfee CS, Bosinger S, Cairns CB, Eckalbar W, Guan L, Jayavelu ND, Kleinstein SH, Krammer F, Maecker HT, Ozonoff A, Peters B, Rouphael N, IMPACC Network, Montgomery RR, Reed E, Schaenman J, Steen H, Levy O, Diray-Arce J, Langelier CR. Host-microbe multiomic profiling reveals age-dependent immune dysregulation associated with COVID-19 immunopathology. Sci Transl Med. 2024 Apr 17; 16(743):eadj5154. ( Abstract )	04/17/2024
¶ * 507.	Kates J, Stricker CT, Rising KL[CRiC], Gentsch AT, Solomon E, Powers V, Salcedo VJ, Worster B[CRiC]. Perspectives from patients with chronic lung disease on a telehealth-facilitated integrated palliative care model: a qualitative content analysis study. BMC Palliat Care. 2024 Apr 18; 23(1):103. ( Abstract )	04/18/2024
508.	Worster B[CRiC], Zhu Y, Garber G, Kieffer S, Smith-McLallen A. The impact of outpatient supportive oncology on cancer care cost and utilization. Cancer. 2024 Apr 20. [Epub ahead of print] ( Abstract )	04/20/2024
509.	Eturi A, Bhasin A, Zarrabi KK, Tester WJ[MORA]. Predictive and Prognostic Biomarkers and Tumor Antigens for Targeted Therapy in Urothelial Carcinoma. Molecules. 2024 Apr 22; 29(8). ( Abstract )	04/22/2024
* 510.	Chakravarti N, Boles A, Burzinski R, Sindaco P, Isabelle C, McConnell K, Mishra A[IRT], Porcu P[IRT]. XPO1 blockade with KPT-330 promotes apoptosis in cutaneous T-cell lymphoma by activating the p53-p21 and p27 pathways. Sci Rep. 2024 Apr 23; 14(1):9305. ( Abstract )	04/23/2024
511.	Jorns JM, Sun Y, Kamaraju S, Cheng YC, Kong A, Yen T, Patten CR, Cortina CS, Chitambar CR, Rui H[MORA], Chaudhary LN. Divergent Cellular Expression Patterns of PD-L1 and PD-L2 Proteins in Breast Cancer. J Pers Med. 2024 Apr 29; 14(5). ( Abstract )	04/29/2024
512.	Mondal DK, Xie C, Pascal GJ, Buraschi S, Iozzo RV[TaCO]. Decorin suppresses tumor lymphangiogenesis: A mechanism to curtail cancer progression. Proc Natl Acad Sci U S A. 2024 Apr 30; 121(18):e2317760121. ( Abstract )	04/30/2024
* 513.	Berman RE, Dampier W, Nonnemacher MR[IRT], Wigdahl B[IRT]. What's in a cure: designing a broad-spectrum HIV gene therapy. Curr Opin HIV AIDS. 2024 May 01; 19(3):150-156. ( Abstract )	05/01/2024
¶ 514.	Burus T, VanHelene AD, Rooney MK, Lang Kuhs KA, Christian WJ, McNair C[CRiC], Mishra S, Paulino AC, Smith GL, Frank SJ, Warner JL. Travel-Time Disparities in Access to Proton Beam Therapy for Cancer Treatment. JAMA Netw Open. 2024 May 01; 7(5):e2410670. ( Abstract )	05/01/2024
* 515.	Crochiere RJ, Butryn ML[CRiC], Zhang F, Beaulieu K, Maher JP, Huang Z, Cong C, Forman EM[CRiC]. Intraday relations between physical activity and energy intake among behavioral weight loss participants. Health Psychol. 2024 May; 43(5):376-387. ( Abstract )	05/01/2024
¶ 516.	Dunn MR, Metwally EM, Vohra S, Hyslop T[CRiC], Henderson LM, Reeder-Hayes K, Thompson CA, Lafata JE, Troester MA, Butler EN. Understanding mechanisms of racial disparities in breast cancer: an assessment of screening and regular care in the Carolina Breast Cancer Study. Cancer Causes Control. 2024 May; 35(5):825-837. ( Abstract )	05/01/2024
517.	Eberth JM[CRiC], Michael YL, Jahn JL, Moore RH. Diversity within epidemiology training programs and the public health workforce. Ann Epidemiol. 2024 May; 93:7-9. ( Abstract )	05/01/2024
¶ * 518.	Gleason L, Afifi L, Banner L, Talasila S, Joffe D, Bhatti S, Alpdogan O[IRT], Porcu P[IRT], Nikbakht N[IRT]. Challenges in utilizing ALK expression to distinguish primary cutaneous from systemic anaplastic large cell lymphoma. Mol Clin Oncol. 2024 May; 20(5):35. ( Abstract )	05/01/2024
* 519.	Katcher JG, Klassen AC[CRiC], Hann HW, Chang M, Juon HS[CRiC]. Racial discrimination, knowledge, and health outcomes: The mediating role of hepatitis B-related stigma among patients with chronic hepatitis B. J Viral Hepat. 2024 May; 31(5):248-254. ( Abstract )	05/01/2024
¶ * 520.	Kuemmerli C, Balzano G, Bouwense SA, Braga M, Coolsen M, Daniel SK, Dervenis C, Falconi M, Hwang DW, Kagedan DJ, Kim SC, Lavu H[MORA], Nussbaum D, Partelli S, Passeri MJ, Pecorelli N, Pillarisetty VG, Pucci MJ, Sutcliffe RP, Tingstedt B, van der Kolk M, Vrochides D, Armstrong M, Wei A, Williamsson C, Yeo CJ[MORA], Zani S, Zouros E, Rozzini R, Abu Hilal M. Are enhanced recovery protocols after pancreatoduodenectomy still efficient when applied in elderly patients? A systematic review and individual patient data meta-analysis. J Hepatobiliary Pancreat Sci. 2024 May; 31(5):308-317. ( Abstract )	05/01/2024
521.	Lisberg A, Liu Y, Merry DE[MORA]. Blocking the dimerization of polyglutamine-expanded androgen receptor protects cells from DHT-induced toxicity by increasing AR turnover. J Biol Chem. 2024 May; 300(5):107246. ( Abstract )	05/01/2024
¶ 522.	Lyshchik A[TaCO], Fetzer DT, Kono Y, Wilson SR, Dietrich CF, Clevert DA, Meloni MF, Jang HJ, Kim TK, Lee JM, Minami Y, Kudo M, Piscaglia F. Liver Imaging Reporting and Data System Contrast-Enhanced US Nonradiation Treatment Response Assessment Version 2024. Radiology. 2024 May; 311(2):e232369. ( Abstract )	05/01/2024
* 523.	McPartland C, Salib A, Banks J, Mark JR, Lallas CD[MORA], Trabulsi EJ[MORA], Gomella LG[MORA], Goldberg H, Leiby B, Den R, Chandrasekar T. Risk of Secondary Malignancies After Pelvic Radiation: A Population-based Analysis. Eur Urol Open Sci. 2024 May; 63:52-61. ( Abstract )	05/01/2024
¶ 524.	Michalopoulos GD, Katsos K, Grills IS, Warnick RE, McInerney J, Attia A, Timmerman R, Chang E, Andrews DW[IRT], D'Ambrosio AL, Cobb WS, Pouratian N, Spalding AC, Walter K, Jensen RL, Bydon M, Asher AL, Sheehan JP. Stereotactic radiosurgery in the management of non-small cell lung cancer brain metastases: a prospective study using the NeuroPoint Alliance Stereotactic Radiosurgery Registry. J Neurosurg. 2024 May 01; 140(5):1223-1232. ( Abstract )	05/01/2024
525.	Myers RE[CRiC], Hallman MH, Shimada A, DiCarlo MA, Davis KV, Leach WT, Chambers CV. Primary care patient interests in joining a planned multi-cancer early detection clinical trial. Cancer Med. 2024 May; 13(10):e7312. ( Abstract )	05/01/2024
¶ 526.	Potter AL, Rosenstein AL, Kandala K, Venkateswaran S, Kiang MV, Okusanya OT[MORA], Auchincloss HG, Martin LW, Colson YL, Jeffrey Yang CF. Shortage of thoracic surgeons in the United States: Implications for treatment and survival for stage I lung cancer patients. J Thorac Cardiovasc Surg. 2024 May; 167(5):1603-1614.e9. ( Abstract )	05/01/2024
527.	Rios Diaz AJ, Bevilacqua LA, Habarth-Morales TE, Zalewski A, Metcalfe D, Costanzo C, Yeo CJ[MORA], Palazzo F. Primary anastomosis with diverting loop ileostomy vs. Hartmann's procedure for acute diverticulitis: what happens after discharge? Results of a nationwide analysis. Surg Endosc. 2024 May; 38(5):2777-2787. ( Abstract )	05/01/2024
+* 528.	Till BM, Grenda T[MORA], Tidwell T, Wickes B, Shusted C, Ruane B, Okusanya O[MORA], Evans NR[CRiC], Barta JA[CRiC]. Brief Report: Nonmalignant Surgical Resection Among Individuals with Screening-Detected Versus Incidental Lung Nodules. Clin Lung Cancer. 2024 May; 25(3):e129-e132.e4. ( Abstract )	05/01/2024
¶ 529.	Tucker-Seeley R, Abu-Khalaf M[CRiC], Bona K, Shastri S, Johnson W, Phillips J, Masood A, Moushey A, Hinyard L. Social Determinants of Health and Cancer Care: An ASCO Policy Statement. JCO Oncol Pract. 2024 May; 20(5):621-630. ( Abstract )	05/01/2024
¶ 530.	Van Alsten SC, Dunn MR, Hamilton AM, Ivory JM, Gao X, Kirk EL, Nsonwu-Farley JS, Carey LA, Abdou Y, Reeder-Hayes KE, Roberson ML, Wheeler SB, Emerson MA, Hyslop T[CRiC], Troester MA. Disparities in OncotypeDx Testing and Subsequent Chemotherapy Receipt by Geography and Socioeconomic Status. Cancer Epidemiol Biomarkers Prev. 2024 May 01; 33(5):654-661. ( Abstract )	05/01/2024
¶ + 531.	Calbert ML, Chandramouly G, Adams CM, Saez-Ayala M, Kent T, Tyagi M, Ayyadevara VSSA, Wang Y, Krais JJ, Gordon J, Atkins J, Toma MM, Betzi S, Boghossian AS, Rees MG, Ronan MM, Roth JA, Goldman AR, Gorman N, Mitra R, Childers WE, Graña X, Skorski T, Johnson N, Hurtz C, Morelli X, Eischen CM[IRT], Pomerantz RT[MORA]. 4'-Ethynyl-2'-Deoxycytidine (EdC) Preferentially Targets Lymphoma and Leukemia Subtypes by Inducing Replicative Stress. Mol Cancer Ther. 2024 May 02; 23(5):683-699. ( Abstract )	05/02/2024
532.	Pawar K, Kawamura T, Kirino Y[MORA]. The tRNA half: A strong endogenous Toll-like receptor 7 ligand with a 5'-terminal universal sequence signature. Proc Natl Acad Sci U S A. 2024 May 07; 121(19):e2319569121. ( Abstract )	05/07/2024
533.	Ozaki M, Kageyama K, Kimura K, Eguchi S, Yamamoto A, Tanaka R, Nota T, Yonezawa H, Nishiofuku H, Sakai Y, Tani N, Jogo A, Terai M, Sato T[IRT], Ishizawa T, Miki Y. A rat-based preclinical platform facilitating transcatheter hepatic arterial infusion in immunodeficient rats with liver xenografts of patient-derived pancreatic ductal adenocarcinoma. Sci Rep. 2024 May 08; 14(1):10529. ( Abstract )	05/08/2024
534.	Stepp MA, Menko AS[TaCO]. Clearing the light path: proteoglycans and their important roles in the lens and cornea. Proteoglycan Res. 2024 Apr-Jun; 2(2). ( Abstract )	05/08/2024
¶ 535.	Sikder K, Phillips E, Zhong Z, Wang N, Saunders J, Mothy D, Kossenkov A, Schneider T, Nichtova Z, Csordas G, Margulies KB, Choi JC[MORA]. Perinuclear damage from nuclear envelope deterioration elicits stress responses that contribute to LMNA cardiomyopathy. Sci Adv. 2024 May 10; 10(19):eadh0798. ( Abstract )	05/10/2024
¶ 536.	Martinez-Donate A[CRiC], Rangel MG, Lieberman JT, Gonzalez-Fagoaga JE, Amuedo-Dorantes C, Hassrick EM, Valdez C, Wagner K, Turcios Y, Gonzalez AA, Zhang X. Between the lines: A mixed-methods study on the impacts of parental deportation on the health and well-being of U.S. citizen children. J Migr Health. 2024 May 11; 9:100233. ( Abstract )	05/11/2024
+* 537.	Dyikanov D, Zaitsev A, Vasileva T, Wang I, Sokolov AA, Bolshakov ES, Frank A, Turova P, Golubeva O, Gantseva A, Kamysheva A, Shpudeiko P, Krauz I, Abdou M, Chasse M, Conroy T, Merriam NR, Alesse JE, English N, Shpak B, Shchetsova A, Tikhonov E, Filatov I, Radko A, Bolshakova A, Kachalova A, Lugovykh N, Bulahov A, Kilina A, Asanbekov S, Zheleznyak I, Skoptsov P, Alekseeva E, Johnson JM[MORA], Curry JM[MORA], Linnenbach AJ, South AP[MORA], Yang E, Morozov K, Terenteva A, Nigmatullina L, Fastovetz D, Bobe A, Balabanian L, Nomie K, Yong ST, Davitt CJH, Ryabykh A, Kudryashova O, Tazearslan C, Bagaev A, Fowler N, Luginbuhl AJ[TaCO], Ataullakhanov RI, Goldberg MF. Comprehensive peripheral blood immunoprofiling reveals five immunotypes with immunotherapy response characteristics in patients with cancer. Cancer Cell. 2024 May 13; 42(5):759-779.e12. ( Abstract )	05/13/2024
538.	Fenstermaker TK, Petruk S, Mazo A[MORA]. An emerging paradigm in epigenetic marking: coordination of transcription and replication. Transcription. 2024 Feb-Apr; 15(1-2):22-37. ( Abstract )	05/13/2024
¶ 539.	Hanna GJ, Grover P, Elliott A, McGrath J, Xiu J, Sukari A, Johnson JM[MORA], Wise-Draper T. Molecular Profiling and the Impact of Treatment on Outcomes in Adenoid Cystic Carcinoma Type I and II. Clin Cancer Res. 2024 May 15; 30(10):2225-2232. ( Abstract )	05/15/2024
¶ + 540.	Esquea EM, Ciraku L, Young RG, Merzy J, Talarico AN, Ahmed NN, Karuppiah M, Ramesh A, Chatoff A, Crispim CV, Rashad AA, Cocklin S, Snyder NW, Beld J, Simone NL[CRiC], Reginato MJ[TaCO], Dick A. Selective and brain-penetrant ACSS2 inhibitors target breast cancer brain metastatic cells. Front Pharmacol. 2024 May 16; 15:1394685. ( Abstract )	05/16/2024
¶ 541.	Xie Q, Namba MD, Buck LA, Park K, Jackson JG[TaCO], Barker JM. Effects of Antiretroviral Treatment on Central and Peripheral Immune Response in Mice with EcoHIV Infection. Cells. 2024 May 20; 13(10). ( Abstract )	05/20/2024
* 542.	Khalilieh S, Iyer A, Hammelef E, Zohar N, Gorgov E, Yeo TP, Lavu H[MORA], Bowne W, Yeo CJ[MORA], Nevler A. Major Pancreatic Resection Increases Bone Mineral Density Loss, Osteoporosis, and Fractures. Ann Surg. 2024 May 22. [Epub ahead of print] ( Abstract )	05/22/2024
¶ 543.	Wang D, Geng H, Gondi V, Lee NY, Tsien CI, Xia P, Chenevert TL, Michalski JM, Gilbert MR, Le QT, Omuro AM, Men K, Aldape KD, Cao Y, Srinivasan A, Barani IJ, Sachdev S, Huang J, Choi S, Shi W[MORA], Battiste JD, Wardak Z, Chan MD, Mehta MP, Xiao Y. Radiotherapy Plan Quality Assurance in NRG Oncology Trials for Brain and Head/Neck Cancers: An AI-Enhanced Knowledge-Based Approach. Cancers (Basel). 2024 May 25; 16(11). ( Abstract )	05/25/2024
¶ 544.	Shrestha H, Rädler PD, Dennaoui R, Wicker MN, Rajbhandari N, Sun Y, Peck AR, Vistisen K, Triplett AA, Beydoun R, Sterneck E, Saur D, Rui H[MORA], Wagner KU. The Janus kinase 1 is critical for pancreatic cancer initiation and progression. Cell Rep. 2024 May 28; 43(5):114202. ( Abstract )	05/28/2024
+* 545.	Poiset SJ, Shah S, Cappelli L, Anne P[MORA], Mooney KE, Werner-Wasik M, Laufer TS, Posey JA, Lin D[MORA], Basu Mallick A[MORA], Lavu H[MORA], Bashir B[IRT], Yeo CJ[MORA], Mueller AC[MORA]. Early outcomes of MR-guided SBRT for patients with recurrent pancreatic adenocarcinoma. Radiat Oncol. 2024 May 29; 19(1):65. ( Abstract )	05/29/2024
546.	Abdel-Wahab M, Coleman CN, Eriksen JG, Lee P, Kraus R, Harsdorf E, Lee B, Dicker A[CRiC], Hahn E, Agarwal JP, Prasanna PGS, MacManus M, Keall P, Mayr NA, Jereczek-Fossa BA, Giammarile F, Kim IA, Aggarwal A, Lewison G, Lu JJ, Guedes de Castro D, Kong FS, Afifi H, Sharp H, Vanderpuye V, Olasinde T, Atrash F, Goethals L, Corn BW. Addressing challenges in low-income and middle-income countries through novel radiotherapy research opportunities. Lancet Oncol. 2024 Jun; 25(6):e270-e280. ( Abstract )	06/01/2024
547.	Alexander MH, Cousins WJ, Ewen T, South AP[MORA], Lovat P, Stefanos N. The combined immunohistochemical expression of AMBRA1 and SQSTM1 identifies patients with poorly differentiated cutaneous squamous cell carcinoma at risk of metastasis: A proof of concept study. J Cutan Pathol. 2024 Jun; 51(6):450-458. ( Abstract )	06/01/2024
+* 548.	Alnemri AE, Tekumalla S, Moroco AE, Vathiotis I, Tuluc M, Gargano S, Zhan T, Cognetti DM[TaCO], Curry JM[MORA], Argiris A, Linnenbach A, South AP[MORA], Harshyne LA, Johnson JM[MORA], Luginbuhl AJ[TaCO]. Predictive capacity of immune-related adverse events and cytokine profiling in neoadjuvant immune checkpoint inhibitor trials for head and neck squamous cell carcinoma. Cancer Med. 2024 Jun; 13(11):e7370. ( Abstract )	06/01/2024
¶ 549.	Desai V, Tadinada SM, Shaghaghi H, Summer R[TaCO], Lai JCK, Bhushan A. Combination Treatment of Biochanin A and Atorvastatin Alters Mitochondrial Bioenergetics, Modulating Cell Metabolism and Inducing Cell Cycle Arrest in Pancreatic Cancer Cells. Anticancer Res. 2024 Jun; 44(6):2307-2323. ( Abstract )	06/01/2024
¶ 550.	Epplein M, McCall SJ, Wang F, Alagesan P, Brown H, Wawrzynski J, Labriola C, Zuzul R, Cook C, Dillon M, Hyslop T[CRiC], Patierno SR, Salama NR, Garman KS. Prevalence of the cagA Virulence Factor Varies by Race Among Helicobacter pylori -Infected Patients Undergoing Upper Endoscopy. Clin Transl Gastroenterol. 2024 Jun 01; 15(6):e1. ( Abstract )	06/01/2024
¶ 551.	Epstein M, Syed K, Danella J, Ginzburg S, Belkoff L, Tomaszewski J, Trabulsi E[MORA], Singer EA, Jacobs BL, Raman JD, Guzzo TJ, Uzzo R, Reese AC. Model risk scores may underestimate rate of biochemical recurrence in African American men with localized prostate cancer: a cohort analysis of over 3000 men. Prostate Cancer Prostatic Dis. 2024 Jun; 27(2):257-263. ( Abstract )	06/01/2024
¶ 552.	Fleming S, Gifkins D, Resnick HE, Shalaby W, Rosenberg P, Gaj C, Maio V, Crawford A, Lu-Yao G[CRiC], Gao J, Siefker-Radtke A. Prognostic Value of Fibroblast Growth Factor Receptor Genetic Alterations in Metastatic Urothelial Carcinoma. Clin Genitourin Cancer. 2024 Jun; 22(3):102054. ( Abstract )	06/01/2024
¶ * 553.	Fong ZV, Teinor J, Engineer L, Yeo TP, Rinaldi D, Greer JB, Lavu H[MORA], Qadan M, Johnston FM, Ferrone CR, Chang DC, Yeo CJ[MORA], Wolfgang CL, Warshaw AL, Lillemoe KD, Castillo CF, Weiss MJ, Wu AW, Wolff JL. Caregiver-reported quality of communication in pancreatic and periampullary cancer. Cancer. 2024 Jun 01; 130(11):2051-2059. ( Abstract )	06/01/2024
+ 554.	Ghagane SC, Rangrez S, Nerli RB, Thakur ML[TaCO], Gomella LG[MORA]. Use of TP4303 to identify prostate cancer cells in voided urine samples. Can J Urol. 2024 Jun; 31(3):11892-11896. ( Abstract )	06/01/2024
¶ 555.	Gregory K, Zhao L, Felder TM, Clay-Gilmour A, Eberth JM[CRiC], Murphy EA, Steck SE. Prevalence of health behaviors among cancer survivors in the United States. J Cancer Surviv. 2024 Jun; 18(3):1042-1050. ( Abstract )	06/01/2024
* 556.	Hagerman CJ, Onu MC, Crane NT, Butryn ML[CRiC], Forman EM[CRiC]. Psychological and behavioral responses to daily weight gain during behavioral weight loss treatment. J Behav Med. 2024 Jun; 47(3):492-503. ( Abstract )	06/01/2024
557.	Kelly WK[MORA]. STEAP1 as a potential target for new therapies in prostate cancer. Clin Adv Hematol Oncol. 2024 Jun; 22(5):243-244. ( Abstract )	06/01/2024
¶ 558.	LaFata EM, Allison KC, Audrain-McGovern J, Forman EM[CRiC]. Ultra-Processed Food Addiction: A Research Update. Curr Obes Rep. 2024 Jun; 13(2):214-223. ( Abstract )	06/01/2024
* 559.	Majeed A, Alaparthi S, Halegoua-DeMarzio D, Eberle-Singh J, Jiang W, Anne PR[MORA], Shah AP, Bowne WB, Lin D[MORA]. Complete Pathologic Response to Gemcitabine and Oxaliplatin Chemotherapy After Prior Therapies in a Patient With Hepatocellular Carcinoma and Peritoneal Metastases Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. World J Oncol. 2024 Jun; 15(3):511-520. ( Abstract )	06/01/2024
+ 560.	Nikita N, Gandhi K, Keith SW, Sharma S, Kelly WK[MORA], Lu-Yao G[CRiC]. The rates of septicemia in older adults with prostate cancer treated with abiraterone or enzalutamide: A population-based study. J Geriatr Oncol. 2024 Jun; 15(5):101773. ( Abstract )	06/01/2024
¶ 561.	Poklepovic AS, Gordon SW[IRT], Kothadia S, McGuire WP, Thacker LR, Deng X, Tombes MB, Shrader E, Hudson D, Bandyopadhyay D, Ryan AA, Kmieciak M, Smith S, Dent P. A phase 1 study of regorafenib and sildenafil in adults with advanced solid tumors. Anticancer Drugs. 2024 Jun 01; 35(5):450-458. ( Abstract )	06/01/2024
¶ * 562.	Satyal U, Valentine H, Liu D, Slifker M, Lallas CD[MORA], Trabulsi EJ[MORA], Bukavina L, Szeto L, Hoffman-Censits JH, Mouw KW, Faltas BM, Grivas P, Ibragimova I, Porten SP, Van Allen EM, Geynisman DM, Parker DC, O'Neill JP, Drevik J, Christianson SS, Ginzburg S, Correa AF, Uzzo RG, Ross EA, Zibelman MR, Ghatalia P, Plimack ER, Kutikov A, Abbosh PH. Urine Biopsy as Dynamic Biomarker to Enhance Clinical Staging of Bladder Cancer in Radical Cystectomy Candidates. JCO Precis Oncol. 2024 Jun; 8:e2300362. ( Abstract )	06/01/2024
563.	Schostak M, Bradbury A, Briganti A, Gonzalez D, Gomella L[MORA], Mateo J, Penault-Llorca F, Stenzinger A, Wyatt AW, Bjartell A. Practical Guidance on Establishing a Molecular Testing Pathway for Alterations in Homologous Recombination Repair Genes in Clinical Practice for Patients with Metastatic Prostate Cancer. Eur Urol Oncol. 2024 Jun; 7(3):344-354. ( Abstract )	06/01/2024
+* 564.	Sun G, Eisenbrey JR[TaCO], Smolock AR, Lallas CD[MORA], Anton KF[TaCO], Adamo RD, Shaw CM. Percutaneous Microwave Ablation versus Cryoablation for Small Renal Masses (≤4 cm): 12-Year Experience at a Single Center. J Vasc Interv Radiol. 2024 Jun; 35(6):865-873. ( Abstract )	06/01/2024
¶ +* 565.	Zhang Z, Luo R, Kelly WK[MORA], Chen J, Donahue S, Ip K, Handley NR[CRiC], Tester WJ[MORA], Tsang ML, Kim FJ[MORA], Myers R[CRiC], Lu-Yao G[CRiC], Gu J, Lin J, Li B, Wang C, Yang H[CRiC]. Prostein expression on circulating tumor cells as a prognostic marker in metastatic castration-resistant prostate cancer. Prostate Cancer Prostatic Dis. 2024 Jun; 27(2):339-347. ( Abstract )	06/01/2024
* 566.	Zohar N, Kowal L, Moskal D, Ponzini F, Sun G, Lamm RJ, Williamson J, Nevler A, Lavu H[MORA], Maley WR, Yeo CJ[MORA], Bowne WB. Contemporary report of surgical outcomes after single-stage total pancreatectomy: A 10-year experience. J Surg Oncol. 2024 Jun; 129(7):1235-1244. ( Abstract )	06/01/2024
* 567.	Adams CM, McBride A, Michener P, Shkundina I, Mitra R, An HH, Porcu P[IRT], Eischen CM[IRT]. Identifying Targetable Vulnerabilities to Circumvent or Overcome Venetoclax Resistance in Diffuse Large B-Cell Lymphoma. Cancers (Basel). 2024 Jun 03; 16(11). ( Abstract )	06/03/2024
¶ 568.	Montoya B, Melo-Silva CR, Tang L, Kafle S, Lidskiy P, Bajusz C, Vadovics M, Muramatsu H, Abraham E, Lipinszki Z, Chatterjee D, Scher G, Benitez J, Sung MMH, Tam YK, Catanzaro NJ, Schäfer A, Andino R, Baric RS, Martinez DR, Pardi N, Sigal LJ[IRT]. mRNA-LNP vaccine-induced CD8 T cells protect mice from lethal SARS-CoV-2 infection in the absence of specific antibodies. Mol Ther. 2024 Jun 05; 32(6):1790-1804. ( Abstract )	06/05/2024
¶ 569.	Sacco JJ, Carvajal RD, Butler MO, Shoushtari AN, Hassel JC, Ikeguchi A, Hernandez-Aya L, Nathan P, Hamid O, Piulats JM, Rioth M, Johnson DB, Luke JJ, Espinosa E, Leyvraz S, Collins L, Holland C, Sato T[IRT]. Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma. J Immunother Cancer. 2024 Jun 06; 12(6). ( Abstract )	06/06/2024
¶ + 570.	Chua V, Lopez-Anton M, Mizue Terai , Ryota Tanaka , Baqai U, Purwin TJ, Haj JI, Waltrich FJ, Trachtenberg I, Luo K, Tudi R, Jeon A, Han A, Chervoneva I[CRiC], Davies MA, Aguirre-Ghiso JA, Sato T[IRT], Aplin AE[TaCO]. Slow proliferation of BAP1-deficient uveal melanoma cells is associated with reduced S6 signaling and resistance to nutrient stress. Sci Signal. 2024 Jun 11; 17(840):eadn8376. ( Abstract )	06/11/2024
+* 571.	Estephan LE, Kumar G, Stewart M, Banoub R, Linnenbach A, Harshyne LA, Martinez-Outschoorn UE[TaCO], Mahoney MG[IRT], Curry JM[MORA], Johnson J[MORA], South AP[MORA], Luginbuhl AJ[TaCO]. Altered extracellular matrix correlates with an immunosuppressive tumor microenvironment and disease progression in younger adults with oral cavity squamous cell carcinoma. Front Oncol. 2024 Jun 18; 14:1412212. ( Abstract )	06/18/2024
+* 572.	Van Duyne R, Irollo E, Lin A, Johnson JA, Guillem AM, O'Brien EV, Merja L, Nash B, Jackson JG[TaCO], Sarkar A, Klase ZA[IRT], Meucci O[IRT]. Adult Human Brain Tissue Cultures to Study NeuroHIV. Cells. 2024 Jun 29; 13(13). ( Abstract )	06/29/2024
573.	Bloom MD, Bashir B[IRT]. Emerging role of circulating tumor DNA for early detection of recurrence in biliary tract cancers. J Gastrointest Oncol. 2024 Jun 30; 15(3):1358-1362. ( Abstract )	06/30/2024
¶ 574.	Ahmed N, Sun F, Teigland C, Kilgore KM, Mohammadi I, Chambers J, Dieyi C, Feng C, Osborn J, Fu C, Gergis U[IRT]. Chimeric Antigen Receptor T-Cell Access in Patients with Relapsed/Refractory Large B-Cell Lymphoma: Association of Access with Social Determinants of Health and Travel Time to Treatment Centers. Transplant Cell Ther. 2024 Jul; 30(7):714-725. ( Abstract )	07/01/2024
* 575.	Banner L, Rohan TZ, Zachian R, Gross T, Yang HY, Joffe D, Porcu P[IRT], Nikbakht N[IRT]. Increased incidence of thyroid, renal, lung, melanoma, bladder, and prostate cancers after diagnosis of primary cutaneous B-cell lymphoma: A Surveillance, Epidemiology, and End Results database analysis. J Am Acad Dermatol. 2024 Jul; 91(1):151-153. ( Abstract )	07/01/2024
576.	Ben-Arye E, Lopez AM[CRiC], Daoud N, Zoller L, Walker E, Davidescu M, Shulman K, Gressel O, Stein N, Brosh S, Schiff E, Samuels N. Identifying Factors Associated With Disparities in Access to Integrative Oncology Program. J Pain Symptom Manage. 2024 Jul; 68(1):10-21. ( Abstract )	07/01/2024
577.	Hernandez-Lara MA, Richard J, Deshpande DA[TaCO]. Diacylglycerol kinase is a keystone regulator of signaling relevant to the pathophysiology of asthma. Am J Physiol Lung Cell Mol Physiol. 2024 Jul 01; 327(1):L3-L18. ( Abstract )	07/01/2024
* 578.	Joffe D, Rohan TZ, Mandel J, Suriano J, Banner L, Valiga A, Porcu P[IRT], Gong JZ, Lee JB, Alpdogan O[IRT], Nikbakht N[IRT]. The development of 2 clonally and histologically distinct subtypes of extranodal B-cell lymphomas in the brain and skin in 1 individual. JAAD Case Rep. 2024 Jul; 49:51-54. ( Abstract )	07/01/2024
¶ 579.	Kulkarni AA, Hennessy C, Wilson G, Ramesh V, Hwang C, Awosika J, Bakouny Z, Khan H, Vilar-Compte D, McKay R, Jani C, Weissmann L, Griffiths E, Batist G, Bouganim N, Mavromatis B, Bashir B[IRT], Nguyen RH, Riess JW, Puc M, Kasi A, Berg S, Castillo DR, Hayes-Lattin B, Hosmer W, Flora D, Mishra S, French B, Warner JL, Lopes G, Peters S, Florez N. Brief Report: Impact of Anti-Cancer Treatments on Outcomes of COVID-19 in Patients With Thoracic Cancers: A CCC19 Registry Analysis. Clin Lung Cancer. 2024 Jul; 25(5):e229-e237.e7. ( Abstract )	07/01/2024
580.	Mongiat M, Pascal G, Poletto E, Williams DM, Iozzo RV[TaCO]. Proteoglycans of basement membranes: Crucial controllers of angiogenesis, neurogenesis, and autophagy. Proteoglycan Res. 2024 Jul-Sep; 2(3). ( Abstract )	07/01/2024
¶ 581.	Narayan VM, Boorjian SA, Alemozaffar M, Konety BR, Shore ND, Gomella LG[MORA], Kamat AM, Bivalacqua TJ, Montgomery JS, Lerner SP, Busby JE, Poch M, Crispen PL, Steinberg GD, Schuckman AK, Downs TM, Mashni J, Lane BR, Guzzo TJ, Bratslavsky G, Karsh LI, Woods ME, Brown G, Canter D, Luchey A, Lotan Y, Inman BA, Williams MB, Cookson MS, Chang SS, Sankin AI, O'Donnell MA, Sawutz D, Philipson R, Parker NR, Yla-Herttuala S, Rehm D, Jakobsen JS, Juul K, Dinney CPN. Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial. J Urol. 2024 Jul; 212(1):74-86. ( Abstract )	07/01/2024
¶ 582.	Poiset SJ, Song A, In Yoon H, Huang J, Jain S, Palmer JD, Matsui JK, Cappelli L, Mazza JM, Ali AS, Evans JJ, Farrell CJ, Kearns KN, Sheehan JP, Shi W[MORA]. Long-Term Outcomes of Surgery and Radiation Treatment for Adult Patients with Craniopharyngioma. World Neurosurg. 2024 Jul; 187:e852-e859. ( Abstract )	07/01/2024
+* 583.	Thakur M[TaCO], Tomar VS, Dale E, Gomella LG[MORA], Solomides C, Kolesnikov O, Keith SW, Navarro HT, Dahlgren O, Chaga M, Trabulsi EJ[MORA]. Targeting genomic receptors in voided urine for confirmation of benign prostatic hyperplasia. BJUI Compass. 2024 Jul; 5(7):675-680. ( Abstract )	07/01/2024
¶ 584.	Tylek T, Wong J, Vaughan AE, Spiller KL[IRT]. Biomaterial-mediated intracellular control of macrophages for cell therapy in pro-inflammatory and pro-fibrotic conditions. Biomaterials. 2024 Jul; 308:122545. ( Abstract )	07/01/2024
¶ 585.	Wefel JS, Deshmukh S, Brown PD, Grosshans DR, Sulman EP, Cerhan JH, Mehta MP, Khuntia D, Shi W[MORA], Mishra MV, Suh JH, Laack NN, Chen Y, Curtis AA, Laba JM, Elsayed A, Thakrar A, Pugh SL, Bruner DW. Impact of Apolipoprotein E Genotype on Neurocognitive Function in Patients With Brain Metastases: An Analysis of NRG Oncology's RTOG 0614. Int J Radiat Oncol Biol Phys. 2024 Jul 01; 119(3):846-857. ( Abstract )	07/01/2024
* 586.	West R, Meredith L, Tham E, Yeo TP, Bowne WB, Nevler A, Yeo CJ[MORA], Lavu H[MORA]. Peripancreatic fluid collections following distal pancreatectomy and splenectomy-when is intervention warranted? J Gastrointest Surg. 2024 Jul; 28(7):1027-1032. ( Abstract )	07/01/2024
¶ * 587.	Zheng R, Lam E, Altshuler P, Crutcher M, Lavu H[MORA], Yeo CJ[MORA], Stickle D, Leiby B, Kraft WK. Pharmacokinetics of apixaban in patients undergoing pancreaticoduodenectomy (PAP-UP). Int J Clin Pharmacol Ther. 2024 Jul; 62(7):319-325. ( Abstract )	07/01/2024
588.	Cunningham ML, Schiewer MJ[MORA]. PARP-ish: Gaps in Molecular Understanding and Clinical Trials Targeting PARP Exacerbate Racial Disparities in Prostate Cancer. Cancer Res. 2024 Jul 02; 84(13):2049-2059. ( Abstract )	07/02/2024
¶ 589.	Namani S, Kavetsky K, Lin CY, Maharjan S, Gamper HB, Li NS, Piccirilli JA, Hou YM[MORA], Drndic M. Unraveling RNA Conformation Dynamics in Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like Episode Syndrome with Solid-State Nanopores. ACS Nano. 2024 Jul 02; 18(26):17240-17250. ( Abstract )	07/02/2024
¶ 590.	Bhansali RS, Ellin F, Relander T, . . . Porcu P[IRT], . . . Svoboda J, Jerkeman M, Barta SK. The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas. Blood Adv. 2024 Jul 09; 8(13):3507-3518. ( Abstract )	07/09/2024
¶ 591.	Vekariya U, Minakhin L, Chandramouly G, Tyagi M, Kent T, Sullivan-Reed K, Atkins J, Ralph D, Nieborowska-Skorska M, Kukuyan AM, Tang HY, Pomerantz RT[MORA], Skorski T. PARG is essential for Polθ-mediated DNA end-joining by removing repressive poly-ADP-ribose marks. Nat Commun. 2024 Jul 11; 15(1):5822. ( Abstract )	07/11/2024
¶ 592.	Quintanilha JCF, Kelly WK[MORA], Innocenti F. Contribution of plasma levels of VEGF-A and angiopoietin-2 in addition to a genetic variant in KCNAB1 to predict the risk of bevacizumab-induced hypertension. Pharmacogenomics J. 2024 Jul 12; 24(4):22. ( Abstract )	07/12/2024
593.	Karliner J, Liu Y, Merry DE[MORA]. Mutant androgen receptor induces neurite loss and senescence independently of ARE binding in a neuronal model of SBMA. Proc Natl Acad Sci U S A. 2024 Jul 16; 121(29):e2321408121. ( Abstract )	07/16/2024
594.	Cappelli L, Emrich J, Komarnicky-Kocher L, Vinogradskiy Y[CRiC], Mourtada F. I-125 eye-plaque seed economics: To re-use or to not re-use? A single institutional cost savings analysis of re-using I-125 radioactive seeds for eye-Plaque brachytherapy. Brachytherapy. 2024 Jul-Aug; 23(4):463-469. ( Abstract )	07/17/2024
¶ 595.	Patel RP, Ghilardi G, Zhang Y, Chiang YH, Xie W, Guruprasad P, Kim KH, Chun I, Angelos MG, Pajarillo R, Hong SJ, Lee YG, Shestova O, Shaw C, Cohen I, Gupta A, Vu T, Qian D, Yang S, Nimmagadda A, Snook AE[IRT], Siciliano N, Rotolo A, Inamdar A, Harris J, Ugwuanyi O, Wang M, Carturan A, Paruzzo L, Chen L, Ballard HJ, Blanchard T, Xu C, Abdel-Mohsen M, Gabunia K, Wysocka M, Linette GP, Carreno B, Barrett DM, Teachey DT, Posey AD, Powell DJ, Sauter CT, Pileri S, Pillai V, Scholler J, Rook AH, Schuster SJ, Barta SK, Porazzi P, Ruella M. CD5 deletion enhances the antitumor activity of adoptive T cell therapies. Sci Immunol. 2024 Jul 19; 9(97):eadn6509. ( Abstract )	07/19/2024
¶ * 596.	Armache M, Assi S, Wu R, Jain A, Lu J, Gordon L, Jacobs LM, Fundakowski CE, Rising KL[CRiC], Leader AE[CRiC], Fakhry C, Mady LJ. Readability of Patient Education Materials in Head and Neck Cancer: A Systematic Review. JAMA Otolaryngol Head Neck Surg. 2024 Aug 01; 150(8):713-724. ( Abstract )	08/01/2024
¶ 597.	Brose MS[TaCO], Capdevila J, Elisei R, Bastholt L, Führer-Sakel D, Leboulleux S, Sugitani I, Taylor MH, Wang Z, Wirth LJ, Worden FP, Bernard J, Caferra P, Colzani RM, Liu S, Schlumberger M. Vandetanib in locally advanced or metastatic differentiated thyroid cancer refractory to radioiodine therapy. Endocr Relat Cancer. 2024 Aug 01; 31(8). ( Abstract )	08/01/2024
¶ 598.	Burus T, Martinez J, DelNero P, Pepper S, Ratnayake I, Oh DL, McNair C[CRiC], Krebill H, Mudaranthakam DP. Interinstitutional Approach to Advancing Geospatial Technologies for US Cancer Centers. JCO Clin Cancer Inform. 2024 Aug; 8:e2400099. ( Abstract )	08/01/2024
* 599.	Chitguppi C, Rosen M, Nyquist G, Toskala E, Evans J, Gargano S, Tuluc M, Ertel A, Dsouza G, Addya S, Johnson J[MORA], Bar-Ad V[MORA], Rabinowitz M. SMARCB1-Retained and SMARCB1-Deficient SNUC are Genetically Distinct: A Pilot Study Using RNA Sequencing. J Neurol Surg B Skull Base. 2024 Aug; 85(4):325-331. ( Abstract )	08/01/2024
¶ * 600.	Garabet R, Dampier W, Tillman S, Malone K, Szep Z, Althoff A, Pirrone V, Nonnemacher MR[IRT], Wigdahl B[IRT], Schultheis M, Devlin KN. CD4 nadir and neurocognitive trajectories in people living with HIV. J Neurovirol. 2024 Aug; 30(4):423-433. ( Abstract )	08/01/2024
601.	Gomella LG[MORA]. The Centennial Celebration of the CJU Legends in Urology. Can J Urol. 2024 Aug; 31(4):11915. ( Abstract )	08/01/2024
602.	Granda-Cameron C, Kates J, Wen KY[CRiC]. mHealth Interventions to Improve the Breast Cancer Continuum of Care from Prevention to Survivorship of Hispanic Women: A Scoping Review. J Racial Ethn Health Disparities. 2024 Aug; 11(4):1869-1887. ( Abstract )	08/01/2024
603.	Iskandar AS, Zarrabi KK, Tester WJ[MORA]. Renal cell carcinoma: entering the age of biomarkers. Can J Urol. 2024 Aug; 31(4):11921-11930. ( Abstract )	08/01/2024
¶ * 604.	Kono Y, Piscaglia F, Wilson SR, Medellin A, Rodgers SK, Planz V, Kamaya A, Fetzer DT, Berzigotti A, Sidhu PS, Wessner CE, Bradigan K, Kuon Yeng Escalante CM, Siu Xiao T, Eisenbrey JR[TaCO], Forsberg F[TaCO], Lyshchik A[TaCO], CEUS LI-RADS Trial Group. Clinical impact of CEUS on non-characterizable observations and observations with intermediate probability of malignancy on CT/MRI in patients at risk for HCC. Abdom Radiol (NY). 2024 Aug; 49(8):2639-2649. ( Abstract )	08/01/2024
¶ 605.	Lawrence YR, Miszczyk M, Dawson LA, Diaz Pardo DA, Aguiar A, Limon D, Pfeffer RM, Buckstein M, Barry AS, Meron T, Dicker AP[CRiC], Wydmański J, Zimmermann C, Margalit O, Hausner D, Morag O, Golan T, Jacobson G, Dubinski S, Stanescu T, Fluss R, Freedman LS, Ben-Ayun M, Symon Z. Celiac plexus radiosurgery for pain management in advanced cancer: a multicentre, single-arm, phase 2 trial. Lancet Oncol. 2024 Aug; 25(8):1070-1079. ( Abstract )	08/01/2024
606.	Martin JF, Kane GC, Shusted CS, Barta JA[CRiC]. Implementation of High-Quality Lung Cancer Screening: Impact of Centralized vs. Decentralized Processes. Popul Health Manag. 2024 Aug; 27(4):291-293. ( Abstract )	08/01/2024
¶ +* 607.	Mastrolonardo EV, Llerena P, Lu J, Nunes K, Choi GK, Amin D, Bridgham KM, Campbell D, Philips R, Cognetti DM[TaCO], Luginbuhl AJ[TaCO], Curry JM[MORA]. Obesity and Survival After Immune Checkpoint Inhibition for Head and Neck Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg. 2024 Aug 01; 150(8):688-694. ( Abstract )	08/01/2024
¶ 608.	Mrugala MM, Shi W[MORA], Iwomoto F, Lukas RV, Palmer JD, Suh JH, Glas M. Global post‑marketing safety surveillance of Tumor Treating Fields (TTFields) therapy in over 25,000 patients with CNS malignancies treated between 2011-2022. J Neurooncol. 2024 Aug; 169(1):25-38. ( Abstract )	08/01/2024
609.	Niazi M, Miller R, Kolb R, Ji W, Lozano A, Ahrens M, Hanlon A, Pickles M, Song A, Bar-Ad V[MORA], Hockstein N, Park SJ, Raben A, Shukla G. Association Between Time From Surgery to Radiation Therapy and Multimodality Treatment Outcomes in HPV+ Head and Neck Cancer: A Multi-Institutional Cohort Experience. Adv Radiat Oncol. 2024 Aug; 9(8):101515. ( Abstract )	08/01/2024
¶ 610.	Paller CJ, Zahurak ML, Mandl A, Metri NA, Lalji A, Heath E, Kelly WK[MORA], Hoimes C, Barata P, Taksey J, Garrison DA, Patra K, Milne GL, Anders NM, Nauroth JM, Durham JN, Marshall CH, Markowski MC, Eisenberger MA, Antonarakis ES, Carducci MA, Denmeade SR, Levine M. High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial. Cancer Res Commun. 2024 Aug 01; 4(8):2174-2182. ( Abstract )	08/01/2024
¶ * 611.	Preston WA, Collins ML, Gönen M, Murtha T, Rivera V, Lamm R, Schafer M, Yarmohammadi H, Covey A, Brody LA, Topper S, Nevler A, Lavu H[MORA], Yeo CJ[MORA], Balachandran VP, Drebin JA, Soares KC, Wei AC, Kingham TP, D'Angelica MI, Jarnagin WR. Hemorrhage Sites and Mitigation Strategies After Pancreaticoduodenectomy. JAMA Surg. 2024 Aug 01; 159(8):891-899. ( Abstract )	08/01/2024
+ 612.	Rshaidat H, Meredith L, Woodroof J, Aikhionbare I, Koeneman SH, Shusted C, Ruane B, Barta J[CRiC], Okusanya OT[MORA]. Incidence and Management of Cardiothoracic Relevant Extrapulmonary Findings Found on Low-Dose Computed Tomography. Ann Thorac Surg. 2024 Aug; 118(2):358-364. ( Abstract )	08/01/2024
¶ 613.	Sedrak MS, Sun CL, Bae M, Freedman RA, Magnuson A, O'Connor T, Moy B, Wildes TM, Klepin HD, Chapman AE[CRiC], Tew WP, Dotan E, Fenton MA, Kim H, Katheria V, Muss HB, Cohen HJ, Gross CP, Ji J. Functional decline in older breast cancer survivors treated with and without chemotherapy and non-cancer controls: results from the Hurria Older PatiEnts (HOPE) prospective study. J Cancer Surviv. 2024 Aug; 18(4):1131-1143. ( Abstract )	08/01/2024
* 614.	Shusted CS, Eberth JM[CRiC], Juon HS[CRiC], Barta JA[CRiC]. Characteristics associated with early vs. late adoption of lung cancer screening. Prev Med Rep. 2024 Aug; 44:102820. ( Abstract )	08/01/2024
¶ + 615.	Verrillo CE, Quaglia F, Shields CD, Lin S, Kossenkov AV, Tang HY, Speicher D, Naranjo NM, Testa A, Kelly WK[MORA], Liu Q, Leiby B, Musante L, Sossey-Alaoui K, Dogra N, Chen TY, Altieri DC, Languino LR[TaCO]. Expression of the αVβ3 integrin affects prostate cancer sEV cargo and density and promotes sEV pro-tumorigenic activity in vivo through a GPI-anchored receptor, NgR2. J Extracell Vesicles. 2024 Aug; 13(8):e12482. ( Abstract )	08/01/2024
¶ 616.	Vidal CM, Alva-Ornelas JA, Chen NZ, Senapati P, Tomsic J, Robles VM, Resto C, Sanchez N, Sanchez A, Hyslop T[CRiC], Emwas N, Aljaber D, Bachelder N, Martinez E, Ann D, Jones V, Winn RA, Miele L, Ochoa AC, Dietze EC, Natarajan R, Schones D, Seewaldt VL. Insulin Resistance in Women Correlates with Chromatin Histone Lysine Acetylation, Inflammatory Signaling, and Accelerated Aging. Cancers (Basel). 2024 Aug 01; 16(15). ( Abstract )	08/01/2024
* 617.	Wen KY[CRiC], Burke SE, Jacoby JL, Liang J, Simone NL[CRiC]. RE: Dietary interventions in cancer: a systematic review of all randomized controlled trials. J Natl Cancer Inst. 2024 Aug 01; 116(8):1402-1403. ( Abstract )	08/01/2024
¶ 618.	Xu Q, Fan J, Vinogradskiy Y[CRiC], Chawla AK, Kubicek G, Yang H, Huynh K, LaCouture T, Grimm J, Nie W. Feasibility of patient-specific quality assurance (PSQA) for real-time robotic stereotactic body radiotherapy (SBRT) based on tumor motion traces. J Appl Clin Med Phys. 2024 Aug; 25(8):e14352. ( Abstract )	08/01/2024
¶ 619.	Zager JS, Orloff M[IRT], Ferrucci PF, Choi J, Eschelman DJ, Glazer ES, Ejaz A, Howard JH, Richtig E, Ochsenreither S, Reddy SA, Lowe MC, Beasley GM, Gesierich A, Bender A, Gschnell M, Dummer R, Rivoire M, Arance A, Fenwick SW, Sacco JJ, Haferkamp S, Weishaupt C, John J, Wheater M, Ottensmeier CH. Efficacy and Safety of the Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter Phase 3 Study. Ann Surg Oncol. 2024 Aug; 31(8):5340-5351. ( Abstract )	08/01/2024
¶ 620.	Ito F, Li Z, Minakhin L, Chandramouly G, Tyagi M, Betsch R, Krais JJ, Taberi B, Vekariya U, Calbert M, Skorski T, Johnson N, Chen XS, Pomerantz RT[MORA]. Structural basis for a Polθ helicase small-molecule inhibitor revealed by cryo-EM. Nat Commun. 2024 Aug 14; 15(1):7003. ( Abstract )	08/14/2024
¶ * 621.	Ashare RL, Worster B[CRiC], Nugent SM, Smith DM, Morasco BJ, Leader AE[CRiC], Case AA, Meghani SH. Cannabis and opioid perceptions, co-use, and substitution among patients across 4 NCI-Designated Cancer Centers. J Natl Cancer Inst Monogr. 2024 Aug 15; 2024(66):267-274. ( Abstract )	08/15/2024
¶ 622.	Ellison GL, Helzlsouer KJ, Rosenfield SM, Kim Y, Ashare RL, Blaes AH, Cullen J, Doran N, Ebbert JO, Egan KM, Heffner JL, Lee RT, McClure EA, McDaniels-Davidson C, Meghani SH, Newcomb PA, Nugent S, Hernandez-Ortega N, Salz T, Vidot DC, Worster B[CRiC], Zylla DM. Perceptions, prevalence, and patterns of cannabis use among cancer patients treated at 12 NCI-Designated Cancer Centers. J Natl Cancer Inst Monogr. 2024 Aug 15; 2024(66):202-217. ( Abstract )	08/15/2024
¶ 623.	Gagliardi M, Kean R, Dai B, Augustine JJ, Roberts M, Fleming J, Hooper DC[IRT], Ashizawa AT. BP1003 Decreases STAT3 Expression and Its Pro-Tumorigenic Functions in Solid Tumors and the Tumor Microenvironment. Biomedicines. 2024 Aug 20; 12(8). ( Abstract )	08/20/2024
624.	Herbine K, Nayak AR, Temiakov D[TaCO]. Structural basis for substrate binding and selection by human mitochondrial RNA polymerase. Nat Commun. 2024 Aug 20; 15(1):7134. ( Abstract )	08/20/2024
¶ 625.	Mercedes R, Head D, Zook E, Eidelman E, Tomaszewski J, Ginzburg S, Uzzo R, Smaldone M, Danella J, Guzzo TJ, Lee D, Belkoff L, Walker J, Reese A, Shah MS[MORA], Jacobs B, Raman JD. Appropriateness of Imaging for Low-Risk Prostate Cancer-Real World Data from the Pennsylvania Urologic Regional Collaboration (PURC). Curr Oncol. 2024 Aug 20; 31(8):4746-4752. ( Abstract )	08/20/2024
¶ 626.	Zamora ME, Essien EO, Bhamidipati K, Murthy A, Liu J, Kim H, Patel MN, Nong J, Wang Z, Espy C, Chaudhry FN, Ferguson LT, Tiwari S, Hood ED, Marcos-Contreras OA, Omo-Lamai S, Shuvaeva T, Arguiri E, Wu J, Rauova L, Poncz M, Basil MC, Cantu E, Planer JD, Spiller K[IRT], Zepp J, Muzykantov VR, Myerson JW, Brenner JS. Marginated Neutrophils in the Lungs Effectively Compete for Nanoparticles Targeted to the Endothelium, Serving as a Part of the Reticuloendothelial System. ACS Nano. 2024 Aug 20; 18(33):22275-22297. ( Abstract )	08/20/2024
627.	Yankey A, Oh M, Lee BL, Desai TK, Somarowthu S[MORA]. A novel partnership between lncTCF7 and SND1 regulates the expression of the TCF7 gene via recruitment of the SWI/SNF complex. Sci Rep. 2024 Aug 21; 14(1):19384. ( Abstract )	08/21/2024
¶ 628.	Bialkowska K, El Khalki L, Rana PS, Wang W, Lindner DJ, Parker Y, Languino LR[TaCO], Altieri DC, Pluskota E, Sossey-Alaoui K, Plow EF. Role of Kindlin 2 in prostate cancer. Sci Rep. 2024 Aug 27; 14(1):19809. ( Abstract )	08/27/2024
¶ 629.	Hasan P, Berezhnaya E, Rodríguez-Prados M, Weaver D, Bekeova C, Cartes-Saavedra B, Birch E, Beyer AM, Santos JH, Seifert EL, Elrod JW, Hajnoczky G[TaCO]. MICU1 and MICU2 control mitochondrial calcium signaling in the mammalian heart. Proc Natl Acad Sci U S A. 2024 Aug 27; 121(35):e2402491121. ( Abstract )	08/27/2024
¶ 630.	Jain T, Estrada-Merly N, Salas MQ, . . . Gergis U[IRT], . . . Scott BL, Saber W, Gupta V. Donor types and outcomes of transplantation in myelofibrosis: a CIBMTR study. Blood Adv. 2024 Aug 27; 8(16):4281-4293. ( Abstract )	08/27/2024
¶ 631.	Wang SM, Li Y, Nash A, Ren Y, Thomas SM, Francescatti AB, Barber A, Lynch T, Frank ES, Grimm LJ, Thompson AM, Partridge AH, Hyslop T[CRiC], Hwang ES, Ryser MD. Disease-specific survival outcomes for patients after locoregional treatment for ductal carcinoma in situ: observational cohort study. Br J Surg. 2024 Aug 30; 111(9). ( Abstract )	08/30/2024
+* 632.	Kothari PD, Okusanya OT[MORA], Grenda TR[MORA], Evans NR[CRiC], Jacob JD. Robot-Assisted Right S3 Segmentectomy of a Neuroendocrine Tumor. Innovations (Phila). 2024 Jul-Aug; 19(4):438. ( Abstract )	08/31/2024
¶ 633.	Barta JA[CRiC], Mazzone PJ, Nair VS. Multi-Cancer and Single-Cancer Early Detection Testing: Opportunities and Challenges. Chest. 2024 Sep; 166(3):425-428. ( Abstract )	09/01/2024
634.	Bittner Fagan H, Jurkovitz C, Zhang Z, Thompson LA, Patterson F, Zazzarino MA, Myers RE[CRiC]. Primary care outreach and decision counseling for lung cancer screening. J Med Screen. 2024 Sep; 31(3):150-156. ( Abstract )	09/01/2024
+ 635.	Cappelli L, Uppendahl A, Gardner C, Khan M, Kayne A, Vemula S, Poiset SJ, Zhan T, Judy KD, Andrews DW[IRT], Simone NL[CRiC], Alnahhas I, Shi W[MORA]. Baseline single institutional retrospective review of body mass index (BMI) as a prognostic indicator in patients with newly diagnosed glioblastoma (GBM). J Clin Neurosci. 2024 Sep; 127:110754. ( Abstract )	09/01/2024
636.	Del Caño LR, South AP[MORA], O'Toole EA, Kelsell DP, Blaydon DC. A Role for Aquaporin-5 Variants in Regulation of the Actin Cytoskeleton in Non-Epidermolytic Palmoplantar Keratoderma. J Invest Dermatol. 2024 Sep; 144(9):2092-2096. ( Abstract )	09/01/2024
+* 637.	Falatah HA, Lacerda Q, Wessner CE, Lo S, Wheatley MA[MORA], Liu JB[TaCO], Eisenbrey JR[TaCO]. Influence of Phase Change Droplet Activation and Microbubble Cavitation on the Microenvironment of Hepatocellular Carcinoma. Ultrasound Med Biol. 2024 Sep; 50(9):1387-1394. ( Abstract )	09/01/2024
* 638.	Jeurkar C, Leiby B, Rashid S, Gergis U[IRT], Grossso D, Carabasi M, Filicko-O'Hara J[IRT], O'Hara W, Klumpp T, Porcu P[IRT], Flomenberg N, Wagner JL. A prospective study of posttransplant cyclophosphamide for unrelated donor peripheral blood stem cell transplant with special attention to graft content and the impact of a higher γδ T cell dose. Eur J Haematol. 2024 Sep; 113(3):283-289. ( Abstract )	09/01/2024
¶ + 639.	Kwak S, Akbari H, Garcia JA, Mohan S, Dicker Y, Sako C, Matsumoto Y, Nasrallah MP, Shalaby M, O'Rourke DM, Shinohara RT, Liu F, Badve C, Barnholtz-Sloan JS, Sloan AE, Lee M, Jain R, Cepeda S, Chakravarti A, Palmer JD, Dicker AP[CRiC], Shukla G, Flanders AE, Shi W[MORA], Woodworth GF, Davatzikos C. Predicting peritumoral glioblastoma infiltration and subsequent recurrence using deep-learning-based analysis of multi-parametric magnetic resonance imaging. J Med Imaging (Bellingham). 2024 Sep; 11(5):054001. ( Abstract )	09/01/2024
¶ +* 640.	Machado P, Tahmasebi A, Fallon S, Liu JB[TaCO], Dogan BE, Needleman L, Lazar M[MORA], Willis AI, Brill K, Nazarian S, Berger A, Forsberg F[TaCO]. Characterizing Sentinel Lymph Node Status in Breast Cancer Patients Using a Deep-Learning Model Compared With Radiologists' Analysis of Grayscale Ultrasound and Lymphosonography. Ultrasound Q. 2024 Sep 01; 40(3). ( Abstract )	09/01/2024
+ 641.	Mack SJ, Rshaidat H, Ho A, Till BM, Collins ML, Whitehorn GL, Martin J, Jacob JD, Grenda TR[MORA], Evans NR[CRiC], Okusanya OT. Institutional Experience With Robotic Lobectomy After Neoadjuvant Immunotherapy and Chemotherapy. Ann Thorac Surg Short Rep. 2024 Sep; 2(3):453-457. ( Abstract )	09/01/2024
+* 642.	Martin JL, Mack SJ, Rshaidat H, Collins ML, Whitehorn GL, Grenda TR[MORA], Evans NR[CRiC], Okusanya OT[MORA]. Wedge Resection Outcomes: A Comparison of Video-Assisted and Robot-Assisted Wedge Resections. Ann Thorac Surg. 2024 Sep; 118(3):683-690. ( Abstract )	09/01/2024
643.	Melo-Silva CR, Sigal LJ[IRT]. Innate and adaptive immune responses that control lymph-borne viruses in the draining lymph node. Cell Mol Immunol. 2024 Sep; 21(9):999-1007. ( Abstract )	09/01/2024
¶ 644.	Moh M, Puzyrenko A, Summey R, Rader JS, Herrera Cano GE, Gavina JV, Rui H[MORA], Sun Y, Hopp E. Clinicopathologic Characteristics of a Single-institution Cohort of Ovarian Adult Granulosa Cell Tumors, With Biomarker and Therapeutic Implications Utilizing the Detection of Androgen, Estrogen, and Progesterone Hormone Receptor Expression by Immunohistochemistry. Int J Gynecol Pathol. 2024 Sep 01; 43(5):527-534. ( Abstract )	09/01/2024
+* 645.	Rshaidat H, Whitehorn GL, Collins M, Mack SJ, Martin J, Grenda TR[MORA], Evans NR[CRiC], Okusanya OT[MORA]. Factors Associated With Margin Positivity After Lung Resection Surgery. Clin Lung Cancer. 2024 Sep; 25(6):560-566. ( Abstract )	09/01/2024
* 646.	Simhal RK, Wang KR, Shah YB, Lallas CD[MORA], Shah MS[MORA], Chandrasekar T. Peri-operative outcomes following radical prostatectomy in the setting of advanced prostate cancer. BJU Int. 2024 Sep; 134(3):465-472. ( Abstract )	09/01/2024
+ 647.	Thosani DS, Meredith LT, West R, Till BM, Rahman U, Mack S, Okusanya OT, Evans NR[CRiC], Grenda TR[MORA]. Geographic Variation in the Utilization of Services Surrounding Lung Cancer Resection. Ann Thorac Surg Short Rep. 2024 Sep; 2(3):438-442. ( Abstract )	09/01/2024
¶ 648.	Yell N, Eberth JM[CRiC], Alberg AJ, Hung P, Schootman M, McLain AC, Munden RF. Comparison of the characteristics of the population eligible for lung cancer screening under 2013 and population newly eligible under 2021 US Preventive Services Task Force recommendations. Cancer Causes Control. 2024 Sep; 35(9):1233-1243. ( Abstract )	09/01/2024
¶ 649.	Vinogradskiy Y[CRiC], Schubert L, Taylor A, Rudoler S, Lamb J. Radiation Oncology Ransomware Attack Response Risk Analysis Using Failure Modes and Effects Analysis. Pract Radiat Oncol. 2024 Sep-Oct; 14(5):e407-e415. ( Abstract )	09/02/2024
* 650.	Wang KR, Simhal RK, Clark CB, Mann MJ, Mark JR, Lallas CD[MORA], Den R, Trabulsi EJ[MORA]. Complications and Influential Perioperative Factors Associated with SpaceOAR Hydrogel Placement. Adv Urol. 2024 Sep 3; 2024:3439727. ( Abstract )	09/03/2024
¶ 651.	Al-Juhaishi T, Dela Cruz S, Gupta R, Keiffer G[IRT], Morrison VA, Shapira I, Woods A, Norsworthy K, de Claro RA, Theoret MR, Garg R, Pulte ED. Treatment of Acute Myeloid Leukemia in the Community Setting. Oncologist. 2024 Sep 06; 29(9):801-805. ( Abstract )	09/06/2024
¶ 652.	Gongala S, Garcia JA, Korakavi N, Patil N, Akbari H, Sloan A, Barnholtz-Sloan JS, Sun J, Griffith B, Poisson LM, Booth TC, Jain R, Mohan S, Nasralla MP, Bakas S, Tippareddy C, Puig J, Palmer JD, Shi W[MORA], Colen RR, Sotiras A, Ahn SS, Park YW, Davatzikos C, Badve C, ReSPOND Consortium. Sex-Specific Differences in Patients with IDH1-Wild-Type Grade 4 Glioma in the ReSPOND Consortium. AJNR Am J Neuroradiol. 2024 Sep 09; 45(9):1299-1307. ( Abstract )	09/09/2024
¶ 653.	Hayashi M, Girdhar A, Ko YH, Kim KM, DePierro JA, Buchler JR, Arunprakash N, Bajaj A, Cingolani G, Guo L[MORA]. Engineered NLS-chimera downregulates expression of aggregation-prone endogenous FUS. Nat Commun. 2024 Sep 10; 15(1):7887. ( Abstract )	09/10/2024
¶ 654.	Joseph J, Premeaux TA, Tandon R, Murphy EL, Bruhn R, Nicot C, Herrera BB, Lemenze A, Alatrash R, Baffour Tonto P, Ndhlovu LC, Jain P[IRT]. Dendritic Cells Pulsed with HAM/TSP Exosomes Sensitize CD4 T Cells to Enhance HTLV-1 Infection, Induce Helper T-Cell Polarization, and Decrease Cytotoxic T-Cell Response. Viruses. 2024 Sep 10; 16(9). ( Abstract )	09/10/2024
¶ 655.	Kafle S, Montoya B, Tang L, Tam YK, Muramatsu H, Pardi N, Sigal LJ[IRT]. The roles of CD4 T cell help, sex, and dose in the induction of protective CD8 T cells against a lethal poxvirus by mRNA-LNP vaccines. Mol Ther Nucleic Acids. 2024 Sep 10; 35(3):102279. ( Abstract )	09/10/2024
+ 656.	Shigematsu M, Kawamura T, Deshpande DA[TaCO], Kirino Y[MORA]. Immunoactive signatures of circulating tRNA- and rRNA-derived RNAs in chronic obstructive pulmonary disease. Mol Ther Nucleic Acids. 2024 Sep 10; 35(3):102285. ( Abstract )	09/10/2024
¶ 657.	Cherlin T, Jing Y, Shah S, Kennedy A, Telonis AG, Pliatsika V, Wilson H, Thompson L, Vlantis PI, Loher P, Leiby B, Rigoutsos I[MORA]. The subcellular distribution of miRNA isoforms, tRNA-derived fragments, and rRNA-derived fragments depends on nucleotide sequence and cell type. BMC Biol. 2024 Sep 12; 22(1):205. ( Abstract )	09/12/2024
* 658.	Meredith LT, Baek D, Agarwal A, Kamal F, Kumar AR, Schlachterman A, Kowalski TE, Yeo CJ[MORA], Lavu H[MORA], Nevler A, Bowne WB. Pancreaticoduodenectomy after endoscopic ultrasound-guided lumen apposing metal stent (LAMS): A case series evaluating feasibility and short-term outcomes. Heliyon. 2024 Sep 15; 10(17):e36404. ( Abstract )	09/15/2024
¶ 659.	Ozanne EM, Maves K, Tramontano AC, Lynch T, Thompson A, Partridge A, Frank E, Collyar D, Basila D, Pinto D, Hyslop T[CRiC], Ryser MD, Rosenberg S, Hwang ES, Punglia RS. Impact of an online decision support tool for ductal carcinoma in situ (DCIS) using a pre-post design (AFT-25). Breast Cancer Res. 2024 Sep 17; 26(1):134. ( Abstract )	09/17/2024
¶ +* 660.	Leader AE[CRiC], Rebbeck TR, Oh WK, Patel AV, Winer EP, Bailey LO, Gomella LG[MORA], Lumpkins CY, Garraway IP, Aiello LB, Baskin ML, Cheng HH, Cooney KA, Ganzak A, George DJ, Halabi S, Hathaway F, Healy C, Kim JW, Leapman MS, Loeb S, Maxwell KN, McNair C[CRiC], Morgan TM, Prindeville B, Soule HR, Steward WL, Suttiratana SC, Taplin ME, Yamoah K, Fortune T, Bennett K, Blanding-Godbolt J, Gross L, Giri VN. Adaptation of the socioecological model to address disparities in engagement of Black men in prostate cancer genetic testing. BMC Public Health. 2024 Sep 18; 24(1):2533. ( Abstract )	09/18/2024
¶ 661.	Wirth LJ, Brose MS[TaCO], Subbiah V, Worden F, Solomon B, Robinson B, Hadoux J, Tomasini P, Weiler D, Deschler-Baier B, Tan DSW, Maeda P, Lin Y, Singh R, Bayt T, Drilon A, Cassier PA. Durability of Response With Selpercatinib in Patients With RET-Activated Thyroid Cancer: Long-Term Safety and Efficacy From LIBRETTO-001. J Clin Oncol. 2024 Sep 20; 42(27):3187-3195. ( Abstract )	09/20/2024
662.	Shinkai A, Hashimoto H, Shimura C, Fujimoto H, Fukuda K, Horikoshi N, Okano M, Niwa H, Debler EW[MORA], Kurumizaka H, Shinkai Y. The C-terminal 4CXXC-type zinc finger domain of CDCA7 recognizes hemimethylated DNA and modulates activities of chromatin remodeling enzyme HELLS. Nucleic Acids Res. 2024 Sep 23; 52(17):10194-10219. ( Abstract )	09/23/2024
¶ + 663.	Schepps S, Xu J, Yang H, Mandel J, Mehta J, Tolotta J, Baker N, Tekmen V, Nikbakht N[IRT], Fortina P, Fuentes I, LaFleur B, Cho RJ, South AP[MORA]. Skin in the game: a review of single-cell and spatial transcriptomics in dermatological research. Clin Chem Lab Med. 2024 Sep 25; 62(10):1880-1891. ( Abstract )	09/25/2024
¶ 664.	Hjorth M, Egan CL, Telles GD, Pal M, Gallego-Ortega D, Fuller OK, McLennan ED, Gillis RD, Oh TG, Muscat GEO, Tegegne S, Mah MSM, Skhinas J, Estevez E, Adams TE, McKay MJ, Molloy M, Watt KI, Qian H, Gregorevic P, Cox TR, Hojman P, Midtgaard J, Christensen JF, Friedrichsen M, Iozzo RV[TaCO], Sloan EK, Drew BG, Wojtaszewski JFP, Whitham M, Febbraio MA. Decorin, an exercise-induced secretory protein, is associated with improved prognosis in breast cancer patients but does not mediate anti-tumorigenic tissue crosstalk in mice. J Sport Health Sci. 2024 Sep 26; 14:100991. [Epub ahead of print] ( Abstract )	09/26/2024
665.	Zhang J, Rui H[MORA], Hu H. Noninvasive multi-cancer detection using blood-based cell-free microRNAs. Sci Rep. 2024 Sep 27; 14(1):22136. ( Abstract )	09/27/2024
* 666.	Calderon-Aparicio A, He J[CRiC], Simone NL[CRiC]. S6K1 Controls DNA Damage Signaling Modulated by the MRN Complex to Induce Radioresistance in Lung Cancer. Int J Mol Sci. 2024 Sep 28; 25(19). ( Abstract )	09/28/2024
¶ 667.	Hoadley A, Fleisher L, Kenny C, Kelly PJ, Ma X, Wu J, Guerra C, Leader AE[CRiC], Alhajji M, D'Avanzo P, Landau Z, Bass SB. Exploring Racial Disparities in Awareness and Perceptions of Oncology Clinical Trials: Cross-Sectional Analysis of Baseline Data From the mychoice Study. JMIR Cancer. 2024 Sep 30; 10:e56048. ( Abstract )	09/30/2024
¶ 668.	Bao T, Lopez G, Crudup T, Lopez AM[CRiC], Paller CJ, Gowin K, Mehta A, Witt CM, Zick SM, Balneaves LG. Advancing Integrative Oncology: The Society for Integrative Oncology Education Committee's Journey and Vision. J Integr Complement Med. 2024 Oct; 30(10):910-912. ( Abstract )	10/01/2024
* 669.	Bi X, Grosso D, Gradone A, Filicko-O'Hara J[IRT], McCorkell KA, O'Hara W, Wagner JL, Flomenberg N, Gergis U[IRT]. A Tender Reduced-Intensity Conditioning for the Unfit: A Novel 4 Gy Total Body Irradiation-Based Conditioning Followed by Two-Step Haploidentical Stem Cell Transplant, Results of a Prospective Trial. Transplant Cell Ther. 2024 Oct; 30(10):1009.e1-1009.e11. ( Abstract )	10/01/2024
¶ 670.	Booher A, Mao JJ, Muniz RC, Romero SAD, Li SQ, Lopez AM[CRiC], Liou KT. Association between Hispanic Ethnicity and Greater Expectation of Benefit from Acupuncture or Massage for Pain in Cancer. J Immigr Minor Health. 2024 Oct; 26(5):953-957. ( Abstract )	10/01/2024
* 671.	Bradt J, Leader A[CRiC], Worster B[CRiC], Myers-Coffman K, Bryl K, Biondo J, Schneible B, Cottone C, Selvan P, Zhang F. Music Therapy for Pain Management for People With Advanced Cancer: A Randomized Controlled Trial. Psychooncology. 2024 Oct; 33(10):e70005. ( Abstract )	10/01/2024
¶ 672.	Cao Y, Sutera P, Silva Mendes W, Yousefi B, Hrinivich T, Deek M, Phillips R, Song D, Kiess A, Cem Guler O, Torun N, Reyhan M, Sawant A, Marchionni L, Simone NL[CRiC], Tran P, Onal C, Ren L. Machine learning predicts conventional imaging metastasis-free survival (MFS) for oligometastatic castration-sensitive prostate cancer (omCSPC) using prostate-specific membrane antigen (PSMA) PET radiomics. Radiother Oncol. 2024 Oct; 199:110443. ( Abstract )	10/01/2024
673.	Duffy BC, King KM, Nepal B, Nonnemacher MR[IRT], Kortagere S. Acute Administration of HIV-1 Tat Protein Drives Glutamatergic Alterations in a Rodent Model of HIV-Associated Neurocognitive Disorders. Mol Neurobiol. 2024 Oct; 61(10):8467-8480. ( Abstract )	10/01/2024
674.	Ezenwankwo E, Nguyen DT, Akpabio IU, Eberth JM[CRiC]. Expanding reach, enhancing capacity: embracing the role of primary care in lung cancer screening and smoking cessation in the United States. Lancet Reg Health Am. 2024 Oct; 38:100870. ( Abstract )	10/01/2024
¶ 675.	Hall WA, Mathison AJ, DeVoe E, Tschannen M, Wendt-Andrae J, Straza M, Awan M, Puckett LL, Lawton CAF, Schultz C, Urrutia R, Kerns S, Torres-Roca JF, Li XA, Erickson B, Nevalainen MT[TaCO], Zimmermann MT, Paulson E. Changes in Daily Apparent Diffusion Coefficient on Fully Quantitative Magnetic Resonance Imaging Correlate With Established Genomic Pathways of Radiation Sensitivity and Reveal Novel Biologic Associations. Int J Radiat Oncol Biol Phys. 2024 Oct 01; 120(2):570-578. ( Abstract )	10/01/2024
+ 676.	Jain A, Goldberg ZN, Briggs E, Amin DR, Urdang ZD, Goldman RA, Cognetti DM[TaCO], Curry JM[MORA]. Modified Frailty Index Associates With Transoral Robotic Surgery Complications and Survival: A National Database Study. Laryngoscope. 2024 Oct; 134(10):4278-4283. ( Abstract )	10/01/2024
¶ 677.	Kazaure HS, Neely NB, Howard LE, Hyslop T[CRiC], Shahsahebi M, Zullig LL, Oeffinger KC. Primary Care Use and 90-Day Mortality Among Older Adults Undergoing Cancer Surgery. JAMA Surg. 2024 Oct 01; 159(10):1170-1176. ( Abstract )	10/01/2024
¶ 678.	Kukulage DSK, Samarasinghe KTG, Matarage Don NNJ, Shivamadhu MC, Shishikura K, Schiff W, Mashhadi Ramezani F, Padmavathi R, Matthews ML, Ahn YH[TaCO]. Protein phosphatase PP2Cα S-glutathionylation regulates cell migration. J Biol Chem. 2024 Oct; 300(10):107784. ( Abstract )	10/01/2024
¶ * 679.	Lombardo J, Castillo E, Castillo R, Miller R, Jones B, Miften M, Kavanagh B, Dicker A[CRiC], Boyle C, Leiby B, Banks J, Simone NL[CRiC], Movsas B, Grills I, Guerrero T, Rusthoven CG, Vinogradskiy Y[CRiC]. Prospective Trial of Functional Lung Avoidance Radiation Therapy for Lung Cancer: Quality of Life Report. Int J Radiat Oncol Biol Phys. 2024 Oct 01; 120(2):593-602. ( Abstract )	10/01/2024
¶ 680.	Marshall CH, Teply BA, Lu J, Oliveira L, Wang H, Mao SS, Kelly WK[MORA], Paller CJ, Markowski MC, Denmeade SR, King S, Sullivan R, Davicioni E, Proudfoot JA, Eisenberger MA, Carducci MA, Lotan TL, Antonarakis ES. Olaparib Without Androgen Deprivation for High-Risk Biochemically Recurrent Prostate Cancer Following Prostatectomy: A Nonrandomized Controlled Trial. JAMA Oncol. 2024 Oct 01; 10(10):1400-1408. ( Abstract )	10/01/2024
681.	Midroni J, Salunkhe R, Liu Z, Chow R, Boldt G, Palma D, Hoover D, Vinogradskiy Y[CRiC], Raman S. Incorporation of Functional Lung Imaging Into Radiation Therapy Planning in Patients With Lung Cancer: A Systematic Review and Meta-Analysis. Int J Radiat Oncol Biol Phys. 2024 Oct 01; 120(2):370-408. ( Abstract )	10/01/2024
¶ 682.	Phan L[CRiC], Zarei K, Chen-Sankey J, Hacker K, Ajith A, Jewett B, Choi K. Exposure to nicotine pouch marketing and nicotine pouch experimentation among U.S. adults who use commercial tobacco. Prev Med Rep. 2024 Oct; 46:102868. ( Abstract )	10/01/2024
¶ 683.	Reyes KP, Rafique Z, Chinnock B, Kumar VA, Gottlieb M, Rising KL[CRiC], Rodriguez RM. Long COVID Among Undocumented Latino Immigrant Populations in the Emergency Department. JAMA Netw Open. 2024 Oct 01; 7(10):e2438806. ( Abstract )	10/01/2024
* 684.	Rohan TZ, Suriano J, Tekmen V, Bhatti S, Talasila S, Joffe D, Holtmeyer C, Lee JB, Alpdogan O[IRT], Nikbakht N[IRT]. Coexistence of large cell transformed mycosis fungoides and diffuse large B-cell lymphoma in one patient. J Cutan Pathol. 2024 Oct; 51(10):761-766. ( Abstract )	10/01/2024
¶ 685.	Ross AE, Zhang J, Huang HC, Yamashita R, Keim-Malpass J, Simko JP, DeVries S, Morgan TM, Souhami L, Dobelbower MC, McGinnis LS, Jones CU, Dess RT, Zeitzer KL, Choi K, Hartford AC, Michalski JM, Raben A, Gomella LG[MORA], Sartor AO, Rosenthal SA, Sandler HM, Spratt DE, Pugh SL, Mohamad O, Esteva A, Chen E, Schaeffer EM, Tran PT, Feng FY. External Validation of a Digital Pathology-based Multimodal Artificial Intelligence Architecture in the NRG/RTOG 9902 Phase 3 Trial. Eur Urol Oncol. 2024 Oct; 7(5):1024-1033. ( Abstract )	10/01/2024
¶ 686.	Sardar S, McNair CM(2)[CRiC], Ravindranath L, Chand SN, Yuan W, Bogdan D, Welti J, Sharp A, Ryan NK, Knudsen LA, Schiewer MJ, DeArment EG, Janas T, Su XA, Butler LM, de Bono JS, Frese K, Brooks N, Pegg N, Knudsen KE, Shafi AA. AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer. Oncogene. 2024 Oct; 43(43):3197-3213. ( Abstract )	10/01/2024
¶ 687.	Schlachetzki JC, Gianella S, Ouyang Z, Lana AJ, Yang X, O'Brien S, Challacombe JF, Gaskill PJ[IRT], Jordan-Sciutto KL, Chaillon A, Moore D, Achim CL, Ellis RJ, Smith DM, Glass CK. Gene expression and chromatin conformation of microglia in virally suppressed people with HIV. Life Sci Alliance. 2024 Oct; 7(10). ( Abstract )	10/01/2024
* 688.	Shah YB, Ghosh A, Hochberg A, Mark JR, Lallas CD[MORA], Shah MS[MORA]. Artificial intelligence improves urologic oncology patient education and counseling. Can J Urol. 2024 Oct; 31(5):12013-12018. ( Abstract )	10/01/2024
¶ * 689.	Shusted CS, Barta JA[CRiC], Nguyen A, Wen KY[CRiC], Juon HS[CRiC], Zeigler-Johnson C. Characterizing Lung Cancer Burden Among Asian-American Communities in Philadelphia. J Racial Ethn Health Disparities. 2024 Oct; 11(5):2583-2595. ( Abstract )	10/01/2024
690.	Tsai MH, Lee M, Coughlin SS, Eberth JM[CRiC], Rogers CR. Cancer History and Social Support Impact Colorectal Cancer Screening Utilization by Race/Ethnicity. Cancer Prev Res (Phila). 2024 Oct 01; 17(10):481-489. ( Abstract )	10/01/2024
* 691.	Wen KY[CRiC], Liang J, Diep D, Barta J[CRiC], Juon HS[CRiC]. Smoking Cessation Interventions Among Asian Americans: a Scoping Review. J Racial Ethn Health Disparities. 2024 Oct; 11(5):3015-3028. ( Abstract )	10/01/2024
¶ 692.	Barnada SM, Giner de Gracia A, Morenilla-Palao C, López-Cascales MT, Scopa C, Waltrich FJ, Mikkers HMM, Cicardi ME, Karlin J, Trotti D, Peterson KA, Brugmann SA, Santen GWE, McMahon SB[MORA], Herrera E, Trizzino M. ARID1A-BAF coordinates ZIC2 genomic occupancy for epithelial-to-mesenchymal transition in cranial neural crest specification. Am J Hum Genet. 2024 Oct 03; 111(10):2232-2252. ( Abstract )	10/03/2024
* 693.	Tichauer KM, Machado P, Liu JB[TaCO], Sarathchandra ASC, Stanczak M, Kraft WK, Forsberg F[TaCO]. Macrophage uptake rate of Sonazoid in breast lymphosonography is highly conserved in healthy controls. Phys Med Biol. 2024 Oct 04; 69(20). ( Abstract )	10/04/2024
694.	Azizi G, Van den Broek B, Ishikawa LLW, Naziri H, Yazdani R, Zhang GX, Ciric B, Rostami A[IRT]. IL-7Rα on CD4 T cells is required for their survival and the pathogenesis of experimental autoimmune encephalomyelitis. J Neuroinflammation. 2024 Oct 08; 21(1):253. ( Abstract )	10/08/2024
¶ 695.	Bashir B[IRT], Wang JS, Falchook G, Fontana E, Arkenau HT, Carter L, Galot R, Basu B, Greystoke A, Subbiah V, Richardson DL, Orr H, Bennett G, Sharma R, Xu H, Paganoni P, Xu C, Campbell C, McKean M. Results From First-in-Human Phase I Dose-Escalation Study of a Novel Bicycle Toxin Conjugate Targeting EphA2 (BT5528) in Patients With Advanced Solid Tumors. J Clin Oncol. 2024 Oct 10; 42(29):3443-3452. ( Abstract )	10/10/2024
696.	von Jan J, Timonen S, Braun T, Jiang Q, Ianevski A, Peng Y, McConnell K, Sindaco P, Müller TA, Pützer S, Klepzig H, Jungherz D, Dechow A, Wahnschaffe L, Giri AK, Kankainen M, Kuusanmäki H, Neubauer HA, Moriggl R, Mazzeo P, Schmidt N, Koch R, Hallek M, Chebel A, Armisen D, Genestier L, Bachy E, Mishra A[IRT], Schrader A, Aittokallio T, Mustjoki S, Herling M. Optimizing drug combinations for T-PLL: restoring DNA damage and P53-mediated apoptotic responses. Blood. 2024 Oct 10; 144(15):1595-1610. ( Abstract )	10/10/2024
697.	Head D, Ako AA, Ginzburg S, Singer E, Jacobs B, Fonshell C, Reese A, Trabulsi E[MORA], Tomaszewski J, Danella J, Belkoff L, Uzzo R, Raman JD. Prioritizing precision: detection of prostate cancer using mri guided fusion needle biopsy across the pennsylvania urologic regional collaborative. Am J Clin Exp Urol. 2024 Oct 15; 12(5):323-330. ( Abstract )	10/15/2024
¶ 698.	Ko YH, Lokareddy RK, Doll SG, Yeggoni DP, Girdhar A, Mawn I, Klim JR, Rizvi NF, Meyers R, Gillilan RE, Guo L[MORA], Cingolani G. Single Acetylation-mimetic Mutation in TDP-43 Nuclear Localization Signal Disrupts Importin α1/β Signaling. J Mol Biol. 2024 Oct 15; 436(20):168751. ( Abstract )	10/15/2024
699.	Lin D[MORA], Tan R, Teigland C, Hernandez S, Kim S, Kilgore KM. Race/ethnicity and socioeconomic position in emergency department utilization in patients with hepatocellular carcinoma. Future Oncol. 2024; 20(24):1765-1777. ( Abstract )	10/15/2024
700.	Dwyer MB, Aumiller JL, Wedegaertner PB[TaCO]. Going Rogue: Mechanisms, Regulation, and Roles of Mutationally Activated Gα in Human Cancer. Mol Pharmacol. 2024 Oct 17; 106(5):198-215. ( Abstract )	10/17/2024
+ 701.	Melillo RJ, El Khoury C, Shaver AL, Cunningham M, Benavides N, Lacerda Q, Kim FJ[MORA], Leader AE[CRiC]. A student-community partnership to enhance cancer research training. BMC Med Educ. 2024 Oct 17; 24(1):1164. ( Abstract )	10/17/2024
* 702.	Prezioso E, Mancheski E, Shivok K, Kaplan Z, Bowne W, Jain A, Lavu H[MORA], Yeo CJ[MORA], Nevler A. Assessing Influence of Mismatch Repair Mutations on Survival in Patients After Resection of Pancreatic Ductal and Periampullary Adenocarcinoma. J Clin Med. 2024 Oct 17; 13(20). ( Abstract )	10/17/2024
¶ 703.	Maharjan S, Gamper H, Yamaki Y, Christian T, Henley RY, Li NS, Suzuki T, Suzuki T, Piccirilli JA, Wanunu M, Seifert E, Wallace DC, Hou YM[MORA]. Post-transcriptional methylation of mitochondrial-tRNA differentially contributes to mitochondrial pathology. Nat Commun. 2024 Oct 18; 15(1):9008. ( Abstract )	10/18/2024
¶ * 704.	Bannone E, Cattelani A, Corvino G, . . . Lavu H[MORA], . . . Yeo CJ[MORA], . . . Werner J, Wolfgang CL, Marchegiani G, International Study Group for Pancreatic Surgery (ISGPS). Clinical and Financial Validation of the International Study Group for Pancreatic Surgery (ISGPS) Definition of Post-Pancreatectomy Acute Pancreatitis (PPAP): International Multicenter Prospective Study. Ann Surg. 2024 Oct 22. [Epub ahead of print] ( Abstract )	10/22/2024
705.	Ehmann MM, Hagerman CJ, Milliron BJ, Butryn ML[CRiC]. The Role of Household Social Support and Undermining in Dietary Change. Int J Behav Med. 2024 Oct 22. [Epub ahead of print] ( Abstract )	10/22/2024
706.	Linton C, Wesolowski J, Lobley A, Yamaji T, Hanada K, Paumet F[IRT]. Specialized contact sites regulate the fusion of chlamydial inclusion membranes. Nat Commun. 2024 Oct 26; 15(1):9250. ( Abstract )	10/26/2024
707.	Kim HJ, Griffith KA, Ricciardi R, Le D, Glenn A, Cameron V, Juon HS[CRiC]. Exploring disparities in healthcare utilization, cancer care experience, and beliefs about cancer among asian and hispanic cancer survivors. Support Care Cancer. 2024 Oct 30; 32(11):756. ( Abstract )	10/30/2024
708.	Shaikh AR, Lin D[MORA]. Liposomal eribulin (E7389-LF) plus nivolumab: a potential treatment option for patients with advanced gastric cancer? J Gastrointest Oncol. 2024 Oct 31; 15(5):2343-2348. ( Abstract )	10/31/2024
¶ 709.	Barajas CB, Rivera-González AC, Vargas Bustamante A, Langellier BA[CRiC], Lopez Mercado D, Ponce NA, Roby DH, Stimpson JP, De Trinidad Young ME, Ortega AN. Health Care Access and Utilization and the Latino Health Paradox. Med Care. 2024 Nov 01; 62(11):706-715. ( Abstract )	11/01/2024
¶ * 710.	Butryn ML[CRiC], Miller NA, Hagerman CJ, Arigo D, LaFata E, Zhang F, Spring B, Forman E[CRiC]. Coach access to digital self-monitoring data: an experimental test of short-term effects in behavioral weight-loss treatment. Obesity (Silver Spring). 2024 Nov; 32(11):2111-2119. ( Abstract )	11/01/2024
¶ 711.	DeCarli K, Bradbury A, Lopez AM[CRiC], Camacho P, Chatwal MS, Friese CR, Jimenez R, Johnson LM, McGuire AL, Spence R, Peppercorn J. Ethical and Clinical Considerations in Ordering and Responding to Molecular Diagnostics and Circulating Tumor DNA as the Science Evolves. JCO Oncol Pract. 2024 Nov; 20(11):1508-1514. ( Abstract )	11/01/2024
712.	Delgado de la Herran H, Vecellio Reane D, Cheng Y, Katona M, Hosp F, Greotti E, Wettmarshausen J, Patron M, Mohr H, Prudente de Mello N, Chudenkova M, Gorza M, Walia S, Feng MS, Leimpek A, Mielenz D, Pellegata NS, Langer T, Hajnoczky G[TaCO], Mann M, Murgia M, Perocchi F. Systematic mapping of mitochondrial calcium uniporter channel (MCUC)-mediated calcium signaling networks. EMBO J. 2024 Nov; 43(21):5288-5326. ( Abstract )	11/01/2024
713.	De Pascali F, Inoue A, Benovic JL[TaCO]. Diverse pathways in GPCR-mediated activation of Ca mobilization in HEK293 cells. J Biol Chem. 2024 Nov; 300(11):107882. ( Abstract )	11/01/2024
714.	Jackson Cullison SR, Flemming JP, Karagoz K, Wermuth PJ, Mahoney MG[IRT]. Mechanisms of extracellular vesicle uptake and implications for the design of cancer therapeutics. J Extracell Biol. 2024 Nov; 3(11):e70017. ( Abstract )	11/01/2024
715.	Kundrick J, Rollins H, Mullachery P, Sharaf A, Schnake-Mahl A, Diez Roux AV[CRiC], Bilal U. Heterogeneity in disparities by income in cardiovascular risk factors across 209 US metropolitan areas. Prev Med Rep. 2024 Nov; 47:102908. ( Abstract )	11/01/2024
716.	Kushinsky S, Puccetti MV, Adams CM, Shkundina I, James N, Mahon BM, Michener P, Eischen CM[IRT]. DNA fork remodeling proteins, Zranb3 and Smarcal1, are uniquely essential for aging hematopoiesis. Aging Cell. 2024 Nov; 23(11):e14281. ( Abstract )	11/01/2024
717.	Le PM, Mattapallil MJ, Caspi RR, Stepp MA, Menko AS[TaCO]. Immunoregulatory Properties of Immune Cells that Associate with the Lens Capsule Surface during Acute and Resolution Phases of Experimental Autoimmune Uveitis. Am J Pathol. 2024 Nov; 194(11):2194-2211. ( Abstract )	11/01/2024
* 718.	Mayer H, Kim GW, Machado P, Eisenbrey JR[TaCO], Vu T, Wallace K, Forsberg F[TaCO]. Investigation Into the Subharmonic Response of Three Contrast Agents in Static and Dynamic Flow Environments Using a Commercially Available Diagnostic Ultrasound Scanner. Ultrasound Med Biol. 2024 Nov; 50(11):1731-1738. ( Abstract )	11/01/2024
¶ 719.	Miller A, Wang V, Jegede V, Necker F, Curry J[MORA], Baik FM, Verma A, Holsinger FC, Tuluc M, Rahman M, Lewis JS, Rosenthal E, Topf MC. How far are we off? Analyzing the accuracy of surgical margin relocation in the head and neck. Head Neck. 2024 Nov; 46(11):2709-2716. ( Abstract )	11/01/2024
720.	Spigel DR, Wang JS, Pronk L, Muskens B, Teufel M, Bashir B[IRT], Burris H. A phase I dose escalation study of the LRP5 antagonist BI 905681 in patients with advanced and metastatic solid tumors. ESMO Open. 2024 Nov; 9(11):103730. ( Abstract )	11/01/2024
+* 721.	Thosani DS, Meredith LT, West R, Till BM, Rahman U, Mack SJ, Koeneman S, Okusanya OT[MORA], Evans NR[CRiC], Grenda TR[MORA]. Association Between Utilization of Services and Perioperative Outcomes for Lung Cancer Resection. Clin Lung Cancer. 2024 Nov; 25(7):e330-e336. ( Abstract )	11/01/2024
722.	Zilberberg J, Uhl C, Scott CB, Andrews DW[IRT], Exley MA. Broad applicability of the Goldspire™ platform for the treatment of solid tumors. Clin Immunol. 2024 Nov; 268:110373. ( Abstract )	11/01/2024
¶ 723.	Jacobs IJ, Obiri-Yeboah D, Stabach PR, Braddock DT, Li Q[MORA]. Novel treatment for PXE: Recombinant ENPP1 enzyme therapy. Mol Ther. 2024 Nov 06; 32(11):3815-3820. ( Abstract )	11/06/2024
¶ 724.	Bellon M, Jain P[IRT], Nicot C. Characterization of HTLV-1 Infectious Molecular Clone Isolated from Patient with HAM/TSP and Immortalization of Human Primary T-Cell Lines. Viruses. 2024 Nov 09; 16(11). ( Abstract )	11/09/2024
¶ 725.	Zarei K, Hamilton-Moseley KR, Chen-Sankey J, Phan L[CRiC], Ajith A, Hacker K, Jewett B, Choi K. Financial hardship during the COVID-19 pandemic and increased receipt of commercial tobacco discount coupons among US adults who use commercial tobacco. Tob Control. 2024 Nov 10; 33(e2):e151-e157. ( Abstract )	11/10/2024
¶ 726.	Bowman RL, Dunbar AJ, Mishra T, Xiao W, Waarts MR, Maestre IF, Eisman SE, Cai L, Mowla S, Shah N, Youn A, Bennett L, Fontenard S, Gounder S, Gandhi A, Bowman M, O'Connor K, Zaroogian Z, Sánchez-Vela P, Martinez Benitez AR, Werewski M, Park Y, Csete IS, Krishnan A, Lee D, Boorady N, Potts CR, Jenkins MT, Cai SF, Carroll MP, Meyer SE[MORA], Miles LA, Ferrell PB, Trowbridge JJ, Levine RL. In vivo models of subclonal oncogenesis and dependency in hematopoietic malignancy. Cancer Cell. 2024 Nov 11; 42(11):1955-1969.e7. ( Abstract )	11/11/2024
¶ 727.	Vinogradskiy Y[CRiC], Bahig H, Bucknell NW, Buchsbaum J, Shu HG. Conference Report: Review of Clinical Implementation of Advanced Quantitative Imaging Techniques for Personalized Radiotherapy. Tomography. 2024 Nov 14; 10(11):1798-1813. ( Abstract )	11/14/2024
¶ * 728.	Müller PC, Kuemmerli C, Billeter AT, Shen B, Jin J, Nickel F, Guidetti C, Kauffmann E, Purchla J, Tschuor C, Krohn PS, Burgdorf SK, Jonas JP, Bussmann FJ, Saint-Marc O, Iben-Khayat A, Andel PCM, Molenaar IQ, Wellner U, Keck T, Moeckli B, Toso C, Di Benedetto F, Valle V, Giulianotti P, Roulin D, Martinie JB, Rama M, Lavu H[MORA], Yeo C[MORA], Mavani PT, Shah MM, Kooby DA, He J, Boggi U, Hackert T, Borel-Rinkes IHM, Müller BP, Clavien PA. Competency, Proficiency, and Mastery: Learning Curves for Robotic Distal Pancreatectomy at 16 International Expert Centers. Ann Surg. 2024 Nov 19. [Epub ahead of print] ( Abstract )	11/19/2024
729.	Yazdani R, Naziri H, Azizi G, Ciric B, Askari M, Ahmadi AM, Aseervatham J, Zhang GX, Rostami A[IRT]. IL-37 suppresses CNS autoimmunity by increasing the frequency of Treg cells and reducing CD4 + T cell-derived IL-10 production. J Neuroinflammation. 2024 Nov 19; 21(1):301. ( Abstract )	11/19/2024
+ 730.	McCord JL, Han JYS, Staudt RE, Philp NJ[TaCO], Snyder CM[IRT]. Immune responses drive chorioretinitis and retinal pathology after neonatal CMV infection. Sci Adv. 2024 Nov 22; 10(47):eadn6379. ( Abstract )	11/22/2024
731.	Hernaez-Estrada B, Steele LA, Spiller KL[IRT]. Effects of a bioengineered allogeneic cellular construct on burn-related macrophage phenotype. Wound Repair Regen. 2024 Nov-Dec; 32(6):992-1007. ( Abstract )	11/23/2024
732.	Barger LN, El Naggar OS, Ha B, Romano G[IRT]. Melanoma in people living with HIV: Immune landscape dynamics and the role of immuno- and antiviral therapies. Cancer Metastasis Rev. 2024 Nov 29; 44(1):9. ( Abstract )	11/29/2024
733.	Gao D, Zhou L, Bao Y, Shi W[MORA], Li L, Gao L. Novel cuprotosis-related gene signature: a prognostic indicator and regulator of the glioma immune microenvironment. Transl Cancer Res. 2024 Nov 30; 13(11):6282-6297. ( Abstract )	11/30/2024
734.	Ajmal N, Lallas CD[MORA], McCue P, Li L. Succinate Dehydrogenase Deficient Renal Cell Carcinoma With Sarcomatoid and Rhabdoid Features-A Diagnostic Dilemma. Int J Surg Pathol. 2024 Dec; 32(8):1508-1513. ( Abstract )	12/01/2024
735.	Capriotti Z, Klase Z[IRT]. Innate immune memory in chronic HIV and HIV-associated neurocognitive disorders (HAND): potential mechanisms and clinical implications. J Neurovirol. 2024 Dec; 30(5-6):451-476. ( Abstract )	12/01/2024
* 736.	Chao T, Wang ZX, Bowne WB, Yudkoff CJ, Torjani A, Swaminathan V, Kavanagh TR, Roadarmel A, Sholevar CJ, Cannaday S, Krampitz G, Zhan T, Gorgov E, Nevler A, Lavu H[MORA], Yeo CJ[MORA], Peiper SC, Jiang W. Association of Mutant KRAS Alleles With Morphology and Clinical Outcomes in Pancreatic Ductal Adenocarcinoma. Arch Pathol Lab Med. 2024 Dec 01; 148(12):1299-1309. ( Abstract )	12/01/2024
¶ 737.	Dunn MR, Li D, Emerson MA, Thompson CA, Nichols HB, Van Alsten SC, Roberson ML, Wheeler SB, Carey LA, Hyslop T[CRiC], Elston Lafata J, Troester MA. A latent class assessment of healthcare access factors and disparities in breast cancer care timeliness. PLoS Med. 2024 Dec; 21(12):e1004500. ( Abstract )	12/01/2024
738.	El Fadel O, Damron L, Fernandez C, Cappelli L, Mooney K, Shi W[MORA]. Accelerated Low-Dose Total Skin Electron Beam Therapy Using the Modified Stanford Technique: An In Vivo Dosimetry Confirmation Study. Cureus. 2024 Dec; 16(12):e75422. ( Abstract )	12/01/2024
¶ 739.	Kasner M[IRT], Fritsche AH, Leong MC, Cameron K, Lee CB, Lin TL, Lee JH, Brogan F, Kovak MR, Honeycutt H, Shaw K, George TJ. North American Cancer Center Clinical Research Capacity and Benchmarking in the Postpandemic Era. JCO Oncol Pract. 2024 Dec; 20(12):1612-1619. ( Abstract )	12/01/2024
¶ * 740.	Kuon Yeng Escalante CM, Siu Xiao T, Nagaraj RU, Savsani E, Mohammed A, Li J, Lyshchik A[TaCO], Liu JB[TaCO], Wessner CE, Tahmasebi A, Soulen MC, Kono Y, Eisenbrey JR[TaCO]. Evaluation of the Contrast-Enhanced Ultrasound Nonradiation Treatment Response Assessment LI-RADS v2024 Using Data From a Multi-Center Transarterial Chemoembolization Study. Acad Radiol. 2024 Dec; 31(12):5078-5086. ( Abstract )	12/01/2024
741.	Langellier BA[CRiC], Argibay S, Henson RM, Kravitz C, Eastus A, Stankov I, Headen I. Participatory Systems Thinking to Elucidate Drivers of Food Access and Diet Disparities among Minoritized Urban Populations. J Urban Health. 2024 Dec; 101(6):1235-1247. ( Abstract )	12/01/2024
¶ 742.	Lewis JA, Klein DE, Eberth JM[CRiC], Carter-Bawa L, Studts JL, Tong BC, Smith RA, Kazerooni EA, Houston TP. The American Cancer Society National Lung Cancer Roundtable strategic plan: Provider engagement and outreach. Cancer. 2024 Dec 01; 130(23):3973-3984. ( Abstract )	12/01/2024
¶ 743.	Maruyama D, Jacobsen E, Porcu P[IRT], Allen P, Ishitsuka K, Kusumoto S, Narita T, Tobinai K, Foss F, Tsukasaki K, Feldman T, Imaizumi Y, Izutsu K, Morishima S, Yamauchi N, Yuda J, Brammer JE, Kawamata T, Ruan J, Nosaka K, Utsunomiya A, Wang J, Zain J, Kakurai Y, Yamauchi H, Hizukuri Y, Biserna N, Tachibana M, Inoue A, Horwitz SM. Valemetostat monotherapy in patients with relapsed or refractory non-Hodgkin lymphoma: a first-in-human, multicentre, open-label, single-arm, phase 1 study. Lancet Oncol. 2024 Dec; 25(12):1589-1601. ( Abstract )	12/01/2024
* 744.	Nam K[TaCO], Torkzaban M, Shames JP, Liao L, Wessner CE, Machado P, Lyshchik A[TaCO], Forsberg F[TaCO]. Characterization of Indeterminate Breast Lesions Based on Pressure Estimates by Noninvasive 3D Contrast-Enhanced Ultrasound. Ultrasound Med Biol. 2024 Dec; 50(12):1854-1860. ( Abstract )	12/01/2024
¶ 745.	Reddy KP, Fayanju OM, Perez-Rojas S, Hyslop T[CRiC], Zafar SY, Bekelman J, Hwang ES. Institutional Costs of Guideline-Concordant Care Non-Receipt among Women with Breast Cancer. Ann Surg Open. 2024 Dec; 5(4):e489. ( Abstract )	12/01/2024
+ 746.	Shing SR, Armache M, Llerena P, O'Connor M, Murphy K, Curry JM[MORA], Luginbuhl AJ[TaCO]. Atypical Presentation and Postoperative Management of Vagal Nerve Tumors. Ann Otol Rhinol Laryngol. 2024 Dec; 133(12):1037-1041. ( Abstract )	12/01/2024
+* 747.	Thosani DS, Till BM, Meredith LT, Kalra A, Barta JA[CRiC], Okusanya OT[MORA], Evans NR[CRiC], Grenda TR[MORA]. Impact and Durability of the Affordable Care Act Medicaid Expansion on Lung Cancer Treatment. Ann Thorac Surg Short Rep. 2024 Dec; 2(4):895-900. ( Abstract )	12/01/2024
¶ 748.	Volk RJ, Myers RE[CRiC], Arenberg D, Caverly TJ, Hoffman RM, Katki HA, Mazzone PJ, Moulton BW, Reuland DS, Tanner NT, Smith RA, Wiener RS. The American Cancer Society National Lung Cancer Roundtable strategic plan: Current challenges and future directions for shared decision making for lung cancer screening. Cancer. 2024 Dec 01; 130(23):3996-4011. ( Abstract )	12/01/2024
+ 749.	Hafazalla K, Lan M, Piper K, Carey P, Khanna O, Shi W[MORA], Evans JJ, Andrews D[IRT], Judy K, Farrell CJ. Improvement in cranial neuropathies following stereotactic radiotherapy as primary treatment for skull base meningiomas. Br J Neurosurg. 2024 Dec 02:1-5. [Epub ahead of print] ( Abstract )	12/02/2024
¶ 750.	Marcus Post L, Pathak DR, Hamilton AS, Hirko KA, Houang RT, Guseman EH, Sanfelippo D, Bohme Carnegie N, Olson LK, Rui H[MORA], Schwartz AG, Velie EM. Adiposity throughout Adulthood and Risk of Young-Onset Breast Cancer Tumor Subtypes in the Young Women's Health History Study. Cancer Epidemiol Biomarkers Prev. 2024 Dec 02; 33(12):1659-1670. ( Abstract )	12/02/2024
751.	Young M, Booth DM, Smith D, Tigano M, Hajnoczky G[TaCO], Joseph SK. Transcriptional regulation in the absence of inositol trisphosphate receptor calcium signaling. Front Cell Dev Biol. 2024 Dec 6; 12:1473210. ( Abstract )	12/06/2024
* 752.	Shusted CS, Mukhtar S, Lee J, Ruane B, Muse E, Emeigh-McBride L, Gatson-Anderson E, Kane GC, Wen KY[CRiC], Juon HS[CRiC], Barta JA[CRiC]. Factors Associated With Receipt of Tobacco Treatment Integrated With Nurse Navigation in a Centralized Lung Cancer Screening Program at an Urban Academic Medical Center. Cancer Control. 2024 Jan-Dec;31:10732748241304966. ( Abstract )	12/09/2024
* 753.	Hochberg AR, Gomella PT, Im B, Ghosh A, Shah S, Thompson RAM, Zarrabi KK, Shah MS[MORA], Mark JR, Izes JK, Lallas CD[MORA], Gomella LG[MORA], Metwalli AR. Is the TriNetX Database a Good Tool for Investigation of Real-World Management of Von Hippel-Lindau? J Kidney Cancer VHL. 2024 Dec 10; 11(4):28-38. ( Abstract )	12/10/2024
¶ 754.	Barta JA[CRiC], Farjah F, Thomson CC, Dyer DS, Wiener RS, Slatore CG, Smith-Bindman R, Rosenthal LS, Silvestri GA, Smith RA, Gould MK. The American Cancer Society National Lung Cancer Roundtable strategic plan: Optimizing strategies for lung nodule evaluation and management. Cancer. 2024 Dec 15; 130(24):4177-4187. ( Abstract )	12/15/2024
¶ 755.	Farjah F, Barta JA[CRiC], Wood DE, Rivera MP, Osarogiagbon RU, Smith RA, Mullett TW, Rosenthal LS, Henderson LM, Detterbeck FC, Silvestri GA. The American Cancer Society National Lung Cancer Roundtable strategic plan: Promoting guideline-concordant lung cancer staging. Cancer. 2024 Dec 15; 130(24):4167-4176. ( Abstract )	12/15/2024
* 756.	Moore K, Lazo M[CRiC], Ortigoza A, Quistberg DA, Sanchez B, Acharya B, Alfaro T, Kroker-Lobos MF, Menezes MC, Sarmiento OL, de Souza Andrade AC, Perez Ferrer C, Hernandez Vasquez A, Caiaffa WT, Diez Roux AV[CRiC], SALURBAL Group. Data Resource Profile: Harmonized health survey data for 240 cities across 11 countries in Latin America: the SALURBAL project. Int J Epidemiol. 2024 Dec 16; 54(1). ( Abstract )	12/16/2024
757.	Huang J, Yang R, Huang X, Zeng K, Liu Y, Luo J, Lyshchik A[TaCO], Lu Q. Feasibility of large language models for CEUS LI-RADS categorization of small liver nodules in patients at risk for hepatocellular carcinoma. Front Oncol. 2024 Dec 18; 14:1513608. ( Abstract )	12/18/2024
758.	Regnault A, Bunod L, Loubert A, Brose MS[TaCO], Hess LM, Maeda P, Lin Y, Speck RM, Gilligan AM, Payakachat N. Assessing tolerability with the Functional Assessment of Cancer Therapy item GP5: psychometric evidence from LIBRETTO-531, a phase 3 trial of selpercatinib in medullary thyroid cancer. J Patient Rep Outcomes. 2024 Dec 19; 8(1):149. ( Abstract )	12/19/2024
759.	Manchel A, Gee M, Vadigepalli R[MORA]. From sampling to simulating: Single-cell multiomics in systems pathophysiological modeling. iScience. 2024 Dec 20; 27(12):111322. ( Abstract )	12/20/2024
+ 760.	Sina EM, Rowe M, Mancuso G, Garber G, Kelly WK[MORA], Leader AE[CRiC]. Evaluating the Impact of a Novel Program to Address Acute Food Insecurity Among Cancer Patients. Nutrients. 2024 Dec 23; 16(24). ( Abstract )	12/23/2024
¶ + 761.	Leslie Salewon M, Pathak R, Dooley WC, Squires RA, Rui H[MORA], Chervoneva I[CRiC], Tanaka T. Surgical delay-associated mortality risk varies by subtype in loco-regional breast cancer patients in SEER-Medicare. Breast Cancer Res. 2024 Dec 30; 26(1):191. ( Abstract )	12/30/2024
¶ 762.	Stein MN, Dumbrava EE, Teply BA, Gergis US[IRT], Guiterrez ME, Reshef R, Subudhi SK, Jacquemont CF, Senesac JH, Bayle JH, Scripture CD, Chatwal MS, Bilen MA, Stadler WM, Becerra CR. PSCA-targeted BPX-601 CAR T cells with pharmacological activation by rimiducid in metastatic pancreatic and prostate cancer: a phase 1 dose escalation trial. Nat Commun. 2024 Dec 30; 15(1):10743. ( Abstract )	12/30/2024
* 763.	Baybutt TR, Entezari AA, Caspi A, Staudt RE, Carlson RD, Waldman SA[IRT], Snook AE[IRT]. CD8α Structural Domains Enhance GUCY2C CAR-T Cell Efficacy. Cancer Biol Ther. 2024 Dec 31; 25(1):2398801. ( Abstract )	12/31/2024
¶ 764.	Lefler DS, Manobianco SA, Bashir B[IRT]. Immunotherapy resistance in solid tumors: mechanisms and potential solutions. Cancer Biol Ther. 2024 Dec 31; 25(1):2315655. ( Abstract )	12/31/2024
¶ + 765.	Naranjo NM, Kennedy A, Testa A, Verrillo CE, Altieri AD, Kean R, Hooper DC[IRT], Yu J, Zhao J, Abinader O, Pickles MW, Hawkins A, Kelly WK[MORA], Mitra R, Languino LR[TaCO]. Neuroendocrine gene subsets are uniquely dysregulated in prostate adenocarcinoma. Cancer Biol Ther. 2024 Dec 31; 25(1):2364433. ( Abstract )	12/31/2024
* 766.	Palecki J, Bhasin A, Bernstein A, Mille PJ, Tester WJ[MORA], Kelly WK[MORA], Zarrabi KK. T-Cell redirecting bispecific antibodies: a review of a novel class of immuno-oncology for advanced prostate cancer. Cancer Biol Ther. 2024 Dec 31; 25(1):2356820. ( Abstract )	12/31/2024
* 767.	Beachy S, Rising KL[CRiC], Hass RW, Hyslop T[CRiC], Muti I, Kemp M, Powell RE, Martino C, Yehia BR[CRiC], Cacchione JG, Henwood P. Validation of the Jefferson health-related social needs screener. Front Health Serv. 2025; 5:1658661. ( Abstract )	01/01/2025
¶ 768.	Bekadja MA, Niederwieser D, Kharfan-Dabaja MA, El Fakih R, Garderet L, Yakoub-Agha I, Greinix H, Weisdorf DJ, Galeano S, Ahmed SO, Chabanon C, Hashmi SK, Ruggeri A, Gergis U[IRT], Bazarbachi A, Hamad N, Albeihany A, Pasquini M, Hanbali A, Szer J, Kodera Y, Kumar A, Elhassan T, McLornan D, Worel N, Greco R, Mohty M, Atsuta Y, Koh M, Sureda A, Rondelli D, Aljurf M, Rasheed W. Non-cryopreserved autologous peripheral blood stem cell transplantation for multiple myeloma and lymphoma in countries with limited resources: practice considerations from the Worldwide Network for Blood and Marrow Transplantation. Bone Marrow Transplant. 2025 Jan; 60(1):19-27. ( Abstract )	01/01/2025
* 769.	Bradt J, Gumert L, Cottone C, Low MY, Lacson C, Myers-Coffman K, Bryl K, Selvan P, Biondo J, Millstein A, Cephas A, Sofield S, Worster B[CRiC], Leader AE[CRiC]. Beyond Distraction: Music Therapy for Chronic Pain Management in People with Advanced Cancer. Integr Cancer Ther. 2025; 24:15347354251395283. ( Abstract )	01/01/2025
¶ 770.	Bryce AH, Agarwal N, Beltran H, Hussain MH, Sartor O, Shore N, Antonarakis ES, Armstrong AJ, Calais J, Carducci MA, Dorff TB, Efstathiou JA, Gleave M, Gomella LG[MORA], Higano C, Hope TA, Iagaru A, Morgans AK, Morris DS, Morris MJ, Petrylak DP, Reiter RE, Rettig MB, Ryan CJ, Sellinger SB, Spratt DE, Srinivas S, Tagawa ST, Taplin ME, Yu EY, Zhang T, McKay RR, Koo PJ, Crawford ED. Implementing evidence-based strategies for men with biochemically recurrent and advanced prostate cancer: Consensus recommendations from the US Prostate Cancer Conference 2024. Cancer. 2025 Jan 01; 131(1):e35612. ( Abstract )	01/01/2025
¶ 771.	Ciaccio P, Lombardo J, Fuquay A, Pahlavian S, Grimm R, Kang J, Choi W, Sullivan P, Vinogradskiy Y[CRiC]. Development and validation of an AI-based lung lobe auto-contouring tool using radiation therapy planning free-breathing images. Rep Pract Oncol Radiother. 2025; 30(6):767-772. ( Abstract )	01/01/2025
¶ 772.	Correa-Salazar C, Amon JJ, Page KR, Groves AK, Agudelo-Avellaneda EN, Torres-Benítez DS, Martinez-Donate A[CRiC]. Navigating trauma: Venezuelan women's and adolescent's experiences before and after migration amidst the humanitarian crisis. J Migr Health. 2025 Jan 1; 11:100299. ( Abstract )	01/01/2025
¶ 773.	DeCostanza L, Grogan GM, Bruce AC, Peachey CM, Clark EA, Atkins K, Tylek T, Solga MD, Spiller KL[IRT], Peirce SM, Campbell CA, Cottler PS. Decellularized porcine dermal hydrogel enhances implant-based wound healing in the setting of irradiation. Acta Biomater. 2025 Jan 01; 191:260-275. ( Abstract )	01/01/2025
¶ 774.	Dimitriou F, Orloff MM[IRT], Koch Hein EC, Cheng PF, Hughes IF, Simeone E, Montazeri K, Grover P, Mehmi I, Gerard CL, Gaudy-Marqueste C, Grob JJ, Michielin O, Hamid O, Long GV, Sullivan R, Kapiteijn E, Johnson DB, Ascierto PA, Joshua AM, Carvajal RD, Butler MO, Hassel JC, Dummer R. Treatment sequence with tebentafusp and immune checkpoint inhibitors in patients with metastatic uveal melanoma and metastatic GNA11/GNAQ mutant melanocytic tumors. Eur J Cancer. 2025 Jan; 214:115161. ( Abstract )	01/01/2025
¶ 775.	Eager JM, Cortes-Troncoso J, Kalan L, Campbell A, Rao A, Weingarten MS, Grice EA, Oropallo A, Margolis DJ, Sacan A, Spiller KL[IRT]. Differential Gene Expression in Healing and Non-Healing Diabetic Foot Ulcers and Discovery of Novel Ratiometric Biomarker to Predict Healing Outcome. Wound Repair Regen. 2025; 33(6):e70113. ( Abstract )	01/01/2025
¶ 776.	Geskin L, Querfeld C, Hodak E, Nikbakht N[IRT], Papadavid E, Ardigò M, Wehkamp U, Bagot M. Chlormethine Gel for Treatment of Patients with Mycosis Fungoides: Best Practices and Guidance to Clinicians. Dermatol Ther (Heidelb). 2025 Jan; 15(1):61-73. ( Abstract )	01/01/2025
¶ 777.	Goldberg ZN, Jain A, Wu R, Cognetti DM[TaCO], Goldman RA. Social Determinants of Health Impact Complications Following Free-Flap Reconstruction for Head and Neck Cancer. Otolaryngol Head Neck Surg. 2025 Jan; 172(1):91-99. ( Abstract )	01/01/2025
¶ 778.	Jones KF, Liou KT, Ashare RL, Worster B[CRiC], Yeager KA, Merlin J, Meghani SH. How Racialized Approaches to Opioid Use Disorder and Opioid Misuse Management Hamper Pharmacoequity for Cancer Pain. J Clin Oncol. 2025 Jan; 43(1):10-14. ( Abstract )	01/01/2025
779.	Lawler ME, Goetz ML, Romer-Seibert JS, Gamlen HA, McGlinn E, Meyer SE[MORA]. miR-196b-Oct1/2 axis regulates DNMT3A-mutant AML pathogenesis. Leukemia. 2025 Jan; 39(1):229-233. ( Abstract )	01/01/2025
¶ 780.	Lazo M[CRiC], Li J, Hirsch JA, Moore KA, Auchincloss AH, Tabb LP, Barrientos-Gutierrez T, Clark JM, Solga SF, Budoff MJ, Sánchez BN. Associations between neighborhood built-environment characteristics and hepatic steatosis: The Multi-Ethnic Study of Atherosclerosis. Health Place. 2025 Jan; 91:103392. ( Abstract )	01/01/2025
¶ 781.	Leader AE[CRiC], Song Y, González ET, Fortune T, Graciani N, Zeigler-Johnson C, Glanz K. Developing a city-wide, community-engaged cancer disparities research agenda. Cancer Causes Control. 2025 Jan; 36(1):45-50. ( Abstract )	01/01/2025
¶ 782.	Leung SS, Gonsalves CF, Orloff M[IRT], Adamo RD, Lindenmeyer CC, Eschelman DJ. Percutaneous Hepatic Perfusion Melphalan Induced Sinusoidal Obstruction Syndrome (Veno-Occlusive Disease) in a Patient with Metastatic Uveal Melanoma. Case Rep Oncol. 2025; 18(1):1145-1151. ( Abstract )	01/01/2025
¶ * 783.	Lyshchik A[TaCO], Kuon Yeng Escalante C, Siu Xiao T, Piscaglia F, Kono Y, Medellin-Kowalewski A, Rodgers SK, Planz V, Kamaya A, Fetzer DT, Berzigotti A, Radu IP, Sidhu PS, Wessner CE, Bradigan K, Eisenbrey JR[TaCO], Forsberg F[TaCO], Wilson SR, CEUS LI-RADS Trial Group, CEUS LI-RADS Trial Group Members. Contrast-enhanced US of High-Risk Indeterminate Focal Liver Observations Categorized as LR-4 or LR-M at CT/MRI. Radiology. 2025 Jan; 314(1):e240916. ( Abstract )	01/01/2025
784.	Najar H, Evans J, Vedula S, Keiffer G[IRT], Zhang J. Acute kidney injury after treatment with arsenic trioxide. Clin Nephrol Case Stud. 2025; 13:84-88. ( Abstract )	01/01/2025
785.	Nigam A, Manjuprasanna VN, Naik MU, Naik UP[TaCO]. Platelet spreading and clot retraction are regulated by 2 distinct αβ outside-in signaling pathways. J Pharmacol Exp Ther. 2025 Jan; 392(1):100012. ( Abstract )	01/01/2025
786.	Palecki J, Tucker M, Bernstein A, Melby G, Zhan T, Micaily I[MORA]. HIV and lung cancer: a single cancer center experience. Front Oncol. 2025; 15:1600709. ( Abstract )	01/01/2025
¶ 787.	Plichta JK, Thomas SM, Chanenchuk TC, Chan K, Hyslop T[CRiC], Hwang ES, Greenup RA. Comparison of incident breast cancer cases in the largest national US tumor registries. Cancer. 2025 Jan 01; 131(1):e35525. ( Abstract )	01/01/2025
788.	Rohan TZ, Mandel JL, Yang HY, Banner L, Joffe D, Zachian R, Mehta J, Bhatti S, Zhan T, Nikbakht N[IRT]. Identifying Subsets of Cancer Patients with an Increased Risk of Developing Cutaneous Melanoma: A Surveillance, Epidemiology, and End Results-Based Analysis. JID Innov. 2025 Jan; 5(1):100323. ( Abstract )	01/01/2025
¶ +* 789.	Seedor RS[IRT], Aplin AE[TaCO], Bertolotto C, Carvajal RD, Deacon N, Doble K, Hamid O, Haq R, Kadosh M, Khan S, Kraska J, Lutzky J, McKean M, Montazeri K, Moser J, Onken M, Orloff M[IRT], Sacco JJ, Smalley K, Selig SM. Meeting Report From the 2023 Cure Ocular Melanoma (CURE OM) Global Science Meeting, Philadelphia, PA, November 2023. Pigment Cell Melanoma Res. 2025 Jan; 38(1):e13205. ( Abstract )	01/01/2025
* 790.	Shah MS[MORA], Hochberg AR, Prebay ZJ, Shah YB, Im BH, Simhal RK, Givner D, Wang KR, Simon DP, Mark JR, Metwalli AR, Lallas CD[MORA]. Stent vs Stentless Ileal Conduits After Radical Cystectomy: Is There a Difference in Early Postoperative Outcomes? Urol Pract. 2025 Jan; 12(1):139-146. ( Abstract )	01/01/2025
+ 791.	Shirley MA, Arango-Aliaga V, Patel A, Oeffinger BE, Eisenbrey J[TaCO], Wheatley MA[MORA]. Development of a Polymer Ultrasound Contrast Agent Incorporating Nested Carbon Nanodots. Ultrason Imaging. 2025 Jan; 47(1):45-56. ( Abstract )	01/01/2025
+* 792.	Stumm TW, Mina S, Okusanya O[MORA], Cowan S, Evans NR[CRiC], Grenda TR[MORA]. Metrics for Perioperative Exercise in Patients Undergoing Lung Cancer Resection: A Systematic Review. Clin Lung Cancer. 2025 Jan; 26(1):e33-e40. ( Abstract )	01/01/2025
793.	Summer R[TaCO], Chun P. Pressed for understanding: Interstitial lung disease in dry-cleaning workers. Am J Med Sci. 2025 Jan; 369(1):122-125. ( Abstract )	01/01/2025
794.	Uralov D, Harrington SR, Samarah H, Walia AS, Aweeda M, Mustafa MU, Kumar P, Briskin A, Jackson J, Mastrolonardo EV, Luginbuhl AJ[TaCO]. Improved survival with phosphodiesterase-5 inhibitor use in men with male-predominant cancers: real-world large database study. Front Oncol. 2025; 15:1720304. ( Abstract )	01/01/2025
¶ 795.	Waguespack SG, Cabanillas ME, Bernard-Gauthier V, Assar N, Bloom G, Esparza R, Brose MS[TaCO]. A plain language summary looking at how well larotrectinib works and how safe it is for people with TRK fusion-positive thyroid cancer. Future Oncol. 2025 Jan; 21(2):169-179. ( Abstract )	01/01/2025
¶ 796.	Wang JH, Deek MP, Mendes AA, Song Y, Shetty A, Bazyar S, Van der Eecken K, Chen E, Showalter TN, Royce TJ, Todorovic T, Huang HC, Houck SA, Yamashita R, Kiess AP, Song DY, Lotan T, DeWeese T, Marchionni L, Ren L, Sawant A, Simone N[CRiC], Berlin A, Onal C, Esteva A, Feng FY, Tran PT, Sutera P, Ost P. Validation of an artificial intelligence-based prognostic biomarker in patients with oligometastatic Castration-Sensitive prostate cancer. Radiother Oncol. 2025 Jan; 202:110618. ( Abstract )	01/01/2025
797.	Choi K, Hamilton-Moseley KR, Phan L[CRiC], Azeem A, Jewett B, Zarei K, Hacker K. Knowledge and Use of Menthol-Mimicking Cigarettes Among Adults in the US. JAMA Netw Open. 2025 Jan 02; 8(1):e2454608. ( Abstract )	01/02/2025
¶ 798.	Hua R, Han Y, Ni Q, Fajardo RJ, Iozzo RV[TaCO], Ahmed R, Nyman JS, Wang X, Jiang JX. Pivotal roles of biglycan and decorin in regulating bone mass, water retention, and bone toughness. Bone Res. 2025 Jan 02; 13(1):2. ( Abstract )	01/02/2025
¶ 799.	Kim KM, Girdhar A, Cicardi ME, Kankate V, Hayashi M, Yang R, Carey JL, Fare CM, Shorter J, Cingolani G, Trotti D, Guo L[MORA]. NLS-binding deficient Kapβ2 reduces neurotoxicity via selective interaction with C9orf72-ALS/FTD dipeptide repeats. Commun Biol. 2025 Jan 02; 8(1):2. ( Abstract )	01/02/2025
¶ 800.	Schnake-Mahl A, Diez Roux AV[CRiC], Bilal U, Schwartz G, Burris S. Rigorous Policy Measurement: causal inference challenges and opportunities. Am J Epidemiol. 2025 Jan 06. [Epub ahead of print] ( Abstract )	01/06/2025
¶ 801.	Adams SA, Workman L, Sakhuja M, Yelton B, Wickersham KE, Fairman C, Eberth J[CRiC], Heiney S, Hebert JR, King JH, Hucek FA, Schaurer L, Friedman DB. Reflecting on partnerships established and sustained over four cycles of a federally funded cancer prevention and control research program: lessons learned for community-academic networks. Front Public Health. 2025 Jan 7 ; 12:1384588. ( Abstract )	01/07/2025
802.	Prebay ZJ, Wahlstedt J, Shakir A, Wahlstedt E, Chung PH, Shah MS[MORA]. A TriNetX Analysis of Hypertrophic Scarring Disorders, Genitourinary Strictures, and Urethroplasty Failure. J Clin Med. 2025 Jan 07; 14(2). ( Abstract )	01/07/2025
803.	Parajuli B, Acharya K, Bach HC, Zhang S, Abrams CF, Chaiken I[IRT]. Monovalent Lectin Microvirin Utilizes Hydropathic Recognition of HIV-1 Env for Inhibition of Virus Cell Infection. Viruses. 2025 Jan 09; 17(1). ( Abstract )	01/09/2025
¶ 804.	Chaar DL, Tu L, Moore K, Du J, Opsasnick LA, Ratliff SM, Mosley TH, Kardia SLR, Zhao W, Zhou X, Diez Roux AV[CRiC], Faruque FS, Butler KR, Smith JA. Neighborhood environment associations with cognitive function and structural brain measures in older African Americans. BMC Med. 2025 Jan 13; 23(1):15. ( Abstract )	01/13/2025
¶ 805.	Hemler JR, Wagner RB, Sullivan B, Macenat M, Tagai EK, Vega JL, Hernandez E, Miller SM, Wen KY[CRiC], Ayers CA, Einstein MH, Hudson SV, Kohler RE. A Proposed mHealth Intervention to Address Patient Barriers to Colposcopy Attendance: Qualitative Interview Study of Clinic Staff and Patient Perspectives. JMIR Form Res. 2025 Jan 14; 9:e55043. ( Abstract )	01/14/2025
¶ 806.	Najjar YG, Orloff M[IRT], Mitchell TC, Bowles TL, Betof Warner A, Bollin K, Chandra S, Cohen JV, Eroglu Z, Funchain P, Gaughan E, Glitza Oliva I, Hsu S, Hu-Lieskovan S, Kennedy LB, Truong TG, McKean M, Mehnert J, Moon H, Tsai KK, Wilson M, Tran T, Buchbinder EI, Fecher LA, Guild S, Patel SP. Proceedings of the seventh annual Women in Melanoma Conference. Ther Adv Med Oncol. 2025 Jun 14; 17:17588359251342039. ( Abstract )	01/14/2025
807.	Oyende Y, Taus LJ, Fatatis A[TaCO]. IL-1β in Neoplastic Disease and the Role of Its Tumor-Derived Form in the Progression and Treatment of Metastatic Prostate Cancer. Cancers (Basel). 2025 Jan 17; 17(2). ( Abstract )	01/17/2025
¶ 808.	Leff B, Ritchie CS, Rising KL[CRiC], Cannon K, Wardlow L. Addressing barriers to equitable telehealth for older adults. Front Med (Lausanne). 2025 Jan 23; 12:1483366. ( Abstract )	01/23/2025
¶ 809.	Nakano Y, Gamper H, McGuigan H, Maharjan S, Li J, Sun Z, Yigit E, Grünberg S, Krishnan K, Li NS, Piccirilli JA, Kleiner R, Nichols N, Gregory BD, Hou YM[MORA]. Genome-wide profiling of tRNA modifications by Induro-tRNAseq reveals coordinated changes. Nat Commun. 2025 Jan 26; 16(1):1047. ( Abstract )	01/26/2025
¶ 810.	Adams SA, Babatunde OA, Zahnd WE, Hung P, Wickersham KE, Bell N, Eberth JM[CRiC]. An Investigation of Travel Distance and Timeliness of Breast Cancer Treatment Among a Diverse Cohort in the United States. Int J Environ Res Public Health. 2025 Jan 27; 22(2). ( Abstract )	01/27/2025
¶ 811.	Al Abo M, Foo WC, Howard LE, McGue S, Lacroix B, Kephart J, Clayton A, Thornburg B, Anand M, Rothberg MB, McCall SJ, Huang J, Esther TA, Moul JW, Ferrandino MN, Polascik TJ, Robertson CN, Inman BA, Armstrong AJ, Wu Y, Hyslop T[CRiC], George DJ, Patierno SR, Freedman JA. Genetic ancestry concordant RNA splicing in prostate cancer involves oncogenic genes and associates with recurrence. NPJ Precis Oncol. 2025 Jan 29; 9(1):30. ( Abstract )	01/29/2025
¶ 812.	Greene B, Mckenzie G, Gibbons K, Meghani SH, Worster B[CRiC], Ashare RL. Ask the experts: Community Engagement studios to inform research on cannabis use in cancer symptom management. J Clin Transl Sci. 2025 Jan 30; 9(1):e47. ( Abstract )	01/30/2025
* 813.	Wilde L[IRT], Kasner M[IRT]. Targeting CD47: many misses; hopeful for a hit. Blood. 2025 Jan 30; 145(5):460-462. ( Abstract )	01/30/2025
* 814.	Alfaro T, Martinez-Folgar K, Stern D, Wilches-Mogollon MA, Muñoz MP, Quick H, Alazraqui M, Ramirez-Zea M, Miranda JJ, Lazo M[CRiC], Caiaffa WT, Diez Roux AV[CRiC], Bilal U. Variability and social patterning of cancer mortality in 343 Latin American cities: an ecological study. Lancet Glob Health. 2025 Feb; 13(2):e268-e276. ( Abstract )	02/01/2025
¶ * 815.	Burus T, McAfee CR, Hull PC, Leader AE[CRiC], McNair C[CRiC]. Tracking community outreach and engagement activities among National Cancer Institute-designated cancer centers. J Natl Cancer Inst. 2025 Feb 01; 117(2):335-337. ( Abstract )	02/01/2025
¶ 816.	Christensen D, Belair JA, Basu-Mallick A[MORA], Brown SA, Klein M, Jiang W. Synchronous Low-Grade Central Osteosarcoma and Ewing Sarcoma: A Rare Case Report. Int J Surg Pathol. 2025 Feb; 33(1):131-137. ( Abstract )	02/01/2025
+ 817.	El Khoury CJ, Freedland SJ, Gandhi K, Keith SW, Nikita N, Shaver A, Sharma S, Kelly WMK[MORA], Lu-Yao G[CRiC]. Disparities in the utilization of magnetic resonance imaging for prostate cancer detection: a population-based study. J Natl Cancer Inst. 2025 Feb 01; 117(2):270-278. ( Abstract )	02/01/2025
818.	Gomella LG[MORA]. Celebrating the career and contributions of Dr. Michael Droller. Urol Oncol. 2025 Feb; 43(2):68-73. ( Abstract )	02/01/2025
¶ 819.	Gunn AJ, Anton K[TaCO], Kothary N, Schmit GD, Stavropoulos SW, Richman J, Jansen JO. Embolization before Ablation of T1b Renal Cell Carcinoma (EMBARC). J Vasc Interv Radiol. 2025 Feb; 36(2):318-319. ( Abstract )	02/01/2025
¶ 820.	Hrizat AS, Lin R, Eberle-Singh J, O'Neill R, Xia Y, Testa JR, Uzzo R, McCue PA, Yang H[MORA], Li L. Tumor infiltrating T-cells and loss of expression of SWI/SNF genes in varying stages of clear cell renal cell carcinoma. Pathol Res Pract. 2025 Feb; 266:155774. ( Abstract )	02/01/2025
* 821.	Javed E, Nayak AP, Jannu AK, Cohen AH, Dewes I, Wang R, Tang DD, Deshpande DA[TaCO], Penn RB[TaCO]. A-Kinase-Anchoring Protein Subtypes Differentially Regulate GPCR Signaling and Function in Human Airway Smooth Muscle. Am J Respir Cell Mol Biol. 2025 Feb; 72(2):133-144. ( Abstract )	02/01/2025
¶ * 822.	Kuon Yeng Escalante CM, Siu Xiao T, Kono Y, Piscaglia F, Wilson SR, Medellin A, Rodgers SK, Planz V, Kamaya A, Fetzer DT, Berzigotti A, Sidhu PS, Wessner CE, Bradigan K, Eisenbrey JR[TaCO], Forsberg F[TaCO], Lyshchik A[TaCO], CEUS LI‐RADS Trial Group. Inter-Reader Agreement for Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System Major Features and Final Categorization: A Subanalysis From a Prospective Multicenter Study. J Ultrasound Med. 2025 Feb; 44(2):349-357. ( Abstract )	02/01/2025
823.	Mastrolonardo EV, Llerena P, Curry JM[MORA]. Immune Checkpoint Inhibitors for Head and Neck Squamous Cell Carcinoma-Reply. JAMA Otolaryngol Head Neck Surg. 2025 Feb 01; 151(2):177-178. ( Abstract )	02/01/2025
¶ 824.	Melby G, Zeigler-Johnson C, Dicarlo M, Pham K, Shusted CS, Myers R[CRiC]. Developing a Strategy to Increase Lung Cancer Screening in Areas of Need. Popul Health Manag. 2025 Feb; 28(1):15-21. ( Abstract )	02/01/2025
825.	O'Donnell-Cappelli M, Mandel J, Elder A, Banner L, Nikbakht N[IRT]. Increased Risk of Postoperative Complications in Organ Transplant Recipients Undergoing Mohs Micrographic Surgery. Dermatol Surg. 2025 Feb 01; 51(2):139-143. ( Abstract )	02/01/2025
¶ * 826.	Poiset SJ, Lombardo J, Castillo E, Castillo R, Jones B, Miften M, Kavanagh B, Dicker AP[CRiC], Boyle C, Simone NL[CRiC], Movsas B, Grills I, Rusthoven CG, Vinogradskiy Y[CRiC], Wilson L. Patient-Reported Outcomes: Comparing Functional Avoidance and Standard Thoracic Radiation Therapy in Lung Cancer. JCO Clin Cancer Inform. 2025 Feb; 9:e2400202. ( Abstract )	02/01/2025
827.	Steele LA, Hernaez Estrada B, Spiller KL[IRT]. Effects of a Bioengineered Allogeneic Cellularized Construct (BACC) on Primary Human Macrophage Phenotype. Adv Healthc Mater. 2025 Feb; 14(5):e2303044. ( Abstract )	02/01/2025
¶ 828.	Sutera P, Song Y, Shetty AC, English K, Van der Eecken K, Guler OC, Wang J, Cao Y, Bazyar S, Verbeke S, Van Dorpe J, Fonteyne V, De Laere B, Mishra M, Rana Z, Molitoris J, Ferris M, Kiess A, Song DY, DeWeese T, Pienta KJ, Barbieri C, Marchionni L, Ren L, Sawant A, Simone N[CRiC], Berlin A, Onal C, Tran PT, Ost P, Deek MP. Genomic Determinants Associated with Modes of Progression and Patterns of Failure in Metachronous Oligometastatic Castration-sensitive Prostate Cancer. Eur Urol Oncol. 2025 Feb; 8(1):111-118. ( Abstract )	02/01/2025
829.	Zimmerman MKA, Wilde L[IRT]. Oh node: Extranodal nodular involvement of chronic lymphocytic leukemia in the colon. Am J Hematol. 2025 Feb; 100(2):298-299. ( Abstract )	02/01/2025
¶ +* 830.	Mastrolonardo EV, Nunes KL, Llerena P, Nikitina A, Sobol A, Scott ER, Tuluc M, Davitt CJH, Scher J, Tekumalla S, Mann D, Henao C, Jegede V, Gargano S, Harshyne LA, Alnemri A, Tyshevich A, Kushnarev V, Chasse M, Sookiasian D, Axelrod R[MORA], Zhan T, Leiby BE, Old M, Seim N, Mahoney MG[IRT], Martinez-Outschoorn U[TaCO], Cognetti DM[TaCO], Curry JM[MORA], Prendergast GC, Argiris A, South AP[MORA], Linnenbach AJ, Johnson JM[MORA], Luginbuhl AJ[TaCO]. Response-Adaptive Surgical Timing in Neoadjuvant Immunotherapy Demonstrates Enhanced Pathologic Treatment Response in Head and Neck Squamous Cell Carcinoma. Clin Cancer Res. 2025 Feb 03; 31(3):515-528. ( Abstract )	02/03/2025
¶ 831.	Wei S, Patchefsky AS, Pei J, Brown SA, Basu Mallick A[MORA], Wang Z, Jiang W. PHF1::TFE3-positive fibromyxoid sarcoma? Report of 2 cases and review of 13 cases of PHF1::TFE3-positive ossifying fibromyxoid tumor in the literature. Am J Clin Pathol. 2025 Feb 12; 163(2):224-230. ( Abstract )	02/12/2025
+ 832.	Whitaker R, Sung S, Tylek T, Risser GE, O'Brien EM, Chua PE, Li T, Petrie RJ[TaCO], Han L, Binder-Markey BI, Spiller KL[IRT]. Effects of injury size on local and systemic immune cell dynamics in volumetric muscle loss. NPJ Regen Med. 2025 Feb 13; 10(1):9. ( Abstract )	02/13/2025
¶ 833.	Nomura GRO, Luong AT, Prakash A, Alemand A, Bhowmick T, Ali A, Ren J, Rehani B, Nair G, Castillo R, Vinogradskiy Y[CRiC], Castillo E. TriSwinUNETR lobe segmentation model for computing DIR-free CT-ventilation. Front Oncol. 2025 Feb 17; 15:1475133. ( Abstract )	02/17/2025
* 834.	Evans J, Shivok K, Chen HH, Gorgov E, Bowne WB, Jain A, Lavu H[MORA], Yeo CJ[MORA], Nevler A. Correlation of GNAS Mutational Status with Oncologic Outcomes in Patients with Resected Intraductal Papillary Mucinous Neoplasms. Cancers (Basel). 2025 Feb 19; 17(4). ( Abstract )	02/19/2025
835.	Shigematsu M, Matsubara R, Gumas J, Kawamura T, Kirino Y[MORA]. Angiogenin-catalyzed cleavage within tRNA anticodon-loops identified by cP-RNA-seq. Biosci Biotechnol Biochem. 2025 Feb 20; 89(3):398-405. ( Abstract )	02/20/2025
¶ 836.	Yu EY, Rumble RB, Agarwal N, Cheng HH, Eggener SE, Bitting RL, Beltran H, Giri VN, Spratt D, Mahal B, Lu K, Crispino T, Trabulsi EJ[MORA]. Germline and Somatic Genomic Testing for Metastatic Prostate Cancer: ASCO Guideline. J Clin Oncol. 2025 Feb 20; 43(6):748-758. ( Abstract )	02/20/2025
* 837.	Bloom M, Podder S, Dang H[MORA], Lin D[MORA]. Advances in Immunotherapy in Hepatocellular Carcinoma. Int J Mol Sci. 2025 Feb 24; 26(5). ( Abstract )	02/24/2025
¶ 838.	Bewersdorf JP, Mi X, Lu B, Kuykendall A, Sallman D, Patel M, Stevens D, Philipovskiy A, Sutamtewagul G, Masarova L, Keiffer G[IRT], Verma A, Bhagwat N, Wang M, Moore A, Rager J, Heiser D, Ro S, Hong WJ, Abdel-Wahab O, Stein EM. Phase Ib study of PRT543, an oral protein arginine methyltransferase 5 (PRMT5) inhibitor, in patients with advanced splicing factor-mutant myeloid malignancies. Leukemia. 2025 Mar; 39(3):765-769. ( Abstract )	03/01/2025
839.	Cappelli L, Khan MM, Shields CL, Lally SE, Sharif M, Liu H, Chen Y, Park J, Zhan T, Shi W[MORA]. Favorable Outcomes of Patients With High-Risk Uveal Melanoma Treated With a Novel Linear Accelerator-Based Frameless Fractionated Stereotactic Radiosurgery. Am J Ophthalmol. 2025 Mar; 271:417-423. ( Abstract )	03/01/2025
+ 840.	Carey P, Gardner C, Uppendahl A, Kantor J, Cappelli L, Alnahhas I, Andrews D[IRT], Daskalakis C, Shi W[MORA]. Body mass index as a prognostic indicator of overall survival in glioblastoma: A systematic review and meta analysis. J Clin Neurosci. 2025 Mar; 133:111019. ( Abstract )	03/01/2025
841.	Corcoran C, Bennett R, Miller V[IRT], Krebs F, Dampier W. By any other name: searching for the right plasma nomenclature. IEEE Trans Radiat Plasma Med Sci. 2025 Mar; 9(3):388-394. ( Abstract )	03/01/2025
+ 842.	Fares J, El Fadel O, Zhao J, Li M, Sun J[MORA], Roman J, Loizidis G, Summer R[TaCO]. Mortality and Health Outcomes Among Patients With Sarcoidosis Treated With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers. Chest. 2025 Mar; 167(3):772-780. ( Abstract )	03/01/2025
843.	Hassel JC, Stanhope S, Greenshields-Watson A, Machiraju D, Enk A, Holland C, Abdullah SE, Benlahrech A, Orloff M[IRT], Nathan P, Piperno-Neumann S, Staeger R, Dummer R, Meier-Schiesser B. Tebentafusp Induces a T-Cell-Driven Rash in Melanocyte-Bearing Skin as an Adverse Event Consistent with the Mechanism of Action. J Invest Dermatol. 2025 Mar; 145(3):559-572.e9. ( Abstract )	03/01/2025
* 844.	Juon HS[CRiC], Yang D, Fang CX, Hann HW, Bae H, Chang M, Klassen AC[CRiC]. Perceived HBV-Related Stigma Is Associated With Lower Antiviral Medication Adherence in Patients With Chronic Hepatitis B. J Viral Hepat. 2025 Mar; 32(3):e70010. ( Abstract )	03/01/2025
¶ 845.	Loeb S, Cheng HH, Paller CJ, Weg E, Johnson J[MORA], Gross L, Keith SW, Russo J, Hathaway F, Rivera A, Giri VN. Addressing gaps in healthcare provider knowledge regarding germline testing for prostate cancer through development and testing of a virtual genetics board. Prostate Cancer Prostatic Dis. 2025 Mar; 28(1):220-222. ( Abstract )	03/01/2025
¶ +* 846.	Nunes KL, Jegede V, Mann DS, Llerena P, Wu R, Estephan L, Kumar A, Siddiqui S, Banoub R, Keith SW, Tuluc M, Thal AG, Goldman R, Mady LJ, Cognetti DM[TaCO], Luginbuhl AJ[TaCO], Topf MC, Curry JM[MORA]. A Randomized Pilot Trial of Virtual Reality Surgical Planning for Head and Neck Oncologic Resection. Laryngoscope. 2025 Mar; 135(3):1090-1097. ( Abstract )	03/01/2025
¶ 847.	Partridge AH, Hyslop T[CRiC], Rosenberg SM, Bennett AV, Drier S, Jonsson M, Shimada A, Li Y, Li Y, Lynch T, Frank E, Collyar D, Basila D, Pinto D, Weiss A, Wolf A, Norris K, Witten M, Boisvert M, Giuliano A, Larson KE, Yost K, McAuliffe PF, Krie A, Tamirisa N, Darai S, Carey L, Thompson A, Hwang ES, COMET Study Consortium. Patient-Reported Outcomes for Low-Risk Ductal Carcinoma In Situ: A Secondary Analysis of the COMET Randomized Clinical Trial. JAMA Oncol. 2025 Mar 01; 11(3):300-309. ( Abstract )	03/01/2025
+ 848.	Rshaidat H, Mack SJ, Koeneman SH, Martin J, Whitehorn GL, Madeka I, Gordon SW[IRT], Okusanya OT[MORA]. The Role of Medicaid Expansion on the Receipt of Adjuvant Chemotherapy in Patients With Lung Cancer. Clin Lung Cancer. 2025 Mar; 26(2):131-139. ( Abstract )	03/01/2025
+* 849.	Whitehorn GL, Rshaidat H, Madeka I, Martin J, Mack SJ, Meredith L, Alaparthi S, Grenda TR[MORA], Evans NR[CRiC], Okusanya OT[MORA]. Lobectomy Is Not Associated With Improved Survival as Compared to Segmentectomy in Early-Stage Lung Cancer Patients With Visceral Pleural Invasion. Clin Lung Cancer. 2025 Mar; 26(2):e99-e107.e10. ( Abstract )	03/01/2025
¶ 850.	Xie Q, Dasari R, Namba MD, Buck LA, Side CM, Park K, Jackson JG[TaCO], Barker JM. Astrocytic regulation of cocaine locomotor sensitization in EcoHIV infected mice. Neuropharmacology. 2025 Mar 01; 265:110245. ( Abstract )	03/01/2025
+* 851.	Gomella PT, Leong JY, Gomella LG[MORA], Tomar VS, Teran H, Trabulsi EJ[MORA], Thakur ML[TaCO]. Non-DRE Voided Urine Test to Diagnose Prostate Cancer: Updated Results. Diagnostics (Basel). 2025 Mar 03; 15(5). ( Abstract )	03/03/2025
¶ 852.	Nikita N, Sun Z, Sharma S, Shaver A, Seewaldt V, Lu-Yao G[CRiC]. Epigenetic Landscapes of Aging in Breast Cancer Survivors: Unraveling the Impact of Therapeutic Interventions-A Scoping Review. Cancers (Basel). 2025 Mar 03; 17(5). ( Abstract )	03/03/2025
¶ 853.	Li Q, Huang CC, Huang S, Tian Y, Huang J, Bitaraf A, Dong X, Nevalainen MT[TaCO], Patel M, Wong J, Zhang J, Manley BJ, Park JY, Kohli M, Gore EM, Kilari D, Wang L. 5-hydroxymethylcytosine sequencing of plasma cell-free DNA identifies epigenomic features in prostate cancer patients receiving androgen deprivation therapies. Commun Med (Lond). 2025 Mar 04; 5(1):61. ( Abstract )	03/04/2025
¶ 854.	Maskalenko NA, Zahroun S, Tsygankova O, Anikeeva N, Sykulev Y[IRT], Campbell KS. The FcγRIIIA (CD16) L48-H/R Polymorphism Enhances NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity by Promoting Serial Killing. Cancer Immunol Res. 2025 Mar 04; 13(3):417-429. ( Abstract )	03/04/2025
855.	Liang L, Chen L, Ni C, Shi W[MORA], Zhou Z, Chen S, Zhu W, Liu J, Qiu X, Lin W, Zhang J, Qin Z, Wang Y. Chemoradiation treatment with or without concurrent tumor-treating fields (TTFields) therapy in newly diagnosed glioblastoma (GBM) patients in China. Chin Neurosurg J. 2025 Mar 07; 11(1):5. ( Abstract )	03/07/2025
+ 856.	Cappelli L, Cappelli M, Haldar N, Paul T, Mandel J, Zhan T, Nikbakht N[IRT], Shi W[MORA]. Condensed low-dose total skin electron beam therapy for mycosis fungoides: an institutional retrospective review and subgroup analysis of patients with large cell transformation. Arch Dermatol Res. 2025 Mar 08; 317(1):531. ( Abstract )	03/08/2025
* 857.	Jones JE, Gunderson CE, Wigdahl B[IRT], Nonnemacher MR[IRT]. Impact of chromatin on HIV-1 latency: a multi-dimensional perspective. Epigenetics Chromatin. 2025 Mar 08; 18(1):9. ( Abstract )	03/08/2025
¶ 858.	Le Minh G, Merzy J, Esquea EM, Ahmed NN, Young RG, Sharp RJ, Dhameliya TT, Agana B, Lee MH, Bethard JR, Comte-Walters S, Ball LE, Reginato MJ[TaCO]. GATAD2B O-GlcNAcylation Regulates Breast Cancer Stem-like Potential and Drug Resistance. Cells. 2025 Mar 08; 14(6). ( Abstract )	03/08/2025
¶ 859.	Lubrano S, Cervantes-Villagrana RD, Faraji F, Ramirez S, Sato K, Adame-Garcia SR, Officer A, Arang N, Rigiracciolo DC, Anguiano Quiroz PY, Martini C, Wang Y, Ferguson FM, Bacchiocchi A, Halaban R, Coma S, Holmen SL, Pachter JA, Aplin AE[TaCO], Gutkind JS. FAK inhibition combined with the RAF-MEK clamp avutometinib overcomes resistance to targeted and immune therapies in BRAF V600E melanoma. Cancer Cell. 2025 Mar 10; 43(3):428-445.e6. ( Abstract )	03/10/2025
860.	Buraschi S, Pascal G, Liberatore F, Iozzo RV[TaCO]. Comprehensive investigation of proteoglycan gene expression in breast cancer: Discovery of a unique proteoglycan gene signature linked to the malignant phenotype. Proteoglycan Res. 2025 Jan-Mar; 3(1). ( Abstract )	03/11/2025
¶ +* 861.	Naghdi S, Mishra P, Roy SS, Weaver D, Walter L, Davies E, Antony AN, Lin X, Moehren G, Feitelson MA, Reed CA, Lindsten T, Thompson CB, Dang HT[MORA], Hoek JB[TaCO], Knudsen ES, Hajnoczky G[TaCO]. VDAC2 and Bak scarcity in liver mitochondria enables targeting hepatocarcinoma while sparing hepatocytes. Nat Commun. 2025 Mar 11; 16(1):2416. ( Abstract )	03/11/2025
862.	Nayak AR, Sokolova V, Sillamaa S, Herbine K, Sedman J, Temiakov D[TaCO]. Structural basis for intrinsic strand displacement activity of mitochondrial DNA polymerase. Nat Commun. 2025 Mar 11; 16(1):2417. ( Abstract )	03/11/2025
863.	Chigbu DI, Jain P[IRT]. Editorial: Cancer in people living with HIV/AIDS. Front Cell Infect Microbiol. 2025 Mar 13; 15:1575386. ( Abstract )	03/13/2025
¶ +* 864.	Mastrolonardo EV, Llerena P, De Ravin E, Nunes K, Kaki PC, Bridgham KM, Amin DR, Campbell DJ, Philips R, Koeneman SH, Cognetti DM[TaCO], Luginbuhl AJ[TaCO], Simone NL[CRiC], Johnson JM[MORA], Curry JM[MORA]. Improved survival with elevated BMI following immune checkpoint inhibition across various solid tumor cancer types. Cancer. 2025 Mar 15; 131(6):e35799. ( Abstract )	03/15/2025
¶ 865.	Ang CG, Hyatt NL, Le Minh G, Gupta M, Kadam M, Hogg PJ, Smith AB, Chaiken IM[IRT]. Conformational activation and disulfide exchange in HIV-1 Env induce cell-free lytic/fusogenic transformation and enhance infection. J Virol. 2025 Mar 18; 99(3):e0147124. ( Abstract )	03/18/2025
¶ 866.	Hwang ES, Hyslop T[CRiC], Lynch T, Ryser MD, Weiss A, Wolf A, Norris K, Witten M, Grimm L, Schnitt S, Badve S, Factor R, Frank E, Collyar D, Basila D, Pinto D, Watson MA, West R, Davies L, Donovan JL, Shimada A, Li Y, Li Y, Bennett AV, Rosenberg S, Marks J, Winer E, Boisvert M, Giuliano A, Larson KE, Yost K, McAuliffe PF, Krie A, Tamirisa N, Carey LA, Thompson AM, Partridge AH, COMET Study Investigators. Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical Trial. JAMA. 2025 Mar 18; 333(11):972-980. ( Abstract )	03/18/2025
¶ 867.	Mitchell JL, Buranapraditkun S, Gantner P, Takata H, Dietze K, N'guessan KF, Pollara J, Nohara J, Muir R, Kroon E, Pinyakorn S, Tulmethakaan N, Manasnayakorn S, Chottanapund S, Thantiworasit P, Prueksakaew P, Ratnaratorn N, Puttamaswin S, Nuntapinit B, Fox L, Haddad EK[IRT], Paquin-Proulx D, Phanuphak P, Sacdalan CP, Phanuphak N, Ananworanich J, Hsu D, Vasan S, Ferrari G, Chomont N, Trautmann L, RV254 and RV304 Study Groups. Activation of CXCR3 Tfh cells and B cells in lymph nodes during acute HIV-1 infection correlates with HIV-specific antibody development. J Virol. 2025 Mar 18; 99(3):e0153224. ( Abstract )	03/18/2025
+ 868.	Zhan T, Yi M, Peck AR, Rui H[MORA], Chervoneva I[CRiC]. Estimation and model selection for finite mixtures of Tukey's g- &-h distributions. Stat Comput. 2025; 35(3):67. ( Abstract )	03/18/2025
¶ 869.	McIntire RK, Senter K, Shusted C, Yearwood R, Barta J[CRiC], Keith SW, Zeigler-Johnson C. A Geospatial Analysis of the Lung Cancer Burden in Philadelphia, Using Pennsylvania Cancer Registry Data from 2008-2017. Int J Environ Res Public Health. 2025 Mar 20; 22(3). ( Abstract )	03/20/2025
¶ 870.	D'Angelo D, Sanchez-Vazquez VH, Cartes-Saavedra B, Vecellio Reane D, Cupo RR, Delgado de la Herran H, Ghirardo G, Shorter J, Wevers RA, Wortmann SB, Perocchi F, Rizzuto R, Raffaello A, Hajnoczky G[TaCO]. Dependence of mitochondrial calcium signalling and dynamics on the disaggregase, CLPB. Nat Commun. 2025 Mar 21; 16(1):2810. ( Abstract )	03/21/2025
* 871.	Zohar N, Maguire R, Khalilieh S, Jain A, Bosykh D, Bowne WB, Lavu H[MORA], Yeo CJ[MORA], Nevler A. Gene Expression Profiling of Pancreatic Ductal Adenocarcinoma Cells in Hypercapnia Identifies SIAH3 as a Novel Prognostic Biomarker. Int J Mol Sci. 2025 Mar 21; 26(7). ( Abstract )	03/21/2025
872.	Alnahhas I, Khan MM, Shi W[MORA]. What single-cell RNA sequencing taught us about MGMT expression in glioblastoma. Neurooncol Adv. 2025 Mar 22; 7(1):vdaf058. ( Abstract )	03/22/2025
¶ 873.	Matt SM, Nolan R, Manikandan S, Agarwal Y, Channer B, Oteju O, Daniali M, Canagarajah JA, LuPone T, Mompho K, Runner K, Nickoloff-Bybel E, Li B, Niu M, Schlachetzki JCM, Fox HS, Gaskill PJ[IRT]. Dopamine-driven increase in IL-1β in myeloid cells is mediated by differential dopamine receptor expression and exacerbated by HIV. J Neuroinflammation. 2025 Mar 23; 22(1):91. ( Abstract )	03/23/2025
874.	Metkari AS, Witt RL, Cognetti DM[TaCO], Dhong C, Jia X. Promoting Polarization and Differentiation of Primary Human Salivary Gland Stem/Progenitor Cells in Protease-Degradable Hydrogels via ROCK Inhibition. ACS Appl Mater Interfaces. 2025 Mar 26; 17(12):18083-18095. ( Abstract )	03/26/2025
* 875.	Logan JA, Sadhu S, Hazlewood C, Denton M, Burke SE, Simone-Soule CA, Black C, Ciaverelli C, Stulb J, Nourzadeh H, Vinogradskiy Y[CRiC], Leader A[CRiC], Dicker AP[CRiC], Choi W, Simone NL[CRiC]. Bridging Gaps in Cancer Care: Utilizing Large Language Models for Accessible Dietary Recommendations. Nutrients. 2025 Mar 28; 17(7). ( Abstract )	03/28/2025
¶ 876.	McGregor K, Harel M, Dicker AP[CRiC], Subramanian J, Santos ES, Sela I, Elon Y, Gandara DR. CGE25-111: Enhancing Oncology Treatment Personalization through Plasma Proteomics and Machine Learning. J Natl Compr Canc Netw. 2025 Mar 28; 23(3.5). ( Abstract )	03/28/2025
¶ 877.	Sunbul FS, Almuqbil RM, Zhang H, Alhudaithi SS, Fernandez ME, Aldaqqa RR, Garcia VA, Robila V, Halquist MS, Gordon SW[IRT], Bos PD, da Rocha SRP. An improved experimental model of osteosarcoma lung metastases to investigate innovative therapeutic interventions and sex as a biological variable. Int J Pharm. 2025 Mar 30; 673:125372. ( Abstract )	03/30/2025
¶ 878.	Brose MS[TaCO], Westphalen CB, Pan X, Bernard-Gauthier V, Kurtinecz M, Guo H, Aris V, Brett NR, Majdi A, Subbiah V, Pennell NA, Kehl KL, Drilon A. Larotrectinib Compared With Real-World Non-Tropomyosin Receptor Kinase Inhibitor Therapies in Patients With Tropomyosin Receptor Kinase Fusion Cancer. JCO Precis Oncol. 2025 Apr; 9:e2400500. ( Abstract )	04/01/2025
879.	Choi E, Barta JA[CRiC]. Use of lung-cancer trends for global and public health priorities. Lancet Respir Med. 2025 Apr; 13(4):296-297. ( Abstract )	04/01/2025
+ 880.	Fares J, El Fadel O, Zhao J, Sun J[MORA], Li M, Roman J, Loizidis G, Summer R[TaCO]. Response. Chest. 2025 Apr; 167(4):e144-e145. ( Abstract )	04/01/2025
881.	Golovin AV, Panteleev S, Zlobin AS, Anikeeva N, Smirnov I, Gabibov A, Sykulev Y[IRT]. The role of peptide conformation presented by MHC in the induction of TCR triggering. Biophys J. 2025 Apr 01; 124(7):1073-1084. ( Abstract )	04/01/2025
¶ 882.	Huang J, Tan KS, Altorki N, Antonoff M, Blackmon S, Bueno R, Burt B, Demmy T, Evans N[CRiC], Donahoe L, Harpole D, Jarrar D, Kozower B, Lanuti M, Liberman M, Lin J, Liou D, Liptay M, Luketich J, Pennathur A, Petersen G, Ripley R, Rochefort M, Seder CW, Shrager J, Su S, Tong B, Shargall Y, Vaporciyan A, Waddell T, Weksler B, Wigle D, Yendamuri S, Jones DR. Initial patient characteristics of Thoracic Surgical Oncology Group 102: A multicenter prospective registry of active surveillance in patients with multiple ground-glass opacities. J Thorac Cardiovasc Surg. 2025 Apr; 169(4):1100-1107. ( Abstract )	04/01/2025
¶ 883.	Kamaraju S, Fowler AM, Tarima S, Chaudhary LN, Burkard ME, Giever T, Cheng YC, Parkes A, Lange CA, Pipp-Dahm M, Hegeman R, Siddiqui N, Stella A, Rajguru S, Twaroski K, Zurbriggen L, Jorns JM, Rui H[MORA], Keigley QJ, Perlman SB, Salem K, Bradshaw TJ, Sahmoud T, Wisinski K. A Phase II Trial of Onapristone and Fulvestrant for Patients With ER+ and HER2- Metastatic Breast Cancer. Clin Breast Cancer. 2025 Apr; 25(3):251-260. ( Abstract )	04/01/2025
¶ * 884.	Kemp M, Rising KL[CRiC], Laynor G, Miao J, Worster B[CRiC], Chang AM, Monick AJ, Guth A, Esteves Camacho T, McIntosh K, Amadio G, Shughart L, Hsiao T, Leader AE[CRiC]. Barriers to telehealth uptake and use: a scoping review. JAMIA Open. 2025 Apr; 8(2):ooaf019. ( Abstract )	04/01/2025
¶ * 885.	Lee G, Juon H[CRiC], Kim E, Smith KC, Hann HW, Chang M, Klassen AC[CRiC]. HBV Transmission Knowledge Among Korean-American Chronic Hepatitis B Patients in the United States. J Community Health. 2025 Apr; 50(2):306-316. ( Abstract )	04/01/2025
886.	Myers MI, Hines KJ, Gray A, Spagnuolo G, Rosenwasser R, Iacovitti L[TaCO]. Intracerebral Transplantation of Autologous Mesenchymal Stem Cells Improves Functional Recovery in a Rat Model of Chronic Ischemic Stroke. Transl Stroke Res. 2025 Apr; 16(2):248-261. ( Abstract )	04/01/2025
887.	Podder SK, Doermann A, Ibrahim G, Bowen M, Koeneman SH, Schleider C, Shindle K, Cowan SW, Yeo CJ[MORA], Hanna N. Impact of Disease Etiology and Indication for Colectomy on Postoperative Outcomes: NSQIP Colectomy-Targeted Database Study. J Am Coll Surg. 2025 Apr 01; 240(4):365-376. ( Abstract )	04/01/2025
888.	Rohan TZ, Mandel J, Banner L, Zachian R, Yang H, Lee E, O'Donnell-Cappelli M, Bhatti S, Zhan T, Lee JB, Nikbakht N[IRT]. The risk of developing second primary malignancies in cutaneous melanoma survivors. J Am Acad Dermatol. 2025 Apr; 92(4):914-917. ( Abstract )	04/01/2025
+* 889.	Rshaidat H, Madeka I, Whitehorn GL, Martin J, Mack SJ, Alaparthi S, Grenda TR[MORA][MORA], Evans NR[CRiC], Okusanya OT. Describing the intersection of ethnicity and gender in early-stage non-small cell lung cancer. JTCVS Open. 2025 Apr; 24:438-450. ( Abstract )	04/01/2025
¶ * 890.	Ruiz M, Braunstein Z, McLaughlin E, Mishra A[IRT], Porcu P[IRT], Brammer JE. Short-course subcutaneous alemtuzumab induces clinical responses in relapsed T-cell large granular leukemia. Haematologica. 2025 Apr 01; 110(4):995-998. ( Abstract )	04/01/2025
+ 891.	Setya N, Ghagane SC, Nerli RB, Bokare A, Thakur ML[TaCO], Gomella L[MORA]. VPAC receptor positivity in comparison with mp-MRI in the diagnosis of prostate cancer: A preliminary study. BJUI Compass. 2025 Apr; 6(4):e70006. ( Abstract )	04/01/2025
¶ * 892.	Simhal RK, McPartland C, Wang KR, Buck M, Shah YB, Poluch ML, Hochberg AR, Im BH, Chandrasekar T, Shah MS[MORA], Lallas CD[MORA]. Bowel regimens before radical cystectomy: An analysis of a modern cohort. Int J Urol. 2025 Apr; 32(4):402-408. ( Abstract )	04/01/2025
+ 893.	Varney SD, Erkes DA, Mersky GL, Mustafa MU, Chua V, Chervoneva I[CRiC], Purwin TJ, Alnemri E[IRT], Aplin AE[TaCO]. Metabolic Inhibition Induces Pyroptosis in Uveal Melanoma. Mol Cancer Res. 2025 Apr 01; 23(4):350-362. ( Abstract )	04/01/2025
+ 894.	Tracewell MA, Karlin JE, Barnada SM, McDuffie EL, Scott CP, Barta JA[CRiC], McMahon SB[MORA]. Somatic p53 mutations that are markedly overrepresented in lung cancer confer resistance to reactive oxygen species-induced cell death. Carcinogenesis. 2025 Apr 03; 46(2). ( Abstract )	04/03/2025
¶ 895.	Burke-Garcia A, Cutroneo E, Afanaseva D, Madden K, Sustaita-Ruiz A, Selvan P, Rivera Sanchez E, Leader A[CRiC]. Findings from a qualitative analysis: Social media influencers of color as trusted messengers of HPV vaccination messages. PLoS One. 2025 Apr 4; 20(4):e0319160. ( Abstract )	04/04/2025
896.	Mikkilineni S, Pineda-Reyes JP, Wilde L[IRT], Ferber A, Wang ZX, Peiper S, Uppal G, Gong J, Liu J. Case Report: Myeloid neoplasms with the t(3;12)(q26.2;p13.1)/MECOM-ETV6 translocation: report of two new cases and review of the literature. Front Oncol. 2025 Apr 4; 15:1526044. ( Abstract )	04/04/2025
* 897.	Rodríguez López S, Diez Roux AV[CRiC], Tumas N, Moore K, Sarmiento OL, Sánchez BN, Pérez-Ferrer C, Flores-Alvarado S, Mazariegos M, Bilal U, Lazo M[CRiC]. Neighbourhoods' social, built, and natural environment characteristics and body mass index in Latin American cities. Int J Epidemiol. 2025 Apr 12; 54(3). ( Abstract )	04/12/2025
¶ 898.	Lopez JS, Milhem M, Butler MO, Thistlethwaite F, Van Tine BA, D'Angelo SP, Johnson ML, Sato T[IRT], Arkenau HT, Edukulla R, Wustner J, Marshall S, Rodon J. Phase 1 study of IMCnyeso, a T cell receptor bispecific ImmTAC targeting NY-ESO-1-expressing malignancies. Cell Rep Med. 2025 Apr 15; 6(4):101994. ( Abstract )	04/15/2025
¶ 899.	Sacco JJ, Kirk P, Leach E, Shoushtari AN, Carvajal RD, Britton-Rivet C, Khakoo S, Collins L, de la Cruz-Merino L, Eroglu Z, Ikeguchi AP, Nathan P, Hamid O, Butler MO, Stanhope S, Ranade K, Sato T[IRT]. Evolution of the tumor immune landscape during treatment with tebentafusp, a T cell receptor-CD3 bispecific. Cell Rep Med. 2025 Apr 15; 6(4):102076. ( Abstract )	04/15/2025
900.	Fanari O, Tavakoli S, Qiu Y, Makhamreh A, Nian K, Akeson S, Meseonznik M, McCormick CA, Bloch D, Gamper H, Jain M, Hou YM[MORA], Wanunu M, Rouhanifard SH. Probing enzyme-dependent pseudouridylation using direct RNA sequencing to assess epitranscriptome plasticity in a neuronal cell line. Cell Syst. 2025 Apr 16; 16(4):101238. ( Abstract )	04/16/2025
¶ * 901.	Murray RM, Chiang SC, Klassen AC[CRiC], Manganello JA, Leader AE[CRiC], Lo WJ, Massey PM. Developing an Online Community Advisory Board (CAB) of Parents From Social Media to Co-Design an Human Papillomavirus Vaccine Intervention: Participatory Research Study. JMIR Form Res. 2025 Apr 16; 9:e65986. ( Abstract )	04/16/2025
* 902.	Terai M, Seedor R[IRT], Ashraf U, Hubbard G, Koshkin S, Orloff M[IRT], Sato T[IRT]. Short Report: The Variants in CHEK2 in Metastatic Uveal Melanoma. J Clin Med. 2025 Apr 18; 14(8). ( Abstract )	04/18/2025
¶ 903.	Ito F, Li Z, Minakhin L, Khant HA, Pomerantz RT[MORA], Chen XS. Structural basis for Polθ-helicase DNA binding and microhomology-mediated end-joining. Nat Commun. 2025 Apr 19; 16(1):3725. ( Abstract )	04/19/2025
¶ 904.	Leader AE[CRiC], Burke-Garcia A, Afanaseva D, Cutroneo E, Selvan P, Madden K, Banks J, Sustaita-Ruiz A. Partnering with social media influencers to promote HPV vaccination in diverse communities. Vaccine. 2025 Apr 19; 53:127085. ( Abstract )	04/19/2025
¶ + 905.	Machtay M, Torres-Saavedra PA, Thorstad W, Nguyen-Tân PF, Siu LL, Holsinger FC, El-Naggar A, Chung C, Cmelak A, Burtness B, Bednarz G, Quon H, Breen SL, Gwede CK, Dicker AP[CRiC], Yao M, Jordan RC, Dorth J, Lee N, Chan JW, Dunlap N, Bar-Ad V[MORA], Stokes WA, Chakravarti A, Sher D, Rao S, Harris J, Yom SS, Le QT, NRG Oncology RTOG 0920 Collaborating Team. Postoperative Radiotherapy ± Cetuximab for Intermediate-Risk Head and Neck Cancer. J Clin Oncol. 2025 Apr 20; 43(12):1474-1487. ( Abstract )	04/20/2025
906.	Baga K, Salvatore GM, Bercovitz I, Folk AL, Singh R, König LM, Butryn ML[CRiC], Mogle JA, Arigo D. Physical Activity Measurement Reactivity Among Midlife Adults With Elevated Risk for Cardiovascular Disease: Protocol for Coordinated Analyses Across Six Studies. JMIR Res Protoc. 2025 Apr 23; 14:e67438. ( Abstract )	04/23/2025
907.	Chatterjee D, Kurup D[IRT], Smeyne RJ. Environmental exposures and familial background alter the induction of neuropathology and inflammation after SARS-CoV-2 infection. NPJ Parkinsons Dis. 2025 Apr 23; 11(1):86. ( Abstract )	04/23/2025
* 908.	Sutter J, Hope JL, Wigdahl B[IRT], Miller V[IRT], Krebs FC. Immunological Control of Herpes Simplex Virus Type 1 Infection: A Non-Thermal Plasma-Based Approach. Viruses. 2025 Apr 23; 17(5). ( Abstract )	04/23/2025
¶ + 909.	Cappelli L, Kayne A, Newman J, Elguindy A, Epperla N, Palmer JD, Martinez-Outschoorn U[TaCO], Porcu P[IRT], Shi W[MORA], Alnahhas I. Primary central nervous system lymphoma: Predictors of response to induction therapy and patterns of progression. Neurooncol Adv. 2025; 7(1):vdaf082. ( Abstract )	04/24/2025
¶ 910.	Mori MP, Lozoya OA, Brooks AM, Bortner CD, Nadalutti CA, Ryback B, Rickard BP, Overchuk M, Rizvi I, Rogasevskaia T, Huang KT, Hasan P, Hajnoczky G[TaCO], Santos JH. Mitochondrial membrane hyperpolarization modulates nuclear DNA methylation and gene expression through phospholipid remodeling. Nat Commun. 2025 Apr 29; 16(1):4029. ( Abstract )	04/29/2025
¶ * 911.	Bitting RL, McNair C[CRiC], Wyatt AW, Vandekerkhove G, Choi T, Leader AE[CRiC], Blanding-Godbolt J, Gross L, Hamade K, Halabi S, Giri VN. Factors Affecting Genomic Testing in Prostate Cancer: Results From the Decision-Making, Experience, and Confidence In Determining Genomic Evaluation (DECIDE) Survey. JCO Precis Oncol. 2025 May; 9:e2400821. ( Abstract )	05/01/2025
912.	Chen M, Yang Y, Cui M, Wang B[TaCO]. Solute transport from synovial fluid to articular cartilage and subchondral bone at different stages of osteoarthritis in a live mouse model. J Orthop Translat. 2025 May; 52:291-300. ( Abstract )	05/01/2025
+* 913.	Cunanan CJ, Amirfallah A, Sanders AB, Gallant KC, Cavallo MR, Homer EA, El Naggar OS, Farnan JK, Romano G[IRT], Hope JL, Jackson JG[TaCO], Hartsough EJ[TaCO]. BAP1 Loss Affords Lipotoxicity Resistance in Uveal Melanoma. Pigment Cell Melanoma Res. 2025 May; 38(3):e70021. ( Abstract )	05/01/2025
¶ 914.	Dwyer MB, Luo J, Todd TD, Blumer KJ, Tall GG, Wedegaertner PB[TaCO]. The guanine nucleotide exchange factor Ric-8A regulates the sensitivity of constitutively active Gαq to the inhibitor YM-254890. J Biol Chem. 2025 May; 301(5):108426. ( Abstract )	05/01/2025
¶ 915.	Expert Panel on Urological Imaging, Taffel MT, Khatri G, Purysko AS, Avery R, Caserta MP, Chang SD, De Leon AD, Ganeshan D, Gupta RT, Lew SQ, Lyshchik A[TaCO], Nicola R, Piel C, Sener A, Smith AD, Nikolaidis P. ACR Appropriateness Criteria® Renal Transplant Dysfunction: 2024 Update. J Am Coll Radiol. 2025 May; 22(5S):S372-S395. ( Abstract )	05/01/2025
916.	Grenda TR[MORA]. Finding the Correct Divide: Left Upper Lobe Segmentectomy Versus Lobectomy. Ann Surg Oncol. 2025 May; 32(5):3056-3057. ( Abstract )	05/01/2025
* 917.	Isabelle C, Boles A, McConnell K, Keller R, Burzinski R, Hutchins Z, Calabretto G, Cheslow L, Xu J, Chakravarti N, Porcu P[IRT], Nikbakht N[IRT], Mishra A[IRT]. CD38 in the pathobiology of cutaneous T-cell lymphoma and the potential for combination therapeutic intervention. Leukemia. 2025 May; 39(5):1146-1156. ( Abstract )	05/01/2025
918.	Jannu AK, Penn RB[TaCO]. Channeling Relaxation through Multiple Means: TMEM16A Antagonism for Asthma. Am J Respir Cell Mol Biol. 2025 May; 72(5):466-468. ( Abstract )	05/01/2025
* 919.	Kaplan Z, Prezioso E, Jain A, Lavu H[MORA], Yeo CJ[MORA], Bowne WB, Nevler A. Clinical Implications of Mismatch Repair Deficiency in Pancreatic Ductal Adenocarcinoma. Cancer Med. 2025 May; 14(10):e70960. ( Abstract )	05/01/2025
¶ 920.	Kharfan-Dabaja MA, Mohty R, Easwar N, Johnston P, Iqbal M, Epperla N, Yared J, Ahmed N, Hamadani M, Beitinjaneh A, Narkhede M, Jagadeesh D, Ramakrishnan Geethakumari P, Dholaria B, Gergis U[IRT], Munoz J, Sandoval-Sus J, Locke FL, Fein J, Khurana A, Ayala E, Annunzio K, Rapoport AP, Lutfi F, Akhtar OS, Lekakis L, Mehta A, Oluwole OO, Logue J, Jain MD, Shore T, Durani U, Alhaj Moustafa M, McGuirk J, Lin Y, Yamshon S, Chavez JC. Chimeric antigen receptor T cell therapy in octogenarians with B cell lymphoma: a real-world US multicenter collaborative study. Bone Marrow Transplant. 2025 May; 60(5):632-639. ( Abstract )	05/01/2025
¶ 921.	Khera R, Sawano M, Warner F, Coppi A, Pedroso AF, Spatz ES, Yu H, Gottlieb M, Saydah S, Stephens KA, Rising KL[CRiC], Elmore JG, Hill MJ, Idris AH, Montoy JCC, O'Laughlin KN, Weinstein RA, Venkatesh A, INSPIRE Group. Assessment of health conditions from patient electronic health record portals vs self-reported questionnaires: an analysis of the INSPIRE study. J Am Med Inform Assoc. 2025 May 01; 32(5):784-794. ( Abstract )	05/01/2025
922.	Le PM, Pal-Ghosh S, Stepp MA, Menko AS[TaCO]. Shared Phenotypes of Immune Cells Recruited to the Cornea and the Surface of the Lens in Response to Formation of Corneal Erosions. Am J Pathol. 2025 May; 195(5):960-981. ( Abstract )	05/01/2025
¶ 923.	Liu YK, Cisneros J, Nair G, Stevens C, Castillo R, Vinogradskiy Y[CRiC], Castillo E. Perfusion estimation from dynamic non-contrast computed tomography using self-supervised learning and a physics-inspired U-net transformer architecture. Int J Comput Assist Radiol Surg. 2025 May; 20(5):959-970. ( Abstract )	05/01/2025
* 924.	Machado P, Blackman R, Liu JB[TaCO], Dempsey C, Forsberg F[TaCO], Fox T. Evaluating Bone Fracture Healing in a Rabbit Model Using Doppler Imaging Modes, Shear Wave Elastography, X-Ray, and Dual-Energy X-Ray Absorptiometry. J Ultrasound Med. 2025 May; 44(5):927-933. ( Abstract )	05/01/2025
¶ * 925.	Manganello JA, Murray RM, Lo WJ, Chiang SC, Guan M, Klassen AC[CRiC], Leader AE[CRiC], Hill LT, Massey PM. Differences in HPV Vaccine Information Usefulness and Understanding Between Parents With and Without a Child with Special Healthcare Needs. Matern Child Health J. 2025 May; 29(5):686-695. ( Abstract )	05/01/2025
926.	Nayak AR, Holdcraft CJ, Yin AC, Nicoletto RE, Zhao C, Zheng H, Temiakov D[TaCO], Goldberg GS. Maackia amurensis seed lectin structure and sequence comparison with other M. amurensis lectins. J Biol Chem. 2025 May; 301(5):108466. ( Abstract )	05/01/2025
* 927.	Nusrat F, Gorgov E, Khanna A, Isesele O, Bowne W, Lavu H[MORA], Yeo CJ[MORA], Jiang W, Jain A, Nevler A. Prognostic Properties of KRAS Gene Mutation Subtypes in Resected Pancreatic Ductal Adenocarcinoma. Pancreas. 2025 May 01; 54(5):e449-e454. ( Abstract )	05/01/2025
¶ 928.	Odisio BC, Wah TM, Fotiadis N, Anton K[TaCO], Yoon CJ, Stanziola J, Mamun A, Meyers EE, De Leon H. Safety and Effectiveness of Microwave Ablation of Liver Tumors: Initial Real-World Results from the Multinational NeuWave Observational Liver Ablation (NOLA) Registry. J Vasc Interv Radiol. 2025 May; 36(5):813-822.e5. ( Abstract )	05/01/2025
¶ 929.	Patel S, Jenkins E, Kusurkar RP, Lee S, Jiang W, Nevler A, McCoy M, Pishvaian MJ, Sears RC, Brody JR, Yeo CJ[MORA], Jain A. Targeting BARD1 suppresses a Myc-dependent transcriptional program and tumor growth in pancreatic ductal adenocarcinoma. Neoplasia. 2025 May; 63:101152. ( Abstract )	05/01/2025
¶ * 930.	Siu Xiao T, Kuon Yeng Escalante CM, Tahmasebi A, Kono Y, Piscaglia F, Wilson SR, Medellin-Kowalewski A, Rodgers SK, Planz V, Kamaya A, Fetzer DT, Berzigotti A, Radu IP, Sidhu PS, Wessner CE, Bradigan K, Eisenbrey JR[TaCO], Forsberg F[TaCO], Lyshchik A[TaCO]. Combining CEUS and CT/MRI LI-RADS major imaging features: diagnostic accuracy for classification of indeterminate liver observations in patients at risk for HCC. Abdom Radiol (NY). 2025 May; 50(5):2066-2077. ( Abstract )	05/01/2025
931.	Young RG, Ahmed NN, Reginato MJ[TaCO]. New job for an old tool: PI3Kβ phosphorylates OGT to regulate acetyl-CoA in glioblastoma. Trends Cell Biol. 2025 May; 35(5):361-363. ( Abstract )	05/01/2025
* 932.	Zuber C, Swartz K, Chapman AE[CRiC], Rhodes L, Zhan TT, Wen KY[CRiC]. Evaluation of the Distress Thermometer in older patients with cancer. J Geriatr Oncol. 2025 May; 16(4):102221. ( Abstract )	05/01/2025
¶ * 933.	Cocozza T, Smith R, Lopez AM[CRiC], Rudoler S, Slamon R, Zhan T, Vega JL, Dhamankar M, Padmanabhan A, Miller SM, Wen KY[CRiC]. Multilevel Factors Influencing Perceived Barriers to Adjuvant Endocrine Therapy Among Breast Cancer Patients at Medication Onset. Int J Environ Res Public Health. 2025 May 06; 22(5). ( Abstract )	05/06/2025
934.	Scharrig E, Sanmillan ML, Giraudo CG[IRT]. Analysis of immune synapses by τau-STED imaging and 3D-quantitative colocalization of lytic granule markers. Methods Cell Biol. 2025; 193:1-13. ( Abstract )	05/06/2025
+ 935.	Yi M, Zhan T, Rui H[MORA], Chervoneva I[CRiC]. Functional protein biomarkers based on distributions of expression levels in single-cell imaging data. Bioinformatics. 2025 May 06; 41(5). ( Abstract )	05/06/2025
936.	Shigematsu M, Kawamura T, Kirino Y[MORA]. TaqMan RT-qPCR for tRNA half quantification. Methods Enzymol. 2025; 711:155-170. ( Abstract )	05/07/2025
¶ * 937.	Hochberg AR, Ho AH, Thompson RAM, Buck MB, Lallas CD[MORA], Ibilibor C, Tomaszewski JJ, Ginzburg S, Correa A, Uzzo R, Smaldone MC, Danella JF, Guzzo TJ, Lee DJ, Belkoff L, Walker J, Raman JD, Clark RK, Reese A, Jacobs B, Jang T, Kowalczyk KJ, Smith M, Shah MS[MORA]. Real-World Management of High-Risk Prostate Cancer Post-Radical Prostatectomy: Insights from a Regional Quality Collaborative. Cancers (Basel). 2025 May 08; 17(10). ( Abstract )	05/08/2025
938.	Shigematsu M, Gumas J, Kirino Y[MORA]. cP-RNA-seq for tRNA half sequencing. Methods Enzymol. 2025; 711:135-153. ( Abstract )	05/08/2025
¶ 939.	Schumacher LM, Miller N, Jennings EL, Chabria R, Butryn ML[CRiC]. Acceptance and Commitment Therapy for Obesity. Curr Obes Rep. 2025 May 10; 14(1):41. ( Abstract )	05/10/2025
¶ * 940.	Guan M, Chiang SC, Murray RM, Lo WJ, Hill LT, Klassen AC[CRiC], Manganello JA, Leader AE[CRiC], Massey PM. Narratives or not? Examining the roles of message format and individuals' stages of change in the context of HPV vaccination promotion. Health Educ Res. 2025 May 12; 40(3). ( Abstract )	05/12/2025
¶ * 941.	Villalba DR, Jannu AK, Javed E, Dandekar I, Wang R, Deshpande DA[TaCO], An SS, Panettieri RA, Tang DD, Penn RB[TaCO], Nayak AP. Ovarian Cancer G protein-coupled receptor-1 signaling bias dictates anti-contractile effect of benzodiazepines on airway smooth muscle. Respir Res. 2025 May 13; 26(1):183. ( Abstract )	05/13/2025
942.	Li Ju, Choi W, Anne R[MORA]. Deep Learning-Based Auto-Segmentation for Liver Yttrium-90 Selective Internal Radiation Therapy. Technol Cancer Res Treat. 2025 Jan-Dec; 24:15330338251327081. ( Abstract )	05/14/2025
¶ 943.	Trieu P, Fetzer D, McLeod B, Schweickert K, Gutstein L, Egleston B, Domchek S, Fleisher L, Wagner L, Wen KY[CRiC], Cacioppo C, Ebrahimzadeh JE, Falcone D, Langer C, Wood E, Karpink K, Posen S, Selmani E, Bradbury AR. Developing the MyCancerGene Digital Health Portal to Improve Patients' Understanding of Germline Cancer Genetic Test Results: Development, User, and Usability Testing Study. JMIR Form Res. 2025 May 14; 9:e56282. ( Abstract )	05/14/2025
¶ + 944.	Akbari H, Bakas S, Sako C, Fathi Kazerooni A, Villanueva-Meyer J, Garcia JA, Mamourian E, Liu F, Cao Q, Shinohara RT, Baid U, Getka A, Pati S, Singh A, Calabrese E, Chang S, Rudie J, Sotiras A, LaMontagne P, Marcus DS, Milchenko M, Nazeri A, Balana C, Capellades J, Puig J, Badve C, Barnholtz-Sloan JS, Sloan AE, Vadmal V, Waite K, Ak M, Colen RR, Park YW, Ahn SS, Chang JH, Choi YS, Lee SK, Alexander GS, Ali AS, Dicker AP[CRiC], Flanders AE, Liem S, Lombardo J, Shi W[MORA], Shukla G, Griffith B, Poisson LM, Rogers LR, Kotrotsou A, Booth TC, Jain R, Lee M, Mahajan A, Chakravarti A, Palmer JD, DiCostanzo D, Fathallah-Shaykh H, Cepeda S, Santonocito OS, Di Stefano AL, Wiestler B, Melhem ER, Woodworth GF, Tiwari P, Valdes P, Matsumoto Y, Otani Y, Imoto R, Aboian M, Koizumi S, Kurozumi K, Kawakatsu T, Alexander K, Satgunaseelan L, Rulseh AM, Bagley SJ, Bilello M, Binder ZA, Brem S, Desai AS, Lustig RA, Maloney E, Prior T, Amankulor N, Nasrallah MP, O'Rourke DM, Mohan S, Davatzikos C, ReSPOND consortium. Machine learning-based prognostic subgrouping of glioblastoma: A multicenter study. Neuro Oncol. 2025 May 15; 27(4):1102-1115. ( Abstract )	05/15/2025
* 945.	Jeurkar C, Majeed A, Wilde L[IRT], Keiffer G[IRT], Kasner M[IRT]. A Century of Hypomethylating Agent: A Remarkable Response to Azacitidine Monotherapy for Relapsed Acute Myeloid Leukemia - A Case Report. Case Rep Oncol. 2025 May 15; 18(1):575-581. ( Abstract )	05/15/2025
¶ * 946.	Kates J, Katcher J, Stricker CT, Rising KL[CRiC], Kemp M, Pogorzelska-Maziarz M, LeNoir J, Worster B[CRiC]. Acceptability and Preliminary Impact of Telehealth-Facilitated Integrated Palliative Care for Chronic Obstructive Pulmonary Disease. J Palliat Med. 2025 May 21. [Epub ahead of print] ( Abstract )	05/21/2025
¶ 947.	Harel M, Dahan N, Lahav C, Jacob E, Elon Y, Puzanov I, Kelly RJ, Shaked Y, Leibowitz R, Carbone DP, Gandara DR, Dicker AP[CRiC]. Decoding resistance to immune checkpoint inhibitors in non-small cell lung cancer: a comprehensive analysis of plasma proteomics and therapeutic implications. J Immunother Cancer. 2025 May 22; 13(5). ( Abstract )	05/22/2025
948.	Nersisyan S, Loher P, Rigoutsos I[MORA]. CorrAdjust unveils biologically relevant transcriptomic correlations by efficiently eliminating hidden confounders. Nucleic Acids Res. 2025 May 22; 53(10). ( Abstract )	05/22/2025
¶ 949.	Szydlo K, Santos L, Christian TW, Maharjan S, Dorsey A, Masuda I, Jia J, Wu Y, Tang W, Hou YM[MORA], Ignatova Z. m6A modification is incorporated into bacterial mRNA without specific functional benefit. Nucleic Acids Res. 2025 May 22; 53(10). ( Abstract )	05/22/2025
¶ +* 950.	Wen KY[CRiC], Palmisiano N, Smith R, Slamon R, Keiffer G[IRT], Fidler C, Kasner M[IRT], Wilde L[IRT]. A smart pill bottle and text messaging intervention for promoting medication adherence in patients with chronic myeloid leukemia: a pilot study of txt4 TKI. Support Care Cancer. 2025 May 24; 33(6):498. ( Abstract )	05/24/2025
951.	Hart T, Rabinowitz A, Vaccaro M, Banks J, Chervoneva I[CRiC]. Behavioral Activation With Remote Technology for Emotional Distress Following Moderate-Severe Traumatic Brain Injury: Results of a Randomized Controlled Trial. J Head Trauma Rehabil. 2025 May 28. [Epub ahead of print] ( Abstract )	05/28/2025
¶ 952.	Li L, Dioguardi Burgio M, Fetzer DT, Ferraioli G, Lyshchik A[TaCO], Meloni MF, Rafailidis V, Sidhu PS, Vilgrain V, Wilson SR, Zhou J. Contrast-Enhanced Ultrasound for Hepatocellular Carcinoma Diagnosis-AJR Expert Panel Narrative Review. AJR Am J Roentgenol. 2025 May 28. [Epub ahead of print] ( Abstract )	05/28/2025
¶ 953.	Wudhikarn K, Herr MM, Chen M, Martens MJ, Baird JH, Gowda L, Rangarajan HG, Abid MB, Kharfan-Dabaja MA, Williams KM, Ganguly S, Young JH, Sharma A, Fatobene G, Jain T, Kanakry CG, Modi D, Grover NS, Salem B, Batista MV, Vergidis P, Yin DE, Beitinjaneh AM, Kelkar AH, Nishihori T, Holter-Chakrabarty J, Gergis U[IRT], Smith M, El Boghdadly Z, Dandoy CE, Murthy HS, Huppler AR, Perales MA, Chemaly RF, Hill JA, Riches M, Auletta JJ. Infection after CD19 chimeric antigen receptor T cell therapy for large B cell lymphoma: Real-world analysis from CIBMTR. Blood Adv. 2025 May 28. [Epub ahead of print] ( Abstract )	05/28/2025
954.	Shah SD, Deshpande DA[TaCO]. Biased Orthosteric Agonism and Allosteric Modulation: Emerging Strategies for Developing New Class of β-Agonists for Obstructive Airway Diseases. Am J Respir Cell Mol Biol. 2025 May 29. [Epub ahead of print] ( Abstract )	05/29/2025
¶ 955.	Adamo RG, van der Pol CB, Alabousi M, . . . Abedrabbo N, Lerner E, . . . Naringrekar H, Bashir MR, . . . Polikoff A, . . . Eisenbrey JR[TaCO], . . . Jing X, Kim YY, McInnes MDF. Diagnostic Performance of CT/MRI LI-RADS Version 2018 Major Feature Combinations: Individual Participant Data Meta-Analysis. Radiology. 2025 Jun; 315(3):e243450. ( Abstract )	06/01/2025
+* 956.	Alaparthi SS, Ho A, Rshaidat H, Whitehorn G, Madeka I, Ishwar A, Grenda T[MORA], Jacob JD, Evans NR[CRiC], Okusanya OT[MORA]. Outcomes of Segmentectomy With or Without Preoperative Biopsy in Non-Small Cell Lung Cancer (NSCLC). Clin Lung Cancer. 2025 Jun; 26(4):299-306. ( Abstract )	06/01/2025
* 957.	Alfaro MKC, Shusted CS, Giamboy T, Kane GC, Evans NR[CRiC], Ruane BM, Gatson-Anderson E, Muse E, McMullen M, Kinsey AM, Murray S, McNair C[CRiC], Barta JA[CRiC]. Using an Integrated, Digital Framework to Standardize and Expand a Multisite Lung Cancer Screening Program. JCO Clin Cancer Inform. 2025 Jun; 9:e2400322. ( Abstract )	06/01/2025
¶ 958.	Arai Y, Brazauskas R, He N, Al-Homsi AS, Chhabra S, Battiwalla M, Yanada M, Steinberg A, Diaz Perez MA, Hong S, Kanda J, Bashey A, Frangoul HA, Badawy SM, Verdonck LF, Lazarus HM, Yared JA, Hashem H, Sharma A, Aljurf M, Dias AL, Abid MB, Wirk B, Freytes CO, Zeidan AM, Gergis U[IRT], Beitinjaneh A, Askar M, Pu JJ, Lehmann LE, Rangarajan HG, Wood WA, Hashmi S, Yano S, Kako S, Ozawa Y, Doki N, Kanda Y, Fukuda T, Katayama Y, Ichinohe T, Tanaka J, Teshima T, Okamoto S, Atsuta Y, Saber W. Efficacy of Total-Body Irradiation-based Intensified Myeloablative Regimens for Acute Leukemia-An International Collaborative Study. EJHaem. 2025 Jun; 6(3):e70061. ( Abstract )	06/01/2025
+* 959.	Bhattacharya P, Linnenbach A, South AP, Martinez-Outschoorn U[TaCO], Curry JM[MORA], Johnson JM[MORA], Harshyne LA, Mahoney MG[IRT], Luginbuhl AJ[TaCO], Vadigepalli R[MORA]. Tumor microenvironment governs the prognostic landscape of immunotherapy for head and neck squamous cell carcinoma: A computational model-guided analysis. PLoS Comput Biol. 2025 Jun; 21(6):e1013127. ( Abstract )	06/01/2025
960.	Cartes-Saavedra B, Ghosh A, Hajnoczky G[TaCO]. The roles of mitochondria in global and local intracellular calcium signalling. Nat Rev Mol Cell Biol. 2025 Jun; 26(6):456-475. ( Abstract )	06/01/2025
¶ 961.	Contrera KJ, Kansara S, Goyal N, Mady LJ, Puram SV, Young GD, Zandberg DP, Uppaluri R, Ferrarotto R, Holsinger FC, Ferris RL, Wenig BL, Curry JM[MORA]. Neoadjuvant Therapy for Mucosal Head and Neck Squamous Cell Carcinoma: A Review From the American Head and Neck Society. JAMA Otolaryngol Head Neck Surg. 2025 Jun 01; 151(6):615-625. ( Abstract )	06/01/2025
¶ 962.	Golkar E, Neupane T, Wilson L, Kwak J, Castillo R, Castillo E, Vinogradskiy Y[CRiC]. Comprehensive clinical evaluation of novel 4DCT-based lung function imaging methods. J Appl Clin Med Phys. 2025 Jun; 26(6):e70088. ( Abstract )	06/01/2025
¶ 963.	Gowin K, Ahn ER, Lopez AM[CRiC]. Synthesis and Educational Overview of the ASCO-Society of Integrative Oncology Guidelines: On the Path to Implementation. Am Soc Clin Oncol Educ Book. 2025 Jun; 45(3):e471830. ( Abstract )	06/01/2025
* 964.	Hafer R, Duong T, Yang HY, Tolotta J, Mandel JL, Banner L, Porcu P[IRT], Nikbakht N[IRT]. The Risk of Developing Keratinocyte Malignancies in Patients with Cutaneous T-Cell Lymphoma. J Invest Dermatol. 2025 Jun; 145(6):1523-1526.e8. ( Abstract )	06/01/2025
965.	Kawamura T, Shigematsu M, Kirino Y[MORA]. A hormone-dependent tRNA half promotes cell cycle progression via destabilization of p21 mRNA. PLoS Biol. 2025 Jun; 23(6):e3003194. ( Abstract )	06/01/2025
¶ 966.	Kudlek L, Eustachio Colombo P, Mueller J, Sharp SJ, Boothby CE, Griffin SJ, Butryn M[CRiC], Chwyl C, Forman E, Hagerman C, Hawkins M, Juarascio A, Knäuper B, Kolehmainen M, Levin ME, Lillis J, Maiz E, Manasse S, Palmeira L, Pietiläinen KH, Sherwood NE, Ahern AL. Individual participant data meta-analysis of eating behaviour traits as effect modifiers in acceptance and commitment therapy-based weight management interventions. Int J Obes (Lond). 2025 Jun; 49(6):1142-1152. ( Abstract )	06/01/2025
+* 967.	Madeka I, Mack SJ, Rshaidat H, Ishwar A, Koeneman S, Alaparthi S, Whitehorn GL, Ho A, Grenda TR[MORA], Evans NR[CRiC], Okusanya OT[MORA]. Medicaid Expansion is Associated with Differences in Local Therapy for Non-small Cell Lung Cancer. Ann Surg Oncol. 2025 Jun; 32(6):3913-3923. ( Abstract )	06/01/2025
¶ 968.	Namba MD, Xie Q, Park K, Jackson JG[TaCO], Barker JM. EcoHIV infection effects on cocaine seeking and neuroimmune responses in male mice depend on cocaine exposure pattern. Addict Neurosci. 2025 Jun; 15. ( Abstract )	06/01/2025
¶ 969.	Nixon AB, Liu Y, Yang Q, Luo B, Starr MD, Brady JC, Kelly WK[MORA], Beltran H, Morris MJ, George DJ, Armstrong AJ, Halabi S. Prognostic and predictive analyses of circulating plasma biomarkers in men with metastatic castration resistant prostate cancer treated with docetaxel/prednisone with or without bevacizumab. Prostate Cancer Prostatic Dis. 2025 Jun; 28(2):355-362. ( Abstract )	06/01/2025
* 970.	Russ DH, Barta JA[CRiC], Evans NR[CRiC], Kane GC. Anatomic Distribution and Clinical Presentation of Pulmonary Carcinoids: A Single-institutional Study. Ann Thorac Surg Short Rep. 2025 Jun; 3(2):299-303. ( Abstract )	06/01/2025
¶ 971.	Shao YF, Baca Y, Hinton A, Xiu J, VanderWalde A, Hadfield M, Park SJ, Darabi S, Sato T[IRT], Moser JC. Immune Profiling of Uveal Melanoma Liver Metastases and Response to Checkpoint Inhibitors. J Immunother. 2025 Jun 01; 48(5):189-195. ( Abstract )	06/01/2025
¶ +* 972.	Bizzaro CL, Bach CA, Santos RA, Verrillo CE, Naranjo NM, Chaudhari I, Picone FJ, Iqbal W, Blidner AG, Rabinovich GA, Fatatis A[TaCO], Jacobi J, Goodrich DW, Zarrabi KK, Kevin Kelly W[MORA], Schiewer MJ, Languino LR[TaCO]. Exploring STEAP1 Expression in Prostate Cancer Cells in Response to Androgen Deprivation and in Small Extracellular Vesicles. Mol Cancer Res. 2025 Jun 03; 23(6):542-552. ( Abstract )	06/03/2025
973.	Alexeev V, Huitema L, Phillips T, Patel P, Garza MS, Ringpfeil F, Salas-Alanis JC, Igoucheva O[MORA]. Cross-sectional analysis of wound-associated soluble factors in early, established, and chronic wounds of recessive dystrophic epidermolysis bullosa patients. Arch Dermatol Res. 2025 Jun 04; 317(1):796. ( Abstract )	06/04/2025
974.	Machado P, Vu T, Rosenblum N, Shafer A, Forsberg F[TaCO], Liu JB. Initial Evaluation of Lymphosonography to Identify Sentinel Lymph Nodes in Cervical and Vulvar Cancer Patients. J Clin Ultrasound. 2025 Jun 09. [Epub ahead of print] ( Abstract )	06/09/2025
¶ 975.	Wu HC, Glabonjat RA, Schilling K, Anderson WA, Gao S, Relloso AD, LoIacono N, Slowly M, Nigra AE, Sanchez T, Sobel MH, Galvez-Fernandez M, Budoff MJ, Gamble MV, Navas-Acien A, Lazo M[CRiC]. The Association of Arsenic Exposure and Metabolism Biomarkers with Subclinical Measures of Liver Disease: a cross-sectional investigation in the Multi-Ethnic Study of Atherosclerosis. Environ Health Perspect. 2025 Jun 10. [Epub ahead of print] ( Abstract )	06/10/2025
+ 976.	Ho C, Luchetta J, Nash B, Festa LK, Johnson JA, Sacan A, Jackson JG[TaCO], Sanz-Clemente A, Brandimarti R, Meucci O[IRT]. CXCL12 Engages Cortical Inhibitory Neurons to Enhance Dendritic Spine Plasticity and Structured Network Activity. J Neurosci. 2025 Jun 11; 45(24). ( Abstract )	06/11/2025
¶ 977.	Saba NF, Flamand Y, Lin DT, Chung CH, McDonald MW, Flampouri S, Khan SA, Snyderman CH, Hanna EY, El-Sayed IH, Solares CA, Le CH, Ghaly M, Hwang PH, Shin DM, Axelrod RS[MORA], Ikpeazu CV, Adkins DR, Duan F, Cohen M, Samuels MA, Swiecicki PL, Subramaniam RM, Chakravarthy AB, Burtness BA. Neoadjuvant Chemotherapy and Surgery versus Surgery for Organ Preservation of T3 and T4a Nasal and Paranasal Sinus Squamous Cell Carcinoma: ECOG-ACRIN EA3163. Clin Cancer Res. 2025 Jun 13; 31(12):2339-2346. ( Abstract )	06/13/2025
¶ 978.	Stankov I, Useche A, Lekkas P, Henson RM, Headen I, Purtle J, Langellier BA[CRiC]. Causal Loop Diagrams of Food Systems, Diet, and Obesity: A Scoping Review of Methods, Contextual Factors, and Outcomes. Obes Rev. 2025 Jun 15:e13966. [Epub ahead of print] ( Abstract )	06/15/2025
¶ 979.	Barta JA[CRiC], Arenberg D, Backhus L, Detterbeck F, Gould MK, Nair VS, Pasquinelli M, Powell CA, Sandler K, Silvestri G, Triplette M, Vachani A, Wiener RS, Mazzone PJ. Components Necessary for High-Quality Lung Cancer Screening: A 10-Year Update. Chest. 2025 Jun 17. [Epub ahead of print] ( Abstract )	06/17/2025
¶ 980.	Jaehnig EJ, Fernandez-Martinez A, Vashist TD, Holt MV, Williams L, Lei JT, Moon CI, Kim BJ, Dou Y, Zhao H, Korchina V, Gibbs RA, Muzny DM, Doddapaneni H, Perou CM, Carey LA, Robles AI, Hyslop T[CRiC], Wen Y, McCart L, Krek A, Petralia F, Miles G, Kavuri SM, Gillette MA, Mani DR, Carr SA, Zhang B, Ellis MJ, Satpathy S, Anurag M. Proteogenomic analysis of the CALGB 40601 (Alliance) HER2+ breast cancer neoadjuvant trial reveals resistance biomarkers. Cell Rep Med. 2025 Jun 17; 6(6):102154. ( Abstract )	06/17/2025
+ 981.	Melillo RJ, El Khoury C, Godbolt JB, Greene Q, Bussard KM[TaCO], Leader AE[CRiC]. Increasing community members' engagement in cancer research: the making research CLEAR program. Res Involv Engagem. 2025 Jun 19; 11(1):68. ( Abstract )	06/19/2025
¶ 982.	Cammy R, Banks J, Vaughan-Briggs C, Garber G, Pantilat S, Worster B[CRiC]. A descriptive study of the connections between social risk and healthcare utilization with supportive oncology care. J Psychosoc Oncol. 2025; 43(4):481-495. ( Abstract )	06/24/2025
¶ 983.	Ibilibor C, Jones M, Tomaszewski J, Ginzburg S, Correa A, Uzzo R, Smaldone M, Danella J, Guzzo TJ, Lee D, Belkoff L, Walker J, Raman JD, Reese A, Shah MS[MORA], Jacobs B, Jang T, Kowalczyk K, Smith M. Investigating the Usage of Abiraterone in African American Men with Metastatic Prostate Cancer. J Racial Ethn Health Disparities. 2025 Jun 24. [Epub ahead of print] ( Abstract )	06/24/2025
984.	Khan MM, Shi W[MORA], Alnahhas I. Contrast enhancement, G-CIMP subtype, and CDKN2A/B homozygous deletion in IDH-mutant astrocytoma. Neurooncol Adv. 2025 Jun 26; 7(1):vdaf136. ( Abstract )	06/26/2025
¶ 985.	Abedrabbo N, Lam ET, McInnes MDF, . . . Naringrekar H, . . . Polikoff A, . . . Eisenbrey JR[TaCO], . . . Kang Z, Bashir MR, Costa AF. Impact of LI-RADS CT and MRI Ancillary Features on Diagnostic Performance: An Individual Participant Data Meta-Analysis. Radiology. 2025 Jul; 316(1):e242278. ( Abstract )	07/01/2025
+* 986.	Bridgham K, Llerena P, Kumar A, Mastrolonardo E, Banoub R, Clark T, Luginbuhl A[TaCO], Cognetti DM[TaCO], Curry JM[MORA]. The use of 3D computer-aided design to optimize photoimmunotherapy catheter placement. Oral Oncol. 2025 Jul; 166:107365. ( Abstract )	07/01/2025
987.	Conaway S, Richard J, Deshpande DA[TaCO]. Spatiotemporal calcium signaling patterns underlying opposing effects of histamine and TAS2R agonists in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol. 2025 Jul 01; 329(1):L70-L83. ( Abstract )	07/01/2025
¶ 988.	Dunn MR, Niu H, Li D, Emerson MA, Thompson CA, Nichols HB, Roberson ML, Wheeler SB, Hyslop T[CRiC], Elston Lafata J, Troester MA. Applying a Novel Measure of Community-Level Healthcare Access to Assess Breast Cancer Care Timeliness. Cancer Epidemiol Biomarkers Prev. 2025 Jul 01; 34(7):1199-1209. ( Abstract )	07/01/2025
989.	Engel A, Summer R[TaCO], Roman J. Hermansky-Pudlak Syndrome in the United States. Chest. 2025 Jul; 168(1):156-159. ( Abstract )	07/01/2025
990.	Gheyas RN, Williams RC, Ryan KA, Menko AS[TaCO]. The link of FOXO1 and FOXO4 transcription factors to development of the lens. Dev Dyn. 2025 Jul; 254(7):829-852. ( Abstract )	07/01/2025
¶ + 991.	Lefler DS, Elliott A, Jiang W, Martinez-Outschoorn U[TaCO], Al-Sabah J, Freed DM, King CM, Maki RG, Riedel RF, Modiano JF, Hübschmann D, Glimm H, Fröhling S, Oberley M, Boikos SA, Basu Mallick A[MORA]. Pansarcoma Analysis of Cyclin-Dependent Kinase and Cyclin Outlier Gene Expression Highlights CDK7 as a Potential Therapeutic Target in Chordoma. JCO Precis Oncol. 2025 Jul; 9:e2500149. ( Abstract )	07/01/2025
992.	Leong JY, D'Amico MJ, Capella CE, Gomella LG[MORA], Izes JK. Port site metastasis after robotic assisted laparoscopic radical prostatectomy: Diagnosis via prostate-specific membrane antigen (PSMA)-targeted F-DCFPyL PET/CT. Urol Case Rep. 2025 Jul; 61:103082. ( Abstract )	07/01/2025
* 993.	Phan L[CRiC], Wen KY[CRiC], Kim HJ, Barta JA[CRiC], Juon HS[CRiC]. Sociodemographic and psychosocial characteristics of e-cigarette ever-use: U.S. HINTS 6 Survey. Prev Med Rep. 2025 Jul; 55:103113. ( Abstract )	07/01/2025
¶ 994.	Saifi O, Pinnix CC, Kelsey CR, Ballas LK, Milgrom SA, Advani R, Kasner MT[IRT], Flampouri S, Terezakis SA, Sellmyer M, Plastaras JP, Hoppe BS. Radiate equity: the inclusion of radiation oncology and other specialties in lymphoma collaborative groups. Lancet Haematol. 2025 Jul; 12(7):e555-e559. ( Abstract )	07/01/2025
* 995.	Simone NL[CRiC], Burke S, Hamade K, Leader A[CRiC], McNair C[CRiC]. Mapping disparities: identifying cancer care gaps in sexual and gender minority patients. J Natl Cancer Inst Monogr. 2025 Jul 01; 2025(69):153-160. ( Abstract )	07/01/2025
¶ 996.	Stopeck AT, Abu-Khalaf M[CRiC], Borges V, Chmielowski B, Rao R, Xie B, Dudek AZ, Mina L, O'Shaughnessy J, Chisamore M, Mattson P, Gargano M, Cox J, Osterwalder B, Drees J, Harrison B, Chan ASH, Qiu X, Ottoson N, Bose N, Uhlik M, Graff J, Iglesias J. Phase 2 trial of imprime and pembrolizumab immunotherapy in metastatic triple negative breast cancer patients who have progressed beyond first line chemotherapy. J Immunol. 2025 Jul 01; 214(7):1529-1538. ( Abstract )	07/01/2025
¶ 997.	Zager JS, Orloff M[IRT], Ferrucci PF, Choi J, Eschelman DJ, Glazer ES, Ejaz A, Howard JH, Richtig E, Ochsenreither S, Reddy SA, Lowe MC, Beasley GM, Gesierich A, Bender A, Gschnell M, Dummer R, Rivoire M, Arance A, Fenwick SW, Sacco JJ, Haferkamp S, Weishaupt C, John J, Wheater M, Ottensmeier CH. An Open-label, Randomized Study of Melphalan/Hepatic Delivery System Versus Best Alternative Care in Patients with Unresectable Metastatic Uveal Melanoma. Ann Surg Oncol. 2025 Jul; 32(7):4976-4988. ( Abstract )	07/01/2025
¶ 998.	Oppong D, Padmavathi R, Kukulage DSK, Shivamadhu MC, Newberry EA, Faustino AM, Tang HY, Ahn YH[TaCO]. Dehydroglutathione, a glutathione derivative to introduce non-reversible glutathionylation. RSC Chem Biol. 2025 Jul 02; 6(7):1156-1164. ( Abstract )	07/02/2025
¶ + 999.	Sayeed A, Garcia V, Verrillo CE, DeRita RM, Hossain MN, Krishn SR, Sey S, Shields CD, Altieri AD, Liu Q, Sossey-Alaoui K, Kelly WK[MORA], Languino LR[TaCO]. Irradiation of prostate cancer alters circulating small extracellular vesicle functions. Sci Rep. 2025 Jul 02; 15(1):23217. ( Abstract )	07/02/2025
+ 1000.	Fedoroff MY, Zhao L, Wang S, Bhushan A, Yang H[MORA], Bussard KM[TaCO], Peiper SC, He J[CRiC]. Amino acid transporter LAT1 (SLC7A5) promotes metabolic rewiring in TNBC progression through the L-Trp/QPRT/NAD pathway. J Exp Clin Cancer Res. 2025 Jul 03; 44(1):190. ( Abstract )	07/03/2025
¶ * 1001.	Müller PC, Sedlaczek P, Billeter AT, Shen B, Jin J, Nickel F, Guidetti C, Kauffmann E, Purchla J, Berchtold C, Tschuor C, Krohn PS, Burgdorf SK, Jonas JP, Bussmann FJ, Saint-Marc O, Iben-Khayat A, Andel PCM, Molenaar IQ, Wellner U, Keck T, Moeckli B, Toso C, Di Benedetto F, Valle V, Giulianotti P, Roulin D, Martinie J, Rama M, Lavu H[MORA], Yeo CJ[MORA], Mavani PT, Shah MM, Kooby DA, He J, Boggi U, Hackert T, Borel-Rinkes IHM, Clavien PA, Müller BP, Kuemmerli C. Conversion of Robotic Distal Pancreatectomy: Predictors and Outcomes in an International Multicenter Study. Ann Surg. 2025 Jul 03. [Epub ahead of print] ( Abstract )	07/03/2025
1002.	Redding A, Fonteneau G, Heinrich S, Gaida MM, Grabocka E[MORA]. Cytosolic Phospholipase A2 Determines Intercellular Heterogeneity of Stress Granules and Chemotherapy Response. Cancer Discov. 2025 Jul 03; 15(7):1437-1457. ( Abstract )	07/03/2025
¶ * 1003.	Fall F, Eisenbrey JR[TaCO], Tam A, Contreras K, Maxwell A, Vlaisavljevich E, Liu JB, Kuon Yeng Escalante C, Siu Xiao T, Mohammed A, Forsberg F[TaCO], Goldberg A, Koenig G. Contrast-enhanced ultrasound-guided high intensity focused ultrasound treatment of grade 4 liver lacerations in a swine model. J Trauma Acute Care Surg. 2025 Jul 04. [Epub ahead of print] ( Abstract )	07/04/2025
¶ 1004.	Dennaoui R, Rädler PD, Wicker MN, Vistisen K, Ferraiuolo RM, Triplett AA, Shrestha H, Liner TA, Manthey KC, Rui H[MORA], Cardiff RD, Gunn TM, Perou CM, Wagner KU. Overexpression of TSG101 causes the development of adenosquamous mammary carcinoma. Breast Cancer Res. 2025 Jul 07; 27(1):126. ( Abstract )	07/07/2025
¶ 1005.	Fike AJ, Bricker KN, Gonzalez MV, Maharjan A, Bui T, Nuon K, Emrich SM, Weber JL, Luckenbill SA, Choi NM, Sauteraud R, Liu DJ, Olsen NJ, Caricchio R, Trebak M, Chodisetti SB, Rahman ZSM[IRT]. IRF7 controls spontaneous autoimmune germinal center and plasma cell checkpoints. J Exp Med. 2025 Jul 07; 222(7). ( Abstract )	07/07/2025
* 1006.	Perez Kerkvliet CJ, Leong JY, Thompson RAM, Zarrabi KK, Kelly WK[MORA], Lallas C[MORA], Gomella L[MORA], Shah M[MORA]. Treatment Intensification Prior to Radical Prostatectomy for Clinically Localized Prostate Cancer. Cancers (Basel). 2025 Jul 07; 17(13). ( Abstract )	07/07/2025
¶ 1007.	Yousafzai NA, Santos MF, Kim Y, Avihen Schahaf N, Zielke K, Languino L[TaCO], Sossey-Alaoui K, Lorico A. Role of Kindlin-2-Expressing Extracellular Vesicles in the Invasiveness of Triple Negative Breast Cancer Tumor Cells. Cells. 2025 Jul 07; 14(13). ( Abstract )	07/07/2025
¶ 1008.	Ryser MD, Thomas SM, Li Y, Lynch T, Barber A, Francescatti AB, Collyar D, Byng D, Grimm LJ, Partridge AH, Thompson AM, Hyslop T[CRiC], Hwang ES. Cancer outcomes in women without upfront surgery for ductal carcinoma in situ: observational cohort study. BMJ. 2025 Jul 08; 390:e083542. ( Abstract )	07/08/2025
¶ 1009.	Shen F, Smith R, McDevitt T, Menard K, Tian S, Chu G, Chaudhary R, McCann J, Oyer H, Wang S, Max S, Francis P, Kelly WK[MORA], Drake CG. Human kallikrein 2: A novel lineage-specific surface target in prostate cancer. Clin Cancer Res. 2025 Jul 08. [Epub ahead of print] ( Abstract )	07/08/2025
¶ 1010.	Zenk M, Baid U, Pati S, . . . Shukla G, Liem S, Alexandre GS, Lombardo J, . . . Flanders AE, Dicker AP[CRiC], . . . Menze B, Maier-Hein K, Bakas S. Towards fair decentralized benchmarking of healthcare AI algorithms with the Federated Tumor Segmentation (FeTS) challenge. Nat Commun. 2025 Jul 08; 16(1):6274. ( Abstract )	07/08/2025
¶ 1011.	Channer B, Daniali M, Sheldon L, Emanuel K, Agarwal Y, Kist T, Murphy BJ, Niu M, Dampier W, Fox H, Gaskill PJ[IRT]. Microenvironmental conditions and serum availability alter primary human macrophage NF-κB inflammatory response and function. J Leukoc Biol. 2025 Jul 09; 117(7). ( Abstract )	07/09/2025
1012.	Pascal GJ, Kim S, Xie C, Mondal D, Iozzo RV[TaCO]. Proteoglycans are protagonists in autophagy, lymphangiogenesis, and neurodegenerative diseases. Trends Cell Biol. 2025 Jul 10. [Epub ahead of print] ( Abstract )	07/10/2025
* 1013.	Bloom M, Shaikh AR, Sun Z, Bashir B[IRT], Snook AE[IRT]. Cancer Vaccination and Immune-Based Approaches in Pancreatic Cancer. Cancers (Basel). 2025 Jul 15; 17(14). ( Abstract )	07/15/2025
¶ 1014.	Flaherty KT, Aplin AE[TaCO], Davies MA, Hacohen N, Herlyn M, Hoon D, Hwu P, Lotem M, Mulé J, Wargo JA, Fisher DE. Facts and Hopes: Toward the Next Quantum Leap in Melanoma. Clin Cancer Res. 2025 Jul 15; 31(14):2882-2889. ( Abstract )	07/15/2025
1015.	Fradin JJ, Riley JM, Storozynsky E, Tchantchaleishvili V, Wilde LR[IRT]. Nonbacterial Thrombotic Endocarditis as a Presenting Paraneoplastic Manifestation of Acute Promyelocytic Leukemia. JACC Case Rep. 2025 Jul 16; 30(19):104043. ( Abstract )	07/16/2025
¶ 1016.	Xie Q, Namba MD, Dasari R, Buck LA, Side CM, Goldberg SL, Park K, Jackson JG[TaCO], Giacometti L, Barker JM. Chemogenetic activation of medial prefrontal cortex projections to the nucleus accumbens shell suppresses cocaine-primed reinstatement in EcoHIV infected mice. Psychopharmacology (Berl). 2025 Jul 16. [Epub ahead of print] ( Abstract )	07/16/2025
¶ 1017.	Kava CM, Smith JL, Kobernik EK, Eberth JM[CRiC], French C, Nash SH, Zahnd WE, Hall IJ. Interventions to Increase Colorectal Cancer Screening Uptake in Rural Settings: A Scoping Review. Prev Chronic Dis. 2025 Jul 17; 22:E44. ( Abstract )	07/17/2025
+ 1018.	Wallace M, Dasgupta R, Cravero K, Yang H, South AP[MORA], Nikbakht N[IRT]. The utility of collagen VII topical gene therapy in the treatment of surgical defect after excision of recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma. Br J Dermatol. 2025 Jul 17; 193(2):337-339. ( Abstract )	07/17/2025
1019.	Bouteau A, Qin Z, Zurawski S, Zurawski G, Igyarto BZ[IRT]. Langerhans cells drive Tfh and B cell responses independent of canonical cytokine signals. Front Immunol. 2025 Jul 18; 16:1611812. ( Abstract )	07/18/2025
¶ 1020.	Woofter K, Kennedy EB, Adelson K, Bowman R, Chapman AE[CRiC], Dixit N, Gerber R, Jefferies P, Martin E, Mulvey TM, Olsen M, O'Mahony D, Polite B, Sadeghi N, Shaw M, Skelton MR, Cox J. Oncology Medical Homes: ASCO-Community Oncology Alliance Standards. JCO Oncol Pract. 2025 Jul 21:OP2500498. [Epub ahead of print] ( Abstract )	07/21/2025
* 1021.	Madeka I, Yi S, Evans J, Baek D, Naringrekar HV, Lavu H[MORA], Yeo CJ[MORA], Nevler A, Bowne WB. Clinicopathologic risk factors for post-operative complications after enucleation of pancreatic neoplasms. World J Surg Oncol. 2025 Jul 22; 23(1):293. ( Abstract )	07/22/2025
¶ 1022.	Ma KPK, Stober T, Gottlieb M, Geyer RE, Rising K[CRiC], Saydah S, Santangelo M, Gatling K, Grau D, Wang RC, Montoy JC, Idris A, MacDonald S, Hill MJ, Huebinger R, Prado MG, Gentile NL, Spatz E, Maliki C, Dorney J, Elmore JG, L'Hommedieu M, Weinstein RA, Venkatesh AK, Stephens KA, INSPIRE Group. Participant engagement in a national longitudinal study of COVID-19: Insights from the INSPIRE study. PLoS One. 2025 Jul 22; 20(7):e0325948. ( Abstract )	07/22/2025
¶ 1023.	Schnake-Mahl A, Diez Roux AV[CRiC], Liu B, Holaday LW, Siu A, McCulley E, Bilal U, Ornstein KA. Where you live and where you receive care: Using cross-classified multilevel modeling to examine hospital and neighborhood variation in in-hospital mortality and mortality disparities. Ann Epidemiol. 2025 Jul 22; 110:16-22. [Epub ahead of print] ( Abstract )	07/22/2025
¶ 1024.	Gottlieb M, Spatz ES, Yu H, Ebna Mannan I, Santangelo M, Malicki C, Gentile NL, Geyer RE, Charlton A, Dyal JW, Elmore JG, Gatling K, Hill MJ, Montoy JCC, O'Laughlin KN, Rising KL[CRiC], Saydah S, Stephens KA, Wang RC, Wisk LE, Venkatesh AK, Weinstein RA, Innovative Support for Patients with SARS-CoV-2 Infections Registry (INSPIRE) Group. Effects of long COVID on healthcare utilization. PLoS One. 2025 Jul 23; 20(7):e0327218. ( Abstract )	07/23/2025
1025.	Chabria R, Hagerman CJ, Crane N, Ehmann M, Knudsen FM, Brown KL, Forman E, Butryn ML[CRiC]. Racial disparities in the efficacy of traditional versus acceptance-based behavioral weight loss. Health Psychol. 2025 Jul 24. [Epub ahead of print] ( Abstract )	07/24/2025
* 1026.	Song Y, Sifat M, Phan L[CRiC], Banks J, Melillo R, Leader AE[CRiC]. Sociodemographic Correlates of Cancer-Related Beliefs Among Chinese Speaking Adults in Greater Philadelphia. J Racial Ethn Health Disparities. 2025 Jul 25. [Epub ahead of print] ( Abstract )	07/25/2025
¶ 1027.	Wesolowski R, Rugo HS, Specht JM, Han H, Kabos P, Vaishampayan U, Wander SA, Gogineni K, Spira A, Schott AF, Abu-Khalaf M[CRiC], Mutka SC, Suzuki S, Sullivan B, Gorbatchevsky I, Layman RM. Gedatolisib Combined with Palbociclib and Letrozole in Patients with No Prior Systemic Therapy for Hormone Receptor Positive, HER2 Negative Advanced Breast Cancer. Clin Cancer Res. 2025 Jul 25. [Epub ahead of print] ( Abstract )	07/25/2025
+ 1028.	Madeka I, Ho A, Rshaidat H, Alaparthi S, Whitehorn GL, Ishwar A, Grenda TR[MORA], Jacob J, Evans NR[CRiC], Okusanya OT. Evaluating Clinical Outcomes Across Sex and Ethnicity in Patients With Early-Stage Non-small Cell Lung Cancer (NSCLC). J Surg Res. 2025 Jul 26; 314:59-70. [Epub ahead of print] ( Abstract )	07/26/2025
¶ 1029.	Rosenberg SM, Rushing C, Schreiber KL, Crowell KA, Bedrosian I, Hughes KS, Lynch T, Basila D, Collyar D, Frank ES, Darai S, Lanahan C, Marks JR, Plichta JK, Hyslop T[CRiC], Thompson AM, Partridge AH, Hwang ES. Patient-reported Outcomes After Routine Treatment of In Situ/Atypical Lesions: The PORTAL Study. Ann Surg Oncol. 2025 Jul 27. [Epub ahead of print] ( Abstract )	07/27/2025
+* 1030.	Caksa S, Purwin TJ, Erkes DA, DeRosa KM, Kitterman E, Barnada SM, Stefanski CD, Wilson HP, Mersky GL, Glasheen MQ, Heilizer JS, Ajmal N, Sun Y, Chan JSY, Rui H[MORA], Chervoneva I[CRiC], Capparelli C[TaCO], Aplin AE[TaCO]. Elevated Transglutaminase-2 in SOX10-Deficient Melanoma Promotes Tumor Onset and Decreases Intratumoral CD4+ T Cells. Cancer Res. 2025 Jul 31. [Epub ahead of print] ( Abstract )	07/31/2025
+* 1031.	Moroco AE, Nunes K, Alnemri A, Bridgham K, Llerena P, Tuluc M, Gargano S, Zhan T, Thal AG, Cognetti DM[TaCO], Curry JM[MORA], Johnson JM[MORA], Luginbuhl AJ[TaCO]. Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab. JAMA Otolaryngol Head Neck Surg. 2025 Jul 31. [Epub ahead of print] ( Abstract )	07/31/2025
¶ 1032.	Zeidner JF, Sallman DA, Récher C, Daver NG, Leung AYH, Hiwase DK, Subklewe M, Pabst T, Montesinos P, Larson RA, Wilde L[IRT], Enjeti AK, Kawashima I, Papayannidis C, O'Nions J, Johnson L, Dong M, Huang J, Bagheri T, Hacohen Kleiman G, Lee C, Vyas P. Magrolimab plus azacitidine vs physician's choice for untreated TP53-mutated acute myeloid leukemia: the ENHANCE-2 study. Blood. 2025 Jul 31; 146(5):590-600. ( Abstract )	07/31/2025
¶ 1033.	Bakhtsiyarava M, Kephart JL, Sánchez BN, Ramarao MVS, Arunachalam S, Gouveia N, Dronova I, Schinasi LH, Bilal U, Caiaffa WT, Jaffe A, Diez Roux AV[CRiC], Rodríguez DA, SALURBAL. Future temperature-related mortality in Latin American cities under climate change and population scenarios. Environ Int. 2025 Aug; 202:109694. ( Abstract )	08/01/2025
¶ * 1034.	Barajas CB, Roby DH, Stimpson JP, Ponce NA, Lazalde GE, Young MT, Kietzman K, Vargas Bustamante A, Rivera-González AC, Langellier BA[CRiC], Eberth JM[CRiC], Stehr M, Ortega AN. Equity in Health Care Access, Utilization, and Experiences for Latino Children in California by Parental Citizenship and Household Language, 2021-22. Acad Pediatr. 2025 Aug; 25(6):102856. ( Abstract )	08/01/2025
¶ 1035.	Charnysh E, McCain S, Truhlar A, Pal S, Reader JM, Sanghavi K, Uhlmann WR, Hendy K, Leader A[CRiC], Blasco D, Prince AER, Feero WG, Brandt R, Giri VN, Lee C, Roberts JS. Perceived understanding and psychosocial outcomes: employees' responses to learning results of workplace genetic testing. Per Med. 2025 Aug; 22(4):211-221. ( Abstract )	08/01/2025
¶ 1036.	Gottlieb M, Chen J, Yu H, Santangelo M, Spatz ES, Gentile NL, Geyer RE, Malicki C, Gatling K, O'Laughlin KN, Stephens KA, Elmore JG, Wisk LE, L'Hommedieu M, Rodriguez R, Montoy JCC, Wang RC, Rising KL[CRiC], Kean E, Dyal JW, Hill MJ, Venkatesh AK, Weinstein RA, INSPIRE Group. Work Impairment and Financial Outcomes Among Adults With vs Without Long COVID. JAMA Netw Open. 2025 Aug 01; 8(8):e2526310. ( Abstract )	08/01/2025
+* 1037.	Islam R, Roche ME, Lin Z, Whitaker-Menezes D, Diaz-Barros V, Serrano E, Martinez Cantarin MP, Philp NJ[TaCO], Basu Mallick A[MORA], Martinez-Outschoorn U[TaCO]. TOMM20 as a driver of cancer aggressiveness via oxidative phosphorylation, maintenance of a reduced state, and resistance to apoptosis. Mol Oncol. 2025 Aug; 19(8):2431-2455. ( Abstract )	08/01/2025
¶ 1038.	Jhun BS, O-Uchi J, Rhee B, Ahrari A, DeMichaelis N, Jeon KI, Booth DM, Sheu SS[TaCO]. Sarcoplasmic reticulum-mitochondria microdomains: hugging and kissing in the heart. Am J Physiol Cell Physiol. 2025 Aug 01; 329(2):C599-C610. ( Abstract )	08/01/2025
¶ 1039.	Leader AE[CRiC], Godbolt JB, Crumpler N, Gross L, Hartman R, Keith SW, Giri VN. Utilizing peer educators to increase genetic testing for prostate cancer among black males: results of a randomized controlled trial. J Natl Med Assoc. 2025 Aug; 117(4):248-257. ( Abstract )	08/01/2025
¶ 1040.	Mady LJ, Baddour K, Owoc MS, Kudrick LD, Gentsch AT, Ebbott D, Skalla B, Amache M, Najjar W, Gupta S, Kacker S, Mazul AL, Fakhry C, Rising KL[CRiC], Hass R, Gharzai LA. Longitudinal Financial Toxicity and Quality of Life in Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg. 2025 Aug 01; 151(8):750-760. ( Abstract )	08/01/2025
¶ 1041.	Milhem MM, Zakharia Y, Davar D, Buchbinder EI, Medina T, Daud A, Ribas A, Chmielowski B, Niu J, Gibney GT, Margolin K, Olszanski AJ, Mehmi I, Sato T[IRT], Shaheen M, Zhao L, Kelley H, Liu H, Kumar S, Bobilev D, Krieg AM, Wooldridge JE, Kirkwood JM. Intratumoral vidutolimod as monotherapy or in combination with pembrolizumab in patients with programmed cell death 1 blockade-resistant melanoma: Final analysis from a phase 1b study. Cancer. 2025 Aug 01; 131(15):e70022. ( Abstract )	08/01/2025
1042.	Nassur J, Dajee D, Leader A[CRiC], DiSantis K. Barriers to Breast, Cervical, and Colorectal Cancer Screenings Faced by Refugees Resettled in the United States: A Rapid Review. J Immigr Minor Health. 2025 Aug; 27(4):609-622. ( Abstract )	08/01/2025
1043.	Puttemans J, Brammerloo Y, Blibek K, Blavier J, Ntombela T, Van Molle I, Joseph J, Olivet J, Saha D, Degey M, Hamaidia M, Jain P[IRT], Geraldine P, Zimmermann P, Kim DK, Baiwir D, Njock MS, Dequiedt F, Salehi-Ashtiani K, Ballet S, Volkov AN, Twizere JC, Maseko SB. Inhibitors of Tax1-PDZ Interactions Block HTLV-1 Viral Transmission by Changing EV Composition. J Extracell Vesicles. 2025 Aug; 14(8):e70137. ( Abstract )	08/01/2025
1044.	Rafalko N, Siegel S, Yerkes P, Eberth JM[CRiC], Burstyn I, Goldstein ND. Quantifying the primary care workforce in the U.S.: A validation study with and without an imperfectly measured referent standard. Ann Epidemiol. 2025 Aug; 108:92-98. ( Abstract )	08/01/2025
1045.	Schlegel LE, Brill-Edwards M, Wang ZX, McNair C[CRiC], Gargano S, Cottrill E. Detection of PTEN Mutations in Fine Needle Aspiration Biopsies of Indeterminate Thyroid Nodules: Impact on Diagnosis and Prognosis. Head Neck. 2025 Aug; 47(8):2145-2151. ( Abstract )	08/01/2025
1046.	Schnake-Mahl A, Rollins H, Goldstein ND, Bilal U, Diez Roux AV[CRiC]. Neighborhood Disparities in Influenza and Influenza like Illness Hospitalization During Seasonal and Pandemic Influenza. Open Forum Infect Dis. 2025 Aug; 12(8):ofaf468. ( Abstract )	08/01/2025
¶ 1047.	Soniat MM[MORA], Myler LR. Using the safety scissors: DNA resection regulation at DNA double-strand breaks and telomeres. DNA Repair (Amst). 2025 Aug; 152:103876. ( Abstract )	08/01/2025
¶ 1048.	Tagai EK, Bradley M, Wen KY[CRiC], Hernandez E, Miller SM. Type of Social Support for Smoking Cessation Among Low-Income Postpartum Women. Int J Behav Med. 2025 Aug; 32(4):640-645. ( Abstract )	08/01/2025
¶ +* 1049.	Tahmasebi A, Siu Xiao T, Wessner CE, Kuon Yeng Escalante CM, Lyshchik A[TaCO], Forsberg F[TaCO], Liu JB, Roth CG, Rodgers SK, Kania LM, Anton K[TaCO], Yadav A, Lallas CD[MORA], Topper SR, Trabulsi EJ[MORA], Eisenbrey JR[TaCO]. Feasibility of Contrast-Enhanced Ultrasound Fusion With Pretreatment MR/CT for Recurrence Detection in Renal Cell Carcinoma Patients During Post-Ablation Surveillance. Ultrasound Med Biol. 2025 Aug; 51(8):1336-1342. ( Abstract )	08/01/2025
¶ 1050.	Wisk LE, L'Hommedieu M, Diaz Roldan K, Ebna Mannan I, Spatz ES, Weinstein RA, Venkatesh AK, Gottlieb M, Huebinger R, Rising KL[CRiC], Montoy JCC, Stephens KA, Rodriguez RM, Hill MJ, O'Laughlin KN, Gentile NL, Idris AH, Li SX, Santangelo M, Kean ER, McDonald SA, Gatling K, Elmore JG, INSPIRE Group. Variability in Long COVID Definitions and Validation of Published Prevalence Rates. JAMA Netw Open. 2025 Aug 01; 8(8):e2526506. ( Abstract )	08/01/2025
1051.	Zhan T, Yi M, Chervoneva I[CRiC]. Quantile index predictors using R package hyper.gam. Bioinformatics. 2025 Aug 02; 41(8). ( Abstract )	08/02/2025
1052.	Miles A, Evers-Hunt H, Naik A, Dimarco R, Donnelly A, Deveney B, Fala N, Thomas C, Binder AF[IRT]. Evaluating a Sepsis Screening Tool in the Outpatient Setting. Clin J Oncol Nurs. 2025 Aug 04; 29(4):297-302. ( Abstract )	08/04/2025
¶ 1053.	Nadiminti KV, Ahn KW, Patel J, Lian Q, Bezerra E, Chen A, Ganguly S, Gergis U[IRT], Hashmi H, Kharfan-Dabaja MA, Kuruvilla J, Lekakis L, Locke FL, Murthy H, Mousthafa MA, Perales MA, Pophali P, Riedell PA, Shah NN, Wang T, Pasquini M, Hamadani M, Turtle CJ, Herrera AF, Shadman M. Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: A CIBMTR Analysis. Transplant Cell Ther. 2025 Aug 05. [Epub ahead of print] ( Abstract )	08/05/2025
¶ 1054.	Barnard ME, Qin B, Emerson MA, Holder EX, Dunn MR, Sarkar S, Xu NN, Li Y, Ambrosone CB, Bandera EV, Palmer JR, Troester MA, Hyslop T[CRiC], Breast Cancer Research Foundation’s Health Equity Initiative. Associations between social drivers of health and breast cancer stage at diagnosis among U.S. Black women. NPJ Breast Cancer. 2025 Aug 06; 11(1):85. ( Abstract )	08/06/2025
¶ 1055.	Halabi S, Guo S, Luo B, Yu C, Knutson TP, Kobilka A, Lyman J, Beltran H, Antonarakis ES, Galsky MD, Rosenberg JE, Ryan CJ, Small EJ, Kelly WK[MORA], Morris MJ, Page D, Dehm SM, Armstrong AJ. Pathogenic Genomic Alterations in Circulating Tumor DNA Predict Overall Survival in Men with Metastatic Castrate-resistant Prostate Cancer. Eur Urol. 2025 Aug 06. [Epub ahead of print] ( Abstract )	08/06/2025
* 1056.	Chen H, Agarwal A, Yellanki S, Lavu H[MORA], Zheng R, Bowne WB, Yeo CJ[MORA], Jain A, Nevler A. P53 Function Status Correlates With Overall Survival in Patients With Resected Pancreatic Cancer. J Surg Oncol. 2025 Aug 07. [Epub ahead of print] ( Abstract )	08/07/2025
¶ 1057.	Pickering H, Alipanah-Lechner N, Chen E, . . . Cairns CB, Haddad EK[IRT], . . . Reed EF, Greenland JR, Calabrese DR. MICBG406A polymorphism reduces risk of mechanical ventilation and death during viral acute lung injury. JCI Insight. 2025 Aug 08; 10(15). ( Abstract )	08/08/2025
¶ 1058.	Freeman TJ, George TJ, Jacobs SA, Yothers G, Kolevska T, Feng H, Lipchik C, Maley S, Song N, Srinivasan A, Finnigan M, Wade JL, Buchschacher GL, Al Baghdadi T, Shipstone A, Lin D[MORA], Puhalla SL, Allegra CJ, Wolmark N, Pogue-Geile KL. NSABP FC-11: A phase II study of neratinib plus trastuzumab or neratinib plus cetuximab in patients with "quadruple wild-type" (KRAS/NRAS/BRAF/PIK3CA) metastatic colorectal cancer based on HER2 status: amplified, non-amplified (wild-type), or mutated. Cancer Chemother Pharmacol. 2025 Aug 09; 95(1):80. ( Abstract )	08/09/2025
1059.	Nash VA, Cortes-Troncoso JF, Chua PE, Spiller KL[IRT]. Affinity-based controlled release of interleukin-4 from scaffolds via biotin-streptavidin interactions for immunomodulation. J Control Release. 2025 Aug 10; 384:113943. ( Abstract )	08/10/2025
¶ 1060.	Kimbrough EM, Nguyen HA, Li H, Mattingly JM, Bailey NA, Ning W, Gamper H, Hou YM[MORA], Gonzalez RL, Dunham CM. An RNA modification prevents extended codon-anticodon interactions from facilitating +1 frameshifting. Nat Commun. 2025 Aug 11; 16(1):7392. ( Abstract )	08/11/2025
* 1061.	Rising KL[CRiC], Gerolamo AM, Sarpoulaki N, Salcedo VJ, Amadio G, Casten R, Chang AM, Gentsch AT, O'Hayer CV, Rovner B[CRiC], Worster B[CRiC]. Patient- and Caregiver-Identified Goals for Advance Care Planning in Patients With Dementia or Cognitive Impairment. Dementia (London). 2025 Aug 11:14713012251361969. [Epub ahead of print] ( Abstract )	08/11/2025
1062.	Wessner CE, Pomeranz C, Blackman R, Hoy MK, Bradigan K, Stache SA, Harwood M, Nazarian L, Forsberg F[TaCO]. Noninvasive Diagnosis of Chronic Exertional Compartment Syndrome With Shear Wave Elastography and Subharmonic Aided Pressure Estimation. J Ultrasound Med. 2025 Aug 12. [Epub ahead of print] ( Abstract )	08/12/2025
¶ 1063.	O'Connor GJ, Wigmore RM, Van NT, Choi JC, Zhang K, Kivolowitz C, Chen A, Ambelil M, Littman DR, Kim SV[IRT]. C10ORF99 (GPR15L) increases susceptibility to colitis and colitis-induced colorectal cancer via GPR15-independent mechanisms, while mediating GPR15-dependent T cell migration to the large intestine. Mucosal Immunol. 2025 Aug 13. [Epub ahead of print] ( Abstract )	08/13/2025
¶ 1064.	Fernandez-Sanz C, De la Fuente S, Nichtova Z, Federico M, Duvezin-Caubet S, Lanvermann S, Tsai HY, Xin Y, Csordas G, Wang W, Mourier A, Sheu SS[TaCO]. Highly Oligomeric DRP1 Strategic Positioning at Mitochondria-Sarcoplasmic Reticulum Contacts in Adult Murine Heart Through ACTIN Anchoring. Cells. 2025 Aug 14; 14(16). ( Abstract )	08/14/2025
1065.	Masuda I, McGuigan H, Maharjan S, Yamaki Y, Hou YM[MORA]. Connecting tRNA Charging and Decoding through the Axis of Nucleotide Modifications at Position 37. J Mol Biol. 2025 Aug 15; 437(16):169095. ( Abstract )	08/15/2025
¶ 1066.	Elisei R, Wirth LJ, Capdevila J, Hoff AO, Tahara M, Sherman EJ, Hu MI, Ge MH, Wadsley J, Vaisman F, Kopeckova K, Krajewska J, Olvera D, Churchill C, Maeda P, Gilligan AM, Lin Y, Payakachat N, Robinson B, Hadoux J, Brose MS[TaCO]. Patient-Reported Tolerability of Selpercatinib Compared to Cabozantinib/Vandetanib: A Secondary Analysis of the LIBRETTO-531 Randomized-Controlled Trial in RET-Mutant Medullary Thyroid Cancer. Thyroid. 2025 Aug 18. [Epub ahead of print] ( Abstract )	08/18/2025
1067.	Springer LE, Rao HZ, Abinader O, Mitra R, Snyder CM[IRT]. Leukotriene B4 regulates T cell recognition and control of MCMV in mucosal tissues. Mucosal Immunol. 2025 Aug 18. [Epub ahead of print] ( Abstract )	08/18/2025
¶ 1068.	Azizi G, Rasouli J, Naziri H, Gonzalez MV, Garifallou J, Zhang GX, Ciric B, Rostami A[IRT]. GM-CSF production by immune cells in steady state and autoimmune neuroinflammation mapped using fate reporting mice. Front Immunol. 2025 Aug 19; 16:1617074. ( Abstract )	08/19/2025
¶ 1069.	Iyer SP, Mehta-Shah N, Advani RH, Bartlett NL, Christensen JH, Morschhauser F, Domingo-Domenech E, Rossi G, Kim WSS, Alpdogan O[IRT], Feldman TA, Camus V, Gritti G, Zinzani PL, Belada D, Mayer J, Choi I, Cheong JW, Rustia E, Fenton K, Fanale M, Savage KJ, Horwitz SM. Association of PET4 Response With Outcomes of BV-CHP vs CHOP in the ECHELON-2 Trial in CD30+ Peripheral T-cell Lymphoma. Blood Adv. 2025 Aug 19. [Epub ahead of print] ( Abstract )	08/19/2025
¶ * 1070.	Paran N, Wirblich C, Olal C, Tarquinio A, Lohmeyer KH, Kurup D[IRT], Schultz-Cherry S, Shittu I, Gray GC, Bente DA, Olafson PU, Schnell MJ[IRT]. Immunogenicity and safety of a rabies-based highly pathogenic influenza A virus H5 vaccine in cattle. NPJ Vaccines. 2025 Aug 19; 10(1):197. ( Abstract )	08/19/2025
¶ + 1071.	Lawler ME, Romer-Seibert JS, Bowman MS, Mitra R, Eischen CM[IRT], Bowman RL, Meyer SE[MORA]. TLR2 Agonism Suppresses Myeloid Leukemogenesis by Reprogramming Leukemia Stem Cells. Blood Adv. 2025 Aug 20. [Epub ahead of print] ( Abstract )	08/20/2025
1072.	Herbine K, Nayak AR, Zamudio-Ochoa A, Temiakov D[TaCO]. Structural basis for promoter recognition and transcription factor binding and release in human mitochondria. Mol Cell. 2025 Aug 21; 85(16):3123-3136.e7. ( Abstract )	08/21/2025
¶ 1073.	Adefarati O, Yearwood R, Song Y, Leader AE[CRiC], Glanz K, Gonzalez ET, Keith SW, Graciani N, Fortune T, Zeigler-Johnson CM. The Impact of a Community Partner Research Training Program. J Cancer Educ. 2025 Aug 22. [Epub ahead of print] ( Abstract )	08/22/2025
1074.	McCausland HC, Nasser JA[CRiC], LaFata EM. A narrative review of public and expert perceptions of ultra-processed foods: Knowledge, opinions, and educational directions. Appetite. 2025 Aug 22; 216:108273. [Epub ahead of print] ( Abstract )	08/22/2025
+ 1075.	Shaver AL, Nikita N, Sharma S, Keith SW, Zarrabi KK, Kelly WK[MORA], Lu-Yao G[CRiC]. The Safety of Abiraterone Acetate in Patients with Metastatic Castration-Resistant Prostate Cancer: An Individual-Participant Data Meta-Analysis Based on 14 Randomized Clinical Trials. Cancers (Basel). 2025 Aug 23; 17(17). ( Abstract )	08/23/2025
¶ +* 1076.	Cognetti DM[TaCO], Curry JM[MORA], Johnson J[MORA], Kwon M, Su SY, Civantos F, Olazagasti C, Valentino J, Arnold SM, Bell RB, Gibson MK, Mannion K, Van Abel KM, Price KA, Dong H, Thorne AH, Suzuki T, Gillenwater AM. Safety and Efficacy Findings From a Phase Ib/II Study of ASP-1929 Photoimmunotherapy With Pembrolizumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma. Head Neck. 2025 Aug 25. [Epub ahead of print] ( Abstract )	08/25/2025
¶ * 1077.	Barajas CB, Young MT, Bustamante AV, Padilla-Frausto I, Garcia RE, Langellier BA[CRiC], Roby DH, Stimpson JP, Ponce NA, Eberth JM[CRiC], Stehr M, Ortega AN. Organizational Perspectives on the Public Charge Rule and Health Care Access for Latino Immigrants in California. Health Serv Res. 2025 Aug 26:e70032. [Epub ahead of print] ( Abstract )	08/26/2025
1078.	Jones AD, Capriotti Z, Santos E, Lin A, Van Duyne R, Smith S, Klase Z[IRT]. HIV-1 controllers possess a unique CD8+ T cell activation phenotype and loss of control is associated with increased expression of exhaustion markers. PLoS One. 2025 Aug 28; 20(8):e0328706. ( Abstract )	08/28/2025
+ 1079.	Alaparthi SS, Ishwar A, Whitehorn G, Madeka I, Grenda T[MORA], Jacob JD, Evans NR[CRiC], Okusanya OT. Is Lobectomy Associated With Improved Outcomes Compared to Segmentectomy in Small Cell Lung Cancer Discovered at the Time of Resection? Clin Lung Cancer. 2025 Aug 29. [Epub ahead of print] ( Abstract )	08/29/2025
¶ 1080.	Yeboa DN, Braunstein SE, Cabrera A, Crago K, Galanis E, Hattab EM, Heron DE, Huang J, Kim MM, Kirkpatrick JP, Knisely JPS, McAleer MF, McClelland S, Milano MT, Moliterno J, Porter A, Redmond KJ, Trifiletti DM, Tsien C, Venkatesulu BP, Vinogradskiy Y[CRiC], Bradfield L, Helms AR, Bovi JA. Radiation Therapy for WHO Grade 4 Adult-Type Diffuse Glioma: An ASTRO Clinical Practice Guideline. Pract Radiat Oncol. 2025 Sep-Oct; 15(5):451-471. ( Abstract )	08/31/2025
* 1081.	Brantly A, Yeakle K, Bouchard MJ, Gaskill PJ[IRT], Nonnemacher MR[IRT]. The role of liver macrophages in viral liver pathogenesis. J Leukoc Biol. 2025 Sep 01; 117(9). ( Abstract )	09/01/2025
¶ 1082.	De Ravin E, Cao AC, Carey RM, Elliott Z, Sakkal M, Slijepcevic A, Petrisor D, Taghizadeh F, Newman JG, Curry J[MORA], Wax MK, Cannady SB. Impact of the "July effect" in head and neck microvascular reconstruction: A retrospective review. World J Otorhinolaryngol Head Neck Surg. 2025 Sep; 11(3):433-439. ( Abstract )	09/01/2025
1083.	Ezenwankwo E, Jones C, Nguyen DT, Eberth JM[CRiC]. Lung Cancer Screening Adherence in Centralized vs Decentralized Screening Programs: A Meta-Analysis of US Cohort Studies Among Individuals With Negative Baseline Results. Chest. 2025 Sep; 168(3):797-809. ( Abstract )	09/01/2025
¶ 1084.	Ghoreifi A, Gomella L[MORA], Hu JC, Konety B, Lunelli L, Rastinehad AR, Salomon G, Taneja S, Tourinho-Barbosa R, Lebastchi AH. Identifying the best candidate for focal therapy: a comprehensive review. Prostate Cancer Prostatic Dis. 2025 Sep; 28(3):684-692. ( Abstract )	09/01/2025
1085.	Glassman DT, Grindley C, Wahlstedt JC, Galen E, Meeks W, Wang K, Gomella LG[MORA]. The Impact of Telehealth on Treatment Decision-Making in Prostate Cancer. Urol Pract. 2025 Sep; 12(5):578-585. ( Abstract )	09/01/2025
¶ * 1086.	Gummadi S, Mohammed A, Alnoury M, Fall F, Siu Xiao T, Contreras K, Maxwell A, Vlaisavljevich E, Liu JB, Wessner CE, Forsberg F[TaCO], Goldberg A, Koenig G, Eisenbrey JR[TaCO]. Contrast-Enhanced B-Flow Ultrasound: A Novel Approach to Liver Trauma Imaging. Ultrason Imaging. 2025 Sep; 47(5):182-188. ( Abstract )	09/01/2025
¶ 1087.	Lin D[MORA], Quan W, Garretson M, Chirikov V, Chen C, Singh P, Davis C, Sugarman R. Q-TWiST analysis of first-line nivolumab plus chemotherapy versus chemotherapy in patients with advanced gastric cancer, gastroesophageal junction cancer, or esophageal adenocarcinoma from CheckMate 649: 4-year follow-up results. Gastric Cancer. 2025 Sep; 28(5):935-944. ( Abstract )	09/01/2025
¶ +* 1088.	Loeb S, Keith SW, Gross L, Hartman RL, Beer TM, Brierley KL, Cheng HH, Couvillon A, Dicker AP[CRiC], Friedman S, Gomella LG[MORA], Karsh L, Kelly WK[MORA], Lallas CD[MORA], Leader AE[CRiC], Mann MJ, Mark JR, Mille P, Paller CJ, Rana HQ, Sokolova AO, Trabulsi EJ[MORA], Whang YE, Giri VN. Patient-Reported Outcomes From Males Regarding Germline Testing for Prostate Cancer: Results From the PROGRESS Registry. JCO Precis Oncol. 2025 Sep; 9:e2500571. ( Abstract )	09/01/2025
1089.	Martin SP, Dang H[MORA]. What is the Current Treatment of Hepatocellular Carcinoma? Adv Surg. 2025 Sep; 59(1):233-243. ( Abstract )	09/01/2025
¶ 1090.	Neupane T, Castillo E, Chen Y, Pahlavian SH, Castillo R, Vinogradskiy Y[CRiC], Choi W. Predicting radiation pneumonitis in lung cancer patients using robust 4DCT-ventilation and perfusion imaging. Radiother Oncol. 2025 Sep 01; 212:111110. [Epub ahead of print] ( Abstract )	09/01/2025
1091.	Nevler A, Yeo CJ[MORA]. You Survived Your Whipple Operation, Now What? Long-Term Consequences of Anemia, Incisional Hernia, Osteopenia, and Pathologic Fractures. Adv Surg. 2025 Sep; 59(1):223-231. ( Abstract )	09/01/2025
¶ 1092.	Omo-Lamai S, Wang Y, Patel MN, Milosavljevic A, Zuschlag D, Poddar S, Wu J, Wang L, Dong F, Espy C, Majumder A, Essien EO, Shen M, Channer B, Papp TE, Tobin M, Maheshwari R, Jeong S, Patel S, Shah A, Murali S, Chase LS, Zamora ME, Arral ML, Marcos-Contreras OA, Myerson JW, Hunter CA, Discher D, Gaskill PJ[IRT], Tsourkas A, Muzykantov VR, Brodsky I, Shin S, Whitehead KA, Parhiz H, Katzen J, Miner JJ, Trauner D, Brenner JS. Limiting endosomal damage sensing reduces inflammation triggered by lipid nanoparticle endosomal escape. Nat Nanotechnol. 2025 Sep; 20(9):1285-1297. ( Abstract )	09/01/2025
1093.	Palecki J, Tucker M, Bernstein A, Melby G, Zhan T, Micaily I[MORA]. Multiple Sclerosis and Lung Cancer: A Single Cancer Center Experience in Philadelphia. Clin Lung Cancer. 2025 Sep; 26(6):e409-e412. ( Abstract )	09/01/2025
+ 1094.	Park PH, Israel LE, Alexander MH, Tartaglia G, South HG, Han S, Curry JM[MORA], Luginbuhl AJ[TaCO], South AP. Partial-EMT cell state correlates with single cell pattern of invasion in head and neck SCC keratinocytes. J Pathol. 2025 Sep; 267(1):92-104. ( Abstract )	09/01/2025
+* 1095.	Shaver AL, Gandhi K, Keith SW, Nikita N, Yang CC, Kim FJ[MORA], Yang H[CRiC], Kelly WK[MORA], Freedland SJ, Lu-Yao G[CRiC]. Unplanned hospitalization among advanced prostate cancer patients by diabetes status: a population-based study. JNCI Cancer Spectr. 2025 Sep 01; 9(5). ( Abstract )	09/01/2025
+ 1096.	Stezzi M, Brose M[TaCO], Gordon SW[IRT], Solomides C, Tuluc M, Miller J. Well-Differentiated Lung Neuroendocrine Tumor Masquerading as Metastatic Medullary Thyroid Cancer. JCEM Case Rep. 2025 Sep; 3(9):luaf172. ( Abstract )	09/01/2025
¶ 1097.	Świrski MI, Tierney JAS, Albà MM, . . . Atkins JF, . . . Berry MJ, . . . Hou YM[MORA], . . .Zagrovic B, TRANSLACORE, Valen E, Baranov PV. Translon: a single term for translated regions. Nat Methods. 2025 Sep 01. [Epub ahead of print] ( Abstract )	09/01/2025
* 1098.	Wessner CE, Forsberg F[TaCO], Lyshchik A[TaCO], O'Kane P, Bradigan K, Liu JB, Delaney LJ, Anton K[TaCO], Topper SR, Civan J, Maley W, Keith SW, Shaw CM, Eisenbrey JR[TaCO]. Microbubble-based Radiosensitization of Hepatocellular Carcinoma: Evaluation of Safety and Efficacy in a Phase II Randomized Trial. Radiology. 2025 Sep; 316(3):e250083. ( Abstract )	09/01/2025
¶ 1099.	Williams RM, Phan L[CRiC]. Reducing Lung Cancer Disparities Calls for Another Look: Inclusion of Priority Populations in Screening Guidelines. Ann Am Thorac Soc. 2025 Sep; 22(9):1292-1294. ( Abstract )	09/01/2025
1100.	Yuan L, Kulkarni M, Chiswick E, Koh C, Sandy P, Nabhan S, Sherman W, Johnson M, Wang J, Falchook G, Johnson J[MORA], Winter C, Gardner H, Chakravarty A, Stoddard M. A novel approach for first-in-human dose selection using population dose-response modelling to find a minimum anticipated biological effect level. Br J Clin Pharmacol. 2025 Sep; 91(9):2555-2566. ( Abstract )	09/01/2025
1101.	Alberti A, Gurizzan C, Resteghini C, Trama A, Bernasconi A, Grisanti S, Zamparini M, Mohamad I, Linares Galiana I, Ozyar E, Franco P, Vecchio S, Bonomo P, Cirauqui B, El-Sherify M, Ursino S, Argiris A, Pan J, Wittekindt C, D'Angelo E, Costa L, Buglione M, Johnson JM[MORA], Airoldi M, Mesia R, Licitra L, Orlandi E, Bossi P, Nasopharyngeal Cancer Portal Group of Investigators. A multicenter retrospective analysis of recurrent/metastatic nasopharyngeal cancer from non-endemic areas: Results in the pre-immunotherapy era. Eur J Cancer. 2025 Sep 02; 229:115749. [Epub ahead of print] ( Abstract )	09/02/2025
1102.	McLean L, Andrews C, Cappelli L, Gillan G, Curtis M, Evans JJ, Shi W[MORA]. Pituitary Macroadenoma and Adamantinomatous Craniopharyngioma: A Rare Case Report of Sellar Collision Tumors. Case Rep Neurol Med. 2025 Sep 4; 2025:6895334. ( Abstract )	09/04/2025
¶ 1103.	Sangotra A, Reddy SL, Kuo CJ, Xiang W, Merry DE[MORA], Grunseich C, Wang S, Lieberman AP. PROTACs therapeutically target the polyglutamine androgen receptor in spinal and bulbar muscular atrophy models. Neurotherapeutics. 2025 Sep 04:e00732. [Epub ahead of print] ( Abstract )	09/04/2025
¶ +* 1104.	Cunningham ML, Vasquez-Gonzalez J, Barnada SM, Tchotorlishvili S, Jones L, Maguire R, Lewis G, Rizwan K, Deng J, Koachar S, Patel D, Shankle H, Mulders T, Ajmal N, Solomides C, Alnemri ES[IRT], Alnemri TF, Shafi AA, Gomella LG[MORA], Kelly WK[MORA], McMahon SB[MORA], Schiewer MJ. PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration-resistant prostate cancer. Mol Oncol. 2025 Sep 07. [Epub ahead of print] ( Abstract )	09/07/2025
¶ 1105.	Yeon M, Perego M, Elokely KM, Abou-Gharbia M, Childers WE, Milcarek AT, Bertolini I, Tang HY, Languino LR[TaCO], Stein GS, Ghule PN, Vietje BP, Taatjes DT, Altieri DC. Parkin Induces Ubiquitination and Large Extracellular Vesicle Release of HMGB1 to Activate Antitumor Immunity. Cancer Res. 2025 Sep 10. [Epub ahead of print] ( Abstract )	09/10/2025
¶ 1106.	Gates C, Gillespie M, Kane A, Philips R, Curry J[MORA], Tekumalla S, Pettit C, Palmer T, Tassone P. Missed Adjuvant Therapy After Resection of Intermediate and High-Risk Oral Cavity Cancer: A Multi-institutional Study. Otolaryngol Head Neck Surg. 2025 Sep 11. [Epub ahead of print] ( Abstract )	09/11/2025
+* 1107.	Llerena P, Samarah H, Nunes K, Lin Z, Bridgham K, Tekumalla S, Jain A, Harshyne L, Shukla SK, Vathiotis I, Tuluc M, Gargano S, Eisenbrey JR[TaCO], Keith S, Cognetti DM[TaCO], Bar-Ad VC[MORA], Luginbuhl AJ[TaCO], Axelrod R[MORA], Vadigepalli R[MORA], Yang H[CRiC], Whitaker-Menezes D, Roche M, Mahoney MG[IRT], Argiris A, Solomides C, Johnson JM[MORA], Barbirou M, Miller A, South AP, Mitra R, Linnenbach AJ, Martinez-Outschoorn U[TaCO], Curry JM[MORA]. Extracellular matrix-myCAF signatures correlate with resistance to neoadjuvant aPD-L1 immune checkpoint inhibition with durvalumab + metformin in HPV+ HNSCC. Clin Cancer Res. 2025 Sep 11. [Epub ahead of print] ( Abstract )	09/11/2025
¶ 1108.	Lubrano S, Cervantes-Villagrana RD, Arang N, Officer A, Adame-Garcia SR, Cuesta-Margolles G, Aplin AE[TaCO], Gutkind JS. Inhibition of anti-apoptotic BCL2 overcomes adaptive resistance to co-targeting of the protein kinase FAK and MEK in GNAQ-driven uveal melanoma. J Biol Chem. 2025 Sep 11:110712. [Epub ahead of print] ( Abstract )	09/11/2025
¶ + 1109.	Bach CA, Hossain MN, Chaudhari IJ, Verrillo CE, Naranjo NM, Amoroso I, Testa A, Sey S, Kelly WK[MORA], Bellis SL, Lorico A, Blidner AG, Rabinovich GA, Languino LR[TaCO]. A novel sialylation pathway mediated by extracellular vesicles in aggressive prostate cancer. PLoS One. 2025 Sep 12; 20(9):e0329014. ( Abstract )	09/12/2025
¶ 1110.	Sato T[IRT], Butler MO, Piperno-Neumann S, Hassel JC, Nathan P, Shoushtari AN, Rutkowski P, Carvajal RD, Baurain JF, Schlaak M, Piulats JM, Sullivan RJ, Ochsenreither S, Dummer R, Kirkwood JM, Ikeguchi A, Joshua AM, Middleton MR, Edukulla R, Pfeiffer C, Sacco JJ. Incidence and Management of Adverse Events Associated with Tebentafusp Treatment in Metastatic Uveal Melanoma: Pooled Safety Analysis of 410 patients. Clin Cancer Res. 2025 Sep 12. [Epub ahead of print] ( Abstract )	09/12/2025
¶ 1111.	Ruban A, Schneider ALC, Liang M, Gottesman RF, Selvin E, Coresh J, Lazo M[CRiC], Koton S. Association between liver enzyme levels and prevalence of migraine: the atherosclerosis risk in communities study. Ther Adv Neurol Disord. 2025 Sep 13; 18:17562864251370097. ( Abstract )	09/13/2025
¶ + 1112.	Mastrolonardo EV, Sussman S, Yun B, Jegede V, Amin DR, Rosenbloom J, South AP, Bar-Ad V[MORA], Wermuth PJ, Luginbuhl AJ[TaCO]. Effects of Oxygen Manipulation on Myofibroblast Phenotypic Transformation in Patients With Radiation-Induced Fibrosis. Wound Repair Regen. 2025 Jul-Aug; 33(4):e70075. ( Abstract )	09/14/2025
¶ 1113.	Chaparro MP, Kravitz C, Langellier BA[CRiC]. Housing costs and food purchasing characteristics: The role of SNAP participation and SNAP purchasing power. Appetite. 2025 Sep 15; 216:108312. [Epub ahead of print] ( Abstract )	09/15/2025
+ 1114.	Flynn JM, Thadani N, Gallagher EE, Azzaro I, Bodnar CM, McCarty CP, Romano G[IRT], Webster MR, Capparelli C[TaCO]. Plasticity and Functional Heterogeneity of Cancer-Associated Fibroblasts. Cancer Res. 2025 Sep 15; 85(18):3378-3398. ( Abstract )	09/15/2025
1115.	Rushovich T, Diez Roux AV[CRiC], Goldstein ND, Schnake-Mahl A. Intersectional Demographic Trends in Infective Endocarditis Among Adults in the US, 2012-2021. J Gen Intern Med. 2025 Sep 15. [Epub ahead of print] ( Abstract )	09/15/2025
* 1116.	Wessner CE, Siu Xiao T, Chang A, Liu J, Chong W, Liu JB, Bradigan K, Forsberg F[TaCO], Lyshchik A[TaCO], O'Kane P, Keith SW, Topper SR, Anton K[TaCO], Eisenbrey JR[TaCO]. Radiosensitization of intrahepatic cholangiocarcinoma and metastatic disease in the liver using microbubble cavitation: results from a phase 2 clinical trial. Cancer Lett. 2025 Sep 15; 633:218026. [Epub ahead of print] ( Abstract )	09/15/2025
¶ * 1117.	Chang SS, Chamie K, Kramolowsky E, Gonzalgo ML, Agarwal PK, Bassett JC, Bjurlin M, Cher ML, Clark W, Cowan BE, David R, Goldfischer E, Guru K, Jalkut MW, Kaffenberger SD, Kaminetsky J, Corcoran A, Koo AS, Sexton WJ, Tikhonenkov SN, Shah MS[MORA], Trabulsi EJ[MORA], Trainer AF, Spilman P, Huang M, Bhar P, Drusbosky LM, Sender L, Brown B, Reddy S, Soon-Shiong P. Prolonged Progression-Free Survival, Disease-Free Survival and Cystectomy Avoidance with IL-15 Receptor Lymphocyte-Stimulating Agent NAI plus BCG in BCG-Unresponsive Papillary-Only NMIBC. J Urol. 2025 Sep 16:101097JU0000000000004782. [Epub ahead of print] ( Abstract )	09/16/2025
¶ +* 1118.	Tiago M, Purwin TJ, Stefanski CD, da Silva RO, Fane ME, Chhabra Y, Haj JI, Teh JL, Kadamb R, Cai W, Rosenbaum SR, Chua V, Hacohen N, Davies MA, Villanueva J, Chervoneva I[CRiC], Weeraratna AT, Erkes DA, Capparelli C[TaCO], Aguirre-Ghiso JA, Aplin AE[TaCO]. Elevated NR2F1 underlies the persistence of invasive disease after treatment of BRAF-mutant melanoma. J Clin Invest. 2025 Sep 16; 135(18). ( Abstract )	09/16/2025
* 1119.	Evans HM, Landy R, Shusted CS, Ruane B, Anderson E, Giamboy T, McMullen M, Kane GC, Juon HS[CRiC], Barta JA[CRiC]. Variation in Lung Cancer Risk Distribution by Race Across Modified PLCO Risk Models Among Lung Cancer Screening Participants. Ann Am Thorac Soc. 2025 Sep 17. [Epub ahead of print] ( Abstract )	09/17/2025
+ 1120.	Laimer M, South AP[MORA], Mayr E, Kitzmueller S, Banner L, Alexander M, Hosler L, Yang H, Parris M, Arora M, Zimmermann G, Schweighofer-Zwink G, Bauer JW, Nikbakht N[IRT]. Efficacy and safety of rigosertib in patients with recessive dystrophic epidermolysis bullosa-associated advanced/metastatic cutaneous squamous cell carcinoma. Br J Dermatol. 2025 Sep 18; 193(4):758-766. ( Abstract )	09/18/2025
¶ 1121.	Thomas JG, Goldstein CM, Bond DS, Lillis J, Hekler E, Goldstein SP, Butryn ML[CRiC], Cao Z, Wing RR. Evaluation of Five Novel Intervention Components in Online Obesity Treatment: Outcomes of a Randomized Factorial Experiment. Obesity (Silver Spring). 2025 Sep 18. [Epub ahead of print] ( Abstract )	09/18/2025
¶ 1122.	Wang L, Lu Q, Li R, Harrison TB, Jia H, Huang M, Dowst H, Zhang R, Badr H[CRiC], Fan JW, Liu H. Understanding Cancer Survivorship Care Needs Using Amazon Reviews: Content Analysis, Algorithm Development, and Validation Study. JMIR Cancer. 2025 Sep 23; 11:e71102. ( Abstract )	09/23/2025
¶ 1123.	Fracasso PM, Simone NL[CRiC], Si Lim SJ, Reckamp KL, Sosa JA, Lieu C, Lee C, Werner TL, Ly QP, Vose JM, White J, Honeycutt H, Shaw K, Cameron K, O'Brien DM, Wilke LG. Benchmarking the Current Landscape: Insights From an Association of American Cancer Institutes Survey on Academic Cancer Service Lines. JCO Oncol Pract. 2025 Sep 24:OP2500073. [Epub ahead of print] ( Abstract )	09/24/2025
¶ 1124.	Holloway RW, Temkin SM, Gordon SW[IRT], Gupta S, Jada SR, Ahmad S, McGuire WP. A Phase Ib Study of Indirect Immunization with Oregovomab and Toll-like-Receptor-3 Stimulation with Hiltonol in Patients with Recurrent Platinum-Resistant Ovarian Cancer. Curr Oncol. 2025 Sep 24; 32(10). ( Abstract )	09/24/2025
¶ 1125.	Allen PB, Goyal S, Iyer S, Talluru S, Huen A, Greenwell B, Scribner J, Paulino D, Speegle S, Baird K, Beaven A, Switchenko JM, Rangarajan S, Mehta A, O'Leary C, Case K, Adams B, Ayers A, Bhaati S, Krishnasamy S, Porcu P[IRT], Sethi T, Foss F, Lechowicz MJ, Rozati S. Racial Differences in Mycosis Fungoides and Sézary Syndrome: A Multicenter Cohort Study. J Am Acad Dermatol. 2025 Sep 29. [Epub ahead of print] ( Abstract )	09/29/2025
¶ * 1126.	Lim TL, Montazeri K, Wehrenberg-Klee E, Desilets A, Seedor R[IRT], Orloff M[IRT], Sato T[IRT], Caplan M, El-Ashmawy M, Izar B, Khan S, Mehmi I, Lawless A, Hong TS, Hamid O, Carvajal RD, Shoushtari A, Sullivan RJ. Concurrent local therapy extends clinical benefit of tebentafusp in metastatic uveal melanoma patients. Oncologist. 2025 Sep 29. [Epub ahead of print] ( Abstract )	09/29/2025
+* 1127.	Altieri A, Reilly SP, Mansalay A, Khoo AS, Johnson N, Khan ZK, Leader A[CRiC], Jain P[IRT], Porcu P[IRT]. HTLV-1 and ATLL: Epidemiology, Oncogenesis, and Opportunities for Community-Informed Research in the United States. Viruses. 2025 Sep 30; 17(10). ( Abstract )	09/30/2025
¶ * 1128.	Barajas CB, De Trinidad Young ME, Bustamante AV, Langellier BA[CRiC], Roby DH, Stimpson JP, Ponce NA, Kietzman K, Eberth JM[CRiC], Stehr M, Ortega AN. Public Benefit Avoidance And Safety Concerns Among Mixed-Status Latino Families In California, 2021-22. Health Aff (Millwood). 2025 Oct; 44(10):1307-1316. ( Abstract )	10/01/2025
¶ 1129.	Calì T, Bayer EM, Eden ER, Hajnoczky G[TaCO], Kornmann B, Lackner L, Liou J, Reinisch K, Rhee HW, Rizzuto R, Scorrano L, Brini M. Key challenges and recommendations for defining organelle membrane contact sites. Nat Rev Mol Cell Biol. 2025 Oct; 26(10):776-796. ( Abstract )	10/01/2025
¶ 1130.	Chen Y, Liu P, Cong X, Castillo E, Castillo R, Grills I, Stevens C, Xu X, Li X, Vinogradskiy Y[CRiC], Ding X. Integrating spot-scanning proton arc therapy with functional avoidance strategies to reduce pulmonary toxicity. Phys Imaging Radiat Oncol. 2025 Oct; 36:100876. ( Abstract )	10/01/2025
¶ 1131.	Fenton KM, Choi K, Hamilton-Moseley KR, Guy MC, Niederdeppe J, Sterling KL, Phan L[CRiC]. A qualitative exploration of cigar smoking beliefs by type among U.S. susceptible Black young adults. Drug Alcohol Depend. 2025 Oct 01; 275:112828. ( Abstract )	10/01/2025
¶ 1132.	Hushpulian DM, Kaidery NA, Soni P, Poloznikov AA, Zakhariants AA, Razumovskaya AV, Silkina MO, Tishkov VI, Kazakov EH, Brown AM, Gaisina IN, Ahn YH[TaCO], Kazakov SV, Krucher N, Sharma SM, Paul BD, Gazaryan IG, Nikulin SV, Thomas B. Functional analysis of bipartite NRF2 activators that overcome feedback regulation for age-related chronic diseases. Redox Biol. 2025 Oct; 86:103794. ( Abstract )	10/01/2025
1133.	Laurano R, Pogorzelska-Maziarz M, Green TC, Beachy S, Rising KL[CRiC], Hom JK, Reed MK. Amputation trends among people who use drugs in the context of Philadelphia's increasingly xylazine adulterated drug supply. Drug Alcohol Depend. 2025 Oct 01; 275:112826. ( Abstract )	10/01/2025
1134.	Le PM, DeDreu J, Mattapallil MJ, Caspi RR, Tomlinson R, Stepp MA, Menko AS[TaCO]. Matrix molecules associated with both regulation of inflammation and pathogenic outcomes associated with the surface of the lens in the eyes of EAU mice. Exp Eye Res. 2025 Oct; 259:110529. ( Abstract )	10/01/2025
1135.	Mayer H, Machado P, Vu T, Berzigotti A, Bosch J, Dajti E, Antonenko A, Wallace K, Forsberg F[TaCO]. A comparative evaluation of two subharmonic-aided pressure estimation (SHAPE) analysis methods. Ultrasonics. 2025 Oct 01; 159:107840. [Epub ahead of print] ( Abstract )	10/01/2025
1136.	Oh M, Kadam RN, Charania ZS, Somarowthu S[MORA]. LncRNA SChLAP1 Promotes Cancer Cell Proliferation and Invasion Via Its Distinct Structural Domains and Conserved Regions. J Mol Biol. 2025 Oct 01; 437(19):169350. ( Abstract )	10/01/2025
1137.	Okazaki K, Cao W, Taleei R, Mourtada F, Li Ju, Mooney K, Anne PR[MORA], Chen Y. Evaluation of image quality in mobile cone-beam CT with dose modulation using automatic exposure control: A phantom study. J Appl Clin Med Phys. 2025 Oct; 26(10):e70248. ( Abstract )	10/01/2025
1138.	Pascal GJ, Mondal DK, Kim S, Xie C, Siva Sankar D, Dengjel J, Iozzo RV[TaCO]. Decorin Evokes a Pro-lysosomal Pathway in Lymphatic Endothelial Cells. Proteoglycan Res. 2025 Oct; 3(4). ( Abstract )	10/01/2025
1139.	Rigoutsos I[MORA], Nersisyan S, Londin E, Nazeraj I, Dong B, Vourekas A, Loher P. Organism-Specific Sequence Motifs Link Ribosomal RNAs to Brain Disorders. Mol Biol Evol. 2025 Oct 01; 42(10). ( Abstract )	10/01/2025
¶ 1140.	Sajisevi M, Nguyen K, Callas P, . . . Cognetti DM[TaCO], . . . Garvey EA, Kakarala K, Enepekides DJ, Hier MP, Davies L, Ryan WR. Practice Patterns in Management of Low- to Intermediate-Grade Salivary Gland Carcinoma: A Multi-Institutional Study. Laryngoscope Investig Otolaryngol. 2025 Oct; 10(5):e70246. ( Abstract )	10/01/2025
1141.	Zhang J, Wen KY[CRiC], Liang J, Diamond V, Dayaratna S. Feasibility and Acceptability of Human Papillomavirus Based Self-sampling in Underserved Minorities in the United States: A Scoping Review. J Low Genit Tract Dis. 2025 Oct 01; 29(4):348-358. ( Abstract )	10/01/2025
¶ 1142.	Pakkiriswami S, Sung JH, Shah KR, Ozkurede U, Sumera MK, Feng F, Chapoy Villanueva H, Cho ES, Torniainen A, van Berlo J, Hajnoczky G[TaCO], Prins KW, Liu JC. Adaptation to Elevated Mitochondrial Calcium Is Distinct in the Left and Right Ventricles. Circ Res. 2025 Oct 07. [Epub ahead of print] ( Abstract )	10/07/2025
+ 1143.	Meredith L, Yang P, Rshaidat H, Koeneman S, Thosani D, Jacob J, Grenda T[MORA], Okusanya O, Palazzo F, Chojnacki KA, Whang S, Evans NR[CRiC]. A Standardized Health System Approach to Ivor Lewis Esophagectomy. J Gastrointest Surg. 2025 Oct 08:102250. [Epub ahead of print] ( Abstract )	10/08/2025
1144.	Shah MS[MORA], Buck M. Man plus machine: large language models can augment medical student education. Nat Rev Urol. 2025 Oct 08. [Epub ahead of print] ( Abstract )	10/08/2025
¶ 1145.	Westvold SJ, Long JB, Fan J, Kc M, Hyslop T[CRiC], Conlin K, Jacobson S, Silber A, Wang SY, Leapman MS, Leeds I, Spees L, Wheeler SB, Gross CP, Oeffinger K, Dinan MA. Cardiovascular risk in long-term survivors of breast, prostate, colon, and rectal cancer. J Natl Cancer Inst. 2025 Oct 09. [Epub ahead of print] ( Abstract )	10/09/2025
¶ 1146.	Starr A, Rathore S, Daniali M, Gaskill PJ[IRT], Akay-Espinoza C, Jordan-Sciutto KL. Differential Effects of Cannabinoid Receptor 2 Agonists on HIV Replication and Inflammatory Activation in Monocyte-Derived Macrophages and Induced Pluripotent Stem Cell-Derived Microglia. J Neuroimmune Pharmacol. 2025 Oct 11; 20(1):87. ( Abstract )	10/11/2025
¶ 1147.	Leader AE[CRiC], Loeb S, Selvan P, Hunter A, Hartman R, Keith SW, Giri VN. A Social Media Campaign and Web-Based Survey About Prostate Cancer Genetics: Mixed Methods Study. JMIR Cancer. 2025 Oct 14; 11:e69787. ( Abstract )	10/14/2025
¶ 1148.	Gudenkauf LM, Tometich DB, Hoogland AI, Li X, Kirtane K, Small BJ, Barata A, Gonzalez BD, Jacobs KD, Chung CH, Shafique MR, Gray J, Khushalani NI, Postow MA, Cella D, Webster KA, Dicker AP[CRiC], Jim HSL. Validation of the Functional Assessment of Cancer Therapy - Immune Checkpoint Modulator 17-Item Symptom Index (FACT-ICM-17) to facilitate implementation in research and clinical care. Cancer. 2025 Oct 15; 131(20):e70102. ( Abstract )	10/15/2025
1149.	Rochani AK, Dave VS, Hernandez-Meadows M, Bajaj A, Lacerda Q, Alzien T, Woytowicz S, Eisenbrey J[TaCO], Camenisch TD, Kaushal G. Albumin as a natural and moldable biomaterial for biomimetic drug delivery applications. Int J Pharm. 2025 Oct 15; 683:126056. ( Abstract )	10/15/2025
¶ 1150.	Chandramouly G, Fried W, Gordon J, Ralph D, Keuk C, Kumari S, Ramanjulu M, Auerbacher W, Minakhin L, Tredinnick T, Tiberi B, Morton G, Betsch R, Cai KQ, Vekariya UM, Tyagi M, Skorski T, Karakashev S, Johnson N, Childers WE, Chen XS, Pomerantz RT[MORA]. RTx-303, an Orally Bioavailable Polθ Polymerase Inhibitor That Potentiates PARP Inhibitors in BRCA Mutant Tumors. J Med Chem. 2025 Oct 22. [Epub ahead of print] ( Abstract )	10/22/2025
¶ 1151.	Padia SA, Modi S, Wehrenberg-Klee E, Adamo RD, Ahmed A, Orloff M[IRT], Helmerhorst HJF, Chmielowski B, Ozkan OS, Burgmans MC, Grözinger MG, Lewandowski RJ, Krishnasamy VP. Treatment of Liver Metastases from Uveal Melanoma with Percutaneous Hepatic Perfusion. J Vasc Interv Radiol. 2025 Oct 23. [Epub ahead of print] ( Abstract )	10/23/2025
¶ 1152.	Zheng Y, Han J, Qu Y, Wang J, Joyce BT, Okeke E, Davwar PM, Duguru MJ, Nyam DP, Odeghe E, Oyeleke G, Lesi OA, Imade GE, Sulaimon AA, Hawkins C, Abdulkareem FB, Badmos K, Gursel DB, Wei JJ, Silas OA, Kocherginsky M, Kim KA, Sun Z, Achenbach CJ, Zhang X, Yang H[CRiC], Sagay AS, Ogunsola FT, Murphy RL, Roberts LR, Hou L. Circulating cell-free DNA methylation biomarkers for hepatocellular carcinoma risk prediction in HIV-positive Nigerian population. Int J Cancer. 2025 Oct 23. [Epub ahead of print] ( Abstract )	10/23/2025
1153.	Adler O, Machado P, Vu T, Forsberg F[TaCO], Gilja OH, Adam D. Perfusion Assessment in CEUS Imaging for Estimating Pancreatic Cancer Response to Sonoporation-Enhanced Chemotherapy. Ultrason Imaging. 2025 Oct 24:1617346251367758. [Epub ahead of print] ( Abstract )	10/24/2025
* 1154.	Chang ML, Kraft M, Kaplan Z, Lavu H[MORA], Yeo CJ[MORA], Bowne W, Nevler A. Assessment of long-term endocrine sequelae of completion (2-stage) versus total (single-stage) pancreatectomy: A multi-institutional research network and single-institution analysis. Surgery. 2025 Oct 24; 190:109830. [Epub ahead of print] ( Abstract )	10/24/2025
¶ 1155.	Chavez-Yenter D, Fetzer D, Egleston B, Domchek S, Fleisher L, Wagner LI, Wen KY[CRiC], Karpink K, Gutstein L, Posen S, Selmani E, McLeod B, Anantharajah A, Brown S, Cacioppo C, Cappadocia J, Ebrahimzadeh JE, Falcone D, Howe S, Langer C, McCarthy-Wood B, Weinberg M, Bradbury AR. The MyCancerGene study: a hybrid type 1 effectiveness-implementation randomized study comparing a patient-centered digital genetic health portal to usual care after receipt of cancer genetic testing. BMC Cancer. 2025 Oct 24; 25(1):1642. ( Abstract )	10/24/2025
¶ 1156.	Jacoby JL, Calderon-Aparicio A, François NB, Thapar M, Burke SE, Xu S, DeAngelis T, Shastri A, Tran PT, Simone NL[CRiC]. Standardizing caloric restriction for preclinical cancer research. Biotechniques. 2025 Oct 24:1-10. [Epub ahead of print] ( Abstract )	10/24/2025
¶ 1157.	Krossa I, Pisibon C, Cheli Y, Bille K, Dalmasso M, Hamadat S, Husser C, Irondelle M, Cherfils-Vicini J, Soysouvanh F, Nahon-Esteve S, Martel A, Lassalle S, Caujolle JP, Maschi C, Baillif S, Hasson D, Carcamo S, Aplin AE[TaCO], Davidson I, Bernstein E, Naim V, Ballotti R, Bertolotto C, Strub T. SETDB1 is critically required for uveal melanoma growth and represents a promising therapeutic target. Cell Death Dis. 2025 Oct 24; 16(1):754. ( Abstract )	10/24/2025
1158.	Gradone A, Bi X, Durugu S, Bao A, Gattas B, Nath AD, Filicko-O'Hara J, O'Hara W, Storozynsky E, Grosso D, Flomenberg N, Gergis U[IRT]. The Heart of the Matter: Cardiac Toxicity in Allogenic Stem Cell Transplant with Post-Transplant Cyclophosphamide. Transplant Cell Ther. 2025 Oct 27. [Epub ahead of print] ( Abstract )	10/27/2025
¶ 1159.	Wardeh L, Williams M, Prestwood C, Wolner Z, Nikbakht N[IRT]. CD5 Expression in CTCL and Its Implications for Anti-CD5 CAR T-Cell Therapy. Int J Mol Sci. 2025 Oct 27; 26(21). ( Abstract )	10/27/2025
¶ 1160.	Whittaker MN, Testa LC, Quigley A, Brooks DL, Grandinette SA, Said H, Dwivedi G, Jindal I, Volpp D, Hacker JL, Qu P, Wang JZ, Levine MA, Ahrens-Nicklas RC, Li Q[MORA], Musunuru K, Alameh MG, Peranteau WH, Wang X. Improved specificity and efficiency of in vivo adenine base editing therapies with hybrid guide RNAs. Nat Biomed Eng. 2025 Oct 28. [Epub ahead of print] ( Abstract )	10/28/2025
+ 1161.	Cunanan CJ, Sanders AB, Gallant KC, Seedor RS[IRT], Hartsough EJ[TaCO]. Functions and clinical implications of the liver microenvironment in hepatic uveal melanoma metastases. Cancer Metastasis Rev. 2025 Oct 29; 44(4):80. ( Abstract )	10/29/2025
¶ 1162.	Plummer MJ, DiMaria-Ghalili RA, Lopez AM[CRiC], Fang CY, Coe CL, Surachman A. Educational attainment, health locus of control and inflammation among cancer survivors in the Midlife in the United States (MIDUS) study. Psychol Health Med. 2025 Oct 29:1-22. [Epub ahead of print] ( Abstract )	10/29/2025
¶ 1163.	Leong JY, Prasad V, Perez Kerkvliet CJ, Wagner AA, Link RE, Shah MS[MORA]. Single port robotic partial nephrectomy via a retroperitoneal approach. Can J Urol. 2025 Oct 30; 32(5):469-475. ( Abstract )	10/30/2025
¶ 1164.	Cui L, Lee J, Miller J, Tang M, Abedian S, Altorki NK, Crupi RS, Groner L, Lindeman NI, Pinheiro LC, Tamimi RM, Villena-Vargas J, Vachani A, Barta JA[CRiC], Gao HO, Sholle E, Solomon JP, Garcia CA, Choi E, Shieh Y. Design and creation of a racially diverse lung cancer registry with detailed genomic and environmental annotation. Cancer Epidemiol Biomarkers Prev. 2025 Oct 31. [Epub ahead of print] ( Abstract )	10/31/2025
1165.	Wang B, Hoffman RD, Hou YM[MORA], Li H. Structural basis for retron co-option of anti-phage ATPase-nuclease. Nat Struct Mol Biol. 2025 Oct 31. [Epub ahead of print] ( Abstract )	10/31/2025
* 1166.	Wessner CE, Chong W, Berreby G, Delaney LJ, Forsberg F[TaCO], Lyshchik A[TaCO], O'Kane P, Liu JB, Anton K[TaCO], Topper SR, Civan J, Maley W, Keith SW, Shaw CM, Eisenbrey JR[TaCO]. Quantitative Contrast-enhanced Ultrasound Evaluation of Hepatocellular Carcinoma Radioembolization. Invest Radiol. 2025 Oct 31. [Epub ahead of print] ( Abstract )	10/31/2025
1167.	Allmang S, Witzel HR, Hausen A, Marquard S, Eckert C, Marnet N, Hörner N, Mayer P, Heinrich S, Dang H[MORA], Roth W, Gaida MM. Aberrant Expression of A Disintegrin and Metalloproteinase With Thrombospondin Motifs 13 (ADAMTS13) in Pancreatic Cancer Leads to Dichotomic Functions. MedComm (2020). 2025 Nov; 6(11):e70462. ( Abstract )	11/01/2025
¶ 1168.	Anderson C, Lee CM, Kelley JR, Walker GV, Dunlap NE, Bar-Ad VC[MORA], Miller DA, King VJ, Peddada AV, Ciuba DF, Vincent F, Muzyka BC, Gillespie-Twardy AL, Sonis ST, Holmlund J, Beardsley RA, Kennedy EP, Saunders D. Avasopasem manganese treatment for severe oral mucositis from chemoradiotherapy for locally advanced head and neck cancer: phase 3 randomized controlled trial (ROMAN). EClinicalMedicine. 2025 Nov; 89:103539. ( Abstract )	11/01/2025
¶ * 1169.	Hoopes JR, Lyshchik A[TaCO], Xiao TS, Berzigotti A, Fetzer DT, Forsberg F[TaCO], Sidhu PS, Wessner CE, Wilson SR, Keith SW. Using Machine Learning to Improve the Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System Diagnosis of Hepatocellular Carcinoma in Indeterminate Liver Nodules. Ultrasound Med Biol. 2025 Nov; 51(11):1953-1960. ( Abstract )	11/01/2025
¶ 1170.	Landry I, Binder AF[IRT], Yorker M, Ramirez S. Redefining central nervous system multiple myeloma: From rare phenomenon to emerging entity. Blood Rev. 2025 Nov; 74:101343. ( Abstract )	11/01/2025
1171.	Li X, Delberghe F, Turco S, Mills D, Wallace K, Valvano G, Zwart W, Forsberg F[TaCO], van den Kroonenberg DL, Wijkstra H, Mischi M. Three-Dimensional Shear-Wave Viscoelastographic Estimation by System Identification for Prostate Cancer Localization. Ultrasound Med Biol. 2025 Nov; 51(11):2089-2098. ( Abstract )	11/01/2025
¶ 1172.	Pijanowski J, Nguyen E, Abdulkadir Y, Hink J, Vinogradskiy Y[CRiC], Lamb J. Enhancing cyberattack resiliency through the radiotherapy backup and recovery dashboard tool. J Appl Clin Med Phys. 2025 Nov; 26(11):e70292. ( Abstract )	11/01/2025
¶ 1173.	Tachibana M, Horwitz S, Jacobsen E, Foss F, Allen P, Porcu P[IRT], Feldman T, Ruan J, Brammer JE, Wang J, Inaba S, Iko Y, Nakajima K, Kakurai Y, Kitami N, Chen Y, Lau Y. Effect of Valemetostat on the Pharmacokinetics of Midazolam and Digoxin: A Phase 1 Drug-Drug Interaction Study in Patients With Non-Hodgkin Lymphoma. Clin Transl Sci. 2025 Nov; 18(11):e70330. ( Abstract )	11/01/2025
¶ 1174.	Thaker NG, Redjal N, Dicker A[CRiC], Loaiza-Bonilla A, Royce T, Subbiah V, Deendyal V, Gabriel JR, Shetty N, Choudhri A, Thaker GH. RadOncRAG: A Novel Retrieval-Augmented Generation Framework Improves Large Language Model Benchmark Performance in Radiation Oncology. JCO Clin Cancer Inform. 2025 Nov; 9:e2500220. ( Abstract )	11/01/2025
¶ 1175.	Aggen DH, McKean M, Hoffman-Censits JH, Lakhani NJ, Alhalabi O, Guancial EA, Bashir B[IRT], Bowman IA, Tan A, Lingaraj T, Ortiz-Otero N, Bartolini W, Timothy M, Kim K, Kacena K, Santillana SS, Luke JJ. IK-175, an oral aryl hydrocarbon receptor inhibitor, alone and with nivolumab in patients with advanced solid tumors and urothelial carcinoma. Clin Cancer Res. 2025 Nov 03. [Epub ahead of print] ( Abstract )	11/03/2025
¶ 1176.	Chan A, Nasr R, Arcos D, Kagramanov D, Asuzu C, Bao T, Cheung YT, Kwon JH, Lacey J, Lee RT, Lustberg M, Ohaeri BM, Rao S, Soto-Perez-de-Celis E, Witt CM, Lopez AM[CRiC]. Evaluation of integrative oncology modalities for symptom management: a MASCC/SIO global survey. BMC Complement Med Ther. 2025 Nov 03; 25(1):406. ( Abstract )	11/03/2025
¶ 1177.	Taylor M, Westvold SJ, Long JB, Hyslop T[CRiC], Silber A, Forman R, Yasin F, Kwaramba T, Wang SY, Leapman MS, Cecchini M, Leeds I, Spees L, Wheeler SB, Gross CP, Oeffinger K, Dinan MA. Risk of Late-Onset Depression in Long-Term Survivors of Breast, Prostate, and Colorectal Cancer. JAMA Netw Open. 2025 Nov 03; 8(11):e2544812. ( Abstract )	11/03/2025
* 1178.	Ott CA, Purwin TJ, Chen PY, Chowdhury S, Mellor GL, Luo K, Mersky GL, Tiago M, Madden WD, Varney SD, Erkes DA, Lamar J, Capparelli C[TaCO], Bollag G, Aplin AE[TaCO]. Targeting TAZ-TEAD in minimal residual disease enhances the duration of targeted therapy in melanoma models. Nat Commun. 2025 Nov 05; 16(1):9655. ( Abstract )	11/05/2025
+ 1179.	Cheslow L, Caksa S, Cain RE, Waldman SA[IRT], Aplin AE[TaCO]. Aqueous humor biomarkers in ocular oncology: Insights and advances. Cell Rep Med. 2025 Nov 07:102447. [Epub ahead of print] ( Abstract )	11/07/2025
* 1180.	Katcher JG, Shusted CC, Bhatt P, Ruane BM, Markle J, Kane GC, Wen KY[CRiC], Juon HS[CRiC], Barta JA[CRiC]. Brief Report: Lung Cancer Diagnoses among Lung Cancer Screening Program Participants With Family History of Lung Cancer. Clin Lung Cancer. 2025 Nov 07; 27(1):34-37. [Epub ahead of print] ( Abstract )	11/07/2025
1181.	Prebay ZJ, Schneider A, Shah S, Dispagna M, Shah MS[MORA]. Surgical success following robotic upper urinary tract reconstruction, results from a global network of healthcare organizations. J Robot Surg. 2025 Nov 08; 19(1):761. ( Abstract )	11/08/2025
1182.	Shivamadhu MC, Kukulage DSK, Padmavathi R, Oppong D, Mashhadi Ramezani F, Eldershaw DN, Collins BM, Ahn YH[TaCO]. Redox Regulation of Cell Migration via Nischarin S-glutathionylation. Free Radic Biol Med. 2025 Nov 08. [Epub ahead of print] ( Abstract )	11/08/2025
¶ 1183.	Müller PC, Berchtold C, Kuemmerli C, Breuer E, Li Z, Vallorani A, Hansen C, Guidetti C, Eden J, Campbell BA, Wu P, Cecchetto SN, Gudmundsdottir H, Kendrick M, Starlinger PP, Pecorelli N, Guarneri G, Farooqui W, Tschuor C, Burgdorf SK, Mühlhäusser J, Gass JM, Goh BKP, Koh YX, Rebelo A, Kleeff J, Seip T, Santibanes M, Todeschini L, Marchegiani G, Belfil N, Lesurtel M, Machado M, Boggi U, Kauffmann E, Cappelle M, Koerkamp BG, Di Benedetto F, Roberts K, Nevler A, Lavu H[MORA], Dutkowski P, Nickel F, Hackert T, He J, Falconi M, Truty M, Billeter AT, Müller BP, Outcomes for Total Pancreatectomy Group, Halle-Smith J, Valle V, Giulianotti P, Giannone F, Pessaux P, Sánchez-Velázquez P, Thapa PB, Maharjan D, Torres O, Kuzman M, Pandanaboyana S. International Reference Values for Surgical Outcomes of Total Pancreatectomy. JAMA Surg. 2025 Nov 12. [Epub ahead of print] ( Abstract )	11/12/2025
1184.	Shah SS, Manning JA, Lim Y, Sinha D, Murthy AMV, Ganesan R, Robinson N, Alnemri ES[IRT], Masters SL, Vince JE, Kumar S. NEDD4L-mediated Gasdermin D and E ubiquitination regulates cell death and tissue injury. Cell Death Differ. 2025 Nov 19. [Epub ahead of print] ( Abstract )	11/19/2025
1185.	Berezhnaya E, Cartes-Saavedra B, Singh R, Rodríguez-Prados M, Reiner O, Alkuraya FS, Hajnoczky G[TaCO]. MICU2 controls mitochondrial calcium signaling and migration in neurons during development. Cell Rep. 2025 Nov 20; 44(12):116583. [Epub ahead of print] ( Abstract )	11/20/2025
¶ 1186.	Huang DY, Lallas CD[MORA], Davis RM, Keith SW, Moeller PJ, Kim IK, Ghosh A, Aguirre F, Thompson RAM, Drabo EF, Maio V. Comparative analysis of Robotic-Assisted, Laparoscopic, and open radical nephrectomy: Utilization, Costs, and clinical outcomes. J Robot Surg. 2025 Nov 24; 20(1):41. ( Abstract )	11/24/2025
¶ 1187.	Silverstein HI, Forman EM, Gilden AH, Hagerman CJ, Milliron BJ, Zhang FZ, Butryn ML[CRiC]. Protocol for a pilot RCT investigating a weight loss navigation program for adults. Contemp Clin Trials. 2025 Nov 24; 160:108163. [Epub ahead of print] ( Abstract )	11/24/2025
1188.	Bridgham K, Duong T, Kaki P, Allcroft T, Liu K, Mastrolonardo E, Kenny H, De Ravin E, Thal A, Curry J[MORA]. Neck Spasms After Lateral Neck Dissection: A Survey of Head and Neck Cancer Patients. Head Neck. 2025 Nov 25. [Epub ahead of print] ( Abstract )	11/25/2025
¶ 1189.	O'Brien EM, Tylek T, Geisler HC, Mukalel AJ, Whitaker RC, Sung S, Binder-Markey BI, Weissman D, Mitchell MJ, Spiller KL[IRT]. Macrophage cell therapy enabled by interleukin-4 mRNA-loaded lipid nanoparticles to sustain a pro-reparative phenotype in inflammatory injuries. Biomaterials. 2025 Nov 25; 328:123869. [Epub ahead of print] ( Abstract )	11/25/2025
¶ 1190.	Dasgupta R, Park PH, Wallace M, Marzula V, McDaniel A, Jaynes J, Portocarrero C, Yates C, Nikbakht N[IRT]. A CD206 targeting peptide exhibits preclinical therapeutic efficacy in cutaneous T-cell lymphoma. J Invest Dermatol. 2025 Nov 26. [Epub ahead of print] ( Abstract )	11/26/2025
+ 1191.	Wilski-Cronin NA, Erkes DA, Purwin TJ, Melissaratos DS, Stefanski CD, Caksa S, Kitterman E, Heilizer JS, Chervoneva I[CRiC], Fernandes-Alnemri T, Alnemri ES[IRT], Aplin AE[TaCO]. Pyroptosis modulates multiple immune cell populations in targeted therapy-treated melanoma. Cancer Immunol Res. 2025 Nov 26. [Epub ahead of print] ( Abstract )	11/26/2025
¶ 1192.	Forman R, Westvold SJ, Long JB, Fan J, Hyslop T[CRiC], Conlin K, Jacobson S, Wang SY, Leapman MS, Cecchini M, Leeds I, Spees L, Presley C, Yasin F, Taylor M, Kwaramba T, Gross CP, Oeffinger K, Dinan MA. Personalized risk assessment of frailty in long-term cancer survivors. J Geriatr Oncol. 2025 Nov 29; 17(1):102804. [Epub ahead of print] ( Abstract )	11/29/2025
+ 1193.	Alaparthi SS, Ishwar A, Madeka I, Ho A, Grenda T[MORA], Evans NR[CRiC], Okusanya OT. Outcomes of minimally invasive lung resection with concomitant chest wall resection in non-small cell lung cancer (NSCLC). J Thorac Dis. 2025 Nov 30; 17(11):10254-10261. ( Abstract )	11/30/2025
¶ 1194.	Alexander SPH, Fabbro D, Peach CJ, Gibb AJ, Kelly E, Mathie AA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Southan C, Davies JA, Beuve A, Brouckaert P, Bryant C, Burnett JC, Farndale RW, Friebe A, Garthwaite J, Hobbs AJ, Jarvis GE, Kilpatrick L, Koesling D, Kuhn M, Leitinger B, MacEwan D, Monie TP, Potter LR, Russwurm M, Schmidt HHHW, Stasch JP, Waldman SA[IRT]. The Concise Guide to PHARMACOLOGY 2025/26: Catalytic receptors. Br J Pharmacol. 2025 Dec; 182 Suppl 1:S259-S306. ( Abstract )	12/01/2025
1195.	Andreuzzi E, Fejza A, Capuano A, Poletto E, Pivetta E, Doliana R, Pellicani R, Favero A, Maiero S, Fornasarig M, Cannizzaro R, Iozzo RV[TaCO], Spessotto P, Mongiat M. Retraction notice to "Deregulated expression of Elastin Microfibril Interfacer 2 (EMILIN2) in gastric cancer affects tumor growth and angiogenesis." [Matrix Biol. Plus 6-7 (2020) 100029]. Matrix Biol Plus. 2025 Dec; 28:100184. ( Abstract )	12/01/2025
¶ 1196.	Carter-Bawa L, Prosper AE, Barta JA[CRiC]. Beyond Early Detection-Reframing Radiology's Role in Lung Cancer Care. J Am Coll Radiol. 2025 Dec; 22(12):1445-1447. ( Abstract )	12/01/2025
¶ 1197.	Castagnino PA, Haas DA, Musante L, Tancler NA, Tran BV, Kean R, Steck AR, Martinez LA, Mostaghel EA, Hooper DC, Kim FJ[MORA]. Sigma1 inhibitor suppression of adaptive immune resistance mechanisms mediated by cancer cell derived extracellular vesicles. Cancer Biol Ther. 2025 Dec; 26(1):2455722. ( Abstract )	12/01/2025
¶ 1198.	Cisneros J, Feldt NH, Vinogradskiy Y[CRiC], Castillo R, Castillo E. Detection of phase-binning and interpolation artifacts in 4-dimensional computed tomography imaging using deep learning and rule-based approaches. Med Phys. 2025 Dec; 52(12):e70191. ( Abstract )	12/01/2025
1199.	Jayaram A, Galande S, Sharbati S, Deshpande D[TaCO], Pawar K. Profile of tRNA-derived short non-coding RNAs during monocyte differentiation and their role in macrophage survival. RNA Biol. 2025 Dec; 22(1):1-9. ( Abstract )	12/01/2025
* 1200.	Karp DN, Hamade K, McNair CM[CRiC], Leader AE[CRiC]. Development of a Composite Measure to Identify Priority Areas of Need for Cancer Screening Interventions. JCO Clin Cancer Inform. 2025 Dec; 9:e2500132. ( Abstract )	12/01/2025
¶ 1201.	Koo AS, Jia W, Kim SH, Scalf M, Boos CE, Chen Y, Wang D, Voter AF, Bajaj A, Smith LM, Keck JL, Bakkenist CJ, Guo L[MORA], Tibbetts RS. DNA-damage dependent isoform switching modulates RIF1 DNA repair complex assembly and phase separation. J Biol Chem. 2025 Dec; 301(12):110857. ( Abstract )	12/01/2025
¶ 1202.	Kumar N, Halcrow PW, Quansah DNK, Liang B, Meucci O[IRT], Geiger JD. Involvement of endolysosome iron in HIV-1 gp120-, morphine-, and iron supplementation-induced disruption of the reactive species interactome and induction of neurotoxicity. Redox Rep. 2025 Dec; 30(1):2546496. ( Abstract )	12/01/2025
1203.	Li J, Lazo M[CRiC], Bilal U, Tabb LP, Hirsch JA, Lovasi GS, Melly S, Sánchez BN. Twenty-five-year changes in alcohol environment in US metropolitan areas: Examining patterns by area level sociodemographic characteristics. Cities. 2025 Dec; 167. ( Abstract )	12/01/2025
1204.	Luo X, Zhang M, Chen L, Wang R, Lian J, Yang Z, Iozzo RV[TaCO], Wang J, Zhang Y, Bi X. Decorin Deficiency Promotes D-Galactose-Induced Skeletal Muscle Atrophy and Fibrosis by Regulating ITGB1/Akt/mTOR Signalling Pathway. J Cachexia Sarcopenia Muscle. 2025 Dec; 16(6):e70144. ( Abstract )	12/01/2025
+ 1205.	Madeka I, Whitehorn GL, Ho A, Ishwar A, Alaparthi S, Grenda TR[MORA], Evans NR[CRiC], Okusanya OT. Is Robotic-Assisted Surgery Associated With Receipt of Guideline-Directed Lymph Node Sampling in Wedge Resection for Early-Stage NSCLC? Ann Thorac Surg Short Rep. 2025 Dec; 3(4):856-860. ( Abstract )	12/01/2025
1206.	Nguyen TD, Eberth JM[CRiC], Ezenwankwo E, Schwartz GL. Housing Insecurity and Threats of Utility Shut-Offs Among Cancer Survivors in the United States, BRFSS 2022-2023. Cancer Med. 2025 Dec; 14(23):e71436. ( Abstract )	12/01/2025
¶ 1207.	Pearson LK, Zheng Y, Nikita N, Lu-Yao G[CRiC], Presley CJ, Wagner LI, Simon MA, Dotan E. Unveiling Factors Associated With Older Adult Accrual to Cancer Clinical Trials: Lessons From the ECOG-ACRIN Experience. J Natl Compr Canc Netw. 2025 Dec; 23(12). ( Abstract )	12/01/2025
* 1208.	Williams MN, Joffe D, Mandel J, Scheppes S, Wallace M, Portocarrero C, Abinader O, Mitra R, Mishra A[IRT], Nikbakht N[IRT]. Spatial transcriptomics uncovers unique tumor microenvironments in folliculotropic versus classic mycosis fungoides. J Invest Dermatol. 2025 Dec 01. [Epub ahead of print] ( Abstract )	12/01/2025
1209.	Netting DJ, López-Haber C, Hutchins Z, Martina JA, Puertollano R, Mantegazza AR[IRT]. The lysosomal carrier SLC29A3 supports antibacterial signaling, and promotes autophagy by activating TRPML1 in murine dendritic cells. Proc Natl Acad Sci U S A. 2025 Dec 02; 122(48):e2511539122. ( Abstract )	12/02/2025
¶ 1210.	Rising KL[CRiC], Kemp M, Gerolamo A, Diamond N, Ostroff P, Malone S, Alexander K, Powell R. Beyond the Check Box: Development of the Nutrition Health Related Social Need Assessment and Referral Tool (N-HART). J Gen Intern Med. 2025 Dec 02. [Epub ahead of print] ( Abstract )	12/02/2025
* 1211.	Lawrence JM, Dampier W, Mell JC, De Souza DR, Schardien K, Yeakle K, Barnett RJ, Sen B, Ahmed A, Bouchard M, Wigdahl B[IRT], Nonnemacher MR[IRT]. Inflammatory microglia signals drive A1-like polarization of astrocytes even in the presence of HIV-1 Tat. Mol Neurobiol. 2025 Dec 04; 63(1):251. ( Abstract )	12/04/2025
¶ 1212.	Ezenwankwo E, Yell N, Eberth JM[CRiC]. Lung Cancer Screening in the United States, 2024: A National Health Interview Survey Analysis. Chest. 2025 Dec 08. [Epub ahead of print] ( Abstract )	12/08/2025
¶ * 1213.	Stulberg EL, Wu C, Law CA, Sabayan B, Elser H, Kumar A, Zheutlin AR, Bress AP, Wolk DA, Rising K[CRiC], Casten R, Rovner B[CRiC], de Havenon A, Schneider ALC. Income, Race-Ethnicity, and Dementia Risk Factors in the United States. Neurology. 2025 Dec 09; 105(11):e214402. ( Abstract )	12/09/2025
¶ * 1214.	Worster B[CRiC], Kaminoff L, Mason A, Pontiggia L, Madden K, Kemp M, Guth A, Diamond N, Herens A, Rising K[CRiC], Kates J. Effectiveness and Impact of Telehealth-Integrated Palliative Care for Persons Living with Dementia and Their Caregivers. Telemed J E Health. 2025 Dec 09. [Epub ahead of print] ( Abstract )	12/09/2025
¶ 1215.	Hollis RL, Miller A, Lankes HA, Wong KK, Rodgers W, Millan D, Carty K, Coleman RL, Moore KN, Alvarez Secord A, O'Malley DM, Chan JK, Hagemann AR, Gaillard S, Guntupalli SR, Edelson M[MORA], Rose PG, Dorigo O, Banerjee S, Ewing A, Churchman M, Sood AK, Herrington CS, Gourley C, Gershenson DM. Molecular profiling and tumour biomarker analysis of GOG281/LOGS: a positive late-phase trial of trametinib for recurrent/persistent low grade-serous ovarian cancer. Clin Cancer Res. 2025 Dec 11. [Epub ahead of print] ( Abstract )	12/11/2025
¶ + 1216.	Neupane M, Kumar M, Mwamufiya MA, Donnelly CM, Ibragimova A, Curcio B, Chervoneva I[CRiC], Vasilevskaya I, Silver DP[MORA]. MECP2-Dependent Cancers Can Be Targeted by Epigenetic Drugs: A New Role for Epigenetic Cancer Therapy. Mol Cancer Ther. 2025 Dec 11. [Epub ahead of print] ( Abstract )	12/11/2025
¶ 1217.	Kasner MT[IRT], Courtenay-Luck N, Dinardo C, Post SM, Baratam P, Magrath GN, Nakamura T, Fujii A, Prados S, Honda N, Mcbride M, Edwards-Holmes P, Stuart R. Anexelekto (Axl)/Mer inhibitor tamnorzatinib in patients with relapsed/refractory acute myeloid leukaemia: Results from a phase I (monotherapy) and phase II (combination with venetoclax) clinical study. Acta Haematol. 2025 Dec 12:1-18. [Epub ahead of print] ( Abstract )	12/12/2025
¶ 1218.	Slomovitz BM, Weroha SJ, Deng W, Chon HS, Podder V, Jenkins Vogel MT, Backes F, Thomas ED, Chen LM, Tenney ME, Westin SN, Markham MJ, Miller DS, Edelson MI[MORA], Muller CY, Callahan MJ, Holman LL, Liu JR, Teplinsky E, Kamat A, Guy M, Chern JY, Lea J, Murphy M, Choong GM, Moore ED, Alvarez EA, Rodgers WH, O'Malley DM, Copeland LJ, Herzog TJ, Coleman RL, Gershenson DM. Phase II Trial of Ribociclib Plus Letrozole in Women With Recurrent Low-Grade Serous Carcinoma of the Ovary, Fallopian Tube, or Peritoneum: A GOG Partners Trial (GOG 3026). J Clin Oncol. 2025 Dec 12:JCO2501348. [Epub ahead of print] ( Abstract )	12/12/2025
¶ +* 1219.	Zinner RG, Mastrolonardo EV, Johnson JM[MORA], Nunes K, Llerena P, Elliott Z, Tuluc M, Curry JM[MORA], Fundakowski CE[TaCO], Yampolsky A, Goldman R, Solomides CC, Gargano SM, Naringrekar H, Harshyne L, Poller D, Leiby BE, Bar-Ad V[MORA], Axelrod R[MORA], Argiris A, Luginbuhl AJ[TaCO], Cognetti DM[TaCO]. Neoadjuvant nivolumab plus carboplatin and paclitaxel in patients with locally advanced resectable squamous cell carcinoma of the head and neck: a phase II, single-arm trial. Clin Cancer Res. 2025 Dec 12. [Epub ahead of print] ( Abstract )	12/12/2025
¶ 1220.	Wenham RM, Buras AL, Gordon SW[IRT], Whiting J, Fridley BL, Dorman D, Apte SM, Chon HS, Shahzad MM, Randall LM, Havrilesky LJ, Davidson BA, Secord AA. A phase 2 study of pembrolizumab and weekly paclitaxel for platinum-resistant epithelial ovarian cancer. Int J Gynecol Cancer. 2025 Dec 13:102856. [Epub ahead of print] ( Abstract )	12/13/2025
1221.	Glucksman E, Aguirre F, Thompson RAM, Grindley C, McElroy T, Horan S, Matheson M, Shah MS[MORA]. Holmium Laser Enucleation of the Prostate vs Multi-Port Robotic-Assisted Simple Prostatectomy vs Single-Port Robotic-Assisted Simple Prostatectomy: A Single-Center Experience. J Endourol. 2025 Dec 15. [Epub ahead of print] ( Abstract )	12/15/2025
¶ 1222.	Dennaoui R, Wicker MN, Moen C, Schlederer M, Vistisen K, Triplett AA, Rülicke T, Rui H[MORA], Kenner L, Casanova E, Wagner KU. STAT-independent functions of Janus kinases 1 and 2 are obligatory for the postnatal development of mammary epithelial ducts. Cell Rep. 2025 Dec 16; 45(1):116703. [Epub ahead of print] ( Abstract )	12/16/2025
¶ +* 1223.	Yamoah K, Trivedi P, Awasthi S, Grass GD, Torres-Roca J, Johnstone PA, Dhillon J, Park JY, Davicioni E, Hakansson A, Liu Y, Fink AK, Katende E, Smith R, Putney R, Poch M, Li R, Manley B, Fernandez D, Gage K, Ferguson K, Lu-Yao G[CRiC], Kim Y, Katsoulakis E, Leone A, Vapiwala N, Deville C, Rebbeck TR, Dicker AP[CRiC], Kelly W[MORA], Yin V, Burri RJ, Ercole CE, Pow-Sang J. A Prospective Validation of the Decipher Genomic Classifier in Men With Early Localized Prostate Cancer: The VANDAAM Study. J Natl Compr Canc Netw. 2025 Dec 17; 24(1). ( Abstract )	12/17/2025
+* 1224.	Mastrolonardo EV, De Ravin E, Kaki PC, Estephan LE, Nunes K, Kenny H, Bridgham K, Tasoulas J, Koeneman SH, Goldman RA, Fundakowski C[TaCO], Thal A, Cognetti DM[TaCO], Johnson JM[MORA], Luginbuhl AJ[TaCO], Curry JM[MORA]. Pathologic Response and Survival After Neoadjuvant Immunotherapy for Resectable Mucosal HNSCC: A Systematic Review and Meta-Analysis. JAMA Otolaryngol Head Neck Surg. 2025 Dec 18. [Epub ahead of print] ( Abstract )	12/18/2025
1225.	Ben-Arye E, Malin MA, Gressel O, Keshet Y, Carlson LE, Samuels N, Lopez AM[CRiC], Balneaves LG, David A, Frenkel M, Schiff E. A national multi-disciplinary integrative oncology training program in Israel: Trainee perspectives. J Pain Symptom Manage. 2025 Dec 20. [Epub ahead of print] ( Abstract )	12/20/2025
¶ 1226.	Soputro NA, Saxena S, Bamby J, Biasatti A, Aguirre F, Calvo RS, Nieto-Blanco G, Thompson R, Okhawere KE, Kupsaw G, Al-Bayati A, Duncan S, Jimenez G, Patil D, Imtiaz S, Lorentz CA, Linehan JA, Crivellaro S, Vourganti S, Autorino R, Shah MS[MORA], Wagner A, Chang P, Ahmed M, Stifelman MD, Yuh B, Badani KK, Kaouk J. Single-port Robotic Retroperitoneal Partial Nephrectomy via Low Anterior Access: A Propensity-matched Comparative Analysis to Standard Transperitoneal Multiport Robotic Surgery from the Single Port Advanced Research Consortium (SPARC). Eur Urol Focus. 2025 Dec 22. [Epub ahead of print] ( Abstract )	12/22/2025
+ 1227.	Leader AE[CRiC], Pham K, Cianci N, Knapp H, Doka F, Barron S, Kolesnikov O, DeHoratius J, Bradley K, Robles L, Giamboy R, Dahlgren O, Gomella LG[MORA]. Evaluating the impact of a community-based prostate cancer screening program. Arch Public Health. 2025 Dec 24; 83(1):305. ( Abstract )	12/24/2025
1228.	Dunn MR, Van Alsten SC, Emerson MA, Reeder-Hayes K, Hyslop T[CRiC], Troester MA. Tumor biology and access to care and metastatic breast cancer outcomes. Breast Cancer Res Treat. 2025 Dec 26; 215(2):46. ( Abstract )	12/26/2025
* 1229.	Grim M, Zheng R, Hanna N, Lavu H[MORA], Yeo CJ[MORA], Nevler A. Perioperative fluid management in pancreaticoduodenectomy in the era of Goal Directed Fluid Therapy: a review of the literature. J Gastrointest Surg. 2025 Dec 27:102316. [Epub ahead of print] ( Abstract )	12/27/2025
¶ 1230.	Zager JS, Orloff M[IRT], Ferrucci PF, Choi J, Eschelman DJ, Glazer ES, Ejaz A, Richtig E, Ochsenreither S, Reddy SA, Lowe MC, Beasley GM, Gesierich A, Gschnell M, Dummer R, Arance A, Fenwick SW, Sacco JJ, John J, Wheater M, Ottensmeier CH. Subgroup analyses of the phase 3 FOCUS study of melphalan/hepatic delivery system in patients with unresectable metastatic uveal melanoma. J Cancer Res Clin Oncol. 2025 Dec 29; 152(1):25. ( Abstract )	12/29/2025
¶ * 1231.	Alban J, Bowen RC, Reichstein DA, . . . Dulka S, . . . Seedor RS[IRT], . . . Orloff M[IRT], . . . Gandhi N, Harbour JW, Chandra S. Metastatic Uveal Melanoma Surveillance: A Delphi Panel Consensus. Cancers (Basel). 2025 Dec 30; 18(1). ( Abstract )	12/30/2025
1232.	Agarwal Y, Ramani M, Manikandan S, Bonar K, Montilla Luna J, Gaskill PJ[IRT], Matt SM. Epigenetic regulation of inflammation by dopamine in primary human macrophages. Front Immunol. 2026; 17:1779072. ( Abstract )	01/01/2026
¶ 1233.	Alnahhas I, Kayne A, Khan MM, Shi W[MORA]. Single-cell RNA sequencing suggests different progenitor lineages between IDH mutant and IDHwt glioma. Neurooncol Adv. 2026; 8(1):vdag003. ( Abstract )	01/01/2026
¶ 1234.	Belovsky MP, Bloom J, Kim RS, Agarwal A, Lavu H[MORA], Nevler A, Kothari R. Perioperative Euglycemic Diabetic Ketoacidosis in Nondiabetic Patients Receiving Hyperthermic Intraperitoneal Chemotherapy: A Case Series. A A Pract. 2026 Jan 01; 20(1):e02131. ( Abstract )	01/01/2026
¶ 1235.	Brose MS[TaCO], Keam B, Krajewska J, Hoff AO, Vaisman F, Lin CC, Hitre E, Bowles DW, Robinson B, Sherman SI, Ngamphaiboon N, Guo X, Simmons A, Williamson D, Andrianova S, Berry N, Capdevila J. Cabozantinib versus placebo in patients with radioiodine-refractory differentiated thyroid cancer after prior vascular endothelial growth factor receptor-targeted therapy (COSMIC-311): outcomes by BRAF status. Front Oncol. 2026; 16:1748566. ( Abstract )	01/01/2026
* 1236.	Cao M, Alvarez J, Mitra R, Xu M, Baybutt TR, Sun Z, Taylor O, Doermann AS, Staudt RE, Waldman SA[IRT], Snook AE[IRT]. IFNγ-induced antigen loss in chimeric antigen receptor-T cell therapy. Front Immunol. 2026; 17:1772472. ( Abstract )	01/01/2026
¶ * 1237.	Chang SS, Chamie K, Kramolowsky E, Gonzalgo ML, Agarwal PK, Bassett JC, Bjurlin M, Cher ML, Clark W, Cowan BE, David R, Goldfischer E, Guru K, Jalkut MW, Kaffenberger SD, Kaminetsky J, Corcoran A, Koo AS, Sexton WJ, Tikhonenkov SN, Shah MS[MORA], Trabulsi EJ[MORA], Trainer AF, Spilman P, Huang M, Bhar P, Drusbosky LM, Sender L, Brown B, Reddy S, Soon-Shiong P. Reply by Authors. J Urol. 2026 Jan; 215(1):52-53. ( Abstract )	01/01/2026
¶ * 1238.	Chang SS, Chamie K, Kramolowsky E, Gonzalgo ML, Agarwal PK, Bassett JC, Bjurlin M, Cher ML, Clark W, Cowan BE, David R, Goldfischer E, Guru K, Jalkut MW, Kaffenberger SD, Kaminetsky J, Corcoran A, Koo AS, Sexton WJ, Tikhonenkov SN, Shah MS[MORA], Trabulsi EJ[MORA], Trainer AF, Spilman P, Huang M, Bhar P, Drusbosky LM, Sender L, Brown B, Reddy S, Soon-Shiong P. Reply by Authors. J Urol. 2026 Jan; 215(1):55-56. ( Abstract )	01/01/2026
¶ 1239.	Dudipala H, Nazari SS, Werneck da Cunha I, Coligado N, Baca Y, Wei S, Elliott A, Smith ND, Geynisman DM, Brown JT, Zarrabi KK[MORA], Agarwal N, Antonarakis ES, Herchenhorn D, McKay RR. Molecular alteration profiles characterize intraductal carcinoma of the prostate. Cancer. 2026 Jan 01; 132(1):e70238. ( Abstract )	01/01/2026
1240.	Elder A, Yang HY, O'Donnell-Cappelli M, Mandel JL, Wallace M, Banner L, Hafer R, Rohan TZ, Nikbakht N[IRT]. Increased Risk of Postoperative Complications in Patients with Hypertension Undergoing Mohs Micrographic Surgery. JID Innov. 2026 Jan; 6(1):100414. ( Abstract )	01/01/2026
¶ 1241.	Gallia GL, Hann CL, Lucas CG, Luna LP, Kamson DO, Sato T[IRT]. Exceptional response of radiotherapy-naïve cranial meningiomas to dual immune checkpoint blockade in BAP1 tumor predisposition syndrome. Neurooncol Adv. 2026; 8(1):vdag095. ( Abstract )	01/01/2026
* 1242.	Im BH, Zarrabi KK[MORA], Hochberg AR, Shah MS[MORA], Mark JR, Izes JK, Gomella PT, Lallas CD[MORA], Gomella LG[MORA], Metwalli AR. The Effects of Bone-Remodeling Therapy on Survival, Pain, and Skeletal Related Events in the Setting of Renal Cell Carcinoma With Bone Metastases: A Multicenter Investigation From a Large Global Health Research Network (TriNetX). Cancer Med. 2026 Jan; 15(1):e71133. ( Abstract )	01/01/2026
¶ * 1243.	Juon HS[CRiC], Gee GC, Katcher JG, Yang D, Smith K, Klassen AC[CRiC]. Limited English proficiency, acculturative stress, and quality of life among Korean American patients with chronic hepatitis B. J Migr Health. 2026; 13:100406. ( Abstract )	01/01/2026
* 1244.	LuPone T, Brantly A, Oteju O, Matt SM, Runner K, Nickoloff-Bybel EA, Nonnemacher MR[IRT], Gaskill PJ[IRT]. High-throughput high content quantification of HIV-1 viral infectious output. PLoS One. 2026; 21(3):e0328121. ( Abstract )	01/01/2026
1245.	Maio V, Shah R, Lin M, J Moeller P, Alnahhas I, Hass R, Shi W[MORA], Keith SW. Metformin exposure after glioblastoma diagnosis and mortality: A large population-based study. Neurooncol Adv. 2026; 8(1):vdag041. ( Abstract )	01/01/2026
1246.	Salvatore GM, Benasi G, Harsora R, Butryn ML[CRiC], Mogle JA, Arigo D. Examining physical activity and menstrual cycle experiences among insufficiently active women: Project PACE protocol. Health Psychol Behav Med. 2026; 14(1):2706211. ( Abstract )	01/01/2026
1247.	Shelukar S, Agarwal A, Gross J, Truscello D, Flerova E, Gesiotto Q, Alpdogan O[IRT], Civan JM, Sass DA. A Rare Case of Fluid Overload-Associated Large B-Cell Lymphoma in a Patient With Hepatitis C Cirrhosis. ACG Case Rep J. 2026 Jan; 13(1):e01970. ( Abstract )	01/01/2026
1248.	Venkatesh A, Camacho D, Summer R[TaCO], Dong M. New therapies, new challenges: Cystic lung disease after cancer immunotherapy. Respir Med Case Rep. 2026; 59:102356. ( Abstract )	01/01/2026
¶ 1249.	Hudson A, Jayaram A, Garmezy B, Zorko NA, Zarrabi KK[MORA], Mathews L, Rupnow B, Li M, Ghosh D, Urtishak K, Francis P, Wang SC, Attiyeh E, de Bono J. A phase 1, first-in-human, dose escalation study of JNJ-80038114, a PSMAxCD3 bispecific antibody, in participants with metastatic castration-resistant prostate cancer. Cancer Chemother Pharmacol. 2026 Jan 06; 96(1):5. ( Abstract )	01/06/2026
¶ 1250.	Liou KT, Bradt J, Currier MB, Baser R, Panageas K, MacLeod J, Walker D, Li SQ, Lopez AM[CRiC], McConnell K, Mao JJ. Music Therapy Versus Cognitive Behavioral Therapy via Telehealth for Anxiety in Cancer Survivors: A Randomized Clinical Trial. J Clin Oncol. 2026 Jan 06:JCO2500726. [Epub ahead of print] ( Abstract )	01/06/2026
1251.	Eng N, Taute E, Dang H[MORA], Martin SP. Identification of high functioning hepatocellular carcinoma transplant centers in the modern allocation system. HPB (Oxford). 2026 Jan 07. [Epub ahead of print] ( Abstract )	01/07/2026
1252.	Oh M, Lee BL, Somarowthu S[MORA]. Decoding the lncRNA World: Comprehensive Approaches to lncRNA Structure and Interactome Studies. Cells. 2026 Jan 07; 15(2). ( Abstract )	01/07/2026
¶ 1253.	Yasin F, Westvold SJ, Long JB, Hyslop T[CRiC], Cecchini M, Leeds I, Silber A, Wang SY, Spees L, Forman R, Kwaramba T, Taylor M, Gross CP, Dinan MA. Risk of late recurrence of colorectal and breast cancer among older long-term cancer survivors. JNCI Cancer Spectr. 2026 Jan 07. [Epub ahead of print] ( Abstract )	01/07/2026
* 1254.	Perner MS, Moore K, Trotta A, Chen H, Lazo M[CRiC], Sarmiento OL, Rodriguez D, Alazraqui M, Diez Roux AV[CRiC]. Trends in adults body mass index related to changes in socioeconomic status of 201 large Latin American cities. Soc Sci Med. 2026 Jan 09; 392:118966. [Epub ahead of print] ( Abstract )	01/09/2026
¶ + 1255.	Gordon N, Gallagher PT, Richter OI, Poudel Neupane N, Mandigo AC, McCann JJ, Dylgjeri E, Vasilevskaya I, McNair C[CRiC], Paller CJ, Kelly WK[MORA], Knudsen KE, Schiewer MJ, Shafi AA. PARP inhibition and pharmacological ascorbate demonstrate synergy in castration-resistant prostate cancer. Mol Oncol. 2026 Jan 14. [Epub ahead of print] ( Abstract )	01/14/2026
+ 1256.	Madeka I, Koeneman S, Alaparthi S, Grenda T[MORA], Evans NR[CRiC], Okusanya OT. Clinical Outcomes in Non-Small Cell Lung Cancer Among Sustained Adopters of Robotic Thoracic Surgery. Ann Thorac Surg. 2026 Jan 14. [Epub ahead of print] ( Abstract )	01/14/2026
¶ 1257.	Chirra M, Elliott A, Shaikh H, McGrath J, El-Gamal D, Karnezis AN, Abdulla FR, Ikpeazu C, Leddon J, Sukari A, Zandberg DP, Johnson JM[MORA], Sun L, Wise-Draper TM. Molecular Profiling and Real-World Outcomes of BRAF V600E-Mutated Papillary Thyroid Cancer. Clin Cancer Res. 2026 Jan 16. [Epub ahead of print] ( Abstract )	01/16/2026
1258.	Gumas JT, Shigematsu M, Borgmann-Winter KE, Hahn CG, Kirino Y[MORA]. Elevated tRNA halves in olfactory epithelial cells of patients with schizophrenia. J Clin Invest. 2026 Jan 16; 136(2). ( Abstract )	01/16/2026
¶ * 1259.	Simone-Soule CA, Burke SE, Abul-Enin D, Kunta C, Adekeye A[CRiC], Tran P, Leader A[CRiC], Dicker AP[CRiC], Simone NL[CRiC]. Patient Advocate-Trainee Engagement in Oncology Education: Insights from a Short Pilot Survey. J Cancer Educ. 2026 Jan 16. [Epub ahead of print] ( Abstract )	01/16/2026
1260.	Wallace CG, Capriotti Z, Klase Z[IRT]. HIV associated epigenetic trends and chronic diseases: insights into the hidden burden of chronic infection. Clin Epigenetics. 2026 Jan 16. [Epub ahead of print] ( Abstract )	01/16/2026
¶ +* 1261.	Sridhar S, Moroco A, Gowrishankar S, Mehrad M, Ely K, Lewis JS, Tuluc M, Gargano S, Hicks M, Mannion K, Thal AG, Luginbuhl AJ[TaCO], Curry JM[MORA], Cognetti DM[TaCO], Topf MC. Accuracy of frozen section for HPV-Associated squamous cell carcinoma of unknown primary. Oral Oncol. 2026 Jan 19; 174:107861. [Epub ahead of print] ( Abstract )	01/19/2026
¶ 1262.	Yarman Y, Zhao X, Ahn H, Thomson HA, Sarkar A, Yuan T, Roberts ME, Wurtzel J, Diamond SL, Tesmer JJG, French DL, Tomaiuolo M, Turro E, Astle W, Goldfinger LE, McKenzie SE, Benovic J[TaCO], Stalker TJ, Poncz M, Ma P. Understanding how a highly prevalent GRK5 polymorphism affects platelets and enhances thrombotic risk. Blood. 2026 Jan 20. [Epub ahead of print] ( Abstract )	01/20/2026
¶ 1263.	Le DT, Folprecht G, Varghese AM, Gutierrez M, Noel M, Trikalinos NA, Chen E, Dayyani F, Davis SL, Ma WW, Basu Mallick A[MORA], Garrido-Laguna I, Osawa M, O'Brien S, Novosiadly RD, Xu K, Greenawalt DM, Dutta S, Twyman Saint Victor C, Lenz HJ. Phase 1b/2 study of BMS-813160, a CCR2/5 dual antagonist, in combination with chemotherapy or nivolumab in patients with advanced pancreatic or colorectal cancer. J Immunother Cancer. 2026 Jan 22; 14(1). ( Abstract )	01/22/2026
1264.	Sarfaraz N, Kaur R, Harper S, Oni L, Somarowthu S[MORA], Bouchard MJ. The Liver-Enriched Long Non-Coding RNA FAM99A Suppresses Tumorigenesis through Negative Regulation of Protein Synthesis. J Mol Biol. 2026 Jan 23:169653. [Epub ahead of print] ( Abstract )	01/23/2026
¶ 1265.	Hack S, Karni RJ, Maniaci A, Fundakowski CE[TaCO], Castellani L, Incandela F, Accorona R, Mayo-Yanez M, Violati M, Giannini L, Mevio N, Saibene AM. Evaluation of large language models as decision support tools for head and neck cancer management: A blinded multidisciplinary simulation study. Oral Oncol. 2026 Jan 30; 174:107877. [Epub ahead of print] ( Abstract )	01/30/2026
+ 1266.	Alaparthi SS, Rshaidat H, Meredith L, Koeneman SH, Grindley C, Heilizer JS, Kothari PD, Chandar P, Grenda TR[MORA], Evans NR[CRiC], Okusanya OT. Factors associated with upstaging in patients with resectable non-small cell lung cancer: a modern institutional sample. J Thorac Dis. 2026 Jan 31; 18(1):24. ( Abstract )	01/31/2026
+ 1267.	Alexeev V, Terai M, Koshkin S, Igoucheva O[MORA], Sato T[IRT]. Cancer Vaccine Targeting Mutated GNAQ-Expressing Uveal Melanoma. Cancers (Basel). 2026 Jan 31; 18(3). ( Abstract )	01/31/2026
¶ 1268.	Akbar N, Burger D, Bussolati B, Buzás EI, Carney RP, Cho YE, Driedonks TAP, Falcon-Perez JM, Fujita Y, Goberdhan DCI, Hendrix A, Huang Y, Mathivanan S, Mahoney MG[IRT], Mohanty S, Möller A, Hooten NN, Pluchino S, Salomon C, Torrecilhas AC, Veiga SI, Witwer KW. Updating MISEV: When, What, How, and Why? J Extracell Vesicles. 2026 Feb; 15(2):e70230. ( Abstract )	02/01/2026
1269.	Jia Y, Fu L, Rudoler S, Gressen E, Vinogradskiy Y[CRiC], Xu Q. Evaluation of the InTempo path set for CyberKnife prostate and lung SBRT: A single-institution experience. J Appl Clin Med Phys. 2026 Feb; 27(2):e70509. ( Abstract )	02/01/2026
¶ 1270.	Labriola C, Alagesan P, Brown H, Wang F, Hyslop T[CRiC], Zuzul R, Sekaya G, Epplein M, Garman KS. Helicobacter pylori Eradication Rates among Patients Undergoing Endoscopy Remain Stagnant Despite Evolving Clinical Practice Patterns. South Med J. 2026 Feb; 119(2):62-70. ( Abstract )	02/01/2026
¶ * 1271.	Kim E, Juon H[CRiC], Lee G, Smith KC, Chang M, Klassen AC[CRiC]. The Role of Social Ties and Social Support in Maintaining Physical and Mental Well-Being Among Korean Americans Living with Chronic Hepatitis B. J Racial Ethn Health Disparities. 2026 Feb 02. [Epub ahead of print] ( Abstract )	02/02/2026
¶ 1272.	Burke-Garcia A, Afanaseva D, Cutroneo E, Madden K, Sustaita-Ruiz A, Rivera Sanchez E, Leader A[CRiC]. Human Papillomavirus Vaccine Perceptions Among Noncollege Young Adults and TikTok Influencers: Qualitative Study. JMIR Form Res. 2026 Feb 06; 10:e80783. ( Abstract )	02/06/2026
+ 1273.	Neupane M, Kumar M, Mwamufiya MA, Donnelly CM, Ibragimova A, Curcio B, Chervoneva I[CRiC], Vasilevskaya I, Silver DP[MORA]. MECP2-Dependent Cancers Can Be Targeted by Epigenetic Drugs: A New Role for Epigenetic Cancer Therapy. Mol Cancer Ther. 2026 Feb 11:OF1-OF14. [Epub ahead of print] ( Abstract )	02/11/2026
¶ 1274.	O'Dwyer KM, Winestone LE, Cheung MC, Benitez L, Buldini B, Cole PD, Damlaj M, Dholaria B, Dias AL, Dils A, Fritsch M, Greer JP, Hayes-Lattin B, Henry M, Jaffe A, Jamy O, Kebriaei P, Mehrtens I, Shah NN, Wilde L[IRT], Young P, Mai HJ, Kanaan G, Sereda Y, Saldanha IJ, Balk EM, Gupta S. ASH 2026 Guidelines for Management of Relapsed/Refractory Disease in Adolescents and Young Adults with ALL. Blood Adv. 2026 Feb 11. [Epub ahead of print] ( Abstract )	02/11/2026
¶ +* 1275.	Ilori T, Gerber K, Burke S, Shimada A, Ali A, Loeb S, Yutong L, Lazar M[MORA], Rosenblum NG, Anne PR[MORA], Simone NL[CRiC]. Intimacy After Diagnosis: Navigating Sexual Health Conversations and Disparities Among Cancer Survivors. Am J Hosp Palliat Care. 2026 Feb 14:10499091261425190. [Epub ahead of print] ( Abstract )	02/14/2026
¶ 1276.	McKay RR, Maughan BL, Morgans AK, Shore ND, Yu EY, Madan RA, Berchuck JE, Carthon BC, Finkelstein SE, Gomella L[MORA], Gorin MA, Hahn AW, Loeb S, Narayan VK, Petrylak DP, Ryan CJ, Tawagi K, Tran PT, Dorff T. Evolving strategies in prostate cancer: Emerging approaches and unmet needs from the Bridging the Gaps in Prostate Cancer expert panel. Cancer. 2026 Feb 15; 132(4):e70304. ( Abstract )	02/15/2026
¶ 1277.	Cisneros J, Herrera CJ, Liu YK, Du LV, Vinogradskiy Y[CRiC], Castillo R, Nair G, Castillo E. Clinical validation of perfusion imaging with pulmonary function test data using Voronoi-based discretization. Phys Med Biol. 2026 Feb 16. [Epub ahead of print] ( Abstract )	02/16/2026
+* 1278.	Calderon-Aparicio A, Francois N, Grenda T[MORA], Xu S, Okusanya O, He J[CRiC], Simone NL[CRiC]. S6K1 Modulates STAT3 Activation to Promote Resistance to Radiotherapy in Lung Cancer. Int J Mol Sci. 2026 Feb 17; 27(4). ( Abstract )	02/17/2026
¶ 1279.	Awad R, Naringrekar H, Adamo RG, Lam E, Alabousi M, Kashif Al-Ghita M, Wilson SR, Salameh JP, Bashir MR, Costa AF, van der Pol CB, Terzi E, Piscaglia F, Stefanini B, Chen LD, Meitner-Schellhaas B, Strobel D, Wang W, Jing X, Kang HJ, Eisenbrey JR[TaCO], Polikoff A, McInnes MD. Performance of CEUS LI-RADS v2017 major feature combinations: individual patient data meta-analysis. Abdom Radiol (NY). 2026 Feb 18. [Epub ahead of print] ( Abstract )	02/18/2026
* 1280.	Jeurkar C, King L, Baek D, Wilde L[IRT], Keiffer G[IRT], Kasner M[IRT]. Management of Acute Myeloid Leukemia: A Review. Cancers (Basel). 2026 Feb 18; 18(4). ( Abstract )	02/18/2026
* 1281.	Waldman SA[IRT], Snook AE[IRT]. Could GUCY2C-targeted pharmacotherapy be effective in treating colorectal cancer? Expert Rev Clin Pharmacol. 2026 Feb 19. [Epub ahead of print] ( Abstract )	02/19/2026
¶ 1282.	Stott D, Forde D, Ippolito R, Deutsch JM, Vitolins MZ, Bruneau M, Nasser JA[CRiC], Milliron BJ. Comparing barriers and facilitators to interacting with nature among individuals with different dietary behaviors: A mixed methods study. J Nutr. 2026 Feb 23:101434. [Epub ahead of print] ( Abstract )	02/23/2026
1283.	Civan J, Force M, Shaikh AR, Bodzin A, Lin D[MORA]. Predicting and Managing Hepatocellular Carcinoma Recurrence After Liver Transplant: A Single-Center Experience 2012-2024. Cancers (Basel). 2026 Feb 24; 18(5). ( Abstract )	02/24/2026
¶ * 1284.	Subudhi SK, Siddiqui BA, Zarrabi KK[MORA], Kelly WK[MORA], Drake CG. The path forward for T cell engagers in patients with prostate cancer. J Immunother Cancer. 2026 Feb 24; 14(2). ( Abstract )	02/24/2026
¶ 1285.	Armstrong AJ, Morris MJ, Abida W, Aggarwal RR, Antonarakis ES, Attard G, Beltran H, Bryce A, Carducci MA, Cheng HH, Chen DL, Chi KN, Childs DS, Dahut W, Emmett L, Fizazi K, Gafita A, George DJ, Hermann K, Hofman MS, Hope T, Hussain M, Kelly WK[MORA], Kessler E, Kuo PH, Lang J, Liu G, Marshall CH, Morgans AK, McKay RR, Nanus D, Nelson P, Paller C, Reichert ZR, Ryan CJ, Sartor AO, Schöder H, Schwartz LH, Sharifi N, Stadler WM, Stein M, Sternberg CN, Szmulewitz RZ, Tagawa ST, Sokolova AO, Wyatt AW, Yamoah K, Yu EY, Halabi S, Scher HI, PCWG4 Writing Group. Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4. J Clin Oncol. 2026 Feb 26:JCO2502834. [Epub ahead of print] ( Abstract )	02/26/2026
¶ 1286.	Cortina CS, Molina G, Witt EE, Myers SP, Obeng-Gyasi S, Ju T, Rosenberg SM, Fackche N, Bayard S, Kangas-Dick A, Bea VJ, Willis A[MORA], Society of Surgical Oncology SPHERE Committee. ASO Education and Training: Taking the Next Step in Surgical Oncology Health Disparities Research: Identifying Root Causes and Targets for Actionable Change. Ann Surg Oncol. 2026 Feb 26. [Epub ahead of print] ( Abstract )	02/26/2026
¶ 1287.	Nugent SM, Ashare RL, Cullen J, Haque R, Hu J, Lee RT, Meghani SH, Potosky AL, Reboussin BA, Romero-Sandoval A, Wagoner KG, Wang Y, Worster B[CRiC], Filipski KK, Freedman AN. Leveraging the national cancer institute's collaborative efforts to understand the benefits and harms of cannabis use among individuals with cancer. J Natl Cancer Inst. 2026 Feb 26. [Epub ahead of print] ( Abstract )	02/26/2026
¶ 1288.	Tyagi M, Naik U[TaCO], Tyagi K, Sharma M, Kaushal G, Bhushan A, Bukrinsky M, Tyagi P. HIV Infection, Neurotoxicity, Inflammation, Premature Aging, and Therapeutic Challenges to PLWH: An Overview. Int J Mol Sci. 2026 Feb 26; 27(5). ( Abstract )	02/26/2026
1289.	Manca E, Lavu H[MORA], Nevler A. Pancreatic anastomotic technique during pancreaticoduodenectomy: does it boil down to surgeon preference? Gland Surg. 2026 Feb 28; 15(2):33. ( Abstract )	02/28/2026
1290.	Li Y, Lu S, Mao S, Li Q, Zou X, Li S, Li X, Lu D, Xu M, Xu HX, Jiang T, Lyshchik A[TaCO], Li L, Zhou J. Contrast-Enhanced US Using Perfluorobutane for Diagnosing Small HCC in High-Risk Patients: Comparison with MRI LI-RADS Version 2018. Radiology. 2026 Mar; 318(3):e252271. ( Abstract )	03/01/2026
+* 1291.	Llerena P, Kaki PC, Nunes K, Mastrolonardo E, Bridgham K, Moroco AE, Samarah H, Barbirou M, Baek D, Wang C, Bar-Ad V[MORA], Cognetti DM[TaCO], Curry JM[MORA], Johnson JM[MORA], Yang H[CRiC], Harshyne LA, Luginbuhl AJ[TaCO]. Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor of Survival Outcomes in Head and Neck Squamous Cell Carcinoma Receiving Neoadjuvant Immunotherapy. Cancer Med. 2026 Mar; 15(3):e71693. ( Abstract )	03/01/2026
¶ + 1292.	Patel A, Haldar N, Micaily I[MORA], Greenberg M, Nardone E, Lippert JA, Fundakowski C[TaCO], Mueller AC. Urgent radiotherapy for superior vena cava syndrome in metastatic non-small cell lung cancer: a case report. Tech Innov Patient Support Radiat Oncol. 2026 Mar; 37:100365. ( Abstract )	03/01/2026
* 1293.	Stewart C, Leong JY, Kelly WK[MORA], Shah MS[MORA]. Metastatic castrate-resistant prostate cancer to the penis resulting in malignant priapism and urethral obstruction. Urol Case Rep. 2026 Mar; 65:103380. ( Abstract )	03/01/2026
¶ * 1294.	Barger LN, Wang D, Saravia AL, Mezzano V, Ward G, Loomis C, Feldman C, Tuluc M, Seedor RS[IRT], Gaskill PJ[IRT], Coghill AE, Suneja G, Dehzangi I, Hope JL, Jour G, Romano G[IRT]. Population analysis and immunologic landscape of melanoma in people living with HIV. Clin Cancer Res. 2026 Mar 2. [Epub ahead of print] ( Abstract )	03/02/2026
¶ 1295.	Evans MG, Ribeiro JR, Maney T, Helmstetter A, Johnson J[MORA], Karnezis AN, Bales C, Sledge GW, Spetzler D, Vanderwalde A, Oberley M, Halmos B, Borghaei H, Abdulla F, Bryant D, Hirsch FR, Ghani H. An AI Approach to Differentiating Lung Squamous Cell Carcinoma From Metastases of Other Origins. JAMA Netw Open. 2026 Mar 02; 9(3):e260908. ( Abstract )	03/02/2026
¶ 1296.	Choi K, Jewett B, Hamilton-Moseley KR, Zarei K, Hacker K, Phan L[CRiC]. Patterns of tobacco product use among US adults who use nicotine pouches and the association between nicotine pouch use and tobacco product use cessation. Tob Control. 2026 Mar 03. [Epub ahead of print] ( Abstract )	03/03/2026
¶ 1297.	Van Galen J[IRT], Ratcliffe SJ, Bourque J. Short- and Long-term Metabolic Exposure Data as Predicators of Coronary Microvascular Dysfunction in a Positron Emission Tomography Myocardial Perfusion Imaging (PET-MPI) Cohort with Near Concurrent Angiography. Biomarkers. 2026 Mar 03:1-8. [Epub ahead of print] ( Abstract )	03/03/2026
* 1298.	Nguyen TD, Ezenwankwo E, Phan L[CRiC], DiCarlo M, Indictor A, Myers R[CRiC], Eberth JM. Process perspectives on lung cancer screening in primary care: a qualitative study of providers and staff in an urban U.S. healthcare system. BMC Health Serv Res. 2026 Mar 04. [Epub ahead of print] ( Abstract )	03/04/2026
¶ 1299.	Rangel ML, Stelzig D, Martinez Enriquez C, Badr H[CRiC]. Multi-Stakeholder Perspectives on Barriers to Mental Health Support for Informal Caregivers. Int J Environ Res Public Health. 2026 Mar 06; 23(3). ( Abstract )	03/06/2026
¶ * 1300.	Kang TK, Ang CG, Canziani G, Elkateb H, Thomas D, Yang D, Smith Iii AB, Haddad EK[IRT], Chaiken I[IRT], Deak P. HIV virion capturing liposomes for therapeutic vaccination. Biomaterials. 2026 Mar 07; 331:124124. [Epub ahead of print] ( Abstract )	03/07/2026
+* 1301.	Lu-Yao G[CRiC], Nikita N, Keith SW, Gandhi K, Shaver AL, Sharma S, Steinbock-Malfer C, Yang H[CRiC], Yang C, Zarrabi KK[MORA], Freedland SJ, Kelly WK[MORA]. Risk of fracture following androgen receptor pathway inhibitors in men with advanced prostate cancer. J Natl Cancer Inst. 2026 Mar 07. [Epub ahead of print] ( Abstract )	03/07/2026
¶ 1302.	Gesualdi J, Prah J, Solomon S, Cyrus J, Baçi E, Gaskill PJ[IRT], Akay-Espinoza Ç, Jordan-Sciutto KL. Neuroinflammatory crosstalk between microglia and astrocytes increases viral replication in an iPSC-derived model of CNS HIV infection. Sci Rep. 2026 Mar 11. [Epub ahead of print] ( Abstract )	03/11/2026
¶ 1303.	Aznar MC, Davey A, Wilson LJ[CRiC], Osorio EV, Bulbeck H, Thomson A, Watson-Wood K, Goddard J, Pirlepesov F, Gajjar A, van Herk M, Ashford JM, Conklin HM, Vaughan K, McCabe MG, Merchant TE. Cognitive outcomes after radiotherapy for medulloblastoma: a voxel-based analysis. Int J Radiat Oncol Biol Phys. 2026 Mar 12. [Epub ahead of print] ( Abstract )	03/12/2026
¶ 1304.	Cortina CS, Myers SP, Molina G, Bea VJ, Willis A[MORA]. ASO Author Reflections: Eliminating Surgical Oncology Health Disparities Through Actionable Change. Ann Surg Oncol. 2026 Mar 12. [Epub ahead of print] ( Abstract )	03/12/2026
* 1305.	Fang CX, Nam Y, Klassen AC[CRiC], Juon HS[CRiC]. Social determinants of health and quality of life among Korean Americans with chronic hepatitis B. BMC Public Health. 2026 Mar 12. [Epub ahead of print] ( Abstract )	03/12/2026
1306.	Lin M, Sottung E, Phan VH, Kimani ME, Lallas CD[MORA], Davis RM, Keith SW, Moeller PJ, Maio V. Comparative outcomes and costs of robotic assisted, laparoscopic, and open partial nephrectomy: a contemporary analysis of national inpatient sample data. World J Urol. 2026 Mar 12; 44(1). ( Abstract )	03/12/2026
* 1307.	Jones JE, Gunderson CE, Wigdahl B[IRT], Nonnemacher MR[IRT]. Breaking into HIV-1's Epigenetic Vault: Cure Strategies to Eliminate the Viral Reservoir. Viruses. 2026 Mar 13; 18(3). ( Abstract )	03/13/2026
¶ 1308.	Levy S, Meghani S, Worster B[CRiC], Kilanowski C, Smith D, Case AA, Ashare RL. Cannabis stigma and symptom management considerations in cancer survivors: a mixed-methods exploration of patient perspectives. Support Care Cancer. 2026 Mar 13; 34(4). ( Abstract )	03/13/2026
¶ 1309.	Le BV, Vekariya U, Toma MM, Nieborowska-Skorska M, Caron MC, Gozdecka M, Haydar Z, Walsh M, Ghosh J, Vaughan-Williams E, Podszywalow-Bartnicka P, Kukuyan AM, Ziolkowska S, Atkins J, Hadzijusufovic E, Chandramouly G, Nejati R, Piwocka K, Pomerantz R[MORA], Vassiliou GS, Huntly BJP, Valent P, Wasik M, Bellacosa A, Masson JY, Gupta GP, Challen GA, Skorski T. Polθ activity modulates sensitivity to standard therapies in DNMT3A-deficient leukemia. Cell Rep Med. 2026 Mar 17; 7(3):102687. ( Abstract )	03/17/2026
1310.	Xiao TS, Tahmasebi A, Khatami SM, Kuon Yeng Escalante CM, Mohammed A, Alnoury M, Guglielmo FF, Eisenbrey JR[TaCO], Civan J. Comparison of simulated transient elastography sample volumes and global measurements on MRE and MRI-PDFF in patients with suspected MASLD. Clin Imaging. 2026 Mar 17; 134:110786. [Epub ahead of print] ( Abstract )	03/17/2026
¶ 1311.	Choi E, Shusted C, Yang H, Evans H, Katcher J, Shieh Y, Vachani A, Rendle K, Barta JA[CRiC]. Impact of Race and Acculturation on Lung Cancer Screening Eligibility: A Multi-Center Lung Cancer Cohort Study. Am J Respir Crit Care Med. 2026 Mar 19. [Epub ahead of print] ( Abstract )	03/19/2026
¶ 1312.	Silverwood SM, Carlson CM, Zhu H, Biancia CD, Dempsey C, Shulman A, Keiper T, Koufigar S, Yorke AA, Jalal B, Yu C, Dimitriadou D, Wilson L[CRiC], Nano T, Gillespie EF, Li B. A Longitudinal Assessment of Remote IMRT/VMAT Training for Medical Physicists in Low- and Middle-Income Countries. Int J Radiat Oncol Biol Phys. 2026 Mar 21. [Epub ahead of print] ( Abstract )	03/21/2026
¶ +* 1313.	Dolui S, Dogan B, Wessner C, Porembka J, Machado P, Ozcan B, Unni N, Abu-Khalaf M[CRiC], Forsberg F[TaCO], Nam K[TaCO], Hoyt K. Assessment of Early Breast Cancer Response to Chemotherapy with Ultrasound Radiomics. Diagnostics (Basel). 2026 Mar 23; 16(6). ( Abstract )	03/23/2026
1314.	Malboubi M, Esteki MH, Vaghela MB, Korsak LIT, Petrie RJ[TaCO], Moeendarbary E, Charras G. The cytoplasm of living cells can sustain transient and steady intracellular pressure gradients. Elife. 2026 Mar 23; 14. ( Abstract )	03/23/2026
¶ 1315.	De Moor JS, Liang MI, Beauchemin MP, Glaser KM, Badr H[CRiC], Yabroff KR, Fawzy Doran J, Majid A, Bell RA, Obeng-Gyasi S, Sampson A, Rhoades DA, Blinder V, Graves K, Park ER, Banegas MP, Pisu M, Kirchhoff AC, Wheeler SB, Rosenstein DL, Sadigh G, Edward JS, Bryant M, Jagsi R, Halpern M, You W, Nipp RD, Hershman DL, Henrikson NB. Opportunities and Challenges for Addressing Financial Hardship as an Integrated Part of Cancer Care Delivery. J Natl Cancer Inst. 2026 Mar 24. [Epub ahead of print] ( Abstract )	03/24/2026
1316.	Kulkarni P, Chan K, Tseng C, Milarachi EN, Goldrich D, LaBarge B, Walter V, Goyal N, Curry JM[MORA], Linnenbach A, Broach JR, Goldenberg D. PTPR family deletions are associated with greater genomic structural instability in young adult tongue cancer. Oral Oncol. 2026 Mar 24; 176:107944. [Epub ahead of print] ( Abstract )	03/24/2026
¶ 1317.	Antonarakis ES, Cao Q, Catharine V, Carneiro BA, De Souza AL, VanderWeele DJ, Singh P, Bryce AH, Kelly WK[MORA], Jha GG, Lewis B, Barata PC, Sartor AO, Stadler WM, Proudfoot JA, Davicioni E, Dhawan M, Morgans AK, Ryan CJ. Carboplatin, Cabazitaxel and Abiraterone in High-Volume Metastatic Castration-Sensitive Prostate Cancer: The CASCARA Phase 2 Study. Clin Cancer Res. 2026 Mar 25. [Epub ahead of print] ( Abstract )	03/25/2026
+* 1318.	Wen KY[CRiC], Freedman J, Tafese A, Kelly W[MORA], Simone N[CRiC]. Fasting-Based Dietary Interventions in Cancer Patients and Survivors: A Scoping Review. Nutrients. 2026 Mar 25; 18(7). ( Abstract )	03/25/2026
¶ * 1319.	Duggan S, Fuleihan A, Menta AK, Goldberg M, Lallas C[MORA], Shah M[MORA], Shenot P, Metwalli A, Hubosky S, Gomella P, Smith W, Jimbo M, Chung P, Bloch P, Gomella L[MORA]. Urologic Device Innovation and Trends: An Analysis of Food and Drug Administration Approvals From 1990-2023. Urol Pract. 2026 Mar 26:101097UPJ0000000000001002. [Epub ahead of print] ( Abstract )	03/26/2026
¶ 1320.	Matthew Y, Foley N, Claiborne DT, Klase Z[IRT], Dick A. Latent HIV Reservoirs in the Central Nervous System: Mechanisms, Barriers, and Therapeutic Approaches. ACS Infect Dis. 2026 Mar 26. [Epub ahead of print] ( Abstract )	03/26/2026
¶ 1321.	Van Galen J[IRT], Willis SD, Bains A, Small SH. Measurable residual disease testing in acute myeloid leukemia: current state, foundational models, and tools for future development. Cancer Metastasis Rev. 2026 Mar 27; 45(2). ( Abstract )	03/27/2026
1322.	Ganesh B, Jain A, Yeo CJ, Bashir B[IRT]. CRE26-054: Germline BARD1 Mutation and Exceptional Response to FOLFIRINOX in Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC) - A Case Report. J Natl Compr Canc Netw. 2026 Mar 31; 24(3.5). ( Abstract )	03/31/2026
¶ 1323.	Godbole AR, Wood E, Egleston B, Hoffman-Andrews L, Brown S, Howe S, Shastri S, Mim R, Feng J, Owens A, Domchek S, Pyeritz R, Katona BW, Kallish S, Sirugo G, Weaver J, Fleisher L, Wen KY[CRiC], Elkin E, Nathanson KL, Rader DJ, Bradbury AR. A randomized study of digital versus genetic counselor return of actionable genetic research results to biobank participants (RESPECT3 study). BMC Med Ethics. 2026 Mar 31. [Epub ahead of print] ( Abstract )	03/31/2026
¶ + 1324.	Antonoff MB, Hooda Z, Sun X, Celestino M, Evans N[CRiC], Grenda T[MORA], Lee J, Mehran R, Okusanya OT, Rajaram R, Waddell T, Walsh G, Yeung J, Vaporciyan A, Mitchell KG, Morris VK. Outcomes of Thoracic Surgical Oncology Group 103: Multimodality management in risk-stratified patients with lung-limited metastatic colorectal cancer. JTCVS Open. 2026 Apr; 30:101702. ( Abstract )	04/01/2026
¶ 1325.	Liu YK, Kuo HT, Melek A, Castillo R, Vinogradskiy Y[CRiC], Zhao L, Nair G, Castillo E. Predicting ventilation from single breathing phase non-contrast CT using Swin Transformers. Med Phys. 2026 Apr; 53(4):e70406. ( Abstract )	04/01/2026
* 1326.	Mancheski E, Baek D, Bowne W, Lavu H[MORA], Yeo CJ[MORA], Nevler A. Initial Site of Metastasis Influences Prognosis in Pancreatic Ductal Adenocarcinoma. Cancer Med. 2026 Apr; 15(4):e71760. ( Abstract )	04/01/2026
* 1327.	Wetzel A, Feci A, Gorman J, Lavine I, Manca E, Zheng R, Hanna N, Lavu H[MORA], Yeo CJ[MORA], Nevler A. Survival Impact of Intraoperative Carbon Dioxide Dysregulation in Patients Undergoing Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma. J Am Coll Surg. 2026 Apr 01; 242(4):974-983. ( Abstract )	04/01/2026
¶ 1328.	Gregucci F, Lee-Poturalski C, Dirrim M, Stewart J, Caruthers D, Stiles CD, Hentrich K, Cardenas J, Chan TA, Yu DS, Tran P, Simone N[CRiC], Sawant A, Schwarz J, Robinson C, Haas-Kogan D, Michor F, Vanpouille-Box C, Ng J, Hasan Y, Yu J, Ren L, Marchionni L, Hugo G, Berbeco R, Nakamura JL, Lindsay J, Yang X, Deasy JO, Weichselbaum RR, Formenti SC. Radiation Oncology-Biology Integration Network (ROBIN): Bridging the gap between biological research and clinical practice. Clin Cancer Res. 2026 Apr 06. [Epub ahead of print] ( Abstract )	04/06/2026
¶ 1329.	Miller CA, Kumar AM, Mendoza JA, Barsell JD, Diala OR, Glasgow TE, Dahman B, Bradley C, Resnicow K, Leader A[CRiC], Briant KJ, Poynter JN, Winn RA, Fuemmeler BF. Cancer prevention in context: interplay of perceived discrimination, neighborhood deprivation, and cancer-related risk and protective factors. J Natl Cancer Inst. 2026 Apr 06. [Epub ahead of print] ( Abstract )	04/06/2026
+* 1330.	Wen KY[CRiC], Freedman J, Zarrabi KK[MORA], Slamon R, Smith R, Liang J, Mille P[MORA], Tester WJ[MORA], Kelly W[MORA]. A Prolonged Nightly Fasting Plus Telehealth Coaching Intervention (PNF+) for Men on Androgen Deprivation Therapy for PCa: A Pilot Feasibility Randomized Controlled Trial. Nutrients. 2026 Apr 07; 18(7). ( Abstract )	04/07/2026
1331.	Ahmed NN, Young RG, Merzy J, Reginato MJ[TaCO]. Sugar Storm: O-GlcNAc signaling amid the clouds of cancer complexity. Glycobiology. 2026 Apr 09. [Epub ahead of print] ( Abstract )	04/09/2026
¶ 1332.	Dunn MR, Mukhopadhyay S, Gomez SL, McCullough LE, Hyslop T[CRiC], Emerson MA, Troester MA. Comparing Neighborhood Indices of Socioeconomic Status, Segregation, and Healthcare Access for Predicting Late-Stage Breast Cancer. J Urban Health. 2026 Apr 10. [Epub ahead of print] ( Abstract )	04/10/2026
¶ 1333.	Fetzer DT, Kono Y, Piscaglia F, Dietrich CF, Meloni F, Lu Q, Clevert DA, Lyshchik A[TaCO], Minami Y, Lee JM, Kim TK, Jang HJ, Kudo M, Wilson SR. Contrast-enhanced ultrasound LI-RADS nonradiation treatment response assessment: applications, challenges, and future directions. Abdom Radiol (NY). 2026 Apr 10. [Epub ahead of print] ( Abstract )	04/10/2026
¶ 1334.	Hassan AH, Nakano Y, Gamper H, Masuda I, Vesela L, Pinkas M, Nagarajan SN, Dworkin J, Blaha G, Hou YM[MORA], Demo G. Mechanistic insights into E. coli recovery from growth arrest. Nat Commun. 2026 Apr 11. [Epub ahead of print] ( Abstract )	04/11/2026
1335.	Ang CG, Eyunni S, Chaiken IM[IRT]. Inflammation and RONS Dysregulation by Redox Enzymes as Mechanistic Links in HIV-1-Cancer Comorbidity. Pathogens. 2026 Apr 14; 15(4). ( Abstract )	04/14/2026
1336.	Acharya S, Meredith LT, Kaplan Z, Persaud R, Moskal D, Wummer B, Jiang W, Zheng R, Naringrekar H, Lavu H[MORA], Yeo CJ, Nevler A, Bowne WB. Solid Pseudopapillary Neoplasms (SPNs) of the Pancreas: Appraisal of Contemporary Clinicopathologic Features - Clinical Implications and Surgical Outcomes of Patients Treated and Followed at a Single Institution. J Surg Oncol. 2026 Apr 16. [Epub ahead of print] ( Abstract )	04/16/2026
¶ 1337.	Darrah JM, Varadarajan I, Mehta A, Saultz JN, McKinney MS, Ghosh M, Gergis U[IRT], Krueger A, Galinsky KJ, Bende G, Ramachandran A, Sundaresan V, Kasar S, Hupf B, Chen S, Sellner L, Karmali R. A Phase 2, Open-Label, Multicenter Study of the Safety and Efficacy of TAK-007 in Adult Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma. Blood Cancer Discov. 2026 Apr 17. [Epub ahead of print] ( Abstract )	04/17/2026
¶ 1338.	Shan Y, Huang Y, Lee A, Elmorsi RM, Phan T, Chaudhury I, Corbiere T, Collins LB, Hirsch EB, Weinberg BA, Johnson JM[MORA], Antonarakis ES, Lou E, Huang RS. Sex-biased intratumoral microbiome influences tumor molecular and immune landscape and disease outcomes. Cell Rep Med. 2026 Apr 20:102757. [Epub ahead of print] ( Abstract )	04/20/2026
1339.	Hagerman C, Choo-Kang D, LaFata E, Rohde P, Butryn M[CRiC]. A cognitive dissonance-based intervention to reduce ultra-processed food intake: Protocol for a pilot randomized controlled trial. Contemp Clin Trials. 2026 Apr 22; 165:108327. [Epub ahead of print] ( Abstract )	04/22/2026
¶ 1340.	Wang Y, Huang Q, Zhou Y, Hooper R, Sanders-Braggs R, Chen M, Tian Y, Kent T, Pomerantz R[MORA], Clando G, Chung W, Issa JJ, Soboloff J, Zhang Y. EZH2 and intracellular Ca signals interdependently coordinate alloreactive and CAR-T-cell responses. Cell Mol Immunol. 2026 Apr 22. [Epub ahead of print] ( Abstract )	04/22/2026
+ 1341.	Young RG, Esquea EM, Ciraku L, Merzy J, Ahmed NN, Talarico AN, Karuppiah M, Medori SM, Warade RP, Gocal W, Dick A, Simone NL[CRiC], Reginato MJ[TaCO]. ACSS2 Suppresses Ferroptosis to Drive Breast Cancer Brain Metastasis. Cancer Res. 2026 Apr 22. [Epub ahead of print] ( Abstract )	04/22/2026
1342.	Lopez de Arbina A, Zamudio-Ochoa A, Muñoz-Oreja M, Perez-Rodriguez D, Mosqueira-Martín L, Lasalandra R, Villar-Fernandez M, Fernandez-Pelayo U, Rodriguez-Gomez L, Lee S, Gil-Bea F, Osinalde N, Vallejo-Illaramendi A, Temiakov D[TaCO], Spinazzola A, Holt IJ. Mitochondrial DNA replication is regulated by endoplasmic reticulum-mitochondrial contact sites, the mitochondrial calcium uniporter, and manganese. Nucleic Acids Res. 2026 Apr 23; 54(8). ( Abstract )	04/23/2026
¶ 1343.	Harbron RW, Griffin K, Al-Nabulsi I, Andres P, Bernier MO, Berrington de González A, Chassin C, Chua CEL, Milder CM, Rafet SM, Pasqual E, Rose A, Shrestha S, Thierry-Chef I, Ukwuani A, Wilson L[CRiC], Ostroumova E, Mille MM. Exposure and impact: Highlights from the second scientific conference and recent activities of the International Society for Radiation Epidemiology and Dosimetry (ISoRED). J Radiol Prot. 2026 Apr 27. [Epub ahead of print] ( Abstract )	04/27/2026
¶ +* 1344.	Barbirou M, Miller A, Baek D, Hameier A, Wetzel A, Fiedor J, Yang C, Linnenbach A, Nunes K, Llerena P, Samarah H, Bar-Ad V[MORA], Luginbuhl A[TaCO], Li B, Li G, Yampolsky A, Hou L, Curry J[MORA], Wang C, Yang H[CRiC]. Saliva vs Plasma in Liquid Biopsy Sampling for Head and Neck Cancer: A Comparative Study. Clin Chem. 2026 Apr 28. [Epub ahead of print] ( Abstract )	04/28/2026
¶ 1345.	Barry AS, Fluss R, Dawson LA, Hausner D, Buckstein M, Golin T, Freedman L, Miszczyk M, DiazPardo D, Aguiar A, Limon D, Pfeffer RM, Ben-Ayun M, Hammer L, Symon Z, Morag O, Jacobson G, Dicker A[CRiC], Wydmanski J, Zimmermann C, Lawrence YR. Celiac plexus radiosurgery for retroperitoneal pain in advanced cancer: a pre-specified secondary analysis of health-related quality of life in a phase II single-arm trial. EClinicalMedicine. 2026 May; 95:103968. ( Abstract )	05/01/2026
¶ 1346.	Mukalel AJ, Tylek T, Geisler HC, O'Brien E, Frazee C, Li J, Thatte AS, Safford HC, Figueroa-Espada CG, Alameh MG, Hamilton AG, Mai D, Sheppard NC, June CH, Weissman D, Spiller KL[IRT], Mitchell MJ. Bioinspired oxidized mRNA lipid nanoparticles for ex vivo engineering of chimeric antigen receptor macrophages targeting solid tumors. Bioeng Transl Med. 2026 May; 11(3):e70138. ( Abstract )	05/01/2026
¶ 1347.	Patel KR, Pugh SL, Simko JP, Zietman A, Fiorentino M, D'Souza DP, Rosenthal S, Currey A, Dicker A[CRiC], Stish BJ, Horwitz EM, Robin TP, Dominello M, Peters C, Choi K, Efstathiou JA, Narayan S, Grass GD, Rana ZH, Tran PT, Loda M, Nguyen PL. The Association of p27 With Prostate Cancer Outcomes: A Secondary Analysis of NRG/RTOG 8610 and 9202. Adv Radiat Oncol. 2026 May; 11(5):102022. ( Abstract )	05/01/2026
¶ 1348.	Pol M, Metkari AS, Frazier SM, Macugay JB, Gao H, Witt RL, Cognetti DM[TaCO], Assenmacher CA, Jia X. Fostering cell-cell interactions and integrating angiocrine factors to promote the development of salivary microtissues in 3D. Bioeng Transl Med. 2026 May; 11(3):e70118. ( Abstract )	05/01/2026
¶ 1349.	Shah NJ, Ababio Y, Eccleston A, Rao D, Kelly SP, Chang J, Lucht S, Paydar C, Van Doren BA, Bland E, John W, Giegerich S, Laney J, Feinberg B, Zarrabi KK[MORA]. Axitinib-Pembrolizumab and Adverse Event Management in Patients With Advanced Renal Cell Carcinoma. JAMA Netw Open. 2026 May 01; 9(5):e2614061. ( Abstract )	05/01/2026
1350.	Wilson HP, Stefanski CD, Caksa S, Mersky GL, Varney SD, Haj JI, Erkes DA, Purwin TJ, Chua V, Aplin AE[TaCO]. Diacylglycerol Kinase Eta as a Novel Target in NRAS Mutant Melanoma. Pigment Cell Melanoma Res. 2026 May; 39(3):e70090. ( Abstract )	05/01/2026
¶ +* 1351.	Saxena A, Yorker M, Zorko NA, Narayan V, Siddiqui BA, Saraiya B, Tester WJ[MORA], Mille PJ[MORA], Shaver AL, Nikita N, Lu-Yao GL[CRiC], Kelly WK[MORA], Zarrabi KK[MORA]. Prevalence of adverse events following T-cell redirecting therapies in patients with metastatic castrate-resistant prostate cancer: a pooled analysis. Oncologist. 2026 May 02. [Epub ahead of print] ( Abstract )	05/02/2026
1352.	Yang Y, Chen M, Cui M, Lashbrooks E, Wang B[TaCO]. Acidic extracellular pH-induced PTH secretion in male mouse parathyroids is OGR1-dependent. Endocrinology. 2026 May 06. [Epub ahead of print] ( Abstract )	05/06/2026
¶ 1353.	Ziehr DR, Li F, Parnell KM, Krah NM, Leahy KJ, Guillermier C, Gao C, Prell SA, Vigder N, Poli S, Varon J, Baron RM, Maron BA, Philp NJ[TaCO], Hariri LP, Kim EY, Wei KS, Steinhauser ML, Knipe RS, Rutter J, Oldham WM. Lactate transport inhibition therapeutically reprograms fibroblast metabolism in experimental pulmonary fibrosis. Sci Transl Med. 2026 May 06; 18(848):eads2673. ( Abstract )	05/06/2026
¶ 1354.	Soputro NA, Hershenhouse J, Cole S, O'Hara J, Considine J, Nasir-Moin M, Khanmammadova N, Lee Y, Sauer-Calvo R, Kim S, Elanjian A, Mavridis A, Horan S, Al-Bayati A, Patil D, Imtiaz S, Bernardino RM, Gelikman DG, Daher K, Abdollah F, Lorentz A, Lee DI, Pathak R, Hemal K, Han J, Shakuri-Rad J, Nelson RJ, Yuh B, Bassett J, Kim M, Joseph J, Nix JW, Ritch C, Nahar B, Shah MS[MORA], Ahmed M, Stifelman MD, Crivellaro S, Autorino R, Kaouk J. Single Port Robotic Radical Prostatectomy: A Propensity-matched Comparison of Transvesical Versus Extraperitoneal Approaches from the Single Port Advanced Research Consortium. Eur Urol Oncol. 2026 May 07. [Epub ahead of print] ( Abstract )	05/07/2026
1355.	Gerber K, Thapar M, Lazar M, Baker N, Lubas MJ, Sherif K, Ali A, Rosenblum NG, Anne P, Simone NL[CRiC]. Addressing Sexual Toxicity Among Cancer Survivors: Clinicians Challenges and Potential Interventions. Am J Hosp Palliat Care. 2026 May 08:10499091261450884. [Epub ahead of print] ( Abstract )	05/08/2026
* 1356.	Joshi J, Shimada A, Burke SE, Ali AS, Smith A, Smith BC, Hines K, Leader AE[CRiC], Simone NL[CRiC]. Effect of social stressors and social determinants of health (SDOH) on cancer beliefs: Analysis of a cancer center catchment area. J Psychosoc Oncol. 2026 May 09:1-19. [Epub ahead of print] ( Abstract )	05/09/2026
¶ 1357.	Abai S, Danzer MF, Assaf C, Mula-Hussain L, Kirova Y, Kouloulias V, Cowan R, Newmann N, Shi W[MORA], Shelan M, Christian Flores D, Correia D, Campbell BA, Binkley MS, Hoppe RT, Elsayad K. Reduced-dose total skin electron beam radiotherapy in mycosis fungoides and Sézary syndrome: Systematic review and meta-analysis. Int J Radiat Oncol Biol Phys. 2026 May 12. [Epub ahead of print] ( Abstract )	05/12/2026
1358.	Shah R, Haldar N, Jain S, Holt L, Shah S, Iqbal H, Chen AY, Farrell CJ, Haldar D, Evans JJ, Alexander GS, Shi W[MORA]. Long-Term Outcomes and Symptom Response Following Hypofractionated Stereotactic Radiotherapy (hSRT) for Intracranial Meningioma. World Neurosurg. 2026 May 12:125045. [Epub ahead of print] ( Abstract )	05/12/2026
¶ + 1359.	Goetz ML, Romer-Seibert JS, Versace AM, Kogan S, Jeurkar C[IRT], Bowman RL, Brooks N, Frese K, Meyer SE[MORA]. P300/CBP inhibition with inobrodib in combination with gilteritinib and venetoclax targets leukemia stem cells in epigenetic mutant AML. Sci Adv. 2026 May 15; 12(20):eaec9305. ( Abstract )	05/15/2026
¶ + 1360.	Yefet LS, Landry AP, Rogers CL, Wang JZ, Liu J, Patil V, Gui C, Ajisebutu A, Ellenbogen Y, Wei Q, Singh O, Mansouri S, Szot C, Jordan RC, Barani IJ, Straza MW, Shu HG, Pointer KB, Hunter G, Panet-Raymond V, Shi W[MORA], Perlow HK, Kavanagh BD, Gunter T, Robinson C, Pugh SL, Dicker AP[CRiC], Mehta MP, Chakravarti A, Nassiri F, Aldape K, Zadeh G. Modern Molecular Profiling Recontextualizes the NRG/RTOG 0539 Trial and Reveals Hidden High-Risk and Radiotherapy Resistant Meningiomas. Neuro Oncol. 2026 May 15. [Epub ahead of print] ( Abstract )	05/15/2026
¶ 1361.	Piperno-Neumann S, Rutkowski P, Hassel JC, Butler MO, Schlaak M, Sullivan RJ, Dummer R, Kirkwood JM, Sacco JJ, Shoushtari AN, Piulats JM, Salama AKS, Orloff MM[IRT], Joshua AM, Ochsenreither S, Gastaud L, Curti BD, Demidov LV, Milhem MM, Chmielowski B, Kendra KL, Ascierto PA, Bernicker EH, Carvajal RD, Collins L, Lockwood S, Patel JM, Hamid OA, Baurain JF, Nathan PD. Five-Year Survival with Tebentafusp in Metastatic Uveal Melanoma. Ann Oncol. 2026 May 19. [Epub ahead of print] ( Abstract )	05/19/2026
¶ 1362.	Choi K, Hamilton-Moseley KR, Jewett B, Phan L[CRiC], Zarei K, Azeem A, Hacker K. Public Support for Tobacco Price Promotion Bans Among U.S. Adults: An Online Experiment. Am J Prev Med. 2026 May 21:108158. [Epub ahead of print] ( Abstract )	05/21/2026
¶ 1363.	Gonda B, Wang D, Azim SM, Romano G[IRT], Dehzangi I. Deep learning multi-omics integration identifies new molecular subtypes of lung cancer. BioData Min. 2026 May 21. [Epub ahead of print] ( Abstract )	05/21/2026
* 1364.	Singh J, Johar T, Scully V, Waldman SA[IRT], Bashir B[IRT], Snook AE[IRT]. In-Use Stability and Device Compatibility Define Clinically Actionable Handling Limits for a GMP-Produced Attenuated Listeria monocytogenes Vaccine Expressing GUCY2C. Vaccines (Basel). 2026 May 21; 14(5). ( Abstract )	05/21/2026
* 1365.	Bi X, Rashid S, Filicko-O'Hara J, Van Galen J[IRT], O'Hara W, Wagner JL, Grosso D, Flomenberg N, Gergis U[IRT]. The Two-Step Allogeneic Stem Cell Transplant Is Associated with Excellent Engraftment, Improved Survival and Low Nonrelapse Mortality in Patients with Myelofibrosis. Hematol Oncol Stem Cell Ther. 2026 May 22. [Epub ahead of print] ( Abstract )	05/22/2026
1366.	Bridgham K, Kaki P, Hambach B, Moroco A, Mastrolonardo E, Crippen M, Cognetti D[TaCO], Thal A. Socioeconomic Disadvantage and Care Proximity Influence Stage at Presentation in Head and Neck Cancer. Otolaryngol Head Neck Surg. 2026 May 22. [Epub ahead of print] ( Abstract )	05/22/2026
¶ 1367.	Hwang D, Azizi G, Ishikawa LLW, Seyedsadr M, Cox A, Jang S, Kasimoglu E, Rostami A[IRT], Zhang GX, Ciric B. CD11c+ CD8 T cells cause IFN-γ-dependent autoimmune neuroinflammation that is restrained by PD-1 signaling. JCI Insight. 2026 May 22; 11(10). ( Abstract )	05/22/2026
¶ 1368.	Kuroki LM, Enserro DM, Lankes HA, Strickland KC, Previs R, Clements A, Powell MA, Klopp A, Ratner E, DiSilvestro P, Cosgrove C, Cantuaria GH, Spirtos NM, Carney M, Edelson M[MORA], Konecny G, Anderson P, Tarney C, Erickson BK, Newton M, Tewari KS, Thaker PH, Warshal D, Armstrong A, Zhou XC, Secord AA. Molecular classification and association with survival outcomes in high-intermediate and high-risk early-stage endometrial cancers: Ancillary analysis of GOG-0249. Gynecol Oncol. 2026 May 26; 210:63-71. [Epub ahead of print] ( Abstract )	05/26/2026
1369.	Murayama H, Yakobov N, Mahmoudi N, Legrosdidier S, Fournier N, Zuttion S, Matsumoto K, Nishimura M, Ji J, Senger B, Huck L, Gamper HB, Kise Y, Kleiner RE, Frechin M, Hou YM[MORA], Becker HD, Itoh Y, Fischer F, Nureki O. Structure of ergosteryl-aspartate synthase reveals how an entrapped tRNA is used like a prosthetic swinging arm in the synthesis of aminoacylated sterols. Nat Commun. 2026 May 28; 17(1). ( Abstract )	05/28/2026
¶ 1370.	Powell MA, Roed H, Willmott LJ, Cibula D, Black D, Valabrega G, Sharma S, Kommoss S, Landrum LM, Boere I, Mathews C, Sukhin V, Gold MA, Lundgren C, Gill SE, Gilbert L, Cass I, Edelson MI[MORA], Buscema J, Nevadunsky NS, Ring K, Pothuri B, Eshed HD, McCourt C, Coleman RL, Grimshaw M, Austin L, Zajac M, Slomovitz B, Nøttrup T. Four-year survival outcomes with dostarlimab plus chemotherapy in mismatch repair deficient/microsatellite instability-high primary advanced or recurrent endometrial cancer in the RUBY trial. Gynecol Oncol. 2026 May 29. [Epub ahead of print] ( Abstract )	05/29/2026
¶ 1371.	Garrad E, Abuali I, DeLaune J, Kloecker GH, Franklin R, Rangachari D, Al-Hader A, Behrens DL, Garcia CA, Muzaffar M, Shah AY, Wilde L[IRT], Finn LE, Armstrong SA, Patel V, Mistry R, Tawagi K. Artificial Intelligence Among U.S. Hematology Oncology Fellows: A Multicenter Survey of Education, Attitudes, and Clinical Use. JCO Oncol Pract. 2026 May 31:101200OP2600433. [Epub ahead of print] ( Abstract )	05/31/2026
1372.	Fujioka M, Ke W, Schedl P, Jaynes JB[MORA]. Chromatin insulators homie and nhomie can interact with distant copies either together or separately, with distinct outcomes for enhancer-promoter interactions. PLoS Genet. 2026 Jun; 22(6):e1011940. ( Abstract )	06/01/2026
¶ 1373.	Greene B, Ghosh S, Colder C, Meghani S, Worster B[CRiC], Ashare R. Associations between neighborhood disadvantage, cannabis use, and patient-reported outcomes among patients with cancer. Drug Alcohol Depend Rep. 2026 Jun; 19:100449. ( Abstract )	06/01/2026
¶ 1374.	Kim C, Adeyelu T, Maniar R, Farrell A, Zaemes J, Solzak J, Hancock B, Elliott A, Micaily I[MORA], Nagasaka M, Nieva J, Borghaei H, Halmos B, Ma PC, Radovich M, Badve SS, Loehrer PJ. Integrated Molecular and Clinical Analysis of Thymic Epithelial Tumors. JCO Precis Oncol. 2026 Jun; 10(6):e2600001. ( Abstract )	06/01/2026
1375.	Kolliopoulos V, Polanek M, Gamage HEV, Ling MWY, Tiffany A, Nelson ER, Spiller KL[IRT], Harley BAC. Reciprocal Macrophage-MSC Crosstalk Drives Immunomodulatory and Regenerative Phenotypes in a Mineralized Collagen Scaffold. J Biomed Mater Res A. 2026 Jun; 114(6):e70106. ( Abstract )	06/01/2026
¶ 1376.	Li B, Kalluri VS, Weaver AM, Bertolini I, . . . Languino LR[TaCO], . . . Zickler AM, Cheng K, Kalluri R. Advancements in extracellular vesicle research. Extracell Vesicle. 2026 Jun; 7. ( Abstract )	06/01/2026
¶ + 1377.	Madeka I, Noueihed K, Woodroof J, Mack S, Rshaidat H, Whitehorn GL, Alaparthi S, Koeneman SH, Grenda TR[MORA], Evans NR[CRiC], Okusanya OT. Lymph Node Dissection and Postoperative Complications After Lung Cancer Resection. JAMA Netw Open. 2026 Jun 01; 9(6):e2615894. ( Abstract )	06/01/2026
¶ 1378.	Mizuno N, Abraham J, Jimenez-Perez K, Rose I, Springgay L, Boehm D, Ando T, Streblow D, Ward J, Miller S, Pandey U, Junaid A, Joyner D, Muir R, Haddad EK[IRT], Burkhart D, Rasheed O, DeFilippis VR. Characterization of a transmembrane-activating STING agonist using genetically humanized mice. Cell Rep. 2026 Jun 01; 45(6):117475. [Epub ahead of print] ( Abstract )	06/01/2026
1379.	O'Connor GJ, Choi JC, Van NT, Klutkoski AM, Robertson LC, Kim SV[IRT]. Localization of TCR-expressing natural intraepithelial lymphocytes in the colon epithelium depends on GPR15 and epithelium-derived C10ORF99. Mucosal Immunol. 2026 Jun 01:100355. [Epub ahead of print] ( Abstract )	06/01/2026
¶ 1380.	Piwarski SA, Howard LE, Paul MA, Bachelder N, LaCroix B, Clayton A, Allen D, Kephart J, Armstrong AJ, Patierno SR, George DJ, Hyslop T[CRiC], Freedman JA. Genetic ancestry-concordant ceramide metabolism and response to androgen receptor pathway inhibition in metastatic castration-resistant prostate cancer. Cancer. 2026 Jun 01; 132(11):e70371. ( Abstract )	06/01/2026
¶ 1381.	Stulberg EL, Miller RM, Hartman N, Risk M, Wing JJ, Schneider ALC, Edwards D, Cramer SC, Rising KL[CRiC], Becker C, de Havenon A, Lisabeth L. Factors Underlying Stroke Recovery Variation by Neighborhood Socioeconomic Status. JAMA Netw Open. 2026 Jun 01; 9(6):e2616362. ( Abstract )	06/01/2026
+ 1382.	Woodroof J, Noueihed K, Koeneman S, Jacob J, Grenda T[MORA], Evans NR[CRiC], Okusanya OT. The uptake of segmentectomy for non-small cell lung cancer in adopters of robotic surgery. JTCVS Open. 2026 Jun; 31:101744. ( Abstract )	06/01/2026
¶ 1383.	Ellison AL, Rosado-Franco JJ, Mamun L, Knerler S, Daniali M, Mehta K, Williams-McLeod S, Alvarez J, Joyner SS, Vandrey R, Weerts EM, Gaskill PJ[IRT], Corley MJ, Ndhlovu LC, Williams DW. Antiviral and anti-inflammatory effects of Cannabidiol in HIV/SIV infection. Brain Behav Immun. 2026 Jun 02; 137:106843. [Epub ahead of print] ( Abstract )	06/02/2026
1384.	Netting DJ, Grinstein S, Mantegazza AR[IRT]. Beyond Transport: Lysosomal solute carriers as orchestrators of immune signaling. Mol Biol Cell. 2026 Jun 03:mbcE26040158. [Epub ahead of print] ( Abstract )	06/03/2026
¶ 1385.	Trivedi N, Van Vleet R, Eid C, Burke-Garcia A, Leader AE[CRiC]. The Influence of Social Media Messaging on Human Papillomavirus Vaccine Attitudes and Confidence Among Adolescent Males: Group Discussion Study. JMIR Cancer. 2026 Jun 03; 12:e82210. ( Abstract )	06/03/2026
¶ 1386.	Pescador Jimenez M, Chivardi M, Coull BA, Hystad P, Diez Roux AV[CRiC], Kaufman JD, James P. Street view-based exposure to greenspace and mortality: the Multi-Ethnic Study of Atherosclerosis. Environ Int. 2026 Jun 04; 213:110339. [Epub ahead of print] ( Abstract )	06/04/2026
¶ * 1387.	Shah SD, Richard J, Ghosh S, Jerwick J, Gavali JT, Penn RB[TaCO], MacKerell AD, Deshpande DA[TaCO]. Agonist-specific conformational dynamics at the β-adrenoceptor dictate allosteric modulation of Gαs signalling and bronchodilation. Br J Pharmacol. 2026 Jun 07. [Epub ahead of print] ( Abstract )	06/07/2026
¶ 1388.	Wilson JM, Rosenberg SM, Crowell KA, Lynch T, Collyar D, Basila D, Frank ES, Darai S, Hyslop T[CRiC], Valenza C, Thompson AM, Partridge AH, Hwang ES, Schreiber KL. Age-related differences in psychological distress and persistent postsurgical pain after surgery for management of non-invasive breast lesions. Breast Cancer Res Treat. 2026 Jun 08; 217(2). ( Abstract )	06/08/2026
¶ + 1389.	Li T, Canziani G, Liu Y, Patel N, Han B, Fan M, Porter A, Kwok B, Wang C, Li Q[MORA], Birk DE, Iozzo RV[TaCO], Chaiken IM[IRT], Lu XL, Mauck RL, Han L. Decorin Promotes Nascent Proteoglycan Retention in Cartilage Matrix by Strengthening Collagen II-Aggrecan Integration. Acta Biomater. 2026 Jun 09. [Epub ahead of print] ( Abstract )	06/09/2026
¶ * 1390.	Ortiz JR, Kurup D[IRT], Kaufman AC, Ben Hamed S, LaRocco AM, Lyke KE, Litts SM, Datta S, Liang Y, McGilvray MF, Losignor JA, Oshinsky JJ, Palmer KV, Johnson-Mayo IP, Scher G, Balakumar U, Chandwani A, Rapaka RR, Deming ME, Chua JV, Wirblich C, Chen WH, Neuzil KM, Pasetti MF, Schnell MJ[IRT]. Adjuvanted inactivated rabies virus-vectored Lassa virus vaccine in healthy adults: a phase 1 trial. Nat Med. 2026 Jun 09. [Epub ahead of print] ( Abstract )	06/09/2026
1391.	Jiang P, Liu X, Reginato MJ[TaCO], Rosen KV. Mechanistic analysis of MLKL-driven cell survival. Cell Death Discov. 2026 Jun 10. [Epub ahead of print] ( Abstract )	06/10/2026
¶ 1392.	Philips R, Mahajan A, Estephan L, Auger S, Haque W, Palmer D, McQueen J, MacCracken E, Argyris PP, Trzcinska A, Cipriani NA, Lingen M, Hussain I, Muzaffar M, Pasternak-Wise O, Curry J[MORA], Katipally R, Juloori A, Haraf D, Heinlen P, Choudhury NJ, Rosenberg A, Vokes E, Arshad H, Blair E, Agrawal N, Shah S, Pearson AT. Prompt-directed ambient artificial intelligence for automated multidisciplinary tumor board documentation. Ann Oncol. 2026 Jun 10. [Epub ahead of print] ( Abstract )	06/10/2026
1393.	Loizidis G, Summer R[TaCO]. GLP-1-based therapy and ICD-10-documented heart failure or respiratory failure events in non-diabetic adults with rheumatoid arthritis and obesity: a TriNetX federated cohort study. Clin Rheumatol. 2026 Jun 11. [Epub ahead of print] ( Abstract )	06/11/2026
1394.	Chen AY, Reddy A, Ikea-Mario T, Jain S, Xiao Z, Haldar N, Feng R, Farrell CJ, Evans JJ, Shi W[MORA]. Ki-67 ≥ 13% and Local Failure in WHO grade 2 and 3 Meningiomas: A Single-Institution Cohort Study. J Clin Neurosci. 2026 Jun 12; 152:112130. [Epub ahead of print] ( Abstract )	06/12/2026
¶ 1395.	Sayan M, Huang HC, Stewart EL, Showalter TN, Dicker AP[CRiC], Grass GD, Gore EM, McDonald AM, Pennington JD, Hallman MA, Barani IJ, Hsu IC, Rooney M, Pugh SL, Nguyen PL, Tran PT, Roach Iii M. A Multimodal Artificial Intelligence Model to Guide Use of Whole-Pelvic Radiation Therapy in Patients with Localized Prostate Cancer: Exploratory Analysis of RTOG 9413. Cancers (Basel). 2026 Jun 18; 18(12). ( Abstract )	06/18/2026
¶ 1396.	Carey JL, Hayashi M, Welebob E, Ganser LR, Wang H, Buckhaults K, DePierro JA, Shi Z, Shorter J, Myong S, Haeusler A, Guo L[MORA]. RNA G-quadruplexes function as a tunable switch of FUS phase separation. Nucleic Acids Res. 2026 Jun 22; 54(12). ( Abstract )	06/22/2026
1397.	Haldar N, Okazaki K, McLean L, Mourtada F, Taleei R, Li J, Caster J, Anne PR, Vinogradskiy Y[CRiC], Choi W, Chen Y. Contour and dosimetric evaluation of an in-room mobile CBCT scanner for cylinder based brachytherapy. Brachytherapy. 2026 Jun 25. [Epub ahead of print] ( Abstract )	06/25/2026
¶ 1398.	Singh N, Need E, Berndt A, Goff M, Wilson LJ[CRiC], Mourtada F, Guo F, Mastren T, Al-Hilal T, Sood AK, Maity A, Miller SC, Minoshima S, Goel S, Shi S. FOLR1-targeted actinium-225-based alpha-particle therapy eliminates ovarian cancer. Sci Adv. 2026 Jun 26; 12(26):eaef0121. ( Abstract )	06/26/2026
* 1399.	Cao W, Lloyd I, Dichmann M, Halder N, Thomas D, Chen Z, Blomain E, Adejolu F, Beck K, Faherty P, Khan M, Simone N[CRiC], Jain V, Storozynsky E, Dicker AP[CRiC], Choi W, Vinogradskiy Y[CRiC]. Cross-Institutional Validation of a novel LLM-Based Cardiac Event Extraction framework from Electronic Health Records. Int J Radiat Oncol Biol Phys. 2026 Jun 29. [Epub ahead of print] ( Abstract )	06/29/2026
1400.	Atodaria KP, Patel A, Kottapalli N, Tetali P, Iqbal S, Dhruv S, Parvataneni T, Cohen SJ[MORA], Ashfaq A. Rising prevalence of venous thromboembolism in gastrointestinal cancers: a nationwide analysis of 205 million hospitalizations, 2016-2022. J Gastrointest Oncol. 2026 Jun 30; 17(3):145. ( Abstract )	06/30/2026
* 1401.	Effah SN, Barrera SC, Urturi Ortiz N, Dampier W, Nonnemacher MR[IRT], Wigdahl B[IRT]. CRISPR/Cas9-Based Genome Editing: Understanding Differences in DNA Repair Pathways, Profiles, and Outcomes. Int J Mol Sci. 2026 Jun 30; 27(13). ( Abstract )	06/30/2026
1402.	Shah R, Jain S, Haldar N, Holt LA, Walker RL, Farrell CJ, Haldar D, Evans JJ, Alexander GS, Shi W[MORA]. Fractionated stereotactic radiotherapy (fSRT) for symptomatic WHO grade 1 cavernous sinus meningiomas: long-term local control, clinical response, and toxicity outcomes. J Neurooncol. 2026 Jun 30; 178(3). ( Abstract )	06/30/2026
¶ + 1403.	Aplin AE[TaCO], Alsina K, Betof AS, Birkett J, Butler MO, Cole G, Haq R, Karreth FA, Mahajan VB, Marpadga R, Mruthyunjaya P, Nathan P, Nilsson JA, Palmer G, Sacco JJ, Sato T[IRT], Stanhope S, Teng PN, LiPira K. Meeting Report From the 2025 Cure Ocular Melanoma (CURE OM) Global Science Meeting, Amsterdam, the Netherlands, October 2025. Pigment Cell Melanoma Res. 2026 Jul; 39(4):e70102. ( Abstract )	07/01/2026
1404.	Barta JA[CRiC]. Questionnaire-Based Identification and Participation in Lung Cancer Screening in Sweden. JAMA Netw Open. 2026 Jul 01; 9(7):e2625087. ( Abstract )	07/01/2026
¶ * 1405.	Chiang L, Bodzin A, Lin D[MORA], Hanna N, Koeneman S, Dang H[MORA], Yeo CJ, Shubert C, Zheng R. Neoadjuvant Immunotherapy for Hepatocellular Carcinoma Is Associated with Improved Survival After Hepatectomy: A Matched Analysis of the 2017 to 2022 National Cancer Database. Cancers (Basel). 2026 Jul 01; 18(13). ( Abstract )	07/01/2026
* 1406.	Katcher JG, Wen KY[CRiC], Shusted CS, Liang J, Koh K, Juon HS[CRiC], Barta JA[CRiC]. Health beliefs and lung cancer screening uptake among eligible Asian Americans in Philadelphia, Pennsylvania, United States. Prev Med Rep. 2026 Jul; 67:103521. ( Abstract )	07/01/2026
* 1407.	Sifat M, Banks J, Phan L[CRiC], Wen KY[CRiC], Barta JA[CRiC], Melillo R, Juon HS[CRiC]. Cigarette and E-Cigarette Use in Greater Philadelphia: Proportion of Use Compared to National Data and Local Predictors of Smoking Status. Prev Med Rep. 2026 Jul; 67:103498. ( Abstract )	07/01/2026
1408.	Sivakumar S, Shah R, Jain S, Haldar N, Shi W[MORA]. Evaluating the Efficacy, Safety, and Patient Selection Criteria for Radiation Therapy in Early-Stage Dupuytren's Contracture. Cureus. 2026 Jul; 18(7):e112154. ( Abstract )	07/01/2026
* 1409.	Bi X, Gattas B, Grosso D, Alpdogan O[IRT], Bao A, Gradone A, Nath AD, Filicko-O'Hara J, O'Hara W, Van Galen J[IRT], Wilde L[IRT], Jeurkar C[IRT], Kasner MT[IRT], Keiffer G[IRT], Wagner JL, Flomenberg N, Gergis U[IRT]. Harnessing the Power of Two: High-Dose Stem Cell Haploidentical Transplant in Hematologic Malignancies - A Prospective Trial. Transplant Cell Ther. 2026 Jul 03. [Epub ahead of print] ( Abstract )	07/03/2026
1410.	Maceyko M, Shusted C, Daneshpooy S, Woodroof J, Noueihed K, Willis AI, Barta J[CRiC]. Screening Mammography Completion Among Women Enrolled in a Lung Cancer Screening Program. J Am Coll Radiol. 2026 Jul 03. [Epub ahead of print] ( Abstract )	07/03/2026
¶ 1411.	MacNary CA, Rajendra Gaekwar SC, Lemenze A, Naik A, Tandon R, Ahmed S, Herrera BB, Jain P[IRT]. HTLV-1-Derived Exosomes Drive Transcriptional Reprogramming of Monocytes Toward a Mixed M1/M2 Phenotype in HAM/TSP. Pathogens. 2026 Jul 03; 15(7). ( Abstract )	07/03/2026
¶ * 1412.	Chang SS, Chamie K, Seabury CA, Gonzalgo ML, Agarwal PK, Bassett JC, Bjurlin M, Cher ML, Clark W, Cowan BE, David R, Goldfischer E, Guru K, Jalkut MW, Kaffenberger SD, Kaminetsky J, Corcoran A, Koo AS, Sexton WJ, Tikhonenkov SN, Shah MS[MORA], Trabulsi EJ[MORA], Trainer AF, Spilman P, Drusbosky LM, Brown B, Huang M, Bhar P, Sender L, Reddy S, Soon-Shiong P. Durable Responses and Cystectomy Avoidance with IL-15 Receptor Agonist NAI plus BCG In BCG-Unresponsive NMIBC with Carcinoma In Situ +/- Papillary Disease. J Urol. 2026 Jul 06:101097JU0000000000005198. [Epub ahead of print] ( Abstract )	07/06/2026
¶ 1413.	Lopez AM[CRiC], Leibel L, Reale L, Fuentes E, Walker EM. Traditional and Cultural Dance in Integrative Oncology: Embodied Movement for Psychological Well-Being and Symptom Management. J Integr Complement Med. 2026 Jul 06:27683605261435778. [Epub ahead of print] ( Abstract )	07/06/2026
+ 1414.	Edgerton AO, Reginato MJ[TaCO], Kutzler MA, Haddad EK[IRT]. Adenosine as a metabolic checkpoint in CD8+ T cell dysfunction. Trends Immunol. 2026 Jul 08. [Epub ahead of print] ( Abstract )	07/08/2026
1415.	Bhatt R, Ong SE, Erkes DA, Leung KMX, Kinase K, Lim KY, Bonfim-Melo A, Alghamdi E, Daignault-Mill S, Lim Y, Abdul Rahim NJ, Gopalakrishnan A, Ong XY, Goh NLL, Gandini A, Proctor M, Kumar S, Zeng Z, Haass NK, Jones MJ, Clarke P, Aplin AE[TaCO], Gabrielli B. S-phase targeted treatment triggers caspase-dependent lytic immunogenic cell death with pyroptotic features in cancers. Cell Death Differ. 2026 Jul 10. [Epub ahead of print] ( Abstract )	07/10/2026
¶ +* 1416.	Seedor RS[IRT], Terai M, Koshkin S, Aplin AE[TaCO], Orloff M[IRT], Sharpe-Mills E, Naccarato M, Mills A, Molinolo AA, Gutkind JS, Sato T[IRT]. A Phase II Trial of Defactinib Combined with Avutometinib in Patients with Metastatic Uveal Melanoma. Cancers (Basel). 2026 Jul 11; 18(14). ( Abstract )	07/11/2026
1417.	Zhang L, He J[CRiC]. SLC Transporter-Mediated Functional Imaging in Cancer Diagnosis. Biomolecules. 2026 Jul 12; 16(7). ( Abstract )	07/12/2026
+ 1418.	Alaparthi SS, Koeneman SH, Okusanya OT, Grenda T[MORA], Evans NR[CRiC], Cowan SW. Minimally invasive vs. open esophagectomy in patients with a BMI > 35: a NSQIP analysis. Surg Endosc. 2026 Jul 13. [Epub ahead of print] ( Abstract )	07/13/2026
¶ 1419.	Waguespack SG, Brose MS[TaCO], Lin JJ, McDermott R, Almubarak M, Bauman J, Casanova M, Kummar S, Lee SH, Rieke DT, Oh DY, Qi C, Neu N, Burcoveanu DI, Mussi CE, Drilon A, Hong DS, Cabanillas ME. Larotrectinib in TRK fusion differentiated thyroid carcinoma: updated trial data. Endocr Relat Cancer. 2026 Jul 14. [Epub ahead of print] ( Abstract )	07/14/2026
1420.	Cao Z, Cai X, Mei J, Kong N, Liu Y, Shen X, Wu M, Zhen X, Sun J[MORA], Li R, Jiang R, Sun H, Yan G. Targeting the PRMT5-Nur77 methylation axis enhances endometrial decidualization capacity and female fertility in preclinical models. J Clin Invest. 2026 Jul 16. [Epub ahead of print] ( Abstract )	07/16/2026
¶ +* 1421.	Sethi HK, Diamond N, Najjar W, Shing SR, Gentsch AT, Handley NR[CRiC], Binder AF[IRT], Hass RW, Rising KL[CRiC], Fundakowski CE, Mady LJ. Patient Perceptions of Telehealth Use in Head and Neck Cancer Surveillance. JAMA Otolaryngol Head Neck Surg. 2026 Jul 16. [Epub ahead of print] ( Abstract )	07/16/2026
¶ +* 1422.	Choi SI, Dogan B, Wessner CE, Porembka JH, Machado P, Ozcan BB, Unni N, Abu-Khalaf M[CRiC], Hoyt K, Forsberg F[TaCO], Nam K[TaCO]. Early Prediction of the Breast Cancer Response to Neoadjuvant Chemotherapy Based on Intratumoral Interstitial Fluid Pressure using 3-D Subharmonic-Aided Pressure Estimation. Ultrasound Med Biol. 2026 Jul 18. [Epub ahead of print] ( Abstract )	07/18/2026
1423.	Săftoiu A, Ewertsen C, Popescu A, D'Onofrio M, Spârchez Z, Dietrich CF, Jenssen C, Lyshchik A[TaCO], Clevert D, Barr R, Berzigotti A, Sporea I, de Robertis R, Șirli R, Țieranu CG, Croitoru I, Croitoru V, Ochea FA, Fischer T, Ignee A, Iwaki A, Kitano M, Wong VW, Nolsøe C. WFUMB Liver Ultrasound Fusion Imaging Technical Review and Position Statement: Focus on CT/MRI-Based Fusion. Ultrasound Med Biol. 2026 Jul 18. [Epub ahead of print] ( Abstract )	07/18/2026
¶ 1424.	Waldman SA[IRT], Terzic A. The biomarker compass: a revolution driving precision medicine. Biomark Med. 2026 Jul 20:1-4. [Epub ahead of print] ( Abstract )	07/20/2026
¶ 1425.	Chan A, Kagramanov D, Nasr R, Asuzu C, Bao T, Cheung YT, Kwon JH, Lacey J, Lee RT, Lustberg M, Ohaeri BM, Rao S, Soto-Perez-de-Celis E, Witt CM, Lopez AM[CRiC]. Barriers to recommendation of integrative oncology modalities in supportive care: a MASCC/SIO survey. Support Care Cancer. 2026 Jul 22; 34(8). ( Abstract )	07/22/2026
¶ * 1426.	Van Galen J[IRT], Daar JA, Gergis U[IRT], Fung H. From Spirometry to Survival: Ambiguities in Pulmonary Metrics for Cellular Therapy Outcomes. Hematol Oncol Stem Cell Ther. 2026 Jul 22. [Epub ahead of print] ( Abstract )	07/22/2026
+ 1427.	Woodroof J, Noueihed K, Jacob J, Grenda T[MORA], Okusanya O, Evans N[CRiC]. No Node Left Behind: The Link Between Intraoperative Lymph Node Assessment and Outcomes in NSCLC. Ann Thorac Surg. 2026 Jul 25. [Epub ahead of print] ( Abstract )	07/25/2026
¶ 1428.	Miao E, Wo E, Boe L, Lee J, Walch H, Yu H, Parker M, Imber B, Chiang J, Hui C, Myall N, Pollom E, Ni L, Braunstein S, Hadley C, Matsui J, Palmer J, Khandekar M, Marciscano A, Shih H, Lee A, Chen LN, Shu CA, Wang T, Boor I, Patil T, Camidge DR, Messing I, Lebow E, Akdemir E, Kotecha R, Carey K, Shi W[MORA], Khoja L, Sahgal A, Soliman H, Rusthoven CG, George Pike LR. Impact of Genomic Subtype on Intracranial Outcomes in Treatment-naive EGFR mutant NSCLC with Osimertinib (IGnITE). J Thorac Oncol. 2026 Jul 28:104114. [Epub ahead of print] ( Abstract )	07/28/2026
¶ 1429.	Wierda WG, Dorritie KA, Gauthier J, Nath R, Kipps TJ, Riedell PA, Eradat HA, Kenderian SS, Kharfan-Dabaja MA, Shah NN, Solomon SR, Stephens DM, Ermann DA, Arnason JE, Deol A, Feldman TA, Andreadis CB, Ghosh M, Ma S, Schuster SJ, Gergis U[IRT], Vose JM, Soumerai JD, van Besien K, Tuazon SA, Perna SK, Ou SS, Ananthakrishnan R, Rane N, Papp E, Ansari S, Thompson EG, Okal A, Peiser L, Chen Y, Sengupta S, Ray PR, Wang J, Siddiqi T. Lisocabtagene maraleucel combined with ibrutinib in R/R CLL or SLL: primary results from TRANSCEND CLL 004. Blood. 2026 Jul 28. [Epub ahead of print] ( Abstract )	07/28/2026
* 1430.	Gerber K, Thapar M, Rocchetti J, Kantor J, Ali A, Adekeye A[CRiC], Hum C, Lazar M, Anne PR, Wilson K, Wilson LJ[CRiC], Simone NL[CRiC]. Impact of prior sexual trauma on patient experience and comfort in breast cancer radiation therapy. Support Care Cancer. 2026 Jul 30; 34(8). ( Abstract )	07/30/2026
1431.	Ghosh A, Weaver D, Li C, Hajnoczky G[TaCO]. Intermembrane coupling between Bcl-xL and the IP receptor supports local Ca transfer at ER-mitochondrial contacts. Cell Rep. 2026 Jul 30; 45(8):117767. [Epub ahead of print] ( Abstract )	07/30/2026
¶ 1432.	Kansara S, Contrera K, Roof S, Kane AC, Mualla R, Rettig E, Agrawal N, Wenig B, Curry J[MORA], Faden D, Holsinger C. Circulating Tumor DNA in Head and Neck Cancer: A Review From the American Head and Neck Society. JAMA Otolaryngol Head Neck Surg. 2026 Jul 30. [Epub ahead of print] ( Abstract )	07/30/2026
¶ +* 1433.	Wilson LJ[CRiC], Castillo R, Castillo E, Jones B, Miften M, Olsen L, Aragam V, Erickson C, Young A, Meguid RA, Blum M, Grenda TR[MORA], Barta JA[CRiC], Leiby BE, Waxweiler T, Kavanagh B, Mitchell JD, Vinogradskiy Y[CRiC]. Prospective Evaluation of Novel 4DCT-Ventilation Imaging for Preoperative Risk Assessment in Lung Cancer: Results of the LIME Trial. Int J Radiat Oncol Biol Phys. 2026 Jul 30. [Epub ahead of print] ( Abstract )	07/30/2026
+* 1434.	Shaver AL, Steinbock-Malfer C, Tester W[MORA], Mille P[MORA], Kelly WK[MORA], Zarrabi KK[MORA], Lallas CD[MORA], Shah M[MORA], DiMarco R, Brand E, Brown S, Sharma S, Nikita N, Cogen C, Keith SW, Lu-Yao G[CRiC]. Assessing the Feasibility of a Self-Management Intervention for Individuals With Advanced Prostate Cancer and Comorbid Type II Diabetes Mellitus. Cancer Med. 2026 Aug; 15(8):e72046. ( Abstract )	08/01/2026
¶ + 1435.	Kim IE, Hartman R, Gandhi K, Nikita N, Banks J, Kelly WK[MORA], Keith SW, Kim IY, Lu-Yao G[CRiC]. Mortality in Medicare-aged Men with Metastatic Prostate Cancer After the Introduction of Androgen Receptor Pathway Inhibitors: A Population-Based Study. Urology. 2026 Aug 04. [Epub ahead of print] ( Abstract )	08/04/2026
¶ 1436.	Maguire C, Chen J, Rouphael N, Morse BA, Hoch A, Pickering H, Phan HV, Glascock A, Chu V, . . . Haddad EK[IRT], Carnes CB, . . . Reed EF, Levy O, Maecker H, Hunt P, Steen H, Diray-Arce J, Langelier CR, Melamed E. Virus reactivation in acute and long COVID-19. Nature. 2026 Aug 05. [Epub ahead of print] ( Abstract )	08/05/2026
* 1437.	Estephan LE, Jacoby P, Cognetti DM[TaCO], Manobianco SA[TaCO]. Bilateral Ophthalmoplegia After Neoadjuvant Pembrolizumab for Oral Cavity Squamous Cell Carcinoma. Laryngoscope. 2026 Aug 06. [Epub ahead of print] ( Abstract )	08/06/2026
* 1438.	KuonYeng-Escalante C, Liu JB, Xu J, Leung S, Lyshchik A[TaCO], Eisenbrey JR[TaCO]. Umbilical vein recanalization identified on contrast-enhanced ultrasound in a patient with hepatocellular carcinoma during TACE assessment. Radiol Case Rep. 2026 Sep; 21(9):3831-3835. ( Abstract )	09/01/2026
1439.	Mazzanti N, Tamot N, Francese A, Luo J, Borrok MJ, Rossillo J, Plummer J, Patwardhan GA, Sum CS, Ports M, Spiller KL[IRT], Sukumar M. Fine-tuning affinity and spacer design enhances T cell potency in DLL3 and BCMA CAR T cells. MAbs. 2026 Dec; 18(1):2602989. ( Abstract )	12/01/2026
* 1440.	Doermann AS, Caspi A, Evans AE, Feci A, Entezari AA, Snook AE[IRT], Waldman SA[IRT]. Targeting molecular and genetic pathways driving tumorigenesis for precision therapy in colorectal cancer. Cancer Biol Ther. 2026 Dec 31; 27(1):2683096. ( Abstract )	12/31/2026

Historical Program Structure (publications listed with author's program at the time of the publication) - Currently 2023 Site Visit Structure. Full Members Only

There were 1440 publications authored by SKCCC Members from 2023-01-01 to Present.
204 publications(14.17%) were inter-programmatic(+ or +*).
346 publications(24.03%) were intra-programmatic(* or +*).
105 publications(7.29%) were inter-programmatic and intra-programmatic(+*).
445 publications(30.90%) were inter-programmatic and/or intra-programmatic(+, * or +*).

Collaborative Publications With Other NCI Designated Cancer Centers
There were 794 publications with other Cancer Centers (¶) (794/1438) or 55.22% of the publications that were reviewed for collaboration by SKCCC Authors or Administration using less strict affiliation method.
Authors from other Institutions that are/have or are within Cancer Centers are underlined with an abbreviation of their Cancer Center in square brackets.
There were 505 publications with other Cancer Centers (¶) (505/1353) or 37.32% of the publications that were reviewed for collaboration by SKCCC Authors or Administration using Strict Members Only Method.

Authors who were members during publication are in bold.
The Program Numbers/Abbreviations for these authors appear in [] for each Member.
Program Abbreviations are listed below, all publications after January of 2011 should be using the current Program Abbreviations.

Current Codes/Programs
CRiC: Cancer Risk and Control
IRT: Immune Cell Regulation and Targeting
MORA: Molecular Oncology Regulation and Approaches
TaCO: Translational and Cellular Oncology
ZY: Non-Programmatically Aligned

(2) - Author was Co-First Author

The SKCCC Publication database is usually updated weekly or bi-weekly, the last update was completed on 08/07/2026.
Currently using 2025/26 Scopus CiteScores from scopus.com